id	sid	tid	token	lemma	pos
cana-5161	1	1	communications	communication	NOUN
cana-5161	1	2	on	on	ADP
cana-5161	1	3	applied	apply	VERB
cana-5161	1	4	nonlinear	nonlinear	ADJ
cana-5161	1	5	analysis	analysis	NOUN
cana-5161	1	6	issn	issn	NOUN
cana-5161	1	7	:	:	PUNCT
cana-5161	1	8	1074	1074	NUM
cana-5161	1	9	-	-	PUNCT
cana-5161	1	10	133x	133x	NUM
cana-5161	1	11	vol	vol	NOUN
cana-5161	1	12	32	32	NUM
cana-5161	1	13	no	no	NOUN
cana-5161	1	14	.	.	PUNCT
cana-5161	2	1	icmasd	icmasd	NOUN
cana-5161	2	2	(	(	PUNCT
cana-5161	2	3	2025	2025	NUM
cana-5161	2	4	)	)	PUNCT
cana-5161	2	5	1353	1353	NUM
cana-5161	2	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	2	7	neuroprotective	neuroprotective	ADJ
cana-5161	2	8	potential	potential	NOUN
cana-5161	2	9	of	of	ADP
cana-5161	2	10	agmatine	agmatine	NOUN
cana-5161	2	11	in	in	ADP
cana-5161	2	12	mitigating	mitigate	VERB
cana-5161	2	13	aluminium	aluminium	NOUN
cana-5161	2	14	chloride	chloride	NOUN
cana-5161	2	15	-	-	PUNCT
cana-5161	2	16	induced	induce	VERB
cana-5161	2	17	cognitive	cognitive	ADJ
cana-5161	2	18	deficits	deficit	NOUN
cana-5161	2	19	in	in	ADP
cana-5161	2	20	rats	rat	NOUN
cana-5161	2	21	vandana	vandana	PROPN
cana-5161	2	22	bhatia1	bhatia1	PROPN
cana-5161	2	23	*	*	PROPN
cana-5161	2	24	,	,	PUNCT
cana-5161	2	25	vir	vir	PROPN
cana-5161	2	26	vikram1	vikram1	PROPN
cana-5161	2	27	,	,	PUNCT
cana-5161	2	28	priyanka	priyanka	PROPN
cana-5161	2	29	kashyap2	kashyap2	PROPN
cana-5161	2	30	,	,	PUNCT
cana-5161	2	31	anjali	anjali	PROPN
cana-5161	2	32	chandel2	chandel2	PROPN
cana-5161	2	33	,	,	PUNCT
cana-5161	2	34	swati	swati	PROPN
cana-5161	2	35	rana2	rana2	PROPN
cana-5161	2	36	,	,	PUNCT
cana-5161	2	37	dheeraj2	dheeraj2	ADJ
cana-5161	2	38	1	1	X
cana-5161	2	39	.	.	X
cana-5161	2	40	department	department	NOUN
cana-5161	2	41	of	of	ADP
cana-5161	2	42	pharmacology	pharmacology	NOUN
cana-5161	2	43	,	,	PUNCT
cana-5161	2	44	ct	ct	PROPN
cana-5161	2	45	university	university	PROPN
cana-5161	2	46	,	,	PUNCT
cana-5161	2	47	ludhiana	ludhiana	PROPN
cana-5161	2	48	,	,	PUNCT
cana-5161	2	49	142024	142024	NUM
cana-5161	2	50	2	2	NUM
cana-5161	2	51	.	.	PUNCT
cana-5161	2	52	department	department	PROPN
cana-5161	2	53	of	of	ADP
cana-5161	2	54	pharmacology	pharmacology	PROPN
cana-5161	2	55	,	,	PUNCT
cana-5161	2	56	laureate	laureate	PROPN
cana-5161	2	57	institute	institute	PROPN
cana-5161	2	58	of	of	ADP
cana-5161	2	59	pharmacy	pharmacy	PROPN
cana-5161	2	60	,	,	PUNCT
cana-5161	2	61	kangra	kangra	PROPN
cana-5161	2	62	,	,	PUNCT
cana-5161	2	63	177101	177101	NUM
cana-5161	2	64	*	*	PUNCT
cana-5161	2	65	address	address	NOUN
cana-5161	2	66	of	of	ADP
cana-5161	2	67	correspondence	correspondence	NOUN
cana-5161	2	68	:	:	PUNCT
cana-5161	2	69	mrs	mrs	PROPN
cana-5161	2	70	.	.	PROPN
cana-5161	2	71	vandana	vandana	PROPN
cana-5161	2	72	bhatia	bhatia	PROPN
cana-5161	2	73	,	,	PUNCT
cana-5161	2	74	phd	phd	NOUN
cana-5161	2	75	scholar	scholar	NOUN
cana-5161	2	76	,	,	PUNCT
cana-5161	2	77	department	department	NOUN
cana-5161	2	78	of	of	ADP
cana-5161	2	79	pharmacology	pharmacology	NOUN
cana-5161	2	80	,	,	PUNCT
cana-5161	2	81	ct	ct	PROPN
cana-5161	2	82	university	university	PROPN
cana-5161	2	83	,	,	PUNCT
cana-5161	2	84	ludhiana	ludhiana	PROPN
cana-5161	2	85	,	,	PUNCT
cana-5161	2	86	email	email	NOUN
cana-5161	2	87	:	:	PUNCT
cana-5161	2	88	vandana.bhatia40@gmail.com	vandana.bhatia40@gmail.com	PROPN
cana-5161	2	89	,	,	PUNCT
cana-5161	2	90	orcid	orcid	NOUN
cana-5161	3	1	i	i	PRON
cana-5161	3	2	d	d	NOUN
cana-5161	3	3	:	:	PUNCT
cana-5161	3	4	0000	0000	NUM
cana-5161	3	5	-	-	PUNCT
cana-5161	3	6	0002	0002	NUM
cana-5161	3	7	-	-	PUNCT
cana-5161	3	8	1614	1614	NUM
cana-5161	3	9	-	-	PUNCT
cana-5161	3	10	7192	7192	NUM
cana-5161	3	11	article	article	NOUN
cana-5161	3	12	history	history	NOUN
cana-5161	3	13	:	:	PUNCT
cana-5161	3	14	received	receive	VERB
cana-5161	3	15	:	:	PUNCT
cana-5161	3	16	12	12	NUM
cana-5161	3	17	-	-	SYM
cana-5161	3	18	12	12	NUM
cana-5161	3	19	-	-	PUNCT
cana-5161	3	20	2024	2024	NUM
cana-5161	3	21	revised	revise	VERB
cana-5161	3	22	:	:	PUNCT
cana-5161	3	23	25	25	NUM
cana-5161	3	24	-	-	PUNCT
cana-5161	3	25	01	01	NUM
cana-5161	3	26	-	-	PUNCT
cana-5161	3	27	2025	2025	NUM
cana-5161	3	28	accepted	accept	VERB
cana-5161	3	29	:	:	PUNCT
cana-5161	3	30	05	05	NUM
cana-5161	3	31	-	-	PUNCT
cana-5161	3	32	02	02	NUM
cana-5161	3	33	-	-	PUNCT
cana-5161	3	34	2025	2025	NUM
cana-5161	3	35	abstract	abstract	NOUN
cana-5161	3	36	:	:	PUNCT
cana-5161	3	37	introduction	introduction	NOUN
cana-5161	3	38	:	:	PUNCT
cana-5161	3	39	alzheimer	alzheimer	PROPN
cana-5161	3	40	's	's	PART
cana-5161	3	41	disease	disease	NOUN
cana-5161	3	42	(	(	PUNCT
cana-5161	3	43	ad	ad	NOUN
cana-5161	3	44	)	)	PUNCT
cana-5161	3	45	,	,	PUNCT
cana-5161	3	46	a	a	DET
cana-5161	3	47	progressive	progressive	ADJ
cana-5161	3	48	neurodegenerative	neurodegenerative	ADJ
cana-5161	3	49	disorder	disorder	NOUN
cana-5161	3	50	,	,	PUNCT
cana-5161	3	51	is	be	AUX
cana-5161	3	52	characterized	characterize	VERB
cana-5161	3	53	by	by	ADP
cana-5161	3	54	cognitive	cognitive	ADJ
cana-5161	3	55	decline	decline	NOUN
cana-5161	3	56	,	,	PUNCT
cana-5161	3	57	memory	memory	NOUN
cana-5161	3	58	loss	loss	NOUN
cana-5161	3	59	,	,	PUNCT
cana-5161	3	60	and	and	CCONJ
cana-5161	3	61	impaired	impaired	ADJ
cana-5161	3	62	executive	executive	ADJ
cana-5161	3	63	function	function	NOUN
cana-5161	3	64	.	.	PUNCT
cana-5161	4	1	alcl3	alcl3	PROPN
cana-5161	4	2	is	be	AUX
cana-5161	4	3	known	know	VERB
cana-5161	4	4	to	to	PART
cana-5161	4	5	exacerbate	exacerbate	VERB
cana-5161	4	6	oxidative	oxidative	ADJ
cana-5161	4	7	stress	stress	NOUN
cana-5161	4	8	and	and	CCONJ
cana-5161	4	9	neuroinflammation	neuroinflammation	NOUN
cana-5161	4	10	,	,	PUNCT
cana-5161	4	11	contributing	contribute	VERB
cana-5161	4	12	to	to	ADP
cana-5161	4	13	cognitive	cognitive	ADJ
cana-5161	4	14	deficits	deficit	NOUN
cana-5161	4	15	similar	similar	ADJ
cana-5161	4	16	to	to	ADP
cana-5161	4	17	those	those	PRON
cana-5161	4	18	observed	observe	VERB
cana-5161	4	19	in	in	ADP
cana-5161	4	20	ad	ad	NOUN
cana-5161	4	21	.	.	PUNCT
cana-5161	5	1	agmatine	agmatine	NOUN
cana-5161	5	2	,	,	PUNCT
cana-5161	5	3	a	a	DET
cana-5161	5	4	polyamine	polyamine	NOUN
cana-5161	5	5	derived	derive	VERB
cana-5161	5	6	from	from	ADP
cana-5161	5	7	arginine	arginine	NOUN
cana-5161	5	8	,	,	PUNCT
cana-5161	5	9	has	have	AUX
cana-5161	5	10	emerged	emerge	VERB
cana-5161	5	11	as	as	ADP
cana-5161	5	12	a	a	DET
cana-5161	5	13	potential	potential	ADJ
cana-5161	5	14	neuroprotective	neuroprotective	ADJ
cana-5161	5	15	agent	agent	NOUN
cana-5161	5	16	due	due	ADP
cana-5161	5	17	to	to	ADP
cana-5161	5	18	its	its	PRON
cana-5161	5	19	antioxidant	antioxidant	NOUN
cana-5161	5	20	,	,	PUNCT
cana-5161	5	21	antiinflammatory	antiinflammatory	NOUN
cana-5161	5	22	,	,	PUNCT
cana-5161	5	23	and	and	CCONJ
cana-5161	5	24	neuromodulatory	neuromodulatory	ADJ
cana-5161	5	25	properties	property	NOUN
cana-5161	5	26	.	.	PUNCT
cana-5161	6	1	aim	aim	NOUN
cana-5161	6	2	&	&	CCONJ
cana-5161	6	3	objectives	objective	NOUN
cana-5161	6	4	:	:	PUNCT
cana-5161	6	5	this	this	DET
cana-5161	6	6	study	study	NOUN
cana-5161	6	7	aims	aim	VERB
cana-5161	6	8	to	to	PART
cana-5161	6	9	evaluate	evaluate	VERB
cana-5161	6	10	the	the	DET
cana-5161	6	11	neuroprotective	neuroprotective	ADJ
cana-5161	6	12	effects	effect	NOUN
cana-5161	6	13	of	of	ADP
cana-5161	6	14	agmatine	agmatine	NOUN
cana-5161	6	15	against	against	ADP
cana-5161	6	16	aluminium	aluminium	NOUN
cana-5161	6	17	chloride	chloride	NOUN
cana-5161	6	18	(	(	PUNCT
cana-5161	6	19	alcl₃)-induced	alcl₃)-induce	VERB
cana-5161	6	20	cognitive	cognitive	ADJ
cana-5161	6	21	impairments	impairment	NOUN
cana-5161	6	22	in	in	ADP
cana-5161	6	23	male	male	ADJ
cana-5161	6	24	wistar	wistar	PROPN
cana-5161	6	25	rats	rat	NOUN
cana-5161	6	26	.	.	PUNCT
cana-5161	7	1	the	the	DET
cana-5161	7	2	objectives	objective	NOUN
cana-5161	7	3	include	include	VERB
cana-5161	7	4	assessing	assess	VERB
cana-5161	7	5	behavioural	behavioural	ADJ
cana-5161	7	6	changes	change	NOUN
cana-5161	7	7	through	through	ADP
cana-5161	7	8	locomotor	locomotor	NOUN
cana-5161	7	9	activity	activity	NOUN
cana-5161	7	10	,	,	PUNCT
cana-5161	7	11	the	the	DET
cana-5161	7	12	morris	morris	PROPN
cana-5161	7	13	water	water	NOUN
cana-5161	7	14	maze	maze	NOUN
cana-5161	7	15	,	,	PUNCT
cana-5161	7	16	and	and	CCONJ
cana-5161	7	17	object	object	VERB
cana-5161	7	18	recognition	recognition	NOUN
cana-5161	7	19	task	task	NOUN
cana-5161	7	20	,	,	PUNCT
cana-5161	7	21	along	along	ADP
cana-5161	7	22	with	with	ADP
cana-5161	7	23	biochemical	biochemical	ADJ
cana-5161	7	24	and	and	CCONJ
cana-5161	7	25	neurochemical	neurochemical	ADJ
cana-5161	7	26	alterations	alteration	NOUN
cana-5161	7	27	,	,	PUNCT
cana-5161	7	28	focusing	focus	VERB
cana-5161	7	29	on	on	ADP
cana-5161	7	30	oxidative	oxidative	ADJ
cana-5161	7	31	stress	stress	NOUN
cana-5161	7	32	and	and	CCONJ
cana-5161	7	33	hippocampal	hippocampal	ADJ
cana-5161	7	34	glutamate	glutamate	NOUN
cana-5161	7	35	levels	level	NOUN
cana-5161	7	36	as	as	ADP
cana-5161	7	37	potential	potential	ADJ
cana-5161	7	38	mechanisms	mechanism	NOUN
cana-5161	7	39	underlying	underlie	VERB
cana-5161	7	40	cognitive	cognitive	ADJ
cana-5161	7	41	deficits	deficit	NOUN
cana-5161	7	42	.	.	PUNCT
cana-5161	8	1	material	material	NOUN
cana-5161	8	2	&	&	CCONJ
cana-5161	8	3	methods	method	NOUN
cana-5161	8	4	:	:	PUNCT
cana-5161	8	5	a	a	DET
cana-5161	8	6	total	total	NOUN
cana-5161	8	7	of	of	ADP
cana-5161	8	8	thirty	thirty	NUM
cana-5161	8	9	male	male	NOUN
cana-5161	8	10	wistar	wistar	PROPN
cana-5161	8	11	rats	rat	NOUN
cana-5161	8	12	(	(	PUNCT
cana-5161	8	13	n	n	NOUN
cana-5161	8	14	=	=	SYM
cana-5161	8	15	6	6	NUM
cana-5161	8	16	)	)	PUNCT
cana-5161	8	17	were	be	AUX
cana-5161	8	18	split	split	VERB
cana-5161	8	19	up	up	ADP
cana-5161	8	20	into	into	ADP
cana-5161	8	21	five	five	NUM
cana-5161	8	22	groups	group	NOUN
cana-5161	8	23	.	.	PUNCT
cana-5161	9	1	for	for	ADP
cana-5161	9	2	21	21	NUM
cana-5161	9	3	days	day	NOUN
cana-5161	9	4	,	,	PUNCT
cana-5161	9	5	groups	groups	PROPN
cana-5161	9	6	ii	ii	PROPN
cana-5161	9	7	,	,	PUNCT
cana-5161	9	8	iii	iii	PROPN
cana-5161	9	9	,	,	PUNCT
cana-5161	9	10	iv	iv	NOUN
cana-5161	9	11	,	,	PUNCT
cana-5161	9	12	and	and	CCONJ
cana-5161	9	13	v	v	NOUN
cana-5161	9	14	were	be	AUX
cana-5161	9	15	treated	treat	VERB
cana-5161	9	16	with	with	ADP
cana-5161	9	17	alcl3	alcl3	PROPN
cana-5161	10	1	(	(	PUNCT
cana-5161	10	2	100	100	NUM
cana-5161	10	3	mg	mg	NUM
cana-5161	10	4	/	/	SYM
cana-5161	10	5	kg	kg	PROPN
cana-5161	10	6	,	,	PUNCT
cana-5161	10	7	p.o	p.o	PROPN
cana-5161	10	8	.	.	PROPN
cana-5161	10	9	)	)	PUNCT
cana-5161	11	1	and	and	CCONJ
cana-5161	11	2	agmatine	agmatine	VERB
cana-5161	11	3	at	at	ADP
cana-5161	11	4	doses	dose	NOUN
cana-5161	11	5	of	of	ADP
cana-5161	11	6	3	3	NUM
cana-5161	11	7	mg	mg	PROPN
cana-5161	11	8	/	/	SYM
cana-5161	11	9	kg	kg	PROPN
cana-5161	11	10	(	(	PUNCT
cana-5161	11	11	i.p	i.p	PROPN
cana-5161	11	12	.	.	PROPN
cana-5161	11	13	)	)	PUNCT
cana-5161	12	1	,	,	PUNCT
cana-5161	12	2	10	10	NUM
cana-5161	12	3	mg	mg	NUM
cana-5161	12	4	/	/	SYM
cana-5161	12	5	kg	kg	PROPN
cana-5161	12	6	(	(	PUNCT
cana-5161	12	7	i.p	i.p	PROPN
cana-5161	12	8	.	.	PROPN
cana-5161	12	9	)	)	PUNCT
cana-5161	12	10	,	,	PUNCT
cana-5161	12	11	and	and	CCONJ
cana-5161	12	12	30	30	NUM
cana-5161	12	13	mg	mg	NUM
cana-5161	12	14	/	/	SYM
cana-5161	12	15	kg	kg	PROPN
cana-5161	12	16	(	(	PUNCT
cana-5161	12	17	i.p	i.p	PROPN
cana-5161	12	18	.	.	PROPN
cana-5161	12	19	)	)	PUNCT
cana-5161	12	20	,	,	PUNCT
cana-5161	12	21	respectively	respectively	ADV
cana-5161	12	22	,	,	PUNCT
cana-5161	12	23	while	while	SCONJ
cana-5161	12	24	group	group	NOUN
cana-5161	12	25	i	i	PROPN
cana-5161	12	26	(	(	PUNCT
cana-5161	12	27	control	control	PROPN
cana-5161	12	28	)	)	PUNCT
cana-5161	12	29	was	be	AUX
cana-5161	12	30	given	give	VERB
cana-5161	12	31	0.9	0.9	NUM
cana-5161	12	32	%	%	NOUN
cana-5161	12	33	saline	saline	NOUN
cana-5161	12	34	.	.	PUNCT
cana-5161	13	1	the	the	DET
cana-5161	13	2	morris	morris	PROPN
cana-5161	13	3	water	water	PROPN
cana-5161	13	4	maze	maze	NOUN
cana-5161	13	5	(	(	PUNCT
cana-5161	13	6	mwm	mwm	NOUN
cana-5161	13	7	)	)	PUNCT
cana-5161	13	8	and	and	CCONJ
cana-5161	13	9	object	object	VERB
cana-5161	13	10	recognition	recognition	NOUN
cana-5161	13	11	task	task	NOUN
cana-5161	13	12	(	(	PUNCT
cana-5161	13	13	ort	ort	NOUN
cana-5161	13	14	)	)	PUNCT
cana-5161	13	15	were	be	AUX
cana-5161	13	16	used	use	VERB
cana-5161	13	17	to	to	PART
cana-5161	13	18	evaluate	evaluate	VERB
cana-5161	13	19	cognitive	cognitive	ADJ
cana-5161	13	20	abilities	ability	NOUN
cana-5161	13	21	.	.	PUNCT
cana-5161	14	1	in	in	ADP
cana-5161	14	2	brain	brain	NOUN
cana-5161	14	3	tissues	tissue	NOUN
cana-5161	14	4	,	,	PUNCT
cana-5161	14	5	biochemical	biochemical	ADJ
cana-5161	14	6	and	and	CCONJ
cana-5161	14	7	neurochemical	neurochemical	ADJ
cana-5161	14	8	studies	study	NOUN
cana-5161	14	9	were	be	AUX
cana-5161	14	10	examined	examine	VERB
cana-5161	14	11	.	.	PUNCT
cana-5161	15	1	result	result	NOUN
cana-5161	15	2	:	:	PUNCT
cana-5161	15	3	prolonged	prolonged	ADJ
cana-5161	15	4	exposure	exposure	NOUN
cana-5161	15	5	to	to	ADP
cana-5161	15	6	alcl3	alcl3	PROPN
cana-5161	15	7	raised	raise	VERB
cana-5161	15	8	acetylcholinesterase	acetylcholinesterase	NOUN
cana-5161	15	9	activity	activity	NOUN
cana-5161	15	10	,	,	PUNCT
cana-5161	15	11	nitrite	nitrite	NOUN
cana-5161	15	12	,	,	PUNCT
cana-5161	15	13	mda	mda	PROPN
cana-5161	15	14	,	,	PUNCT
cana-5161	15	15	and	and	CCONJ
cana-5161	15	16	decreased	decrease	VERB
cana-5161	15	17	gsh	gsh	PROPN
cana-5161	15	18	levels	level	NOUN
cana-5161	15	19	in	in	ADP
cana-5161	15	20	the	the	DET
cana-5161	15	21	brain	brain	NOUN
cana-5161	15	22	,	,	PUNCT
cana-5161	15	23	all	all	PRON
cana-5161	15	24	of	of	ADP
cana-5161	15	25	which	which	PRON
cana-5161	15	26	markedly	markedly	ADV
cana-5161	15	27	impacted	impact	VERB
cana-5161	15	28	cognitive	cognitive	ADJ
cana-5161	15	29	function	function	NOUN
cana-5161	15	30	.	.	PUNCT
cana-5161	16	1	alcl3	alcl3	X
cana-5161	16	2	therapy	therapy	NOUN
cana-5161	16	3	also	also	ADV
cana-5161	16	4	resulted	result	VERB
cana-5161	16	5	in	in	ADP
cana-5161	16	6	significant	significant	ADJ
cana-5161	16	7	decreases	decrease	NOUN
cana-5161	16	8	in	in	ADP
cana-5161	16	9	the	the	DET
cana-5161	16	10	hippocampal	hippocampal	ADJ
cana-5161	16	11	levels	level	NOUN
cana-5161	16	12	of	of	ADP
cana-5161	16	13	da	da	PROPN
cana-5161	16	14	,	,	PUNCT
cana-5161	16	15	ne	ne	PROPN
cana-5161	16	16	,	,	PUNCT
cana-5161	16	17	serotonin	serotonin	VERB
cana-5161	16	18	,	,	PUNCT
cana-5161	16	19	gaba	gaba	NOUN
cana-5161	16	20	,	,	PUNCT
cana-5161	16	21	and	and	CCONJ
cana-5161	16	22	glutamate	glutamate	VERB
cana-5161	16	23	.	.	PUNCT
cana-5161	17	1	conclusion	conclusion	NOUN
cana-5161	17	2	:	:	PUNCT
cana-5161	17	3	agmatine	agmatine	NOUN
cana-5161	17	4	modulates	modulate	NOUN
cana-5161	17	5	hippocampus	hippocampus	NOUN
cana-5161	17	6	glutamate	glutamate	NOUN
cana-5161	17	7	levels	level	NOUN
cana-5161	17	8	,	,	PUNCT
cana-5161	17	9	restores	restore	VERB
cana-5161	17	10	neurotransmitter	neurotransmitter	NOUN
cana-5161	17	11	levels	level	NOUN
cana-5161	17	12	,	,	PUNCT
cana-5161	17	13	and	and	CCONJ
cana-5161	17	14	reduces	reduce	VERB
cana-5161	17	15	oxidative	oxidative	ADJ
cana-5161	17	16	stress	stress	NOUN
cana-5161	17	17	to	to	PART
cana-5161	17	18	show	show	VERB
cana-5161	17	19	neuroprotective	neuroprotective	ADJ
cana-5161	17	20	effects	effect	NOUN
cana-5161	17	21	against	against	ADP
cana-5161	17	22	alcl3	alcl3	X
cana-5161	17	23	-	-	PUNCT
cana-5161	17	24	induced	induce	VERB
cana-5161	17	25	cognitive	cognitive	ADJ
cana-5161	17	26	deficits	deficit	NOUN
cana-5161	17	27	.	.	PUNCT
cana-5161	18	1	these	these	DET
cana-5161	18	2	results	result	NOUN
cana-5161	18	3	imply	imply	VERB
cana-5161	18	4	that	that	SCONJ
cana-5161	18	5	agmatine	agmatine	NOUN
cana-5161	18	6	has	have	VERB
cana-5161	18	7	therapeutic	therapeutic	ADJ
cana-5161	18	8	potential	potential	NOUN
cana-5161	18	9	in	in	ADP
cana-5161	18	10	reducing	reduce	VERB
cana-5161	18	11	neurotoxicity	neurotoxicity	NOUN
cana-5161	18	12	and	and	CCONJ
cana-5161	18	13	cognitive	cognitive	ADJ
cana-5161	18	14	impairment	impairment	NOUN
cana-5161	18	15	associated	associate	VERB
cana-5161	18	16	with	with	ADP
cana-5161	18	17	aluminium	aluminium	NOUN
cana-5161	18	18	.	.	PUNCT
cana-5161	19	1	keywords	keyword	NOUN
cana-5161	19	2	:	:	PUNCT
cana-5161	19	3	alzheimer	alzheimer	PROPN
cana-5161	19	4	disease	disease	NOUN
cana-5161	19	5	,	,	PUNCT
cana-5161	19	6	aluminum	aluminum	NOUN
cana-5161	19	7	chloride	chloride	NOUN
cana-5161	19	8	,	,	PUNCT
cana-5161	19	9	agmatine	agmatine	NOUN
cana-5161	19	10	.	.	PUNCT
cana-5161	20	1	mailto:vandana.bhatia40@gmail.com	mailto:vandana.bhatia40@gmail.com	X
cana-5161	20	2	communications	communication	NOUN
cana-5161	20	3	on	on	ADP
cana-5161	20	4	applied	apply	VERB
cana-5161	20	5	nonlinear	nonlinear	ADJ
cana-5161	20	6	analysis	analysis	NOUN
cana-5161	20	7	issn	issn	NOUN
cana-5161	20	8	:	:	PUNCT
cana-5161	20	9	1074	1074	NUM
cana-5161	20	10	-	-	PUNCT
cana-5161	20	11	133x	133x	NUM
cana-5161	20	12	vol	vol	NOUN
cana-5161	20	13	32	32	NUM
cana-5161	20	14	no	no	NOUN
cana-5161	20	15	.	.	PUNCT
cana-5161	21	1	icmasd	icmasd	NOUN
cana-5161	21	2	(	(	PUNCT
cana-5161	21	3	2025	2025	NUM
cana-5161	21	4	)	)	PUNCT
cana-5161	21	5	1354	1354	NUM
cana-5161	21	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	21	7	1	1	X
cana-5161	21	8	.	.	PUNCT
cana-5161	21	9	introduction	introduction	NOUN
cana-5161	21	10	memory	memory	NOUN
cana-5161	21	11	plays	play	VERB
cana-5161	21	12	a	a	DET
cana-5161	21	13	pivotal	pivotal	ADJ
cana-5161	21	14	role	role	NOUN
cana-5161	21	15	in	in	ADP
cana-5161	21	16	shaping	shape	VERB
cana-5161	21	17	an	an	DET
cana-5161	21	18	individual	individual	NOUN
cana-5161	21	19	's	's	PART
cana-5161	21	20	daily	daily	ADJ
cana-5161	21	21	life	life	NOUN
cana-5161	21	22	and	and	CCONJ
cana-5161	21	23	activities	activity	NOUN
cana-5161	21	24	.	.	PUNCT
cana-5161	22	1	it	it	PRON
cana-5161	22	2	is	be	AUX
cana-5161	22	3	integral	integral	ADJ
cana-5161	22	4	to	to	ADP
cana-5161	22	5	processes	process	NOUN
cana-5161	22	6	such	such	ADJ
cana-5161	22	7	as	as	ADP
cana-5161	22	8	decision	decision	NOUN
cana-5161	22	9	-	-	PUNCT
cana-5161	22	10	making	making	NOUN
cana-5161	22	11	,	,	PUNCT
cana-5161	22	12	interpersonal	interpersonal	ADJ
cana-5161	22	13	relationships	relationship	NOUN
cana-5161	22	14	,	,	PUNCT
cana-5161	22	15	and	and	CCONJ
cana-5161	22	16	self	self	NOUN
cana-5161	22	17	-	-	PUNCT
cana-5161	22	18	care	care	NOUN
cana-5161	22	19	.	.	PUNCT
cana-5161	23	1	cognition	cognition	NOUN
cana-5161	23	2	encompasses	encompass	VERB
cana-5161	23	3	the	the	DET
cana-5161	23	4	mental	mental	ADJ
cana-5161	23	5	processes	process	NOUN
cana-5161	23	6	underlying	underlie	VERB
cana-5161	23	7	human	human	ADJ
cana-5161	23	8	experiences	experience	NOUN
cana-5161	23	9	,	,	PUNCT
cana-5161	23	10	thought	think	VERB
cana-5161	23	11	,	,	PUNCT
cana-5161	23	12	and	and	CCONJ
cana-5161	23	13	understanding	understanding	NOUN
cana-5161	23	14	.	.	PUNCT
cana-5161	24	1	mild	mild	ADJ
cana-5161	24	2	cognitive	cognitive	ADJ
cana-5161	24	3	impairment	impairment	NOUN
cana-5161	24	4	(	(	PUNCT
cana-5161	24	5	mci	mci	NOUN
cana-5161	24	6	)	)	PUNCT
cana-5161	24	7	is	be	AUX
cana-5161	24	8	characterized	characterize	VERB
cana-5161	24	9	by	by	ADP
cana-5161	24	10	a	a	DET
cana-5161	24	11	quantifiable	quantifiable	ADJ
cana-5161	24	12	decline	decline	NOUN
cana-5161	24	13	in	in	ADP
cana-5161	24	14	cognitive	cognitive	ADJ
cana-5161	24	15	functions	function	NOUN
cana-5161	24	16	,	,	PUNCT
cana-5161	24	17	including	include	VERB
cana-5161	24	18	memory	memory	NOUN
cana-5161	24	19	and	and	CCONJ
cana-5161	24	20	executive	executive	ADJ
cana-5161	24	21	abilities	ability	NOUN
cana-5161	24	22	.	.	PUNCT
cana-5161	25	1	individuals	individual	NOUN
cana-5161	25	2	diagnosed	diagnose	VERB
cana-5161	25	3	with	with	ADP
cana-5161	25	4	mci	mci	PROPN
cana-5161	25	5	have	have	VERB
cana-5161	25	6	an	an	DET
cana-5161	25	7	elevated	elevated	ADJ
cana-5161	25	8	risk	risk	NOUN
cana-5161	25	9	of	of	ADP
cana-5161	25	10	progression	progression	NOUN
cana-5161	25	11	to	to	ADP
cana-5161	25	12	alzheimer	alzheimer	PROPN
cana-5161	25	13	’s	’s	PART
cana-5161	25	14	disease	disease	NOUN
cana-5161	25	15	(	(	PUNCT
cana-5161	25	16	ad	ad	NOUN
cana-5161	25	17	)	)	PUNCT
cana-5161	25	18	or	or	CCONJ
cana-5161	25	19	other	other	ADJ
cana-5161	25	20	forms	form	NOUN
cana-5161	25	21	of	of	ADP
cana-5161	25	22	dementia	dementia	NOUN
cana-5161	25	23	.	.	PUNCT
cana-5161	26	1	aluminium	aluminium	NOUN
cana-5161	26	2	,	,	PUNCT
cana-5161	26	3	a	a	DET
cana-5161	26	4	well	well	ADV
cana-5161	26	5	-	-	PUNCT
cana-5161	26	6	established	establish	VERB
cana-5161	26	7	neurotoxic	neurotoxic	ADJ
cana-5161	26	8	agent	agent	NOUN
cana-5161	26	9	,	,	PUNCT
cana-5161	26	10	has	have	AUX
cana-5161	26	11	been	be	AUX
cana-5161	26	12	implicated	implicate	VERB
cana-5161	26	13	in	in	ADP
cana-5161	26	14	the	the	DET
cana-5161	26	15	pathogenesis	pathogenesis	NOUN
cana-5161	26	16	of	of	ADP
cana-5161	26	17	alzheimer	alzheimer	PROPN
cana-5161	26	18	’s	’s	PART
cana-5161	26	19	disease	disease	NOUN
cana-5161	26	20	.	.	PUNCT
cana-5161	27	1	this	this	DET
cana-5161	27	2	association	association	NOUN
cana-5161	27	3	is	be	AUX
cana-5161	27	4	attributed	attribute	VERB
cana-5161	27	5	to	to	ADP
cana-5161	27	6	its	its	PRON
cana-5161	27	7	ability	ability	NOUN
cana-5161	27	8	to	to	PART
cana-5161	27	9	cross	cross	VERB
cana-5161	27	10	biological	biological	ADJ
cana-5161	27	11	barriers	barrier	NOUN
cana-5161	27	12	and	and	CCONJ
cana-5161	27	13	accumulate	accumulate	VERB
cana-5161	27	14	within	within	ADP
cana-5161	27	15	the	the	DET
cana-5161	27	16	central	central	ADJ
cana-5161	27	17	nervous	nervous	ADJ
cana-5161	27	18	system	system	NOUN
cana-5161	27	19	,	,	PUNCT
cana-5161	27	20	thereby	thereby	ADV
cana-5161	27	21	contributing	contribute	VERB
cana-5161	27	22	to	to	ADP
cana-5161	27	23	neurodegenerative	neurodegenerative	ADJ
cana-5161	27	24	processes	process	NOUN
cana-5161	27	25	(	(	PUNCT
cana-5161	27	26	sun	sun	NOUN
cana-5161	27	27	et	et	PROPN
cana-5161	27	28	al	al	PROPN
cana-5161	27	29	.	.	PROPN
cana-5161	27	30	,	,	PUNCT
cana-5161	27	31	2009	2009	NUM
cana-5161	27	32	)	)	PUNCT
cana-5161	27	33	.	.	PUNCT
cana-5161	28	1	aluminium	aluminium	NOUN
cana-5161	28	2	compounds	compound	NOUN
cana-5161	28	3	are	be	AUX
cana-5161	28	4	commonly	commonly	ADV
cana-5161	28	5	incorporated	incorporate	VERB
cana-5161	28	6	into	into	ADP
cana-5161	28	7	a	a	DET
cana-5161	28	8	wide	wide	ADJ
cana-5161	28	9	range	range	NOUN
cana-5161	28	10	of	of	ADP
cana-5161	28	11	commercially	commercially	ADV
cana-5161	28	12	produced	produce	VERB
cana-5161	28	13	products	product	NOUN
cana-5161	28	14	intended	intend	VERB
cana-5161	28	15	for	for	ADP
cana-5161	28	16	human	human	ADJ
cana-5161	28	17	consumption	consumption	NOUN
cana-5161	28	18	.	.	PUNCT
cana-5161	29	1	aluminium	aluminium	NOUN
cana-5161	29	2	sulfate	sulfate	NOUN
cana-5161	29	3	(	(	PUNCT
cana-5161	29	4	alum	alum	ADJ
cana-5161	29	5	)	)	PUNCT
cana-5161	29	6	is	be	AUX
cana-5161	29	7	frequently	frequently	ADV
cana-5161	29	8	used	use	VERB
cana-5161	29	9	in	in	ADP
cana-5161	29	10	the	the	DET
cana-5161	29	11	treatment	treatment	NOUN
cana-5161	29	12	of	of	ADP
cana-5161	29	13	water	water	NOUN
cana-5161	29	14	intended	intend	VERB
cana-5161	29	15	for	for	ADP
cana-5161	29	16	bottling	bottling	NOUN
cana-5161	29	17	and	and	CCONJ
cana-5161	29	18	in	in	ADP
cana-5161	29	19	municipal	municipal	ADJ
cana-5161	29	20	drinking	drinking	NOUN
cana-5161	29	21	water	water	NOUN
cana-5161	29	22	supplies	supply	NOUN
cana-5161	29	23	as	as	ADP
cana-5161	29	24	a	a	DET
cana-5161	29	25	clarifying	clarify	VERB
cana-5161	29	26	agent	agent	NOUN
cana-5161	29	27	.	.	PUNCT
cana-5161	30	1	additionally	additionally	ADV
cana-5161	30	2	,	,	PUNCT
cana-5161	30	3	aluminium	aluminium	NOUN
cana-5161	30	4	is	be	AUX
cana-5161	30	5	present	present	ADJ
cana-5161	30	6	in	in	ADP
cana-5161	30	7	certain	certain	ADJ
cana-5161	30	8	food	food	NOUN
cana-5161	30	9	preservatives	preservative	NOUN
cana-5161	30	10	,	,	PUNCT
cana-5161	30	11	cookware	cookware	NOUN
cana-5161	30	12	,	,	PUNCT
cana-5161	30	13	drinking	drink	VERB
cana-5161	30	14	water	water	NOUN
cana-5161	30	15	,	,	PUNCT
cana-5161	30	16	and	and	CCONJ
cana-5161	30	17	naturally	naturally	ADV
cana-5161	30	18	occurring	occur	VERB
cana-5161	30	19	dietary	dietary	ADJ
cana-5161	30	20	sources	source	NOUN
cana-5161	30	21	(	(	PUNCT
cana-5161	30	22	schafer	schafer	NOUN
cana-5161	30	23	and	and	CCONJ
cana-5161	30	24	seifert	seifert	PROPN
cana-5161	30	25	,	,	PUNCT
cana-5161	30	26	2006	2006	NUM
cana-5161	30	27	)	)	PUNCT
cana-5161	30	28	.	.	PUNCT
cana-5161	31	1	furthermore	furthermore	ADV
cana-5161	31	2	,	,	PUNCT
cana-5161	31	3	aluminium	aluminium	NOUN
cana-5161	31	4	exposure	exposure	NOUN
cana-5161	31	5	has	have	AUX
cana-5161	31	6	been	be	AUX
cana-5161	31	7	observed	observe	VERB
cana-5161	31	8	to	to	PART
cana-5161	31	9	induce	induce	VERB
cana-5161	31	10	clinical	clinical	ADJ
cana-5161	31	11	signs	sign	NOUN
cana-5161	31	12	and	and	CCONJ
cana-5161	31	13	pathological	pathological	ADJ
cana-5161	31	14	features	feature	NOUN
cana-5161	31	15	in	in	ADP
cana-5161	31	16	experimental	experimental	ADJ
cana-5161	31	17	animal	animal	NOUN
cana-5161	31	18	models	model	NOUN
cana-5161	31	19	that	that	PRON
cana-5161	31	20	closely	closely	ADV
cana-5161	31	21	resemble	resemble	VERB
cana-5161	31	22	those	those	PRON
cana-5161	31	23	associated	associate	VERB
cana-5161	31	24	with	with	ADP
cana-5161	31	25	alzheimer	alzheimer	PROPN
cana-5161	31	26	’s	’s	PART
cana-5161	31	27	disease	disease	NOUN
cana-5161	31	28	(	(	PUNCT
cana-5161	31	29	ad	ad	NOUN
cana-5161	31	30	)	)	PUNCT
cana-5161	31	31	(	(	PUNCT
cana-5161	31	32	sreekumaran	sreekumaran	NUM
cana-5161	31	33	and	and	CCONJ
cana-5161	31	34	ramakrishna	ramakrishna	PROPN
cana-5161	31	35	,	,	PUNCT
cana-5161	31	36	2002	2002	NUM
cana-5161	31	37	)	)	PUNCT
cana-5161	31	38	.	.	PUNCT
cana-5161	32	1	consequently	consequently	ADV
cana-5161	32	2	,	,	PUNCT
cana-5161	32	3	aluminium	aluminium	NOUN
cana-5161	32	4	exposure	exposure	NOUN
cana-5161	32	5	has	have	AUX
cana-5161	32	6	been	be	AUX
cana-5161	32	7	proposed	propose	VERB
cana-5161	32	8	as	as	ADP
cana-5161	32	9	a	a	DET
cana-5161	32	10	contributing	contribute	VERB
cana-5161	32	11	factor	factor	NOUN
cana-5161	32	12	in	in	ADP
cana-5161	32	13	the	the	DET
cana-5161	32	14	development	development	NOUN
cana-5161	32	15	of	of	ADP
cana-5161	32	16	cognitive	cognitive	ADJ
cana-5161	32	17	decline	decline	NOUN
cana-5161	32	18	(	(	PUNCT
cana-5161	32	19	shuchang	shuchang	PROPN
cana-5161	32	20	et	et	PROPN
cana-5161	32	21	al	al	PROPN
cana-5161	32	22	.	.	PROPN
cana-5161	32	23	,	,	PUNCT
cana-5161	32	24	2008	2008	NUM
cana-5161	32	25	)	)	PUNCT
cana-5161	32	26	.	.	PUNCT
cana-5161	33	1	moreover	moreover	ADV
cana-5161	33	2	,	,	PUNCT
cana-5161	33	3	an	an	DET
cana-5161	33	4	expanding	expand	VERB
cana-5161	33	5	body	body	NOUN
cana-5161	33	6	of	of	ADP
cana-5161	33	7	evidence	evidence	NOUN
cana-5161	33	8	suggests	suggest	VERB
cana-5161	33	9	that	that	SCONJ
cana-5161	33	10	aluminium	aluminium	NOUN
cana-5161	33	11	exerts	exert	VERB
cana-5161	33	12	neurotoxic	neurotoxic	ADJ
cana-5161	33	13	effects	effect	NOUN
cana-5161	33	14	through	through	ADP
cana-5161	33	15	the	the	DET
cana-5161	33	16	induction	induction	NOUN
cana-5161	33	17	of	of	ADP
cana-5161	33	18	oxidative	oxidative	ADJ
cana-5161	33	19	stress	stress	NOUN
cana-5161	33	20	(	(	PUNCT
cana-5161	33	21	kumar	kumar	PROPN
cana-5161	33	22	et	et	PROPN
cana-5161	33	23	al	al	PROPN
cana-5161	33	24	.	.	PROPN
cana-5161	33	25	,	,	PUNCT
cana-5161	33	26	2009	2009	NUM
cana-5161	33	27	,	,	PUNCT
cana-5161	33	28	newairy	newairy	PROPN
cana-5161	33	29	et	et	PROPN
cana-5161	33	30	al	al	PROPN
cana-5161	33	31	.	.	PROPN
cana-5161	33	32	,	,	PUNCT
cana-5161	33	33	2009	2009	NUM
cana-5161	33	34	,	,	PUNCT
cana-5161	33	35	dua	dua	PROPN
cana-5161	33	36	et	et	PROPN
cana-5161	33	37	al	al	PROPN
cana-5161	33	38	.	.	PROPN
cana-5161	33	39	,	,	PUNCT
cana-5161	33	40	2010	2010	NUM
cana-5161	33	41	,	,	PUNCT
cana-5161	33	42	sethi	sethi	PROPN
cana-5161	33	43	et	et	PROPN
cana-5161	33	44	al	al	PROPN
cana-5161	33	45	.	.	PROPN
cana-5161	33	46	,	,	PUNCT
cana-5161	33	47	2008	2008	NUM
cana-5161	33	48	)	)	PUNCT
cana-5161	33	49	.	.	PUNCT
cana-5161	34	1	the	the	DET
cana-5161	34	2	administration	administration	NOUN
cana-5161	34	3	of	of	ADP
cana-5161	34	4	aluminium	aluminium	NOUN
cana-5161	34	5	to	to	ADP
cana-5161	34	6	rats	rat	NOUN
cana-5161	34	7	has	have	AUX
cana-5161	34	8	been	be	AUX
cana-5161	34	9	shown	show	VERB
cana-5161	34	10	to	to	PART
cana-5161	34	11	induce	induce	VERB
cana-5161	34	12	cognitive	cognitive	ADJ
cana-5161	34	13	impairments	impairment	NOUN
cana-5161	34	14	and	and	CCONJ
cana-5161	34	15	oxidative	oxidative	ADJ
cana-5161	34	16	damage	damage	NOUN
cana-5161	34	17	within	within	ADP
cana-5161	34	18	the	the	DET
cana-5161	34	19	cortex	cortex	NOUN
cana-5161	34	20	and	and	CCONJ
cana-5161	34	21	hippocampus	hippocampus	NOUN
cana-5161	34	22	of	of	ADP
cana-5161	34	23	the	the	DET
cana-5161	34	24	brain	brain	NOUN
cana-5161	34	25	(	(	PUNCT
cana-5161	34	26	thirunavukkarasu	thirunavukkarasu	PROPN
cana-5161	34	27	et	et	PROPN
cana-5161	34	28	al	al	PROPN
cana-5161	34	29	.	.	PROPN
cana-5161	34	30	,	,	PUNCT
cana-5161	34	31	2012	2012	NUM
cana-5161	34	32	)	)	PUNCT
cana-5161	34	33	.	.	PUNCT
cana-5161	35	1	aluminium	aluminium	NOUN
cana-5161	35	2	-	-	PUNCT
cana-5161	35	3	induced	induce	VERB
cana-5161	35	4	neurotoxicity	neurotoxicity	NOUN
cana-5161	35	5	has	have	AUX
cana-5161	35	6	also	also	ADV
cana-5161	35	7	been	be	AUX
cana-5161	35	8	implicated	implicate	VERB
cana-5161	35	9	in	in	ADP
cana-5161	35	10	the	the	DET
cana-5161	35	11	pathogenesis	pathogenesis	NOUN
cana-5161	35	12	of	of	ADP
cana-5161	35	13	alzheimer	alzheimer	PROPN
cana-5161	35	14	’s	’s	PART
cana-5161	35	15	disease	disease	NOUN
cana-5161	35	16	(	(	PUNCT
cana-5161	35	17	ad	ad	NOUN
cana-5161	35	18	)	)	PUNCT
cana-5161	35	19	,	,	PUNCT
cana-5161	35	20	an	an	DET
cana-5161	35	21	age	age	NOUN
cana-5161	35	22	-	-	PUNCT
cana-5161	35	23	associated	associate	VERB
cana-5161	35	24	neurodegenerative	neurodegenerative	ADJ
cana-5161	35	25	disorder	disorder	NOUN
cana-5161	35	26	.	.	PUNCT
cana-5161	36	1	ad	ad	NOUN
cana-5161	36	2	is	be	AUX
cana-5161	36	3	primarily	primarily	ADV
cana-5161	36	4	characterized	characterize	VERB
cana-5161	36	5	by	by	ADP
cana-5161	36	6	progressive	progressive	ADJ
cana-5161	36	7	cognitive	cognitive	ADJ
cana-5161	36	8	decline	decline	NOUN
cana-5161	36	9	,	,	PUNCT
cana-5161	36	10	accompanied	accompany	VERB
cana-5161	36	11	by	by	ADP
cana-5161	36	12	personality	personality	NOUN
cana-5161	36	13	changes	change	NOUN
cana-5161	36	14	,	,	PUNCT
cana-5161	36	15	impaired	impaired	ADJ
cana-5161	36	16	learning	learning	NOUN
cana-5161	36	17	abilities	ability	NOUN
cana-5161	36	18	,	,	PUNCT
cana-5161	36	19	deterioration	deterioration	NOUN
cana-5161	36	20	of	of	ADP
cana-5161	36	21	motor	motor	NOUN
cana-5161	36	22	functions	function	NOUN
cana-5161	36	23	,	,	PUNCT
cana-5161	36	24	and	and	CCONJ
cana-5161	36	25	eventual	eventual	ADJ
cana-5161	36	26	loss	loss	NOUN
cana-5161	36	27	of	of	ADP
cana-5161	36	28	language	language	NOUN
cana-5161	36	29	skills	skill	NOUN
cana-5161	36	30	(	(	PUNCT
cana-5161	36	31	yankner	yankner	NOUN
cana-5161	36	32	,	,	PUNCT
cana-5161	36	33	1996	1996	NUM
cana-5161	36	34	)	)	PUNCT
cana-5161	36	35	.	.	PUNCT
cana-5161	37	1	the	the	DET
cana-5161	37	2	pathological	pathological	ADJ
cana-5161	37	3	hallmarks	hallmark	NOUN
cana-5161	37	4	of	of	ADP
cana-5161	37	5	aluminium	aluminium	NOUN
cana-5161	37	6	-	-	PUNCT
cana-5161	37	7	induced	induce	VERB
cana-5161	37	8	alzheimer	alzheimer	NOUN
cana-5161	37	9	’s	’s	PART
cana-5161	37	10	disease	disease	NOUN
cana-5161	37	11	(	(	PUNCT
cana-5161	37	12	ad	ad	NOUN
cana-5161	37	13	)	)	PUNCT
cana-5161	37	14	include	include	VERB
cana-5161	37	15	the	the	DET
cana-5161	37	16	presence	presence	NOUN
cana-5161	37	17	of	of	ADP
cana-5161	37	18	senile	senile	ADJ
cana-5161	37	19	plaques	plaque	NOUN
cana-5161	37	20	,	,	PUNCT
cana-5161	37	21	which	which	PRON
cana-5161	37	22	are	be	AUX
cana-5161	37	23	spherical	spherical	ADJ
cana-5161	37	24	aggregations	aggregation	NOUN
cana-5161	37	25	of	of	ADP
cana-5161	37	26	β	β	NOUN
cana-5161	37	27	-	-	ADJ
cana-5161	37	28	amyloid	amyloid	ADJ
cana-5161	37	29	protein	protein	NOUN
cana-5161	37	30	,	,	PUNCT
cana-5161	37	31	accompanied	accompany	VERB
cana-5161	37	32	by	by	ADP
cana-5161	37	33	degenerating	degenerate	VERB
cana-5161	37	34	neuronal	neuronal	ADJ
cana-5161	37	35	processes	process	NOUN
cana-5161	37	36	.	.	PUNCT
cana-5161	38	1	additionally	additionally	ADV
cana-5161	38	2	,	,	PUNCT
cana-5161	38	3	neurofibrillary	neurofibrillary	ADJ
cana-5161	38	4	tangles	tangle	NOUN
cana-5161	38	5	,	,	PUNCT
cana-5161	38	6	consisting	consist	VERB
cana-5161	38	7	of	of	ADP
cana-5161	38	8	paired	pair	VERB
cana-5161	38	9	helical	helical	ADJ
cana-5161	38	10	filaments	filament	NOUN
cana-5161	38	11	and	and	CCONJ
cana-5161	38	12	other	other	ADJ
cana-5161	38	13	associated	associated	ADJ
cana-5161	38	14	proteins	protein	NOUN
cana-5161	38	15	,	,	PUNCT
cana-5161	38	16	are	be	AUX
cana-5161	38	17	also	also	ADV
cana-5161	38	18	observed	observe	VERB
cana-5161	38	19	.	.	PUNCT
cana-5161	39	1	aluminium	aluminium	NOUN
cana-5161	39	2	toxicity	toxicity	NOUN
cana-5161	39	3	and	and	CCONJ
cana-5161	39	4	its	its	PRON
cana-5161	39	5	associated	associated	ADJ
cana-5161	39	6	impact	impact	NOUN
cana-5161	39	7	on	on	ADP
cana-5161	39	8	alzheimer	alzheimer	PROPN
cana-5161	39	9	's	's	PART
cana-5161	39	10	disease	disease	NOUN
cana-5161	39	11	(	(	PUNCT
cana-5161	39	12	ad	ad	NOUN
cana-5161	39	13	)	)	PUNCT
cana-5161	39	14	primarily	primarily	ADV
cana-5161	39	15	affect	affect	VERB
cana-5161	39	16	individuals	individual	NOUN
cana-5161	39	17	in	in	ADP
cana-5161	39	18	middle	middle	ADJ
cana-5161	39	19	to	to	ADP
cana-5161	39	20	older	old	ADJ
cana-5161	39	21	age	age	NOUN
cana-5161	39	22	,	,	PUNCT
cana-5161	39	23	with	with	ADP
cana-5161	39	24	the	the	DET
cana-5161	39	25	prevalence	prevalence	NOUN
cana-5161	39	26	of	of	ADP
cana-5161	39	27	the	the	DET
cana-5161	39	28	condition	condition	NOUN
cana-5161	39	29	showing	show	VERB
cana-5161	39	30	a	a	DET
cana-5161	39	31	significant	significant	ADJ
cana-5161	39	32	increase	increase	NOUN
cana-5161	39	33	after	after	ADP
cana-5161	39	34	the	the	DET
cana-5161	39	35	age	age	NOUN
cana-5161	39	36	of	of	ADP
cana-5161	39	37	65	65	NUM
cana-5161	39	38	(	(	PUNCT
cana-5161	39	39	butterfield	butterfield	PROPN
cana-5161	39	40	et	et	PROPN
cana-5161	39	41	al	al	PROPN
cana-5161	39	42	.	.	PROPN
cana-5161	39	43	,	,	PUNCT
cana-5161	39	44	2013	2013	NUM
cana-5161	39	45	)	)	PUNCT
cana-5161	39	46	.	.	PUNCT
cana-5161	40	1	among	among	ADP
cana-5161	40	2	the	the	DET
cana-5161	40	3	familial	familial	ADJ
cana-5161	40	4	and	and	CCONJ
cana-5161	40	5	sporadic	sporadic	ADJ
cana-5161	40	6	forms	form	NOUN
cana-5161	40	7	of	of	ADP
cana-5161	40	8	alzheimer	alzheimer	PROPN
cana-5161	40	9	’s	’s	PART
cana-5161	40	10	disease	disease	NOUN
cana-5161	40	11	(	(	PUNCT
cana-5161	40	12	ad	ad	NOUN
cana-5161	40	13	)	)	PUNCT
cana-5161	40	14	,	,	PUNCT
cana-5161	40	15	sporadic	sporadic	ADJ
cana-5161	40	16	ad	ad	NOUN
cana-5161	40	17	accounts	account	VERB
cana-5161	40	18	for	for	ADP
cana-5161	40	19	approximately	approximately	ADV
cana-5161	40	20	95	95	NUM
cana-5161	40	21	%	%	NOUN
cana-5161	40	22	of	of	ADP
cana-5161	40	23	cases	case	NOUN
cana-5161	40	24	.	.	PUNCT
cana-5161	41	1	it	it	PRON
cana-5161	41	2	arises	arise	VERB
cana-5161	41	3	from	from	ADP
cana-5161	41	4	a	a	DET
cana-5161	41	5	complex	complex	ADJ
cana-5161	41	6	interplay	interplay	NOUN
cana-5161	41	7	of	of	ADP
cana-5161	41	8	various	various	ADJ
cana-5161	41	9	etiological	etiological	ADJ
cana-5161	41	10	factors	factor	NOUN
cana-5161	41	11	(	(	PUNCT
cana-5161	41	12	barone	barone	PROPN
cana-5161	41	13	et	et	PROPN
cana-5161	41	14	al	al	PROPN
cana-5161	41	15	.	.	PROPN
cana-5161	41	16	,	,	PUNCT
cana-5161	41	17	2014	2014	NUM
cana-5161	41	18	)	)	PUNCT
cana-5161	41	19	.	.	PUNCT
cana-5161	42	1	numerous	numerous	ADJ
cana-5161	42	2	postmortem	postmortem	NOUN
cana-5161	42	3	studies	study	NOUN
cana-5161	42	4	of	of	ADP
cana-5161	42	5	brains	brain	NOUN
cana-5161	42	6	from	from	ADP
cana-5161	42	7	alzheimer	alzheimer	PROPN
cana-5161	42	8	's	's	PART
cana-5161	42	9	disease	disease	NOUN
cana-5161	42	10	(	(	PUNCT
cana-5161	42	11	ad	ad	NOUN
cana-5161	42	12	)	)	PUNCT
cana-5161	42	13	patients	patient	NOUN
cana-5161	42	14	suggest	suggest	VERB
cana-5161	42	15	that	that	SCONJ
cana-5161	42	16	mitochondrial	mitochondrial	ADJ
cana-5161	42	17	dysfunction	dysfunction	NOUN
cana-5161	42	18	and	and	CCONJ
cana-5161	42	19	the	the	DET
cana-5161	42	20	accumulation	accumulation	NOUN
cana-5161	42	21	of	of	ADP
cana-5161	42	22	amyloid	amyloid	NOUN
cana-5161	42	23	β	β	X
cana-5161	42	24	(	(	PUNCT
cana-5161	42	25	aβ	aβ	NOUN
cana-5161	42	26	)	)	PUNCT
cana-5161	42	27	at	at	ADP
cana-5161	42	28	synapses	synapsis	NOUN
cana-5161	42	29	may	may	AUX
cana-5161	42	30	contribute	contribute	VERB
cana-5161	42	31	to	to	ADP
cana-5161	42	32	synaptic	synaptic	ADJ
cana-5161	42	33	damage	damage	NOUN
cana-5161	42	34	,	,	PUNCT
cana-5161	42	35	impair	impair	VERB
cana-5161	42	36	neurotransmission	neurotransmission	NOUN
cana-5161	42	37	,	,	PUNCT
cana-5161	42	38	and	and	CCONJ
cana-5161	42	39	drive	drive	VERB
cana-5161	42	40	cognitive	cognitive	ADJ
cana-5161	42	41	decline	decline	NOUN
cana-5161	42	42	in	in	ADP
cana-5161	42	43	both	both	CCONJ
cana-5161	42	44	elderly	elderly	ADJ
cana-5161	42	45	individuals	individual	NOUN
cana-5161	42	46	and	and	CCONJ
cana-5161	42	47	ad	ad	NOUN
cana-5161	42	48	patients	patient	NOUN
cana-5161	42	49	.	.	PUNCT
cana-5161	43	1	despite	despite	SCONJ
cana-5161	43	2	ongoing	ongoing	ADJ
cana-5161	43	3	research	research	NOUN
cana-5161	43	4	,	,	PUNCT
cana-5161	43	5	the	the	DET
cana-5161	43	6	development	development	NOUN
cana-5161	43	7	of	of	ADP
cana-5161	43	8	an	an	DET
cana-5161	43	9	effective	effective	ADJ
cana-5161	43	10	treatment	treatment	NOUN
cana-5161	43	11	for	for	ADP
cana-5161	43	12	ad	ad	NOUN
cana-5161	43	13	remains	remain	VERB
cana-5161	43	14	elusive	elusive	ADJ
cana-5161	43	15	(	(	PUNCT
cana-5161	43	16	bonda	bonda	PROPN
cana-5161	43	17	et	et	PROPN
cana-5161	43	18	al	al	PROPN
cana-5161	43	19	.	.	PROPN
cana-5161	43	20	,	,	PUNCT
cana-5161	43	21	2010	2010	NUM
cana-5161	43	22	)	)	PUNCT
cana-5161	43	23	.	.	PUNCT
cana-5161	44	1	several	several	ADJ
cana-5161	44	2	studies	study	NOUN
cana-5161	44	3	have	have	AUX
cana-5161	44	4	reported	report	VERB
cana-5161	44	5	that	that	SCONJ
cana-5161	44	6	aluminium	aluminium	NOUN
cana-5161	44	7	toxicity	toxicity	NOUN
cana-5161	44	8	can	can	AUX
cana-5161	44	9	lead	lead	VERB
cana-5161	44	10	to	to	ADP
cana-5161	44	11	the	the	DET
cana-5161	44	12	formation	formation	NOUN
cana-5161	44	13	of	of	ADP
cana-5161	44	14	free	free	ADJ
cana-5161	44	15	communications	communication	NOUN
cana-5161	44	16	on	on	ADP
cana-5161	44	17	applied	apply	VERB
cana-5161	44	18	nonlinear	nonlinear	ADJ
cana-5161	44	19	analysis	analysis	NOUN
cana-5161	44	20	issn	issn	NOUN
cana-5161	44	21	:	:	PUNCT
cana-5161	44	22	1074	1074	NUM
cana-5161	44	23	-	-	PUNCT
cana-5161	44	24	133x	133x	NUM
cana-5161	44	25	vol	vol	NOUN
cana-5161	44	26	32	32	NUM
cana-5161	44	27	no	no	NOUN
cana-5161	44	28	.	.	PUNCT
cana-5161	45	1	icmasd	icmasd	NOUN
cana-5161	45	2	(	(	PUNCT
cana-5161	45	3	2025	2025	NUM
cana-5161	45	4	)	)	PUNCT
cana-5161	45	5	1355	1355	NUM
cana-5161	45	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	45	7	radicals	radical	NOUN
cana-5161	45	8	,	,	PUNCT
cana-5161	45	9	oxidative	oxidative	ADJ
cana-5161	45	10	stress	stress	NOUN
cana-5161	45	11	,	,	PUNCT
cana-5161	45	12	mitochondrial	mitochondrial	ADJ
cana-5161	45	13	dysfunction	dysfunction	NOUN
cana-5161	45	14	,	,	PUNCT
cana-5161	45	15	and	and	CCONJ
cana-5161	45	16	inflammatory	inflammatory	ADJ
cana-5161	45	17	processes	process	NOUN
cana-5161	45	18	.	.	PUNCT
cana-5161	46	1	these	these	DET
cana-5161	46	2	factors	factor	NOUN
cana-5161	46	3	may	may	AUX
cana-5161	46	4	interact	interact	VERB
cana-5161	46	5	and	and	CCONJ
cana-5161	46	6	exacerbate	exacerbate	VERB
cana-5161	46	7	each	each	DET
cana-5161	46	8	other	other	ADJ
cana-5161	46	9	in	in	ADP
cana-5161	46	10	a	a	DET
cana-5161	46	11	vicious	vicious	ADJ
cana-5161	46	12	cycle	cycle	NOUN
cana-5161	46	13	of	of	ADP
cana-5161	46	14	toxicity	toxicity	NOUN
cana-5161	46	15	,	,	PUNCT
cana-5161	46	16	ultimately	ultimately	ADV
cana-5161	46	17	resulting	result	VERB
cana-5161	46	18	in	in	ADP
cana-5161	46	19	neuronal	neuronal	ADJ
cana-5161	46	20	impairment	impairment	NOUN
cana-5161	46	21	,	,	PUNCT
cana-5161	46	22	cellular	cellular	ADJ
cana-5161	46	23	dysfunction	dysfunction	NOUN
cana-5161	46	24	,	,	PUNCT
cana-5161	46	25	and	and	CCONJ
cana-5161	46	26	,	,	PUNCT
cana-5161	46	27	eventually	eventually	ADV
cana-5161	46	28	,	,	PUNCT
cana-5161	46	29	cell	cell	NOUN
cana-5161	46	30	death	death	NOUN
cana-5161	46	31	(	(	PUNCT
cana-5161	46	32	butterfield	butterfield	PROPN
cana-5161	46	33	et	et	PROPN
cana-5161	46	34	al	al	PROPN
cana-5161	46	35	.	.	PROPN
cana-5161	46	36	,	,	PUNCT
cana-5161	46	37	2013	2013	NUM
cana-5161	46	38	)	)	PUNCT
cana-5161	46	39	.	.	PUNCT
cana-5161	47	1	agmatine	agmatine	NOUN
cana-5161	47	2	,	,	PUNCT
cana-5161	47	3	a	a	DET
cana-5161	47	4	cationic	cationic	ADJ
cana-5161	47	5	polyamine	polyamine	NOUN
cana-5161	47	6	,	,	PUNCT
cana-5161	47	7	was	be	AUX
cana-5161	47	8	first	first	ADV
cana-5161	47	9	identified	identify	VERB
cana-5161	47	10	by	by	ADP
cana-5161	47	11	the	the	DET
cana-5161	47	12	german	german	ADJ
cana-5161	47	13	biochemist	biochemist	NOUN
cana-5161	47	14	albrecht	albrecht	PROPN
cana-5161	47	15	kossel	kossel	INTJ
cana-5161	47	16	in	in	ADP
cana-5161	47	17	herring	herre	VERB
cana-5161	47	18	sperm	sperm	NOUN
cana-5161	47	19	during	during	ADP
cana-5161	47	20	the	the	DET
cana-5161	47	21	early	early	ADJ
cana-5161	47	22	20th	20th	ADJ
cana-5161	47	23	century	century	NOUN
cana-5161	47	24	.	.	PUNCT
cana-5161	48	1	it	it	PRON
cana-5161	48	2	is	be	AUX
cana-5161	48	3	synthesized	synthesize	VERB
cana-5161	48	4	through	through	ADP
cana-5161	48	5	the	the	DET
cana-5161	48	6	decarboxylation	decarboxylation	NOUN
cana-5161	48	7	of	of	ADP
cana-5161	48	8	larginine	larginine	NOUN
cana-5161	48	9	by	by	ADP
cana-5161	48	10	the	the	DET
cana-5161	48	11	enzyme	enzyme	NOUN
cana-5161	48	12	arginine	arginine	NOUN
cana-5161	48	13	decarboxylase	decarboxylase	PROPN
cana-5161	48	14	(	(	PUNCT
cana-5161	48	15	adc	adc	PROPN
cana-5161	48	16	)	)	PUNCT
cana-5161	48	17	(	(	PUNCT
cana-5161	48	18	tabor	tabor	NOUN
cana-5161	48	19	and	and	CCONJ
cana-5161	48	20	tabor	tabor	NOUN
cana-5161	48	21	,	,	PUNCT
cana-5161	48	22	1984	1984	NUM
cana-5161	48	23	)	)	PUNCT
cana-5161	48	24	.	.	PUNCT
cana-5161	49	1	as	as	ADP
cana-5161	49	2	an	an	DET
cana-5161	49	3	endogenous	endogenous	ADJ
cana-5161	49	4	neuromodulator	neuromodulator	NOUN
cana-5161	49	5	,	,	PUNCT
cana-5161	49	6	agmatine	agmatine	NOUN
cana-5161	49	7	has	have	AUX
cana-5161	49	8	emerged	emerge	VERB
cana-5161	49	9	as	as	ADP
cana-5161	49	10	a	a	DET
cana-5161	49	11	potential	potential	ADJ
cana-5161	49	12	therapeutic	therapeutic	ADJ
cana-5161	49	13	agent	agent	NOUN
cana-5161	49	14	for	for	ADP
cana-5161	49	15	the	the	DET
cana-5161	49	16	management	management	NOUN
cana-5161	49	17	of	of	ADP
cana-5161	49	18	various	various	ADJ
cana-5161	49	19	central	central	ADJ
cana-5161	49	20	nervous	nervous	ADJ
cana-5161	49	21	system	system	NOUN
cana-5161	49	22	(	(	PUNCT
cana-5161	49	23	cns	cns	NOUN
cana-5161	49	24	)	)	PUNCT
cana-5161	49	25	disorders	disorder	NOUN
cana-5161	49	26	.	.	PUNCT
cana-5161	50	1	multiple	multiple	ADJ
cana-5161	50	2	studies	study	NOUN
cana-5161	50	3	have	have	AUX
cana-5161	50	4	demonstrated	demonstrate	VERB
cana-5161	50	5	that	that	SCONJ
cana-5161	50	6	agmatine	agmatine	NOUN
cana-5161	50	7	is	be	AUX
cana-5161	50	8	synthesized	synthesize	VERB
cana-5161	50	9	in	in	ADP
cana-5161	50	10	both	both	CCONJ
cana-5161	50	11	the	the	DET
cana-5161	50	12	brain	brain	NOUN
cana-5161	50	13	and	and	CCONJ
cana-5161	50	14	spinal	spinal	ADJ
cana-5161	50	15	cord	cord	NOUN
cana-5161	50	16	.	.	PUNCT
cana-5161	51	1	recently	recently	ADV
cana-5161	51	2	,	,	PUNCT
cana-5161	51	3	agmatine	agmatine	NOUN
cana-5161	51	4	has	have	AUX
cana-5161	51	5	garnered	garner	VERB
cana-5161	51	6	significant	significant	ADJ
cana-5161	51	7	attention	attention	NOUN
cana-5161	51	8	due	due	ADP
cana-5161	51	9	to	to	ADP
cana-5161	51	10	its	its	PRON
cana-5161	51	11	neuromodulatory	neuromodulatory	NOUN
cana-5161	51	12	and	and	CCONJ
cana-5161	51	13	neuroprotective	neuroprotective	ADJ
cana-5161	51	14	properties	property	NOUN
cana-5161	51	15	,	,	PUNCT
cana-5161	51	16	leading	lead	VERB
cana-5161	51	17	to	to	ADP
cana-5161	51	18	a	a	DET
cana-5161	51	19	growing	grow	VERB
cana-5161	51	20	number	number	NOUN
cana-5161	51	21	of	of	ADP
cana-5161	51	22	investigations	investigation	NOUN
cana-5161	51	23	into	into	ADP
cana-5161	51	24	its	its	PRON
cana-5161	51	25	effects	effect	NOUN
cana-5161	51	26	on	on	ADP
cana-5161	51	27	the	the	DET
cana-5161	51	28	central	central	ADJ
cana-5161	51	29	nervous	nervous	ADJ
cana-5161	51	30	system	system	NOUN
cana-5161	51	31	(	(	PUNCT
cana-5161	51	32	cns	cns	NOUN
cana-5161	51	33	)	)	PUNCT
cana-5161	51	34	using	use	VERB
cana-5161	51	35	various	various	ADJ
cana-5161	51	36	cellular	cellular	ADJ
cana-5161	51	37	and	and	CCONJ
cana-5161	51	38	animal	animal	NOUN
cana-5161	51	39	models	model	NOUN
cana-5161	51	40	.	.	PUNCT
cana-5161	52	1	preclinical	preclinical	ADJ
cana-5161	52	2	studies	study	NOUN
cana-5161	52	3	,	,	PUNCT
cana-5161	52	4	for	for	ADP
cana-5161	52	5	example	example	NOUN
cana-5161	52	6	,	,	PUNCT
cana-5161	52	7	have	have	AUX
cana-5161	52	8	reported	report	VERB
cana-5161	52	9	that	that	SCONJ
cana-5161	52	10	agmatine	agmatine	NOUN
cana-5161	52	11	exerts	exert	VERB
cana-5161	52	12	beneficial	beneficial	ADJ
cana-5161	52	13	effects	effect	NOUN
cana-5161	52	14	on	on	ADP
cana-5161	52	15	nociception	nociception	NOUN
cana-5161	52	16	(	(	PUNCT
cana-5161	52	17	fairbanks	fairbank	NOUN
cana-5161	52	18	et	et	PROPN
cana-5161	52	19	al	al	PROPN
cana-5161	52	20	.	.	PROPN
cana-5161	52	21	,	,	PUNCT
cana-5161	52	22	2000	2000	NUM
cana-5161	52	23	,	,	PUNCT
cana-5161	52	24	santos	santos	PROPN
cana-5161	52	25	et	et	PROPN
cana-5161	52	26	al	al	PROPN
cana-5161	52	27	.	.	PROPN
cana-5161	52	28	,	,	PUNCT
cana-5161	52	29	2005	2005	NUM
cana-5161	52	30	)	)	PUNCT
cana-5161	52	31	,	,	PUNCT
cana-5161	52	32	morphine	morphine	NOUN
cana-5161	52	33	tolerance	tolerance	NOUN
cana-5161	52	34	(	(	PUNCT
cana-5161	52	35	kolesnikov	kolesnikov	PROPN
cana-5161	52	36	et	et	PROPN
cana-5161	52	37	al	al	PROPN
cana-5161	52	38	.	.	PROPN
cana-5161	52	39	,	,	PUNCT
cana-5161	52	40	1996	1996	NUM
cana-5161	52	41	)	)	PUNCT
cana-5161	52	42	,	,	PUNCT
cana-5161	52	43	drug	drug	NOUN
cana-5161	52	44	withdrawal	withdrawal	NOUN
cana-5161	52	45	(	(	PUNCT
cana-5161	52	46	uzbay	uzbay	NOUN
cana-5161	52	47	et	et	PROPN
cana-5161	52	48	al	al	PROPN
cana-5161	52	49	.	.	PROPN
cana-5161	52	50	,	,	PUNCT
cana-5161	52	51	2000	2000	NUM
cana-5161	52	52	)	)	PUNCT
cana-5161	52	53	,	,	PUNCT
cana-5161	52	54	seizures	seizure	NOUN
cana-5161	52	55	(	(	PUNCT
cana-5161	52	56	bence	bence	NOUN
cana-5161	52	57	et	et	NOUN
cana-5161	52	58	al	al	PROPN
cana-5161	52	59	.	.	PROPN
cana-5161	52	60	,	,	PUNCT
cana-5161	52	61	2003	2003	NUM
cana-5161	52	62	,	,	PUNCT
cana-5161	52	63	su	su	PROPN
cana-5161	52	64	et	et	PROPN
cana-5161	52	65	al	al	PROPN
cana-5161	52	66	.	.	PROPN
cana-5161	52	67	,	,	PUNCT
cana-5161	52	68	2004	2004	NUM
cana-5161	52	69	)	)	PUNCT
cana-5161	52	70	,	,	PUNCT
cana-5161	52	71	depression	depression	NOUN
cana-5161	52	72	(	(	PUNCT
cana-5161	52	73	li	li	PROPN
cana-5161	52	74	et	et	PROPN
cana-5161	52	75	al	al	PROPN
cana-5161	52	76	.	.	PROPN
cana-5161	52	77	,	,	PUNCT
cana-5161	52	78	2003	2003	NUM
cana-5161	52	79	)	)	PUNCT
cana-5161	52	80	,	,	PUNCT
cana-5161	52	81	anxiety	anxiety	NOUN
cana-5161	52	82	(	(	PUNCT
cana-5161	52	83	moretti	moretti	PROPN
cana-5161	52	84	et	et	PROPN
cana-5161	52	85	al	al	PROPN
cana-5161	52	86	.	.	PROPN
cana-5161	52	87	,	,	PUNCT
cana-5161	52	88	2014	2014	NUM
cana-5161	52	89	)	)	PUNCT
cana-5161	52	90	,	,	PUNCT
cana-5161	52	91	memory	memory	NOUN
cana-5161	52	92	(	(	PUNCT
cana-5161	52	93	arteni	arteni	PROPN
cana-5161	52	94	et	et	PROPN
cana-5161	52	95	al	al	PROPN
cana-5161	52	96	.	.	PROPN
cana-5161	52	97	,	,	PUNCT
cana-5161	52	98	2002	2002	NUM
cana-5161	52	99	)	)	PUNCT
cana-5161	52	100	and	and	CCONJ
cana-5161	52	101	parkinson	parkinson	NOUN
cana-5161	52	102	’s	’s	PART
cana-5161	52	103	disease	disease	NOUN
cana-5161	52	104	(	(	PUNCT
cana-5161	52	105	gilad	gilad	NOUN
cana-5161	52	106	et	et	PROPN
cana-5161	52	107	al	al	PROPN
cana-5161	52	108	.	.	PROPN
cana-5161	52	109	,	,	PUNCT
cana-5161	52	110	2005	2005	NUM
cana-5161	52	111	)	)	PUNCT
cana-5161	52	112	.	.	PUNCT
cana-5161	53	1	experimental	experimental	ADJ
cana-5161	53	2	studies	study	NOUN
cana-5161	53	3	investigating	investigate	VERB
cana-5161	53	4	memory	memory	NOUN
cana-5161	53	5	and	and	CCONJ
cana-5161	53	6	learning	learn	VERB
cana-5161	53	7	in	in	ADP
cana-5161	53	8	aged	aged	ADJ
cana-5161	53	9	animal	animal	NOUN
cana-5161	53	10	models	model	NOUN
cana-5161	53	11	treated	treat	VERB
cana-5161	53	12	with	with	ADP
cana-5161	53	13	agmatine	agmatine	NOUN
cana-5161	53	14	have	have	AUX
cana-5161	53	15	predominantly	predominantly	ADV
cana-5161	53	16	demonstrated	demonstrate	VERB
cana-5161	53	17	that	that	SCONJ
cana-5161	53	18	agmatine	agmatine	NOUN
cana-5161	53	19	alleviates	alleviate	VERB
cana-5161	53	20	cognitive	cognitive	ADJ
cana-5161	53	21	deficits	deficit	NOUN
cana-5161	53	22	(	(	PUNCT
cana-5161	53	23	song	song	NOUN
cana-5161	53	24	et	et	PROPN
cana-5161	53	25	al	al	PROPN
cana-5161	53	26	.	.	PROPN
cana-5161	53	27	,	,	PUNCT
cana-5161	53	28	2014	2014	NUM
cana-5161	53	29	)	)	PUNCT
cana-5161	53	30	.	.	PUNCT
cana-5161	54	1	there	there	PRON
cana-5161	54	2	are	be	VERB
cana-5161	54	3	no	no	DET
cana-5161	54	4	studies	study	NOUN
cana-5161	54	5	till	till	SCONJ
cana-5161	54	6	date	date	NOUN
cana-5161	54	7	that	that	PRON
cana-5161	54	8	have	have	AUX
cana-5161	54	9	examined	examine	VERB
cana-5161	54	10	the	the	DET
cana-5161	54	11	biochemical	biochemical	ADJ
cana-5161	54	12	and	and	CCONJ
cana-5161	54	13	molecular	molecular	ADJ
cana-5161	54	14	role	role	NOUN
cana-5161	54	15	of	of	ADP
cana-5161	54	16	agmatine	agmatine	NOUN
cana-5161	54	17	in	in	ADP
cana-5161	54	18	counteracting	counteract	VERB
cana-5161	54	19	neurotoxicity	neurotoxicity	NOUN
cana-5161	54	20	induced	induce	VERB
cana-5161	54	21	by	by	ADP
cana-5161	54	22	aluminium	aluminium	NOUN
cana-5161	54	23	chloride	chloride	NOUN
cana-5161	54	24	(	(	PUNCT
cana-5161	54	25	alcl₃	alcl₃	NOUN
cana-5161	54	26	)	)	PUNCT
cana-5161	54	27	.	.	PUNCT
cana-5161	55	1	this	this	DET
cana-5161	55	2	research	research	NOUN
cana-5161	55	3	aims	aim	VERB
cana-5161	55	4	to	to	PART
cana-5161	55	5	address	address	VERB
cana-5161	55	6	this	this	DET
cana-5161	55	7	gap	gap	NOUN
cana-5161	55	8	by	by	ADP
cana-5161	55	9	evaluating	evaluate	VERB
cana-5161	55	10	the	the	DET
cana-5161	55	11	behavioral	behavioral	ADJ
cana-5161	55	12	,	,	PUNCT
cana-5161	55	13	biochemical	biochemical	ADJ
cana-5161	55	14	,	,	PUNCT
cana-5161	55	15	and	and	CCONJ
cana-5161	55	16	neurochemical	neurochemical	ADJ
cana-5161	55	17	alterations	alteration	NOUN
cana-5161	55	18	caused	cause	VERB
cana-5161	55	19	by	by	ADP
cana-5161	55	20	alcl₃	alcl₃	NOUN
cana-5161	55	21	in	in	ADP
cana-5161	55	22	the	the	DET
cana-5161	55	23	rat	rat	NOUN
cana-5161	55	24	brain	brain	NOUN
cana-5161	55	25	.	.	PUNCT
cana-5161	56	1	considering	consider	VERB
cana-5161	56	2	these	these	DET
cana-5161	56	3	factors	factor	NOUN
cana-5161	56	4	,	,	PUNCT
cana-5161	56	5	the	the	DET
cana-5161	56	6	present	present	ADJ
cana-5161	56	7	study	study	NOUN
cana-5161	56	8	has	have	AUX
cana-5161	56	9	been	be	AUX
cana-5161	56	10	designed	design	VERB
cana-5161	56	11	to	to	PART
cana-5161	56	12	investigate	investigate	VERB
cana-5161	56	13	the	the	DET
cana-5161	56	14	pharmacological	pharmacological	ADJ
cana-5161	56	15	potential	potential	NOUN
cana-5161	56	16	of	of	ADP
cana-5161	56	17	agmatine	agmatine	NOUN
cana-5161	56	18	in	in	ADP
cana-5161	56	19	mitigating	mitigate	VERB
cana-5161	56	20	aluminium	aluminium	NOUN
cana-5161	56	21	chloride	chloride	NOUN
cana-5161	56	22	-	-	PUNCT
cana-5161	56	23	induced	induce	VERB
cana-5161	56	24	neurotoxicity	neurotoxicity	NOUN
cana-5161	56	25	and	and	CCONJ
cana-5161	56	26	associated	associated	ADJ
cana-5161	56	27	cognitive	cognitive	ADJ
cana-5161	56	28	decline	decline	NOUN
cana-5161	56	29	in	in	ADP
cana-5161	56	30	rats	rat	NOUN
cana-5161	56	31	.	.	PUNCT
cana-5161	57	1	2	2	X
cana-5161	57	2	.	.	X
cana-5161	57	3	materials	material	NOUN
cana-5161	57	4	and	and	CCONJ
cana-5161	57	5	methods	method	NOUN
cana-5161	57	6	2.1	2.1	NUM
cana-5161	57	7	animals	animal	NOUN
cana-5161	57	8	in	in	ADP
cana-5161	57	9	the	the	DET
cana-5161	57	10	present	present	ADJ
cana-5161	57	11	study	study	NOUN
cana-5161	57	12	,	,	PUNCT
cana-5161	57	13	experiments	experiment	NOUN
cana-5161	57	14	were	be	AUX
cana-5161	57	15	conducted	conduct	VERB
cana-5161	57	16	using	use	VERB
cana-5161	57	17	male	male	PROPN
cana-5161	57	18	wistar	wistar	PROPN
cana-5161	57	19	rats	rat	NOUN
cana-5161	57	20	weighing	weigh	VERB
cana-5161	57	21	200–250	200–250	NUM
cana-5161	57	22	g	g	NOUN
cana-5161	57	23	,	,	PUNCT
cana-5161	57	24	procured	procure	VERB
cana-5161	57	25	from	from	ADP
cana-5161	57	26	llruvas	llruvas	PROPN
cana-5161	57	27	,	,	PUNCT
cana-5161	57	28	hisar	hisar	PROPN
cana-5161	57	29	.	.	PUNCT
cana-5161	58	1	the	the	DET
cana-5161	58	2	animals	animal	NOUN
cana-5161	58	3	were	be	AUX
cana-5161	58	4	housed	house	VERB
cana-5161	58	5	in	in	ADP
cana-5161	58	6	the	the	DET
cana-5161	58	7	animal	animal	NOUN
cana-5161	58	8	facility	facility	NOUN
cana-5161	58	9	of	of	ADP
cana-5161	58	10	isf	isf	PROPN
cana-5161	58	11	college	college	PROPN
cana-5161	58	12	of	of	ADP
cana-5161	58	13	pharmacy	pharmacy	NOUN
cana-5161	58	14	,	,	PUNCT
cana-5161	58	15	moga	moga	PROPN
cana-5161	58	16	,	,	PUNCT
cana-5161	58	17	punjab	punjab	PROPN
cana-5161	58	18	,	,	PUNCT
cana-5161	58	19	india	india	PROPN
cana-5161	58	20	,	,	PUNCT
cana-5161	58	21	and	and	CCONJ
cana-5161	58	22	provided	provide	VERB
cana-5161	58	23	with	with	ADP
cana-5161	58	24	food	food	NOUN
cana-5161	58	25	and	and	CCONJ
cana-5161	58	26	water	water	NOUN
cana-5161	58	27	ad	ad	NOUN
cana-5161	58	28	libitum	libitum	PROPN
cana-5161	58	29	.	.	PUNCT
cana-5161	59	1	the	the	DET
cana-5161	59	2	rats	rat	NOUN
cana-5161	59	3	were	be	AUX
cana-5161	59	4	maintained	maintain	VERB
cana-5161	59	5	in	in	ADP
cana-5161	59	6	polyacrylic	polyacrylic	ADJ
cana-5161	59	7	cages	cage	NOUN
cana-5161	59	8	under	under	ADP
cana-5161	59	9	standard	standard	ADJ
cana-5161	59	10	husbandry	husbandry	ADJ
cana-5161	59	11	conditions	condition	NOUN
cana-5161	59	12	,	,	PUNCT
cana-5161	59	13	including	include	VERB
cana-5161	59	14	a	a	DET
cana-5161	59	15	controlled	control	VERB
cana-5161	59	16	room	room	NOUN
cana-5161	59	17	temperature	temperature	NOUN
cana-5161	59	18	of	of	ADP
cana-5161	59	19	22±2	22±2	NUM
cana-5161	59	20	°	°	NOUN
cana-5161	59	21	c	c	NOUN
cana-5161	59	22	,	,	PUNCT
cana-5161	59	23	relative	relative	ADJ
cana-5161	59	24	humidity	humidity	NOUN
cana-5161	59	25	of	of	ADP
cana-5161	59	26	55–60	55–60	NUM
cana-5161	59	27	%	%	NOUN
cana-5161	59	28	,	,	PUNCT
cana-5161	59	29	and	and	CCONJ
cana-5161	59	30	a	a	DET
cana-5161	59	31	12	12	NUM
cana-5161	59	32	-	-	PUNCT
cana-5161	59	33	hour	hour	NOUN
cana-5161	59	34	light	light	ADJ
cana-5161	59	35	/	/	SYM
cana-5161	59	36	dark	dark	ADJ
cana-5161	59	37	cycle	cycle	NOUN
cana-5161	59	38	(	(	PUNCT
cana-5161	59	39	lights	light	NOUN
cana-5161	59	40	on	on	ADP
cana-5161	59	41	at	at	ADP
cana-5161	59	42	7:00	7:00	NUM
cana-5161	59	43	am	am	NOUN
cana-5161	59	44	)	)	PUNCT
cana-5161	59	45	.	.	PUNCT
cana-5161	60	1	behavioral	behavioral	ADJ
cana-5161	60	2	analyses	analysis	NOUN
cana-5161	60	3	were	be	AUX
cana-5161	60	4	performed	perform	VERB
cana-5161	60	5	during	during	ADP
cana-5161	60	6	the	the	DET
cana-5161	60	7	animals	animal	NOUN
cana-5161	60	8	'	'	PART
cana-5161	60	9	active	active	ADJ
cana-5161	60	10	phase	phase	NOUN
cana-5161	60	11	,	,	PUNCT
cana-5161	60	12	between	between	ADP
cana-5161	60	13	19:00	19:00	NUM
cana-5161	60	14	and	and	CCONJ
cana-5161	60	15	23:00	23:00	NUM
cana-5161	60	16	hours	hour	NOUN
cana-5161	60	17	.	.	PUNCT
cana-5161	61	1	the	the	DET
cana-5161	61	2	experimental	experimental	ADJ
cana-5161	61	3	protocol	protocol	NOUN
cana-5161	61	4	was	be	AUX
cana-5161	61	5	reviewed	review	VERB
cana-5161	61	6	and	and	CCONJ
cana-5161	61	7	approved	approve	VERB
cana-5161	61	8	by	by	ADP
cana-5161	61	9	the	the	DET
cana-5161	61	10	institutional	institutional	ADJ
cana-5161	61	11	animal	animal	NOUN
cana-5161	61	12	ethics	ethic	NOUN
cana-5161	61	13	committee	committee	NOUN
cana-5161	61	14	(	(	PUNCT
cana-5161	61	15	iaec	iaec	NOUN
cana-5161	61	16	)	)	PUNCT
cana-5161	61	17	and	and	CCONJ
cana-5161	61	18	conducted	conduct	VERB
cana-5161	61	19	in	in	ADP
cana-5161	61	20	accordance	accordance	NOUN
cana-5161	61	21	with	with	ADP
cana-5161	61	22	the	the	DET
cana-5161	61	23	guidelines	guideline	NOUN
cana-5161	61	24	of	of	ADP
cana-5161	61	25	the	the	DET
cana-5161	61	26	indian	indian	ADJ
cana-5161	61	27	national	national	PROPN
cana-5161	61	28	science	science	PROPN
cana-5161	61	29	academy	academy	PROPN
cana-5161	61	30	(	(	PUNCT
cana-5161	61	31	insa	insa	PROPN
cana-5161	61	32	)	)	PUNCT
cana-5161	61	33	for	for	ADP
cana-5161	61	34	the	the	DET
cana-5161	61	35	care	care	NOUN
cana-5161	61	36	and	and	CCONJ
cana-5161	61	37	use	use	NOUN
cana-5161	61	38	of	of	ADP
cana-5161	61	39	experimental	experimental	ADJ
cana-5161	61	40	animals	animal	NOUN
cana-5161	61	41	.	.	PUNCT
cana-5161	62	1	2.2	2.2	NUM
cana-5161	62	2	drugs	drug	NOUN
cana-5161	62	3	and	and	CCONJ
cana-5161	62	4	chemicals	chemical	NOUN
cana-5161	62	5	aluminium	aluminium	NOUN
cana-5161	62	6	chloride	chloride	NOUN
cana-5161	62	7	(	(	PUNCT
cana-5161	62	8	alcl3	alcl3	NOUN
cana-5161	62	9	)	)	PUNCT
cana-5161	62	10	was	be	AUX
cana-5161	62	11	purchased	purchase	VERB
cana-5161	62	12	from	from	ADP
cana-5161	62	13	loba	loba	PROPN
cana-5161	62	14	,	,	PUNCT
cana-5161	62	15	india	india	PROPN
cana-5161	62	16	,	,	PUNCT
cana-5161	62	17	whereas	whereas	SCONJ
cana-5161	62	18	agmatine	agmatine	NOUN
cana-5161	62	19	was	be	AUX
cana-5161	62	20	purchased	purchase	VERB
cana-5161	62	21	from	from	ADP
cana-5161	62	22	sigmaaldrich	sigmaaldrich	PROPN
cana-5161	62	23	,	,	PUNCT
cana-5161	62	24	usa	usa	PROPN
cana-5161	62	25	.	.	PROPN
cana-5161	63	1	alcl3	alcl3	PROPN
cana-5161	64	1	was	be	AUX
cana-5161	64	2	dissolved	dissolve	VERB
cana-5161	64	3	in	in	ADP
cana-5161	64	4	saline	saline	NOUN
cana-5161	64	5	(	(	PUNCT
cana-5161	64	6	abdel	abdel	PROPN
cana-5161	64	7	-	-	PUNCT
cana-5161	64	8	zaher	zaher	PROPN
cana-5161	64	9	et	et	PROPN
cana-5161	64	10	al	al	PROPN
cana-5161	64	11	.	.	PROPN
cana-5161	64	12	,	,	PUNCT
cana-5161	64	13	2017	2017	NUM
cana-5161	64	14	)	)	PUNCT
cana-5161	64	15	and	and	CCONJ
cana-5161	64	16	agmatine	agmatine	VERB
cana-5161	64	17	communications	communication	NOUN
cana-5161	64	18	on	on	ADP
cana-5161	64	19	applied	apply	VERB
cana-5161	64	20	nonlinear	nonlinear	ADJ
cana-5161	64	21	analysis	analysis	NOUN
cana-5161	64	22	issn	issn	NOUN
cana-5161	64	23	:	:	PUNCT
cana-5161	64	24	1074	1074	NUM
cana-5161	64	25	-	-	PUNCT
cana-5161	64	26	133x	133x	NUM
cana-5161	64	27	vol	vol	NOUN
cana-5161	64	28	32	32	NUM
cana-5161	64	29	no	no	NOUN
cana-5161	64	30	.	.	PUNCT
cana-5161	65	1	icmasd	icmasd	NOUN
cana-5161	65	2	(	(	PUNCT
cana-5161	65	3	2025	2025	NUM
cana-5161	65	4	)	)	PUNCT
cana-5161	65	5	1356	1356	NUM
cana-5161	65	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	65	7	was	be	AUX
cana-5161	65	8	dissolved	dissolve	VERB
cana-5161	65	9	in	in	ADP
cana-5161	65	10	distilled	distil	VERB
cana-5161	65	11	water	water	NOUN
cana-5161	65	12	.	.	PUNCT
cana-5161	66	1	all	all	DET
cana-5161	66	2	chemicals	chemical	NOUN
cana-5161	66	3	utilized	utilize	VERB
cana-5161	66	4	in	in	ADP
cana-5161	66	5	the	the	DET
cana-5161	66	6	study	study	NOUN
cana-5161	66	7	were	be	AUX
cana-5161	66	8	of	of	ADP
cana-5161	66	9	analytical	analytical	ADJ
cana-5161	66	10	grade	grade	NOUN
cana-5161	66	11	,	,	PUNCT
cana-5161	66	12	and	and	CCONJ
cana-5161	66	13	solutions	solution	NOUN
cana-5161	66	14	of	of	ADP
cana-5161	66	15	the	the	DET
cana-5161	66	16	drugs	drug	NOUN
cana-5161	66	17	and	and	CCONJ
cana-5161	66	18	chemicals	chemical	NOUN
cana-5161	66	19	were	be	AUX
cana-5161	66	20	freshly	freshly	ADV
cana-5161	66	21	prepared	prepare	VERB
cana-5161	66	22	prior	prior	ADV
cana-5161	66	23	to	to	ADP
cana-5161	66	24	use	use	NOUN
cana-5161	66	25	.	.	PUNCT
cana-5161	67	1	2.3	2.3	NUM
cana-5161	67	2	experimental	experimental	ADJ
cana-5161	67	3	protocol	protocol	NOUN
cana-5161	67	4	thirty	thirty	NUM
cana-5161	67	5	male	male	NOUN
cana-5161	67	6	wistar	wistar	PROPN
cana-5161	67	7	rats	rat	NOUN
cana-5161	67	8	of	of	ADP
cana-5161	67	9	weight	weight	NOUN
cana-5161	67	10	200–250	200–250	NUM
cana-5161	67	11	g	g	NOUN
cana-5161	67	12	were	be	AUX
cana-5161	67	13	selected	select	VERB
cana-5161	67	14	for	for	ADP
cana-5161	67	15	this	this	DET
cana-5161	67	16	study	study	NOUN
cana-5161	67	17	.	.	PUNCT
cana-5161	68	1	animals	animal	NOUN
cana-5161	68	2	were	be	AUX
cana-5161	68	3	divided	divide	VERB
cana-5161	68	4	into	into	ADP
cana-5161	68	5	five	five	NUM
cana-5161	68	6	groups	group	NOUN
cana-5161	68	7	;	;	PUNCT
cana-5161	68	8	each	each	DET
cana-5161	68	9	group	group	NOUN
cana-5161	68	10	has	have	VERB
cana-5161	68	11	6	6	NUM
cana-5161	68	12	animals	animal	NOUN
cana-5161	68	13	.	.	PUNCT
cana-5161	69	1	group	group	NOUN
cana-5161	69	2	1	1	NUM
cana-5161	69	3	vehicle	vehicle	NOUN
cana-5161	69	4	control	control	NOUN
cana-5161	69	5	group	group	NOUN
cana-5161	69	6	(	(	PUNCT
cana-5161	69	7	0.9	0.9	NUM
cana-5161	69	8	%	%	NOUN
cana-5161	69	9	saline	saline	NOUN
cana-5161	69	10	treated	treat	VERB
cana-5161	69	11	)	)	PUNCT
cana-5161	69	12	group	group	NOUN
cana-5161	69	13	2	2	NUM
cana-5161	69	14	alcl3	alcl3	NOUN
cana-5161	69	15	(	(	PUNCT
cana-5161	69	16	100	100	NUM
cana-5161	69	17	mg	mg	NUM
cana-5161	69	18	/	/	SYM
cana-5161	69	19	kg	kg	PROPN
cana-5161	69	20	,	,	PUNCT
cana-5161	69	21	p.o	p.o	PROPN
cana-5161	69	22	)	)	PUNCT
cana-5161	69	23	group	group	NOUN
cana-5161	69	24	3	3	NUM
cana-5161	69	25	alcl3	alcl3	NOUN
cana-5161	69	26	+	+	X
cana-5161	69	27	agmatine	agmatine	NOUN
cana-5161	69	28	(	(	PUNCT
cana-5161	69	29	3	3	NUM
cana-5161	69	30	mg	mg	PROPN
cana-5161	69	31	/	/	SYM
cana-5161	69	32	kg	kg	PROPN
cana-5161	69	33	,	,	PUNCT
cana-5161	69	34	i.p	i.p	PROPN
cana-5161	69	35	)	)	PUNCT
cana-5161	69	36	group	group	NOUN
cana-5161	69	37	4	4	NUM
cana-5161	69	38	alcl3	alcl3	NOUN
cana-5161	69	39	+	+	X
cana-5161	69	40	agmatine	agmatine	NOUN
cana-5161	69	41	(	(	PUNCT
cana-5161	69	42	10	10	NUM
cana-5161	69	43	mg	mg	NUM
cana-5161	69	44	/	/	SYM
cana-5161	69	45	kg	kg	PROPN
cana-5161	69	46	,	,	PUNCT
cana-5161	69	47	i.p	i.p	PROPN
cana-5161	69	48	)	)	PUNCT
cana-5161	69	49	group	group	NOUN
cana-5161	69	50	5	5	NUM
cana-5161	69	51	alcl3	alcl3	NOUN
cana-5161	69	52	+	+	X
cana-5161	69	53	agmatine	agmatine	NOUN
cana-5161	69	54	(	(	PUNCT
cana-5161	69	55	30	30	NUM
cana-5161	69	56	mg	mg	NUM
cana-5161	69	57	/	/	SYM
cana-5161	69	58	kg	kg	PROPN
cana-5161	69	59	,	,	PUNCT
cana-5161	69	60	i.p	i.p	PROPN
cana-5161	69	61	)	)	PUNCT
cana-5161	69	62	2.4	2.4	NUM
cana-5161	69	63	experimental	experimental	ADJ
cana-5161	69	64	procedure	procedure	NOUN
cana-5161	69	65	all	all	DET
cana-5161	69	66	experimental	experimental	ADJ
cana-5161	69	67	groups	group	NOUN
cana-5161	69	68	were	be	AUX
cana-5161	69	69	administered	administer	VERB
cana-5161	69	70	aluminium	aluminium	NOUN
cana-5161	69	71	chloride	chloride	NOUN
cana-5161	69	72	(	(	PUNCT
cana-5161	69	73	alcl₃	alcl₃	NOUN
cana-5161	69	74	)	)	PUNCT
cana-5161	69	75	once	once	ADV
cana-5161	69	76	daily	daily	ADV
cana-5161	69	77	for	for	ADP
cana-5161	69	78	21	21	NUM
cana-5161	69	79	consecutive	consecutive	ADJ
cana-5161	69	80	days	day	NOUN
cana-5161	69	81	.	.	PUNCT
cana-5161	70	1	on	on	ADP
cana-5161	70	2	the	the	DET
cana-5161	70	3	14th	14th	ADJ
cana-5161	70	4	day	day	NOUN
cana-5161	70	5	,	,	PUNCT
cana-5161	70	6	the	the	DET
cana-5161	70	7	animals	animal	NOUN
cana-5161	70	8	received	receive	VERB
cana-5161	70	9	agmatine	agmatine	NOUN
cana-5161	70	10	treatment	treatment	NOUN
cana-5161	70	11	at	at	ADP
cana-5161	70	12	doses	dose	NOUN
cana-5161	70	13	of	of	ADP
cana-5161	70	14	3	3	NUM
cana-5161	70	15	,	,	PUNCT
cana-5161	70	16	10	10	NUM
cana-5161	70	17	,	,	PUNCT
cana-5161	70	18	and	and	CCONJ
cana-5161	70	19	30	30	NUM
cana-5161	70	20	mg	mg	NUM
cana-5161	70	21	/	/	SYM
cana-5161	70	22	kg	kg	PROPN
cana-5161	70	23	via	via	ADP
cana-5161	70	24	intraperitoneal	intraperitoneal	NOUN
cana-5161	70	25	(	(	PUNCT
cana-5161	70	26	i.p	i.p	PROPN
cana-5161	70	27	.	.	PROPN
cana-5161	70	28	)	)	PUNCT
cana-5161	70	29	injection	injection	NOUN
cana-5161	70	30	.	.	PUNCT
cana-5161	71	1	body	body	NOUN
cana-5161	71	2	weight	weight	NOUN
cana-5161	71	3	measurements	measurement	NOUN
cana-5161	71	4	and	and	CCONJ
cana-5161	71	5	behavioral	behavioral	ADJ
cana-5161	71	6	observations	observation	NOUN
cana-5161	71	7	were	be	AUX
cana-5161	71	8	recorded	record	VERB
cana-5161	71	9	both	both	CCONJ
cana-5161	71	10	prior	prior	ADV
cana-5161	71	11	to	to	ADP
cana-5161	71	12	and	and	CCONJ
cana-5161	71	13	following	follow	VERB
cana-5161	71	14	the	the	DET
cana-5161	71	15	completion	completion	NOUN
cana-5161	71	16	of	of	ADP
cana-5161	71	17	the	the	DET
cana-5161	71	18	experiment	experiment	NOUN
cana-5161	71	19	.	.	PUNCT
cana-5161	72	1	from	from	ADP
cana-5161	72	2	days	day	NOUN
cana-5161	72	3	15	15	NUM
cana-5161	72	4	to	to	PART
cana-5161	72	5	19	19	NUM
cana-5161	72	6	,	,	PUNCT
cana-5161	72	7	the	the	DET
cana-5161	72	8	animals	animal	NOUN
cana-5161	72	9	underwent	undergo	VERB
cana-5161	72	10	the	the	DET
cana-5161	72	11	morris	morris	PROPN
cana-5161	72	12	water	water	PROPN
cana-5161	72	13	maze	maze	NOUN
cana-5161	72	14	test	test	NOUN
cana-5161	72	15	as	as	ADP
cana-5161	72	16	a	a	DET
cana-5161	72	17	behavioral	behavioral	ADJ
cana-5161	72	18	assessment	assessment	NOUN
cana-5161	72	19	.	.	PUNCT
cana-5161	73	1	on	on	ADP
cana-5161	73	2	days	day	NOUN
cana-5161	73	3	20	20	NUM
cana-5161	73	4	and	and	CCONJ
cana-5161	73	5	21	21	NUM
cana-5161	73	6	,	,	PUNCT
cana-5161	73	7	the	the	DET
cana-5161	73	8	animals	animal	NOUN
cana-5161	73	9	were	be	AUX
cana-5161	73	10	subjected	subject	VERB
cana-5161	73	11	to	to	ADP
cana-5161	73	12	the	the	DET
cana-5161	73	13	object	object	NOUN
cana-5161	73	14	recognition	recognition	NOUN
cana-5161	73	15	task	task	NOUN
cana-5161	73	16	(	(	PUNCT
cana-5161	73	17	ort	ort	NOUN
cana-5161	73	18	)	)	PUNCT
cana-5161	73	19	and	and	CCONJ
cana-5161	73	20	the	the	DET
cana-5161	73	21	open	open	ADJ
cana-5161	73	22	field	field	NOUN
cana-5161	73	23	test	test	NOUN
cana-5161	73	24	.	.	PUNCT
cana-5161	74	1	twenty	twenty	NUM
cana-5161	74	2	-	-	PUNCT
cana-5161	74	3	four	four	NUM
cana-5161	74	4	hours	hour	NOUN
cana-5161	74	5	after	after	ADP
cana-5161	74	6	the	the	DET
cana-5161	74	7	final	final	ADJ
cana-5161	74	8	dose	dose	NOUN
cana-5161	74	9	administration	administration	NOUN
cana-5161	74	10	,	,	PUNCT
cana-5161	74	11	the	the	DET
cana-5161	74	12	animals	animal	NOUN
cana-5161	74	13	were	be	AUX
cana-5161	74	14	euthanized	euthanize	VERB
cana-5161	74	15	,	,	PUNCT
cana-5161	74	16	and	and	CCONJ
cana-5161	74	17	their	their	PRON
cana-5161	74	18	organs	organ	NOUN
cana-5161	74	19	were	be	AUX
cana-5161	74	20	harvested	harvest	VERB
cana-5161	74	21	,	,	PUNCT
cana-5161	74	22	cleaned	clean	VERB
cana-5161	74	23	,	,	PUNCT
cana-5161	74	24	washed	wash	VERB
cana-5161	74	25	with	with	ADP
cana-5161	74	26	phosphate	phosphate	NOUN
cana-5161	74	27	-	-	PUNCT
cana-5161	74	28	buffered	buffer	VERB
cana-5161	74	29	saline	saline	NOUN
cana-5161	74	30	(	(	PUNCT
cana-5161	74	31	pbs	pbs	PROPN
cana-5161	74	32	,	,	PUNCT
cana-5161	74	33	ph	ph	NOUN
cana-5161	74	34	7.4	7.4	NUM
cana-5161	74	35	)	)	PUNCT
cana-5161	74	36	,	,	PUNCT
cana-5161	74	37	and	and	CCONJ
cana-5161	74	38	subsequently	subsequently	ADV
cana-5161	74	39	used	use	VERB
cana-5161	74	40	for	for	ADP
cana-5161	74	41	various	various	ADJ
cana-5161	74	42	analyses	analysis	NOUN
cana-5161	74	43	.	.	PUNCT
cana-5161	75	1	2.5	2.5	NUM
cana-5161	75	2	behavioral	behavioral	ADJ
cana-5161	75	3	assessment	assessment	NOUN
cana-5161	75	4	2.5.1	2.5.1	NUM
cana-5161	75	5	open	open	ADJ
cana-5161	75	6	field	field	NOUN
cana-5161	75	7	on	on	ADP
cana-5161	75	8	day	day	NOUN
cana-5161	75	9	21	21	NUM
cana-5161	75	10	,	,	PUNCT
cana-5161	75	11	each	each	DET
cana-5161	75	12	animal	animal	NOUN
cana-5161	75	13	was	be	AUX
cana-5161	75	14	assessed	assess	VERB
cana-5161	75	15	for	for	ADP
cana-5161	75	16	locomotor	locomotor	NOUN
cana-5161	75	17	activity	activity	NOUN
cana-5161	75	18	using	use	VERB
cana-5161	75	19	the	the	DET
cana-5161	75	20	open	open	ADJ
cana-5161	75	21	field	field	NOUN
cana-5161	75	22	test	test	NOUN
cana-5161	75	23	.	.	PUNCT
cana-5161	76	1	the	the	DET
cana-5161	76	2	test	test	NOUN
cana-5161	76	3	measures	measure	NOUN
cana-5161	76	4	both	both	CCONJ
cana-5161	76	5	horizontal	horizontal	ADJ
cana-5161	76	6	and	and	CCONJ
cana-5161	76	7	vertical	vertical	ADJ
cana-5161	76	8	activity	activity	NOUN
cana-5161	76	9	,	,	PUNCT
cana-5161	76	10	as	as	ADV
cana-5161	76	11	well	well	ADV
cana-5161	76	12	as	as	ADP
cana-5161	76	13	activity	activity	NOUN
cana-5161	76	14	patterns	pattern	NOUN
cana-5161	76	15	.	.	PUNCT
cana-5161	77	1	the	the	DET
cana-5161	77	2	open	open	ADJ
cana-5161	77	3	field	field	NOUN
cana-5161	77	4	apparatus	apparatus	NOUN
cana-5161	77	5	consisted	consist	VERB
cana-5161	77	6	of	of	ADP
cana-5161	77	7	a	a	DET
cana-5161	77	8	wooden	wooden	ADJ
cana-5161	77	9	,	,	PUNCT
cana-5161	77	10	rectangular	rectangular	ADJ
cana-5161	77	11	chamber	chamber	NOUN
cana-5161	77	12	(	(	PUNCT
cana-5161	77	13	100×100×40	100×100×40	PROPN
cana-5161	77	14	cm	cm	NOUN
cana-5161	77	15	)	)	PUNCT
cana-5161	77	16	with	with	ADP
cana-5161	77	17	a	a	DET
cana-5161	77	18	light	light	ADJ
cana-5161	77	19	brown	brown	ADJ
cana-5161	77	20	color	color	NOUN
cana-5161	77	21	.	.	PUNCT
cana-5161	78	1	the	the	DET
cana-5161	78	2	floor	floor	NOUN
cana-5161	78	3	of	of	ADP
cana-5161	78	4	the	the	DET
cana-5161	78	5	apparatus	apparatus	NOUN
cana-5161	78	6	was	be	AUX
cana-5161	78	7	subdivided	subdivide	VERB
cana-5161	78	8	into	into	ADP
cana-5161	78	9	25	25	NUM
cana-5161	78	10	rectangular	rectangular	ADJ
cana-5161	78	11	squares	square	NOUN
cana-5161	78	12	using	use	VERB
cana-5161	78	13	pencil	pencil	NOUN
cana-5161	78	14	lines	line	NOUN
cana-5161	78	15	.	.	PUNCT
cana-5161	79	1	the	the	DET
cana-5161	79	2	experimental	experimental	ADJ
cana-5161	79	3	room	room	NOUN
cana-5161	79	4	was	be	AUX
cana-5161	79	5	illuminated	illuminate	VERB
cana-5161	79	6	by	by	ADP
cana-5161	79	7	a	a	DET
cana-5161	79	8	40	40	NUM
cana-5161	79	9	-	-	PUNCT
cana-5161	79	10	watt	watt	NOUN
cana-5161	79	11	white	white	PROPN
cana-5161	79	12	bulb	bulb	PROPN
cana-5161	79	13	positioned	position	VERB
cana-5161	79	14	150	150	NUM
cana-5161	79	15	cm	cm	NOUN
cana-5161	79	16	above	above	ADP
cana-5161	79	17	the	the	DET
cana-5161	79	18	apparatus	apparatus	NOUN
cana-5161	79	19	.	.	PUNCT
cana-5161	80	1	the	the	DET
cana-5161	80	2	animal	animal	NOUN
cana-5161	80	3	was	be	AUX
cana-5161	80	4	placed	place	VERB
cana-5161	80	5	at	at	ADP
cana-5161	80	6	the	the	DET
cana-5161	80	7	center	center	NOUN
cana-5161	80	8	of	of	ADP
cana-5161	80	9	the	the	DET
cana-5161	80	10	apparatus	apparatus	NOUN
cana-5161	80	11	two	two	NUM
cana-5161	80	12	hours	hour	NOUN
cana-5161	80	13	after	after	ADP
cana-5161	80	14	an	an	DET
cana-5161	80	15	initial	initial	ADJ
cana-5161	80	16	exposure	exposure	NOUN
cana-5161	80	17	.	.	PUNCT
cana-5161	81	1	during	during	ADP
cana-5161	81	2	the	the	DET
cana-5161	81	3	10	10	NUM
cana-5161	81	4	-	-	PUNCT
cana-5161	81	5	minute	minute	NOUN
cana-5161	81	6	observation	observation	NOUN
cana-5161	81	7	period	period	NOUN
cana-5161	81	8	,	,	PUNCT
cana-5161	81	9	the	the	DET
cana-5161	81	10	number	number	NOUN
cana-5161	81	11	of	of	ADP
cana-5161	81	12	squares	square	NOUN
cana-5161	81	13	crossed	cross	VERB
cana-5161	81	14	,	,	PUNCT
cana-5161	81	15	grooming	groom	VERB
cana-5161	81	16	behavior	behavior	NOUN
cana-5161	81	17	,	,	PUNCT
cana-5161	81	18	and	and	CCONJ
cana-5161	81	19	rearing	rear	VERB
cana-5161	81	20	events	event	NOUN
cana-5161	81	21	were	be	AUX
cana-5161	81	22	recorded	record	VERB
cana-5161	81	23	.	.	PUNCT
cana-5161	82	1	a	a	DET
cana-5161	82	2	crossing	crossing	NOUN
cana-5161	82	3	was	be	AUX
cana-5161	82	4	defined	define	VERB
cana-5161	82	5	as	as	ADP
cana-5161	82	6	the	the	DET
cana-5161	82	7	animal	animal	NOUN
cana-5161	82	8	placing	place	VERB
cana-5161	82	9	all	all	DET
cana-5161	82	10	four	four	NUM
cana-5161	82	11	paws	paw	NOUN
cana-5161	82	12	into	into	ADP
cana-5161	82	13	a	a	DET
cana-5161	82	14	new	new	ADJ
cana-5161	82	15	square	square	NOUN
cana-5161	82	16	.	.	PUNCT
cana-5161	83	1	after	after	ADP
cana-5161	83	2	each	each	DET
cana-5161	83	3	trial	trial	NOUN
cana-5161	83	4	,	,	PUNCT
cana-5161	83	5	the	the	DET
cana-5161	83	6	apparatus	apparatus	NOUN
cana-5161	83	7	was	be	AUX
cana-5161	83	8	thoroughly	thoroughly	ADV
cana-5161	83	9	cleaned	clean	VERB
cana-5161	83	10	.	.	PUNCT
cana-5161	84	1	total	total	ADJ
cana-5161	84	2	locomotor	locomotor	NOUN
cana-5161	84	3	activity	activity	NOUN
cana-5161	84	4	was	be	AUX
cana-5161	84	5	calculated	calculate	VERB
cana-5161	84	6	by	by	ADP
cana-5161	84	7	summing	sum	VERB
cana-5161	84	8	the	the	DET
cana-5161	84	9	number	number	NOUN
cana-5161	84	10	of	of	ADP
cana-5161	84	11	squares	square	NOUN
cana-5161	84	12	crossed	cross	VERB
cana-5161	84	13	,	,	PUNCT
cana-5161	84	14	grooming	groom	VERB
cana-5161	84	15	events	event	NOUN
cana-5161	84	16	,	,	PUNCT
cana-5161	84	17	and	and	CCONJ
cana-5161	84	18	rearing	rear	VERB
cana-5161	84	19	occurrences	occurrence	NOUN
cana-5161	84	20	over	over	ADP
cana-5161	84	21	the	the	DET
cana-5161	84	22	10	10	NUM
cana-5161	84	23	-	-	PUNCT
cana-5161	84	24	minute	minute	NOUN
cana-5161	84	25	period	period	NOUN
cana-5161	84	26	(	(	PUNCT
cana-5161	84	27	thangarajan	thangarajan	NOUN
cana-5161	84	28	et	et	NOUN
cana-5161	84	29	al	al	PROPN
cana-5161	84	30	.	.	PROPN
cana-5161	84	31	,	,	PUNCT
cana-5161	84	32	2014	2014	NUM
cana-5161	84	33	)	)	PUNCT
cana-5161	84	34	.	.	PUNCT
cana-5161	85	1	2.5.2	2.5.2	NUM
cana-5161	85	2	object	object	NOUN
cana-5161	85	3	recognition	recognition	NOUN
cana-5161	85	4	test	test	NOUN
cana-5161	85	5	(	(	PUNCT
cana-5161	85	6	ort	ort	NOUN
cana-5161	85	7	)	)	PUNCT
cana-5161	85	8	the	the	DET
cana-5161	85	9	object	object	NOUN
cana-5161	85	10	recognition	recognition	NOUN
cana-5161	85	11	task	task	NOUN
cana-5161	85	12	(	(	PUNCT
cana-5161	85	13	ort	ort	NOUN
cana-5161	85	14	)	)	PUNCT
cana-5161	85	15	was	be	AUX
cana-5161	85	16	conducted	conduct	VERB
cana-5161	85	17	with	with	ADP
cana-5161	85	18	minor	minor	ADJ
cana-5161	85	19	modifications	modification	NOUN
cana-5161	85	20	to	to	ADP
cana-5161	85	21	the	the	DET
cana-5161	85	22	standard	standard	ADJ
cana-5161	85	23	procedure	procedure	NOUN
cana-5161	85	24	(	(	PUNCT
cana-5161	85	25	pitsikas	pitsikas	NOUN
cana-5161	85	26	et	et	PROPN
cana-5161	85	27	al	al	PROPN
cana-5161	85	28	.	.	PROPN
cana-5161	85	29	,	,	PUNCT
cana-5161	85	30	2001	2001	NUM
cana-5161	85	31	,	,	PUNCT
cana-5161	85	32	giorgetti	giorgetti	VERB
cana-5161	85	33	et	et	PROPN
cana-5161	85	34	al	al	PROPN
cana-5161	85	35	.	.	PROPN
cana-5161	85	36	,	,	PUNCT
cana-5161	85	37	2010	2010	NUM
cana-5161	85	38	)	)	PUNCT
cana-5161	85	39	.	.	PUNCT
cana-5161	86	1	the	the	DET
cana-5161	86	2	test	test	NOUN
cana-5161	86	3	used	use	VERB
cana-5161	86	4	a	a	DET
cana-5161	86	5	wooden	wooden	ADJ
cana-5161	86	6	open	open	ADJ
cana-5161	86	7	box	box	NOUN
cana-5161	86	8	(	(	PUNCT
cana-5161	86	9	80	80	NUM
cana-5161	86	10	×	×	NOUN
cana-5161	86	11	60	60	NUM
cana-5161	86	12	×	×	NOUN
cana-5161	86	13	40	40	NUM
cana-5161	86	14	cm³	cm³	NOUN
cana-5161	86	15	)	)	PUNCT
cana-5161	86	16	with	with	ADP
cana-5161	86	17	two	two	NUM
cana-5161	86	18	distinct	distinct	ADJ
cana-5161	86	19	wooden	wooden	ADJ
cana-5161	86	20	objects	object	NOUN
cana-5161	86	21	(	(	PUNCT
cana-5161	86	22	triangle	triangle	NOUN
cana-5161	86	23	and	and	CCONJ
cana-5161	86	24	cylinder	cylinder	NOUN
cana-5161	86	25	,	,	PUNCT
cana-5161	86	26	~10	~10	ADJ
cana-5161	86	27	cm	cm	NOUN
cana-5161	86	28	height	height	NOUN
cana-5161	86	29	)	)	PUNCT
cana-5161	86	30	for	for	ADP
cana-5161	86	31	discrimination	discrimination	NOUN
cana-5161	86	32	.	.	PUNCT
cana-5161	87	1	communications	communication	NOUN
cana-5161	87	2	on	on	ADP
cana-5161	87	3	applied	apply	VERB
cana-5161	87	4	nonlinear	nonlinear	ADJ
cana-5161	87	5	analysis	analysis	NOUN
cana-5161	87	6	issn	issn	NOUN
cana-5161	87	7	:	:	PUNCT
cana-5161	87	8	1074	1074	NUM
cana-5161	87	9	-	-	PUNCT
cana-5161	87	10	133x	133x	NUM
cana-5161	87	11	vol	vol	NOUN
cana-5161	87	12	32	32	NUM
cana-5161	87	13	no	no	NOUN
cana-5161	87	14	.	.	PUNCT
cana-5161	88	1	icmasd	icmasd	NOUN
cana-5161	88	2	(	(	PUNCT
cana-5161	88	3	2025	2025	NUM
cana-5161	88	4	)	)	PUNCT
cana-5161	88	5	1357	1357	NUM
cana-5161	88	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	88	7	rats	rat	NOUN
cana-5161	88	8	habituated	habituate	VERB
cana-5161	88	9	for	for	ADP
cana-5161	88	10	15	15	NUM
cana-5161	88	11	minutes	minute	NOUN
cana-5161	88	12	before	before	ADP
cana-5161	88	13	a	a	DET
cana-5161	88	14	3	3	NUM
cana-5161	88	15	-	-	PUNCT
cana-5161	88	16	minute	minute	NOUN
cana-5161	88	17	sample	sample	NOUN
cana-5161	88	18	trial	trial	NOUN
cana-5161	88	19	(	(	PUNCT
cana-5161	88	20	t1	t1	NOUN
cana-5161	88	21	)	)	PUNCT
cana-5161	88	22	where	where	SCONJ
cana-5161	88	23	two	two	NUM
cana-5161	88	24	identical	identical	ADJ
cana-5161	88	25	objects	object	NOUN
cana-5161	88	26	were	be	AUX
cana-5161	88	27	placed	place	VERB
cana-5161	88	28	in	in	ADP
cana-5161	88	29	opposite	opposite	ADJ
cana-5161	88	30	corners	corner	NOUN
cana-5161	88	31	.	.	PUNCT
cana-5161	89	1	after	after	ADP
cana-5161	89	2	a	a	DET
cana-5161	89	3	60	60	NUM
cana-5161	89	4	-	-	PUNCT
cana-5161	89	5	minute	minute	NOUN
cana-5161	89	6	interval	interval	NOUN
cana-5161	89	7	,	,	PUNCT
cana-5161	89	8	a	a	DET
cana-5161	89	9	choice	choice	NOUN
cana-5161	89	10	trial	trial	NOUN
cana-5161	89	11	(	(	PUNCT
cana-5161	89	12	t2	t2	NOUN
cana-5161	89	13	)	)	PUNCT
cana-5161	89	14	replaced	replace	VERB
cana-5161	89	15	one	one	NUM
cana-5161	89	16	familiar	familiar	ADJ
cana-5161	89	17	object	object	NOUN
cana-5161	89	18	with	with	ADP
cana-5161	89	19	a	a	DET
cana-5161	89	20	novel	novel	ADJ
cana-5161	89	21	one	one	NOUN
cana-5161	89	22	,	,	PUNCT
cana-5161	89	23	with	with	ADP
cana-5161	89	24	positions	position	NOUN
cana-5161	89	25	counterbalanced	counterbalance	VERB
cana-5161	89	26	to	to	PART
cana-5161	89	27	avoid	avoid	VERB
cana-5161	89	28	bias	bias	NOUN
cana-5161	89	29	.	.	PUNCT
cana-5161	90	1	exploration	exploration	NOUN
cana-5161	90	2	time	time	NOUN
cana-5161	90	3	near	near	ADP
cana-5161	90	4	objects	object	NOUN
cana-5161	90	5	was	be	AUX
cana-5161	90	6	recorded	record	VERB
cana-5161	90	7	,	,	PUNCT
cana-5161	90	8	and	and	CCONJ
cana-5161	90	9	data	datum	NOUN
cana-5161	90	10	analysed	analyse	VERB
cana-5161	90	11	as	as	ADP
cana-5161	90	12	total	total	ADJ
cana-5161	90	13	exploration	exploration	NOUN
cana-5161	90	14	in	in	ADP
cana-5161	90	15	t1	t1	NOUN
cana-5161	90	16	and	and	CCONJ
cana-5161	90	17	time	time	NOUN
cana-5161	90	18	spent	spend	VERB
cana-5161	90	19	on	on	ADP
cana-5161	90	20	the	the	DET
cana-5161	90	21	novel	novel	NOUN
cana-5161	90	22	versus	versus	ADP
cana-5161	90	23	familiar	familiar	ADJ
cana-5161	90	24	object	object	NOUN
cana-5161	90	25	in	in	ADP
cana-5161	90	26	t2	t2	NOUN
cana-5161	90	27	.	.	PUNCT
cana-5161	91	1	2.5.3	2.5.3	NUM
cana-5161	91	2	morris	morris	PROPN
cana-5161	91	3	water	water	PROPN
cana-5161	91	4	maze	maze	NOUN
cana-5161	91	5	test	test	NOUN
cana-5161	91	6	the	the	DET
cana-5161	91	7	morris	morris	PROPN
cana-5161	91	8	water	water	NOUN
cana-5161	91	9	maze	maze	NOUN
cana-5161	91	10	is	be	AUX
cana-5161	91	11	commonly	commonly	ADV
cana-5161	91	12	employed	employ	VERB
cana-5161	91	13	to	to	PART
cana-5161	91	14	assess	assess	VERB
cana-5161	91	15	spatial	spatial	ADJ
cana-5161	91	16	memory	memory	NOUN
cana-5161	91	17	and	and	CCONJ
cana-5161	91	18	learning	learning	NOUN
cana-5161	91	19	(	(	PUNCT
cana-5161	91	20	morris	morris	PROPN
cana-5161	91	21	,	,	PUNCT
cana-5161	91	22	1984	1984	NUM
cana-5161	91	23	)	)	PUNCT
cana-5161	91	24	.	.	PUNCT
cana-5161	92	1	the	the	DET
cana-5161	92	2	experiment	experiment	NOUN
cana-5161	92	3	used	use	VERB
cana-5161	92	4	a	a	DET
cana-5161	92	5	circular	circular	ADJ
cana-5161	92	6	water	water	NOUN
cana-5161	92	7	tank	tank	NOUN
cana-5161	92	8	(	(	PUNCT
cana-5161	92	9	180	180	NUM
cana-5161	92	10	cm	cm	NOUN
cana-5161	92	11	diameter	diameter	NOUN
cana-5161	92	12	,	,	PUNCT
cana-5161	92	13	60	60	NUM
cana-5161	92	14	cm	cm	NOUN
cana-5161	92	15	height	height	NOUN
cana-5161	92	16	)	)	PUNCT
cana-5161	92	17	filled	fill	VERB
cana-5161	92	18	to	to	ADP
cana-5161	92	19	a	a	DET
cana-5161	92	20	depth	depth	NOUN
cana-5161	92	21	of	of	ADP
cana-5161	92	22	40	40	NUM
cana-5161	92	23	cm	cm	NOUN
cana-5161	92	24	with	with	ADP
cana-5161	92	25	opaque	opaque	ADJ
cana-5161	92	26	water	water	NOUN
cana-5161	92	27	at	at	ADP
cana-5161	92	28	25±1	25±1	NUM
cana-5161	92	29	°	°	NOUN
cana-5161	92	30	c	c	NOUN
cana-5161	92	31	.	.	PUNCT
cana-5161	93	1	a	a	DET
cana-5161	93	2	hidden	hide	VERB
cana-5161	93	3	platform	platform	NOUN
cana-5161	93	4	(	(	PUNCT
cana-5161	93	5	10	10	NUM
cana-5161	93	6	cm	cm	NOUN
cana-5161	93	7	diameter	diameter	NOUN
cana-5161	93	8	)	)	PUNCT
cana-5161	93	9	was	be	AUX
cana-5161	93	10	placed	place	VERB
cana-5161	93	11	2	2	NUM
cana-5161	93	12	cm	cm	NOUN
cana-5161	93	13	below	below	ADP
cana-5161	93	14	the	the	DET
cana-5161	93	15	surface	surface	NOUN
cana-5161	93	16	in	in	ADP
cana-5161	93	17	the	the	DET
cana-5161	93	18	center	center	NOUN
cana-5161	93	19	of	of	ADP
cana-5161	93	20	a	a	DET
cana-5161	93	21	designated	designate	VERB
cana-5161	93	22	quadrant	quadrant	NOUN
cana-5161	93	23	.	.	PUNCT
cana-5161	94	1	rats	rat	NOUN
cana-5161	94	2	underwent	undergo	VERB
cana-5161	94	3	training	training	NOUN
cana-5161	94	4	over	over	ADP
cana-5161	94	5	four	four	NUM
cana-5161	94	6	days	day	NOUN
cana-5161	94	7	(	(	PUNCT
cana-5161	94	8	days	day	NOUN
cana-5161	94	9	15	15	NUM
cana-5161	94	10	–	–	PUNCT
cana-5161	94	11	18	18	NUM
cana-5161	94	12	)	)	PUNCT
cana-5161	94	13	with	with	ADP
cana-5161	94	14	four	four	NUM
cana-5161	94	15	trials	trial	NOUN
cana-5161	94	16	per	per	ADP
cana-5161	94	17	day	day	NOUN
cana-5161	94	18	,	,	PUNCT
cana-5161	94	19	starting	start	VERB
cana-5161	94	20	from	from	ADP
cana-5161	94	21	different	different	ADJ
cana-5161	94	22	quadrants	quadrant	NOUN
cana-5161	94	23	,	,	PUNCT
cana-5161	94	24	and	and	CCONJ
cana-5161	94	25	latency	latency	NOUN
cana-5161	94	26	to	to	PART
cana-5161	94	27	locate	locate	VERB
cana-5161	94	28	the	the	DET
cana-5161	94	29	platform	platform	NOUN
cana-5161	94	30	was	be	AUX
cana-5161	94	31	recorded	record	VERB
cana-5161	94	32	.	.	PUNCT
cana-5161	95	1	on	on	ADP
cana-5161	95	2	day	day	NOUN
cana-5161	95	3	19	19	NUM
cana-5161	95	4	,	,	PUNCT
cana-5161	95	5	a	a	DET
cana-5161	95	6	probe	probe	NOUN
cana-5161	95	7	test	test	NOUN
cana-5161	95	8	assessed	assess	VERB
cana-5161	95	9	memory	memory	NOUN
cana-5161	95	10	by	by	ADP
cana-5161	95	11	measuring	measure	VERB
cana-5161	95	12	the	the	DET
cana-5161	95	13	time	time	NOUN
cana-5161	95	14	spent	spend	VERB
cana-5161	95	15	in	in	ADP
cana-5161	95	16	the	the	DET
cana-5161	95	17	target	target	NOUN
cana-5161	95	18	quadrant	quadrant	NOUN
cana-5161	95	19	after	after	SCONJ
cana-5161	95	20	the	the	DET
cana-5161	95	21	platform	platform	NOUN
cana-5161	95	22	was	be	AUX
cana-5161	95	23	removed	remove	VERB
cana-5161	95	24	.	.	PUNCT
cana-5161	96	1	2.6	2.6	NUM
cana-5161	96	2	estimation	estimation	NOUN
cana-5161	96	3	of	of	ADP
cana-5161	96	4	biochemical	biochemical	ADJ
cana-5161	96	5	parameters	parameter	NOUN
cana-5161	96	6	terminally	terminally	ADV
cana-5161	96	7	,	,	PUNCT
cana-5161	96	8	on	on	ADP
cana-5161	96	9	22	22	NUM
cana-5161	96	10	day	day	NOUN
cana-5161	96	11	,	,	PUNCT
cana-5161	96	12	the	the	DET
cana-5161	96	13	hippocampal	hippocampal	ADJ
cana-5161	96	14	rat	rat	NOUN
cana-5161	96	15	brain	brain	NOUN
cana-5161	96	16	regions	region	NOUN
cana-5161	96	17	were	be	AUX
cana-5161	96	18	dissected	dissect	VERB
cana-5161	96	19	out	out	ADP
cana-5161	96	20	,	,	PUNCT
cana-5161	96	21	homogenized	homogenize	VERB
cana-5161	96	22	and	and	CCONJ
cana-5161	96	23	the	the	DET
cana-5161	96	24	supernatant	supernatant	NOUN
cana-5161	96	25	was	be	AUX
cana-5161	96	26	used	use	VERB
cana-5161	96	27	for	for	ADP
cana-5161	96	28	further	further	ADJ
cana-5161	96	29	analysis	analysis	NOUN
cana-5161	96	30	of	of	ADP
cana-5161	96	31	biochemical	biochemical	ADJ
cana-5161	96	32	parameters	parameter	NOUN
cana-5161	96	33	.	.	PUNCT
cana-5161	97	1	2.6.1	2.6.1	NUM
cana-5161	97	2	brain	brain	NOUN
cana-5161	97	3	homogenate	homogenate	NOUN
cana-5161	97	4	preparation	preparation	NOUN
cana-5161	97	5	the	the	DET
cana-5161	97	6	animals	animal	NOUN
cana-5161	97	7	were	be	AUX
cana-5161	97	8	euthanized	euthanize	VERB
cana-5161	97	9	by	by	ADP
cana-5161	97	10	cervical	cervical	ADJ
cana-5161	97	11	dislocation	dislocation	NOUN
cana-5161	97	12	,	,	PUNCT
cana-5161	97	13	and	and	CCONJ
cana-5161	97	14	their	their	PRON
cana-5161	97	15	brains	brain	NOUN
cana-5161	97	16	were	be	AUX
cana-5161	97	17	carefully	carefully	ADV
cana-5161	97	18	extracted	extract	VERB
cana-5161	97	19	and	and	CCONJ
cana-5161	97	20	rinsed	rinse	VERB
cana-5161	97	21	with	with	ADP
cana-5161	97	22	ice	ice	NOUN
cana-5161	97	23	-	-	PUNCT
cana-5161	97	24	cold	cold	ADJ
cana-5161	97	25	isotonic	isotonic	ADJ
cana-5161	97	26	saline	saline	NOUN
cana-5161	97	27	.	.	PUNCT
cana-5161	98	1	cortical	cortical	ADJ
cana-5161	98	2	and	and	CCONJ
cana-5161	98	3	hippocampal	hippocampal	ADJ
cana-5161	98	4	tissue	tissue	NOUN
cana-5161	98	5	samples	sample	NOUN
cana-5161	98	6	were	be	AUX
cana-5161	98	7	then	then	ADV
cana-5161	98	8	homogenized	homogenize	VERB
cana-5161	98	9	in	in	ADP
cana-5161	98	10	ice	ice	NOUN
cana-5161	98	11	-	-	PUNCT
cana-5161	98	12	cold	cold	ADJ
cana-5161	98	13	0.1	0.1	NUM
cana-5161	98	14	mmol	mmol	NOUN
cana-5161	98	15	/	/	SYM
cana-5161	98	16	l	l	NOUN
cana-5161	98	17	phosphate	phosphate	NOUN
cana-5161	98	18	buffer	buffer	NOUN
cana-5161	98	19	(	(	PUNCT
cana-5161	98	20	ph	ph	NOUN
cana-5161	98	21	7.4	7.4	NUM
cana-5161	98	22	)	)	PUNCT
cana-5161	98	23	at	at	ADP
cana-5161	98	24	a	a	DET
cana-5161	98	25	10	10	NUM
cana-5161	98	26	%	%	NOUN
cana-5161	98	27	(	(	PUNCT
cana-5161	98	28	w	w	NOUN
cana-5161	98	29	/	/	SYM
cana-5161	98	30	v	v	NOUN
cana-5161	98	31	)	)	PUNCT
cana-5161	98	32	tissue	tissue	NOUN
cana-5161	98	33	-	-	PUNCT
cana-5161	98	34	to	to	ADP
cana-5161	98	35	-	-	PUNCT
cana-5161	98	36	buffer	buffer	NOUN
cana-5161	98	37	ratio	ratio	NOUN
cana-5161	98	38	.	.	PUNCT
cana-5161	99	1	the	the	DET
cana-5161	99	2	resulting	result	VERB
cana-5161	99	3	homogenate	homogenate	NOUN
cana-5161	99	4	was	be	AUX
cana-5161	99	5	subsequently	subsequently	ADV
cana-5161	99	6	centrifuged	centrifuge	VERB
cana-5161	99	7	at	at	ADP
cana-5161	99	8	10,000	10,000	NUM
cana-5161	99	9	rpm	rpm	NOUN
cana-5161	99	10	for	for	ADP
cana-5161	99	11	15	15	NUM
cana-5161	99	12	minutes	minute	NOUN
cana-5161	99	13	at	at	ADP
cana-5161	99	14	-4	-4	NOUN
cana-5161	99	15	°	°	NOUN
cana-5161	99	16	c	c	NOUN
cana-5161	99	17	.	.	PUNCT
cana-5161	100	1	the	the	DET
cana-5161	100	2	supernatant	supernatant	NOUN
cana-5161	100	3	obtained	obtain	VERB
cana-5161	100	4	was	be	AUX
cana-5161	100	5	collected	collect	VERB
cana-5161	100	6	and	and	CCONJ
cana-5161	100	7	utilized	utilize	VERB
cana-5161	100	8	for	for	ADP
cana-5161	100	9	biochemical	biochemical	ADJ
cana-5161	100	10	analyses	analysis	NOUN
cana-5161	100	11	(	(	PUNCT
cana-5161	100	12	kumar	kumar	PROPN
cana-5161	100	13	et	et	PROPN
cana-5161	100	14	al	al	PROPN
cana-5161	100	15	.	.	PROPN
cana-5161	100	16	,	,	PUNCT
cana-5161	100	17	2011	2011	NUM
cana-5161	100	18	)	)	PUNCT
cana-5161	100	19	.	.	PUNCT
cana-5161	101	1	2.6.2	2.6.2	NUM
cana-5161	101	2	protein	protein	NOUN
cana-5161	101	3	determination	determination	NOUN
cana-5161	101	4	protein	protein	NOUN
cana-5161	101	5	was	be	AUX
cana-5161	101	6	measured	measure	VERB
cana-5161	101	7	in	in	ADP
cana-5161	101	8	all	all	DET
cana-5161	101	9	brain	brain	NOUN
cana-5161	101	10	samples	sample	NOUN
cana-5161	101	11	by	by	ADP
cana-5161	101	12	the	the	DET
cana-5161	101	13	method	method	NOUN
cana-5161	101	14	of	of	ADP
cana-5161	101	15	(	(	PUNCT
cana-5161	101	16	lowry	lowry	PROPN
cana-5161	101	17	et	et	PROPN
cana-5161	101	18	al	al	PROPN
cana-5161	101	19	.	.	PROPN
cana-5161	101	20	,	,	PUNCT
cana-5161	101	21	1951	1951	NUM
cana-5161	101	22	)	)	PUNCT
cana-5161	101	23	using	use	VERB
cana-5161	101	24	bovine	bovine	NOUN
cana-5161	101	25	serum	serum	NOUN
cana-5161	101	26	albumin	albumin	PROPN
cana-5161	101	27	(	(	PUNCT
cana-5161	101	28	bsa	bsa	PROPN
cana-5161	101	29	)	)	PUNCT
cana-5161	101	30	(	(	PUNCT
cana-5161	101	31	1	1	NUM
cana-5161	101	32	mg	mg	NUM
cana-5161	101	33	/	/	SYM
cana-5161	101	34	ml	ml	NOUN
cana-5161	101	35	)	)	PUNCT
cana-5161	101	36	as	as	ADP
cana-5161	101	37	a	a	DET
cana-5161	101	38	standard	standard	NOUN
cana-5161	101	39	.	.	PUNCT
cana-5161	102	1	2.6.3	2.6.3	NUM
cana-5161	102	2	acetylcholinesterase	acetylcholinesterase	NOUN
cana-5161	102	3	activity	activity	NOUN
cana-5161	102	4	the	the	DET
cana-5161	102	5	quantitative	quantitative	ADJ
cana-5161	102	6	estimation	estimation	NOUN
cana-5161	102	7	of	of	ADP
cana-5161	102	8	acetylcholinesterase	acetylcholinesterase	NOUN
cana-5161	102	9	activity	activity	NOUN
cana-5161	102	10	in	in	ADP
cana-5161	102	11	brain	brain	NOUN
cana-5161	102	12	was	be	AUX
cana-5161	102	13	performed	perform	VERB
cana-5161	102	14	according	accord	VERB
cana-5161	102	15	to	to	ADP
cana-5161	102	16	the	the	DET
cana-5161	102	17	method	method	NOUN
cana-5161	102	18	described	describe	VERB
cana-5161	102	19	by	by	ADP
cana-5161	102	20	(	(	PUNCT
cana-5161	102	21	ellman	ellman	NOUN
cana-5161	102	22	et	et	PROPN
cana-5161	102	23	al	al	PROPN
cana-5161	102	24	.	.	PROPN
cana-5161	102	25	,	,	PUNCT
cana-5161	102	26	1961	1961	NUM
cana-5161	102	27	)	)	PUNCT
cana-5161	102	28	.	.	PUNCT
cana-5161	103	1	the	the	DET
cana-5161	103	2	assay	assay	NOUN
cana-5161	103	3	combination	combination	NOUN
cana-5161	103	4	contained	contain	VERB
cana-5161	103	5	0.10	0.10	NUM
cana-5161	103	6	ml	ml	NOUN
cana-5161	103	7	of	of	ADP
cana-5161	103	8	dtnb	dtnb	NOUN
cana-5161	103	9	(	(	PUNCT
cana-5161	103	10	ellman	ellman	NOUN
cana-5161	103	11	reagent	reagent	NOUN
cana-5161	103	12	)	)	PUNCT
cana-5161	103	13	and	and	CCONJ
cana-5161	103	14	0.10	0.10	NUM
cana-5161	103	15	ml	ml	NOUN
cana-5161	103	16	of	of	ADP
cana-5161	103	17	acetylthiocholine	acetylthiocholine	NOUN
cana-5161	103	18	iodide	iodide	NOUN
cana-5161	103	19	,	,	PUNCT
cana-5161	103	20	3	3	NUM
cana-5161	103	21	ml	ml	NOUN
cana-5161	103	22	of	of	ADP
cana-5161	103	23	0.01	0.01	NUM
cana-5161	103	24	m	m	NOUN
cana-5161	103	25	sodium	sodium	NOUN
cana-5161	103	26	phosphate	phosphate	NOUN
cana-5161	103	27	buffer	buffer	NOUN
cana-5161	103	28	(	(	PUNCT
cana-5161	103	29	ph	ph	NOUN
cana-5161	103	30	8)	8)	NUM
cana-5161	103	31	and	and	CCONJ
cana-5161	103	32	0.05	0.05	NUM
cana-5161	103	33	ml	ml	NOUN
cana-5161	103	34	of	of	ADP
cana-5161	103	35	supernatant	supernatant	NOUN
cana-5161	103	36	.	.	PUNCT
cana-5161	104	1	the	the	DET
cana-5161	104	2	change	change	NOUN
cana-5161	104	3	in	in	ADP
cana-5161	104	4	absorbance	absorbance	NOUN
cana-5161	104	5	was	be	AUX
cana-5161	104	6	measured	measure	VERB
cana-5161	104	7	instantly	instantly	ADV
cana-5161	104	8	at	at	ADP
cana-5161	104	9	412	412	NUM
cana-5161	104	10	nm	nm	ADV
cana-5161	104	11	spectrophotometrically	spectrophotometrically	ADV
cana-5161	104	12	.	.	PUNCT
cana-5161	105	1	moreover	moreover	ADV
cana-5161	105	2	,	,	PUNCT
cana-5161	105	3	the	the	DET
cana-5161	105	4	acetylcholinesterase	acetylcholinesterase	NOUN
cana-5161	105	5	activity	activity	NOUN
cana-5161	105	6	in	in	ADP
cana-5161	105	7	the	the	DET
cana-5161	105	8	supernatant	supernatant	NOUN
cana-5161	105	9	was	be	AUX
cana-5161	105	10	expressed	express	VERB
cana-5161	105	11	as	as	ADP
cana-5161	105	12	nmol	nmol	NOUN
cana-5161	105	13	per	per	ADP
cana-5161	105	14	mg	mg	PROPN
cana-5161	105	15	protein	protein	NOUN
cana-5161	105	16	.	.	PUNCT
cana-5161	106	1	2.6.4	2.6.4	NUM
cana-5161	106	2	malondialdehyde	malondialdehyde	NOUN
cana-5161	106	3	(	(	PUNCT
cana-5161	106	4	mda	mda	PROPN
cana-5161	106	5	)	)	PUNCT
cana-5161	106	6	the	the	DET
cana-5161	106	7	significant	significant	ADJ
cana-5161	106	8	estimation	estimation	NOUN
cana-5161	106	9	of	of	ADP
cana-5161	106	10	malondialdehyde	malondialdehyde	PROPN
cana-5161	106	11	(	(	PUNCT
cana-5161	106	12	mda	mda	PROPN
cana-5161	106	13	)	)	PUNCT
cana-5161	106	14	–	–	PUNCT
cana-5161	106	15	end	end	NOUN
cana-5161	106	16	product	product	NOUN
cana-5161	106	17	of	of	ADP
cana-5161	106	18	lipid	lipid	NOUN
cana-5161	106	19	peroxidation	peroxidation	NOUN
cana-5161	106	20	(	(	PUNCT
cana-5161	106	21	lpo	lpo	PROPN
cana-5161	106	22	)	)	PUNCT
cana-5161	106	23	–	–	PUNCT
cana-5161	106	24	in	in	ADP
cana-5161	106	25	brain	brain	NOUN
cana-5161	106	26	homogenate	homogenate	NOUN
cana-5161	106	27	was	be	AUX
cana-5161	106	28	performed	perform	VERB
cana-5161	106	29	according	accord	VERB
cana-5161	106	30	to	to	ADP
cana-5161	106	31	the	the	DET
cana-5161	106	32	method	method	NOUN
cana-5161	106	33	of	of	ADP
cana-5161	106	34	(	(	PUNCT
cana-5161	106	35	wills	will	NOUN
cana-5161	106	36	,	,	PUNCT
cana-5161	106	37	1966	1966	NUM
cana-5161	106	38	)	)	PUNCT
cana-5161	106	39	.	.	PUNCT
cana-5161	107	1	the	the	DET
cana-5161	107	2	amount	amount	NOUN
cana-5161	107	3	of	of	ADP
cana-5161	107	4	mda	mda	PROPN
cana-5161	107	5	was	be	AUX
cana-5161	107	6	estimated	estimate	VERB
cana-5161	107	7	after	after	ADP
cana-5161	107	8	its	its	PRON
cana-5161	107	9	reaction	reaction	NOUN
cana-5161	107	10	with	with	ADP
cana-5161	107	11	thiobarbituric	thiobarbituric	ADJ
cana-5161	107	12	acid	acid	NOUN
cana-5161	107	13	at	at	ADP
cana-5161	107	14	532	532	NUM
cana-5161	107	15	nm	nm	NOUN
cana-5161	107	16	using	use	VERB
cana-5161	107	17	spectrophotometer	spectrophotometer	NOUN
cana-5161	107	18	communications	communication	NOUN
cana-5161	107	19	on	on	ADP
cana-5161	107	20	applied	apply	VERB
cana-5161	107	21	nonlinear	nonlinear	ADJ
cana-5161	107	22	analysis	analysis	NOUN
cana-5161	107	23	issn	issn	NOUN
cana-5161	107	24	:	:	PUNCT
cana-5161	107	25	1074	1074	NUM
cana-5161	107	26	-	-	PUNCT
cana-5161	107	27	133x	133x	NUM
cana-5161	107	28	vol	vol	NOUN
cana-5161	107	29	32	32	NUM
cana-5161	107	30	no	no	NOUN
cana-5161	107	31	.	.	PUNCT
cana-5161	108	1	icmasd	icmasd	NOUN
cana-5161	108	2	(	(	PUNCT
cana-5161	108	3	2025	2025	NUM
cana-5161	108	4	)	)	PUNCT
cana-5161	108	5	1358	1358	NUM
cana-5161	108	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	108	7	(	(	PUNCT
cana-5161	108	8	shimadzu	shimadzu	PROPN
cana-5161	108	9	,	,	PUNCT
cana-5161	108	10	uv-1700	uv-1700	PROPN
cana-5161	108	11	)	)	PUNCT
cana-5161	108	12	.	.	PUNCT
cana-5161	109	1	the	the	DET
cana-5161	109	2	concentration	concentration	NOUN
cana-5161	109	3	of	of	ADP
cana-5161	109	4	mda	mda	PROPN
cana-5161	109	5	was	be	AUX
cana-5161	109	6	calculated	calculate	VERB
cana-5161	109	7	from	from	ADP
cana-5161	109	8	a	a	DET
cana-5161	109	9	standard	standard	ADJ
cana-5161	109	10	curve	curve	NOUN
cana-5161	109	11	and	and	CCONJ
cana-5161	109	12	expressed	express	VERB
cana-5161	109	13	as	as	ADP
cana-5161	109	14	nmol	nmol	NOUN
cana-5161	109	15	per	per	ADP
cana-5161	109	16	mg	mg	PROPN
cana-5161	109	17	protein	protein	NOUN
cana-5161	109	18	.	.	PUNCT
cana-5161	110	1	2.6.5	2.6.5	NUM
cana-5161	110	2	reduced	reduced	ADJ
cana-5161	110	3	glutathione	glutathione	NOUN
cana-5161	110	4	(	(	PUNCT
cana-5161	110	5	gsh	gsh	PROPN
cana-5161	110	6	)	)	PUNCT
cana-5161	110	7	reduced	reduced	ADJ
cana-5161	110	8	glutathione	glutathione	NOUN
cana-5161	110	9	in	in	ADP
cana-5161	110	10	brain	brain	NOUN
cana-5161	110	11	was	be	AUX
cana-5161	110	12	measured	measure	VERB
cana-5161	110	13	according	accord	VERB
cana-5161	110	14	to	to	ADP
cana-5161	110	15	the	the	DET
cana-5161	110	16	method	method	NOUN
cana-5161	110	17	described	describe	VERB
cana-5161	110	18	by	by	ADP
cana-5161	110	19	ellman	ellman	NOUN
cana-5161	110	20	(	(	PUNCT
cana-5161	110	21	1959	1959	NUM
cana-5161	110	22	)	)	PUNCT
cana-5161	110	23	.	.	PUNCT
cana-5161	111	1	1ml	1ml	ADJ
cana-5161	111	2	supernatant	supernatant	NOUN
cana-5161	111	3	was	be	AUX
cana-5161	111	4	precipitated	precipitate	VERB
cana-5161	111	5	with1ml	with1ml	ADV
cana-5161	111	6	of	of	ADP
cana-5161	111	7	4	4	NUM
cana-5161	111	8	%	%	NOUN
cana-5161	111	9	sulfosalicylic	sulfosalicylic	ADJ
cana-5161	111	10	acid	acid	NOUN
cana-5161	111	11	and	and	CCONJ
cana-5161	111	12	cold	cold	ADJ
cana-5161	111	13	digested	digest	VERB
cana-5161	111	14	at	at	ADP
cana-5161	111	15	4	4	NUM
cana-5161	111	16	°	°	ADP
cana-5161	111	17	c	c	NOUN
cana-5161	111	18	for	for	ADP
cana-5161	111	19	1h	1h	NUM
cana-5161	111	20	.	.	PUNCT
cana-5161	112	1	the	the	DET
cana-5161	112	2	samples	sample	NOUN
cana-5161	112	3	were	be	AUX
cana-5161	112	4	centrifuged	centrifuge	VERB
cana-5161	112	5	at	at	ADP
cana-5161	112	6	1200	1200	NUM
cana-5161	112	7	g	g	NOUN
cana-5161	112	8	(	(	PUNCT
cana-5161	112	9	15min	15min	NUM
cana-5161	112	10	)	)	PUNCT
cana-5161	112	11	.	.	PUNCT
cana-5161	113	1	to	to	ADP
cana-5161	113	2	1	1	NUM
cana-5161	113	3	ml	ml	NOUN
cana-5161	113	4	of	of	ADP
cana-5161	113	5	the	the	DET
cana-5161	113	6	supernatant	supernatant	NOUN
cana-5161	113	7	,	,	PUNCT
cana-5161	113	8	0.2mlof	0.2mlof	NOUN
cana-5161	113	9	5	5	NUM
cana-5161	113	10	,	,	PUNCT
cana-5161	113	11	5′-dithiobis(2	5′-dithiobis(2	NOUN
cana-5161	113	12	-	-	ADJ
cana-5161	113	13	nitrobenzoic	nitrobenzoic	ADJ
cana-5161	113	14	acid	acid	NOUN
cana-5161	113	15	)	)	PUNCT
cana-5161	113	16	(	(	PUNCT
cana-5161	113	17	dtnb	dtnb	NOUN
cana-5161	113	18	)	)	PUNCT
cana-5161	113	19	and	and	CCONJ
cana-5161	113	20	2.7	2.7	NUM
cana-5161	113	21	ml	ml	NOUN
cana-5161	113	22	of	of	ADP
cana-5161	113	23	phosphate	phosphate	ADJ
cana-5161	113	24	buffer	buffer	NOUN
cana-5161	113	25	(	(	PUNCT
cana-5161	113	26	0.1	0.1	NUM
cana-5161	113	27	m	m	NOUN
cana-5161	113	28	,	,	PUNCT
cana-5161	113	29	ph8	ph8	PROPN
cana-5161	113	30	)	)	PUNCT
cana-5161	113	31	were	be	AUX
cana-5161	113	32	added	add	VERB
cana-5161	113	33	.	.	PUNCT
cana-5161	114	1	moreover	moreover	ADV
cana-5161	114	2	,	,	PUNCT
cana-5161	114	3	the	the	DET
cana-5161	114	4	yellow	yellow	ADJ
cana-5161	114	5	colour	colour	NOUN
cana-5161	114	6	that	that	PRON
cana-5161	114	7	appears	appear	VERB
cana-5161	114	8	was	be	AUX
cana-5161	114	9	measured	measure	VERB
cana-5161	114	10	instantly	instantly	ADV
cana-5161	114	11	at	at	ADP
cana-5161	114	12	412	412	NUM
cana-5161	114	13	nm	nm	NOUN
cana-5161	114	14	using	use	VERB
cana-5161	114	15	a	a	DET
cana-5161	114	16	spectrophotometer	spectrophotometer	NOUN
cana-5161	114	17	.	.	PUNCT
cana-5161	115	1	moreover	moreover	ADV
cana-5161	115	2	,	,	PUNCT
cana-5161	115	3	the	the	DET
cana-5161	115	4	concentration	concentration	NOUN
cana-5161	115	5	of	of	ADP
cana-5161	115	6	glutathione	glutathione	NOUN
cana-5161	115	7	in	in	ADP
cana-5161	115	8	the	the	DET
cana-5161	115	9	supernatant	supernatant	NOUN
cana-5161	115	10	was	be	AUX
cana-5161	115	11	determined	determine	VERB
cana-5161	115	12	from	from	ADP
cana-5161	115	13	a	a	DET
cana-5161	115	14	standard	standard	ADJ
cana-5161	115	15	curve	curve	NOUN
cana-5161	115	16	and	and	CCONJ
cana-5161	115	17	expressed	express	VERB
cana-5161	115	18	as	as	ADP
cana-5161	115	19	μmol	μmol	NOUN
cana-5161	115	20	per	per	ADP
cana-5161	115	21	mg	mg	PROPN
cana-5161	115	22	protein	protein	NOUN
cana-5161	115	23	.	.	PUNCT
cana-5161	116	1	2.6.6	2.6.6	ADJ
cana-5161	116	2	nitrite	nitrite	NOUN
cana-5161	116	3	the	the	DET
cana-5161	116	4	accumulation	accumulation	NOUN
cana-5161	116	5	of	of	ADP
cana-5161	116	6	nitrite	nitrite	NOUN
cana-5161	116	7	in	in	ADP
cana-5161	116	8	the	the	DET
cana-5161	116	9	supernatant	supernatant	NOUN
cana-5161	116	10	,	,	PUNCT
cana-5161	116	11	an	an	DET
cana-5161	116	12	indicator	indicator	NOUN
cana-5161	116	13	of	of	ADP
cana-5161	116	14	the	the	DET
cana-5161	116	15	production	production	NOUN
cana-5161	116	16	of	of	ADP
cana-5161	116	17	nitric	nitric	ADJ
cana-5161	116	18	oxide	oxide	NOUN
cana-5161	116	19	(	(	PUNCT
cana-5161	116	20	no	no	NOUN
cana-5161	116	21	)	)	PUNCT
cana-5161	116	22	,	,	PUNCT
cana-5161	116	23	was	be	AUX
cana-5161	116	24	determined	determine	VERB
cana-5161	116	25	by	by	ADP
cana-5161	116	26	a	a	DET
cana-5161	116	27	colorimetric	colorimetric	ADJ
cana-5161	116	28	assay	assay	NOUN
cana-5161	116	29	using	use	VERB
cana-5161	116	30	greiss	greiss	ADJ
cana-5161	116	31	reagent	reagent	NOUN
cana-5161	116	32	(	(	PUNCT
cana-5161	116	33	0.1%n-[1	0.1%n-[1	PROPN
cana-5161	116	34	-	-	PUNCT
cana-5161	116	35	naphthyl	naphthyl	NOUN
cana-5161	116	36	]	]	PUNCT
cana-5161	116	37	ethylenediaminedihydrochloride,1%sulfanilamide	ethylenediaminedihydrochloride,1%sulfanilamide	NOUN
cana-5161	116	38	and	and	CCONJ
cana-5161	116	39	2.5	2.5	NUM
cana-5161	116	40	%	%	NOUN
cana-5161	116	41	phosphoric	phosphoric	NOUN
cana-5161	116	42	acid	acid	NOUN
cana-5161	116	43	)	)	PUNCT
cana-5161	116	44	as	as	SCONJ
cana-5161	116	45	described	describe	VERB
cana-5161	116	46	by	by	ADP
cana-5161	116	47	(	(	PUNCT
cana-5161	116	48	green	green	PROPN
cana-5161	116	49	et	et	PROPN
cana-5161	116	50	al	al	PROPN
cana-5161	116	51	.	.	PROPN
cana-5161	116	52	,	,	PUNCT
cana-5161	116	53	1982	1982	NUM
cana-5161	116	54	)	)	PUNCT
cana-5161	116	55	.	.	PUNCT
cana-5161	117	1	the	the	DET
cana-5161	117	2	equal	equal	ADJ
cana-5161	117	3	volumes	volume	NOUN
cana-5161	117	4	of	of	ADP
cana-5161	117	5	greiss	greiss	ADJ
cana-5161	117	6	reagent	reagent	NOUN
cana-5161	117	7	and	and	CCONJ
cana-5161	117	8	supernatant	supernatant	NOUN
cana-5161	117	9	were	be	AUX
cana-5161	117	10	mixed	mix	VERB
cana-5161	117	11	,	,	PUNCT
cana-5161	117	12	the	the	DET
cana-5161	117	13	mixture	mixture	NOUN
cana-5161	117	14	incubated	incubate	VERB
cana-5161	117	15	for	for	ADP
cana-5161	117	16	10	10	NUM
cana-5161	117	17	min	min	NOUN
cana-5161	117	18	at	at	ADP
cana-5161	117	19	room	room	NOUN
cana-5161	117	20	temperature	temperature	NOUN
cana-5161	117	21	in	in	ADP
cana-5161	117	22	the	the	DET
cana-5161	117	23	dark	dark	NOUN
cana-5161	117	24	and	and	CCONJ
cana-5161	117	25	the	the	DET
cana-5161	117	26	absorbance	absorbance	NOUN
cana-5161	117	27	find	find	VERB
cana-5161	117	28	out	out	ADP
cana-5161	117	29	at	at	ADP
cana-5161	117	30	540	540	NUM
cana-5161	117	31	nm	nm	ADV
cana-5161	117	32	spectrophotometrically	spectrophotometrically	ADV
cana-5161	117	33	.	.	PUNCT
cana-5161	118	1	the	the	DET
cana-5161	118	2	concentration	concentration	NOUN
cana-5161	118	3	of	of	ADP
cana-5161	118	4	nitrite	nitrite	NOUN
cana-5161	118	5	in	in	ADP
cana-5161	118	6	the	the	DET
cana-5161	118	7	supernatant	supernatant	NOUN
cana-5161	118	8	was	be	AUX
cana-5161	118	9	determined	determine	VERB
cana-5161	118	10	from	from	ADP
cana-5161	118	11	sodium	sodium	NOUN
cana-5161	118	12	nitrite	nitrite	NOUN
cana-5161	118	13	standard	standard	ADJ
cana-5161	118	14	curve	curve	NOUN
cana-5161	118	15	and	and	CCONJ
cana-5161	118	16	expressed	express	VERB
cana-5161	118	17	as	as	ADP
cana-5161	118	18	μmol	μmol	NOUN
cana-5161	118	19	per	per	ADP
cana-5161	118	20	mg	mg	PROPN
cana-5161	118	21	protein	protein	NOUN
cana-5161	118	22	.	.	PUNCT
cana-5161	119	1	2.6.7	2.6.7	NUM
cana-5161	119	2	statistical	statistical	ADJ
cana-5161	119	3	analysis	analysis	NOUN
cana-5161	119	4	the	the	DET
cana-5161	119	5	values	value	NOUN
cana-5161	119	6	are	be	AUX
cana-5161	119	7	expressed	express	VERB
cana-5161	119	8	as	as	ADP
cana-5161	119	9	mean	mean	PROPN
cana-5161	119	10	±s.d	±s.d	PROPN
cana-5161	119	11	.	.	PUNCT
cana-5161	120	1	moreover	moreover	ADV
cana-5161	120	2	,	,	PUNCT
cana-5161	120	3	the	the	DET
cana-5161	120	4	acquisition	acquisition	NOUN
cana-5161	120	5	trial	trial	NOUN
cana-5161	120	6	results	result	NOUN
cana-5161	120	7	(	(	PUNCT
cana-5161	120	8	mwm	mwm	NOUN
cana-5161	120	9	)	)	PUNCT
cana-5161	120	10	were	be	AUX
cana-5161	120	11	examined	examine	VERB
cana-5161	120	12	by	by	ADP
cana-5161	120	13	using	use	VERB
cana-5161	120	14	two	two	NUM
cana-5161	120	15	-	-	PUNCT
cana-5161	120	16	way	way	NOUN
cana-5161	120	17	anova	anova	X
cana-5161	120	18	(	(	PUNCT
cana-5161	120	19	analysis	analysis	NOUN
cana-5161	120	20	of	of	ADP
cana-5161	120	21	variance	variance	NOUN
cana-5161	120	22	)	)	PUNCT
cana-5161	120	23	and	and	CCONJ
cana-5161	120	24	followed	follow	VERB
cana-5161	120	25	by	by	ADP
cana-5161	120	26	bonferroni	bonferroni	PROPN
cana-5161	120	27	’s	’s	PART
cana-5161	120	28	post	post	X
cana-5161	120	29	hoc	hoc	X
cana-5161	120	30	test	test	NOUN
cana-5161	120	31	for	for	ADP
cana-5161	120	32	many	many	ADJ
cana-5161	120	33	comparisons	comparison	NOUN
cana-5161	120	34	.	.	PUNCT
cana-5161	121	1	in	in	ADP
cana-5161	121	2	ort	ort	NOUN
cana-5161	121	3	,	,	PUNCT
cana-5161	121	4	comparisons	comparison	NOUN
cana-5161	121	5	of	of	ADP
cana-5161	121	6	total	total	ADJ
cana-5161	121	7	time	time	NOUN
cana-5161	121	8	of	of	ADP
cana-5161	121	9	exploration	exploration	NOUN
cana-5161	121	10	during	during	ADP
cana-5161	121	11	t1	t1	NOUN
cana-5161	121	12	and	and	CCONJ
cana-5161	121	13	t2	t2	NOUN
cana-5161	121	14	on	on	ADP
cana-5161	121	15	familiar	familiar	ADJ
cana-5161	121	16	and	and	CCONJ
cana-5161	121	17	novel	novel	ADJ
cana-5161	121	18	object	object	NOUN
cana-5161	121	19	were	be	AUX
cana-5161	121	20	analysed	analyse	VERB
cana-5161	121	21	by	by	ADP
cana-5161	121	22	paired	pair	VERB
cana-5161	121	23	t	t	PROPN
cana-5161	121	24	-	-	PUNCT
cana-5161	121	25	test	test	NOUN
cana-5161	121	26	.	.	PUNCT
cana-5161	122	1	the	the	DET
cana-5161	122	2	discriminative	discriminative	PROPN
cana-5161	122	3	index	index	NOUN
cana-5161	122	4	,	,	PUNCT
cana-5161	122	5	results	result	NOUN
cana-5161	122	6	of	of	ADP
cana-5161	122	7	probe	probe	NOUN
cana-5161	122	8	trial	trial	NOUN
cana-5161	122	9	in	in	ADP
cana-5161	122	10	mwm	mwm	NOUN
cana-5161	122	11	model	model	NOUN
cana-5161	122	12	and	and	CCONJ
cana-5161	122	13	biochemical	biochemical	ADJ
cana-5161	122	14	and	and	CCONJ
cana-5161	122	15	parameters	parameter	NOUN
cana-5161	122	16	were	be	AUX
cana-5161	122	17	analysed	analyse	VERB
cana-5161	122	18	using	use	VERB
cana-5161	122	19	one	one	NUM
cana-5161	122	20	way	way	NOUN
cana-5161	122	21	anova	anova	PROPN
cana-5161	122	22	followed	follow	VERB
cana-5161	122	23	by	by	ADP
cana-5161	122	24	tukey	tukey	PROPN
cana-5161	122	25	's	's	PART
cana-5161	122	26	test	test	NOUN
cana-5161	122	27	,	,	PUNCT
cana-5161	122	28	using	use	VERB
cana-5161	122	29	statistical	statistical	ADJ
cana-5161	122	30	graph	graph	NOUN
cana-5161	122	31	pad	pad	NOUN
cana-5161	122	32	prism	prism	NOUN
cana-5161	122	33	software	software	NOUN
cana-5161	122	34	(	(	PUNCT
cana-5161	122	35	version5.0	version5.0	PROPN
cana-5161	122	36	,	,	PUNCT
cana-5161	122	37	la	la	PROPN
cana-5161	122	38	jolla	jolla	PROPN
cana-5161	122	39	,	,	PUNCT
cana-5161	122	40	ca	ca	PROPN
cana-5161	122	41	,	,	PUNCT
cana-5161	122	42	usa	usa	PROPN
cana-5161	122	43	)	)	PUNCT
cana-5161	122	44	.	.	PUNCT
cana-5161	123	1	the	the	DET
cana-5161	123	2	p	p	X
cana-5161	123	3	<	<	X
cana-5161	123	4	0.05	0.05	NUM
cana-5161	123	5	was	be	AUX
cana-5161	123	6	set	set	VERB
cana-5161	123	7	to	to	PART
cana-5161	123	8	be	be	AUX
cana-5161	123	9	statistically	statistically	ADV
cana-5161	123	10	significant	significant	ADJ
cana-5161	123	11	.	.	PUNCT
cana-5161	124	1	3	3	X
cana-5161	124	2	.	.	X
cana-5161	124	3	results	result	NOUN
cana-5161	124	4	:	:	PUNCT
cana-5161	124	5	3.1	3.1	NUM
cana-5161	124	6	behavioral	behavioral	ADJ
cana-5161	124	7	parameters	parameter	NOUN
cana-5161	124	8	3.1.1	3.1.1	NUM
cana-5161	124	9	effect	effect	NOUN
cana-5161	124	10	of	of	ADP
cana-5161	124	11	agmatine	agmatine	NOUN
cana-5161	124	12	on	on	ADP
cana-5161	124	13	spontaneous	spontaneous	ADJ
cana-5161	124	14	locomotor	locomotor	NOUN
cana-5161	124	15	activity	activity	NOUN
cana-5161	124	16	in	in	ADP
cana-5161	124	17	alcl3	alcl3	PROPN
cana-5161	124	18	treated	treat	VERB
cana-5161	124	19	rats	rat	NOUN
cana-5161	124	20	.	.	PUNCT
cana-5161	125	1	in	in	ADP
cana-5161	125	2	open	open	ADJ
cana-5161	125	3	field	field	NOUN
cana-5161	125	4	test	test	NOUN
cana-5161	125	5	,	,	PUNCT
cana-5161	125	6	alcl3	alcl3	PROPN
cana-5161	125	7	treated	treat	VERB
cana-5161	125	8	rats	rat	NOUN
cana-5161	125	9	showed	show	VERB
cana-5161	125	10	significantly	significantly	ADV
cana-5161	125	11	decreased	decrease	VERB
cana-5161	125	12	locomotor	locomotor	NOUN
cana-5161	125	13	activity	activity	NOUN
cana-5161	125	14	as	as	SCONJ
cana-5161	125	15	compared	compare	VERB
cana-5161	125	16	with	with	ADP
cana-5161	125	17	vehicle	vehicle	NOUN
cana-5161	125	18	control	control	NOUN
cana-5161	125	19	group	group	NOUN
cana-5161	125	20	(	(	PUNCT
cana-5161	125	21	p<0.05	p<0.05	NOUN
cana-5161	125	22	)	)	PUNCT
cana-5161	125	23	.	.	PUNCT
cana-5161	126	1	but	but	CCONJ
cana-5161	126	2	their	their	PRON
cana-5161	126	3	performance	performance	NOUN
cana-5161	126	4	was	be	AUX
cana-5161	126	5	significantly	significantly	ADV
cana-5161	126	6	improved	improve	VERB
cana-5161	126	7	by	by	ADP
cana-5161	126	8	chronic	chronic	ADJ
cana-5161	126	9	treatment	treatment	NOUN
cana-5161	126	10	with	with	ADP
cana-5161	126	11	agmatine	agmatine	NOUN
cana-5161	126	12	(	(	PUNCT
cana-5161	126	13	p<0.05	p<0.05	NOUN
cana-5161	126	14	)	)	PUNCT
cana-5161	126	15	.	.	PUNCT
cana-5161	127	1	agmatine	agmatine	NOUN
cana-5161	127	2	at	at	ADP
cana-5161	127	3	10	10	NUM
cana-5161	127	4	and	and	CCONJ
cana-5161	127	5	30mg	30mg	NUM
cana-5161	127	6	/	/	SYM
cana-5161	127	7	kg	kg	PROPN
cana-5161	127	8	dose	dose	NOUN
cana-5161	127	9	was	be	AUX
cana-5161	127	10	found	find	VERB
cana-5161	127	11	to	to	PART
cana-5161	127	12	be	be	AUX
cana-5161	127	13	effective	effective	ADJ
cana-5161	127	14	in	in	ADP
cana-5161	127	15	ameliorating	ameliorate	VERB
cana-5161	127	16	alcl3	alcl3	NOUN
cana-5161	128	1	induced	induce	VERB
cana-5161	128	2	decreased	decrease	VERB
cana-5161	128	3	locomotor	locomotor	NOUN
cana-5161	128	4	activity	activity	NOUN
cana-5161	128	5	and	and	CCONJ
cana-5161	128	6	restored	restore	VERB
cana-5161	128	7	toward	toward	ADP
cana-5161	128	8	normal	normal	ADJ
cana-5161	128	9	on	on	ADP
cana-5161	128	10	21st	21st	ADJ
cana-5161	128	11	day	day	NOUN
cana-5161	128	12	(	(	PUNCT
cana-5161	128	13	p<0.05	p<0.05	NOUN
cana-5161	128	14	)	)	PUNCT
cana-5161	128	15	(	(	PUNCT
cana-5161	128	16	fig	fig	NOUN
cana-5161	128	17	.	.	PUNCT
cana-5161	129	1	1	1	NUM
cana-5161	129	2	)	)	PUNCT
cana-5161	129	3	.	.	PUNCT
cana-5161	130	1	communications	communication	NOUN
cana-5161	130	2	on	on	ADP
cana-5161	130	3	applied	apply	VERB
cana-5161	130	4	nonlinear	nonlinear	ADJ
cana-5161	130	5	analysis	analysis	NOUN
cana-5161	130	6	issn	issn	NOUN
cana-5161	130	7	:	:	PUNCT
cana-5161	130	8	1074	1074	NUM
cana-5161	130	9	-	-	PUNCT
cana-5161	130	10	133x	133x	NUM
cana-5161	130	11	vol	vol	NOUN
cana-5161	130	12	32	32	NUM
cana-5161	130	13	no	no	NOUN
cana-5161	130	14	.	.	PUNCT
cana-5161	131	1	icmasd	icmasd	NOUN
cana-5161	131	2	(	(	PUNCT
cana-5161	131	3	2025	2025	NUM
cana-5161	131	4	)	)	PUNCT
cana-5161	131	5	1359	1359	NUM
cana-5161	131	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	132	1	figure.1	figure.1	CCONJ
cana-5161	132	2	effect	effect	NOUN
cana-5161	132	3	of	of	ADP
cana-5161	132	4	agmatine	agmatine	NOUN
cana-5161	132	5	on	on	ADP
cana-5161	132	6	spontaneous	spontaneous	ADJ
cana-5161	132	7	locomotor	locomotor	NOUN
cana-5161	132	8	activity	activity	NOUN
cana-5161	132	9	in	in	ADP
cana-5161	132	10	alcl3	alcl3	PROPN
cana-5161	132	11	treated	treat	VERB
cana-5161	132	12	rats	rat	NOUN
cana-5161	132	13	.	.	PUNCT
cana-5161	133	1	values	value	NOUN
cana-5161	133	2	are	be	AUX
cana-5161	133	3	expressed	express	VERB
cana-5161	133	4	as	as	ADP
cana-5161	133	5	mean	mean	NOUN
cana-5161	133	6	±	±	NUM
cana-5161	133	7	sd	sd	NOUN
cana-5161	133	8	.	.	PUNCT
cana-5161	134	1	*	*	PUNCT
cana-5161	134	2	p<0.05	p<0.05	PROPN
cana-5161	134	3	vs	vs	ADP
cana-5161	134	4	vehicle	vehicle	NOUN
cana-5161	134	5	control	control	NOUN
cana-5161	134	6	,	,	PUNCT
cana-5161	134	7	#	#	NOUN
cana-5161	134	8	p<0.05	p<0.05	NOUN
cana-5161	134	9	vs	vs	ADP
cana-5161	134	10	alcl3	alcl3	PROPN
cana-5161	134	11	,	,	PUNCT
cana-5161	134	12	$	$	SYM
cana-5161	134	13	p<0.05	p<0.05	NOUN
cana-5161	134	14	vs	vs	ADP
cana-5161	134	15	alcl3	alcl3	PROPN
cana-5161	134	16	+	+	NOUN
cana-5161	134	17	agmatine	agmatine	NOUN
cana-5161	134	18	(	(	PUNCT
cana-5161	134	19	3	3	NUM
cana-5161	134	20	mg	mg	PROPN
cana-5161	134	21	/	/	SYM
cana-5161	134	22	kg	kg	PROPN
cana-5161	134	23	)	)	PUNCT
cana-5161	134	24	,	,	PUNCT
cana-5161	134	25	@	@	ADP
cana-5161	134	26	p<0.05	p<0.05	NOUN
cana-5161	134	27	vs	vs	ADP
cana-5161	134	28	alcl3	alcl3	PROPN
cana-5161	134	29	+	+	NOUN
cana-5161	134	30	agmatine	agmatine	NOUN
cana-5161	134	31	(	(	PUNCT
cana-5161	134	32	10	10	NUM
cana-5161	134	33	mg	mg	NUM
cana-5161	134	34	/	/	SYM
cana-5161	134	35	kg	kg	NOUN
cana-5161	134	36	)	)	PUNCT
cana-5161	134	37	.	.	PUNCT
cana-5161	135	1	agm	agm	PROPN
cana-5161	135	2	-	-	PUNCT
cana-5161	135	3	agmatine	agmatine	NOUN
cana-5161	135	4	3.1.2	3.1.2	NUM
cana-5161	135	5	effect	effect	NOUN
cana-5161	135	6	of	of	ADP
cana-5161	135	7	agmatine	agmatine	NOUN
cana-5161	135	8	on	on	ADP
cana-5161	135	9	memory	memory	NOUN
cana-5161	135	10	performance	performance	NOUN
cana-5161	135	11	in	in	ADP
cana-5161	135	12	morris	morris	PROPN
cana-5161	135	13	water	water	NOUN
cana-5161	135	14	maze	maze	NOUN
cana-5161	135	15	(	(	PUNCT
cana-5161	135	16	mwm	mwm	NOUN
cana-5161	135	17	)	)	PUNCT
cana-5161	135	18	task	task	NOUN
cana-5161	135	19	in	in	ADP
cana-5161	135	20	alcl3	alcl3	PROPN
cana-5161	135	21	treated	treat	VERB
cana-5161	135	22	rats	rat	NOUN
cana-5161	135	23	.	.	PUNCT
cana-5161	136	1	in	in	ADP
cana-5161	136	2	the	the	DET
cana-5161	136	3	morris	morris	PROPN
cana-5161	136	4	water	water	PROPN
cana-5161	136	5	maze	maze	NOUN
cana-5161	136	6	task	task	NOUN
cana-5161	136	7	,	,	PUNCT
cana-5161	136	8	alcl3	alcl3	PROPN
cana-5161	136	9	treated	treat	VERB
cana-5161	136	10	rats	rat	NOUN
cana-5161	136	11	showed	show	VERB
cana-5161	136	12	poor	poor	ADJ
cana-5161	136	13	learning	learning	NOUN
cana-5161	136	14	abilities	ability	NOUN
cana-5161	136	15	during	during	ADP
cana-5161	136	16	acquisition	acquisition	NOUN
cana-5161	136	17	trial	trial	NOUN
cana-5161	136	18	.	.	PUNCT
cana-5161	137	1	on	on	ADP
cana-5161	137	2	day	day	NOUN
cana-5161	137	3	15	15	NUM
cana-5161	137	4	,	,	PUNCT
cana-5161	137	5	there	there	PRON
cana-5161	137	6	was	be	VERB
cana-5161	137	7	no	no	DET
cana-5161	137	8	significant	significant	ADJ
cana-5161	137	9	difference	difference	NOUN
cana-5161	137	10	between	between	ADP
cana-5161	137	11	the	the	DET
cana-5161	137	12	mean	mean	ADJ
cana-5161	137	13	latencies	latency	NOUN
cana-5161	137	14	of	of	ADP
cana-5161	137	15	all	all	DET
cana-5161	137	16	groups	group	NOUN
cana-5161	137	17	.	.	PUNCT
cana-5161	138	1	but	but	CCONJ
cana-5161	138	2	the	the	DET
cana-5161	138	3	mean	mean	ADJ
cana-5161	138	4	latencies	latency	NOUN
cana-5161	138	5	were	be	AUX
cana-5161	138	6	found	find	VERB
cana-5161	138	7	to	to	PART
cana-5161	138	8	be	be	AUX
cana-5161	138	9	significantly	significantly	ADV
cana-5161	138	10	prolonged	prolong	VERB
cana-5161	138	11	on	on	ADP
cana-5161	138	12	day	day	NOUN
cana-5161	138	13	16	16	NUM
cana-5161	138	14	,	,	PUNCT
cana-5161	138	15	17	17	NUM
cana-5161	138	16	&	&	CCONJ
cana-5161	138	17	18	18	NUM
cana-5161	138	18	(	(	PUNCT
cana-5161	138	19	p<0.05	p<0.05	NOUN
cana-5161	138	20	)	)	PUNCT
cana-5161	138	21	in	in	ADP
cana-5161	138	22	the	the	DET
cana-5161	138	23	alcl3	alcl3	PROPN
cana-5161	138	24	treated	treat	VERB
cana-5161	138	25	rats	rat	NOUN
cana-5161	138	26	as	as	SCONJ
cana-5161	138	27	compared	compare	VERB
cana-5161	138	28	with	with	ADP
cana-5161	138	29	that	that	PRON
cana-5161	138	30	of	of	ADP
cana-5161	138	31	vehicle	vehicle	NOUN
cana-5161	138	32	control	control	NOUN
cana-5161	138	33	,	,	PUNCT
cana-5161	138	34	indicating	indicate	VERB
cana-5161	138	35	learning	learn	VERB
cana-5161	138	36	impairment	impairment	NOUN
cana-5161	138	37	.	.	PUNCT
cana-5161	139	1	but	but	CCONJ
cana-5161	139	2	their	their	PRON
cana-5161	139	3	performance	performance	NOUN
cana-5161	139	4	was	be	AUX
cana-5161	139	5	significantly	significantly	ADV
cana-5161	139	6	improved	improve	VERB
cana-5161	139	7	by	by	ADP
cana-5161	139	8	chronic	chronic	ADJ
cana-5161	139	9	treatment	treatment	NOUN
cana-5161	139	10	with	with	ADP
cana-5161	139	11	agmatine	agmatine	NOUN
cana-5161	139	12	(	(	PUNCT
cana-5161	139	13	p<0.05	p<0.05	NOUN
cana-5161	139	14	)	)	PUNCT
cana-5161	139	15	.	.	PUNCT
cana-5161	140	1	agmatine	agmatine	NOUN
cana-5161	140	2	at	at	ADP
cana-5161	140	3	10	10	NUM
cana-5161	140	4	and	and	CCONJ
cana-5161	140	5	30	30	NUM
cana-5161	140	6	mg	mg	NUM
cana-5161	140	7	/	/	SYM
cana-5161	140	8	kg	kg	PROPN
cana-5161	140	9	dose	dose	NOUN
cana-5161	140	10	was	be	AUX
cana-5161	140	11	found	find	VERB
cana-5161	140	12	to	to	PART
cana-5161	140	13	be	be	AUX
cana-5161	140	14	effective	effective	ADJ
cana-5161	140	15	in	in	ADP
cana-5161	140	16	ameliorating	ameliorate	VERB
cana-5161	140	17	alcl3	alcl3	NOUN
cana-5161	140	18	induced	induce	VERB
cana-5161	140	19	spatial	spatial	ADJ
cana-5161	140	20	memory	memory	NOUN
cana-5161	140	21	deficit	deficit	NOUN
cana-5161	140	22	.	.	PUNCT
cana-5161	141	1	during	during	ADP
cana-5161	141	2	the	the	DET
cana-5161	141	3	probe	probe	NOUN
cana-5161	141	4	trial	trial	NOUN
cana-5161	141	5	on	on	ADP
cana-5161	141	6	day	day	NOUN
cana-5161	141	7	19	19	NUM
cana-5161	141	8	,	,	PUNCT
cana-5161	141	9	with	with	ADP
cana-5161	141	10	the	the	DET
cana-5161	141	11	plateform	plateform	NOUN
cana-5161	141	12	removed	remove	VERB
cana-5161	141	13	,	,	PUNCT
cana-5161	141	14	alcl3	alcl3	PROPN
cana-5161	141	15	treated	treat	VERB
cana-5161	141	16	rats	rat	NOUN
cana-5161	141	17	failed	fail	VERB
cana-5161	141	18	to	to	PART
cana-5161	141	19	remember	remember	VERB
cana-5161	141	20	the	the	DET
cana-5161	141	21	precise	precise	ADJ
cana-5161	141	22	location	location	NOUN
cana-5161	141	23	of	of	ADP
cana-5161	141	24	the	the	DET
cana-5161	141	25	plateform	plateform	NOUN
cana-5161	141	26	,	,	PUNCT
cana-5161	141	27	spending	spend	VERB
cana-5161	141	28	significantly	significantly	ADV
cana-5161	141	29	less	less	ADJ
cana-5161	141	30	time	time	NOUN
cana-5161	141	31	in	in	ADP
cana-5161	141	32	the	the	DET
cana-5161	141	33	target	target	NOUN
cana-5161	141	34	quadrant	quadrant	NOUN
cana-5161	141	35	than	than	ADP
cana-5161	141	36	vehicle	vehicle	NOUN
cana-5161	141	37	treated	treat	VERB
cana-5161	141	38	group	group	NOUN
cana-5161	142	1	[	[	X
cana-5161	142	2	p<0.05	p<0.05	NOUN
cana-5161	142	3	,	,	PUNCT
cana-5161	142	4	fig	fig	NOUN
cana-5161	142	5	.	.	PUNCT
cana-5161	143	1	13	13	NUM
cana-5161	143	2	b	b	NOUN
cana-5161	143	3	]	]	X
cana-5161	143	4	.	.	PUNCT
cana-5161	144	1	but	but	CCONJ
cana-5161	144	2	the	the	DET
cana-5161	144	3	agmatine	agmatine	NOUN
cana-5161	144	4	treated	treat	VERB
cana-5161	144	5	alcl3	alcl3	PROPN
cana-5161	144	6	rats	rat	NOUN
cana-5161	144	7	spend	spend	VERB
cana-5161	144	8	significantly	significantly	ADV
cana-5161	144	9	more	more	ADJ
cana-5161	144	10	time	time	NOUN
cana-5161	144	11	in	in	ADP
cana-5161	144	12	target	target	NOUN
cana-5161	144	13	quadrant	quadrant	NOUN
cana-5161	144	14	(	(	PUNCT
cana-5161	144	15	p<0.05	p<0.05	NOUN
cana-5161	144	16	)	)	PUNCT
cana-5161	144	17	as	as	SCONJ
cana-5161	144	18	compared	compare	VERB
cana-5161	144	19	with	with	ADP
cana-5161	144	20	alcl3	alcl3	PROPN
cana-5161	144	21	alone	alone	ADV
cana-5161	144	22	indicating	indicate	VERB
cana-5161	144	23	improved	improved	ADJ
cana-5161	144	24	consolidation	consolidation	NOUN
cana-5161	144	25	of	of	ADP
cana-5161	144	26	memory	memory	NOUN
cana-5161	144	27	.	.	PUNCT
cana-5161	145	1	moreover	moreover	ADV
cana-5161	145	2	agmatine	agmatine	NOUN
cana-5161	145	3	(	(	PUNCT
cana-5161	145	4	30	30	NUM
cana-5161	145	5	mg	mg	NUM
cana-5161	145	6	/	/	SYM
cana-5161	145	7	kg	kg	PROPN
cana-5161	145	8	)	)	PUNCT
cana-5161	145	9	treated	treat	VERB
cana-5161	145	10	rats	rat	NOUN
cana-5161	145	11	spent	spend	VERB
cana-5161	145	12	significantly	significantly	ADV
cana-5161	145	13	more	more	ADJ
cana-5161	145	14	time	time	NOUN
cana-5161	145	15	in	in	ADP
cana-5161	145	16	the	the	DET
cana-5161	145	17	target	target	NOUN
cana-5161	145	18	quadrant	quadrant	ADJ
cana-5161	145	19	as	as	SCONJ
cana-5161	145	20	compared	compare	VERB
cana-5161	145	21	with	with	ADP
cana-5161	145	22	agmatine	agmatine	NOUN
cana-5161	145	23	(	(	PUNCT
cana-5161	145	24	3	3	NUM
cana-5161	145	25	and	and	CCONJ
cana-5161	145	26	10	10	NUM
cana-5161	145	27	mg	mg	NUM
cana-5161	145	28	/	/	SYM
cana-5161	145	29	kg	kg	NOUN
cana-5161	145	30	)	)	PUNCT
cana-5161	145	31	(	(	PUNCT
cana-5161	145	32	fig	fig	NOUN
cana-5161	145	33	.	.	PUNCT
cana-5161	146	1	2a	2a	NUM
cana-5161	146	2	and	and	CCONJ
cana-5161	146	3	2b	2b	NOUN
cana-5161	146	4	)	)	PUNCT
cana-5161	146	5	.	.	PUNCT
cana-5161	147	1	communications	communication	NOUN
cana-5161	147	2	on	on	ADP
cana-5161	147	3	applied	apply	VERB
cana-5161	147	4	nonlinear	nonlinear	ADJ
cana-5161	147	5	analysis	analysis	NOUN
cana-5161	147	6	issn	issn	NOUN
cana-5161	147	7	:	:	PUNCT
cana-5161	147	8	1074	1074	NUM
cana-5161	147	9	-	-	PUNCT
cana-5161	147	10	133x	133x	NUM
cana-5161	147	11	vol	vol	NOUN
cana-5161	147	12	32	32	NUM
cana-5161	147	13	no	no	NOUN
cana-5161	147	14	.	.	PUNCT
cana-5161	148	1	icmasd	icmasd	NOUN
cana-5161	148	2	(	(	PUNCT
cana-5161	148	3	2025	2025	NUM
cana-5161	148	4	)	)	PUNCT
cana-5161	148	5	1360	1360	NUM
cana-5161	148	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	148	7	figure.2a	figure.2a	PROPN
cana-5161	148	8	effect	effect	NOUN
cana-5161	148	9	of	of	ADP
cana-5161	148	10	agmatine	agmatine	NOUN
cana-5161	148	11	on	on	ADP
cana-5161	148	12	memeory	memeory	ADJ
cana-5161	148	13	performance	performance	NOUN
cana-5161	148	14	in	in	ADP
cana-5161	148	15	morris	morris	PROPN
cana-5161	148	16	water	water	NOUN
cana-5161	148	17	maze	maze	NOUN
cana-5161	148	18	(	(	PUNCT
cana-5161	148	19	mwm	mwm	NOUN
cana-5161	148	20	)	)	PUNCT
cana-5161	148	21	task	task	NOUN
cana-5161	148	22	in	in	ADP
cana-5161	148	23	alcl3	alcl3	PROPN
cana-5161	148	24	treated	treat	VERB
cana-5161	148	25	rats	rat	NOUN
cana-5161	148	26	.	.	PUNCT
cana-5161	149	1	values	value	NOUN
cana-5161	149	2	are	be	AUX
cana-5161	149	3	expressed	express	VERB
cana-5161	149	4	as	as	ADP
cana-5161	149	5	mean	mean	NOUN
cana-5161	149	6	±	±	NUM
cana-5161	149	7	sd	sd	NOUN
cana-5161	149	8	.	.	PUNCT
cana-5161	150	1	*	*	PUNCT
cana-5161	150	2	p<0.05	p<0.05	PROPN
cana-5161	150	3	vs	vs	ADP
cana-5161	150	4	vehicle	vehicle	NOUN
cana-5161	150	5	control	control	NOUN
cana-5161	150	6	,	,	PUNCT
cana-5161	150	7	#	#	NOUN
cana-5161	150	8	p<0.05	p<0.05	NOUN
cana-5161	150	9	vs	vs	ADP
cana-5161	150	10	alcl3	alcl3	PROPN
cana-5161	150	11	,	,	PUNCT
cana-5161	150	12	$	$	SYM
cana-5161	150	13	p<0.05	p<0.05	NOUN
cana-5161	150	14	vs	vs	ADP
cana-5161	150	15	alcl3	alcl3	PROPN
cana-5161	150	16	+	+	NOUN
cana-5161	150	17	agmatine	agmatine	NOUN
cana-5161	150	18	(	(	PUNCT
cana-5161	150	19	3	3	NUM
cana-5161	150	20	mg	mg	PROPN
cana-5161	150	21	/	/	SYM
cana-5161	150	22	kg	kg	PROPN
cana-5161	150	23	)	)	PUNCT
cana-5161	150	24	,	,	PUNCT
cana-5161	150	25	@	@	ADP
cana-5161	150	26	p<0.05	p<0.05	NOUN
cana-5161	150	27	vs	vs	ADP
cana-5161	150	28	alcl3	alcl3	PROPN
cana-5161	150	29	+	+	NOUN
cana-5161	150	30	agmatine	agmatine	NOUN
cana-5161	150	31	(	(	PUNCT
cana-5161	150	32	10	10	NUM
cana-5161	150	33	mg	mg	NUM
cana-5161	150	34	/	/	SYM
cana-5161	150	35	kg	kg	NOUN
cana-5161	150	36	)	)	PUNCT
cana-5161	150	37	figure.2b	figure.2b	NOUN
cana-5161	150	38	effect	effect	NOUN
cana-5161	150	39	of	of	ADP
cana-5161	150	40	agmatine	agmatine	NOUN
cana-5161	150	41	on	on	ADP
cana-5161	150	42	time	time	NOUN
cana-5161	150	43	spent	spend	VERB
cana-5161	150	44	in	in	ADP
cana-5161	150	45	target	target	NOUN
cana-5161	150	46	quadrant	quadrant	NOUN
cana-5161	150	47	(	(	PUNCT
cana-5161	150	48	s	s	NOUN
cana-5161	150	49	)	)	PUNCT
cana-5161	150	50	in	in	ADP
cana-5161	150	51	morris	morris	PROPN
cana-5161	150	52	water	water	NOUN
cana-5161	150	53	maze	maze	NOUN
cana-5161	150	54	(	(	PUNCT
cana-5161	150	55	mwm	mwm	NOUN
cana-5161	150	56	)	)	PUNCT
cana-5161	150	57	task	task	NOUN
cana-5161	150	58	in	in	ADP
cana-5161	150	59	alcl3	alcl3	PROPN
cana-5161	150	60	treated	treat	VERB
cana-5161	150	61	rats	rat	NOUN
cana-5161	150	62	.	.	PUNCT
cana-5161	151	1	values	value	NOUN
cana-5161	151	2	are	be	AUX
cana-5161	151	3	expressed	express	VERB
cana-5161	151	4	as	as	ADP
cana-5161	151	5	mean	mean	NOUN
cana-5161	151	6	±	±	NUM
cana-5161	151	7	sd	sd	NOUN
cana-5161	151	8	.	.	PUNCT
cana-5161	152	1	*	*	PUNCT
cana-5161	152	2	p<0.05	p<0.05	PROPN
cana-5161	152	3	vs	vs	ADP
cana-5161	152	4	vehicle	vehicle	NOUN
cana-5161	152	5	control	control	NOUN
cana-5161	152	6	,	,	PUNCT
cana-5161	152	7	#	#	NOUN
cana-5161	152	8	p<0.05	p<0.05	NOUN
cana-5161	152	9	vs	vs	ADP
cana-5161	152	10	alcl3	alcl3	PROPN
cana-5161	152	11	,	,	PUNCT
cana-5161	152	12	$	$	SYM
cana-5161	152	13	p<0.05	p<0.05	NOUN
cana-5161	152	14	vs	vs	ADP
cana-5161	152	15	alcl3	alcl3	PROPN
cana-5161	152	16	+	+	NOUN
cana-5161	152	17	agmatine	agmatine	NOUN
cana-5161	152	18	(	(	PUNCT
cana-5161	152	19	3	3	NUM
cana-5161	152	20	mg	mg	PROPN
cana-5161	152	21	/	/	SYM
cana-5161	152	22	kg	kg	PROPN
cana-5161	152	23	)	)	PUNCT
cana-5161	152	24	,	,	PUNCT
cana-5161	152	25	@	@	ADP
cana-5161	152	26	p<0.05	p<0.05	NOUN
cana-5161	152	27	vs	vs	ADP
cana-5161	152	28	alcl3	alcl3	PROPN
cana-5161	152	29	+	+	NOUN
cana-5161	152	30	agmatine	agmatine	NOUN
cana-5161	152	31	(	(	PUNCT
cana-5161	152	32	10	10	NUM
cana-5161	152	33	mg	mg	NUM
cana-5161	152	34	/	/	SYM
cana-5161	152	35	kg	kg	NOUN
cana-5161	152	36	)	)	PUNCT
cana-5161	153	1	3.1.3	3.1.3	NUM
cana-5161	153	2	effect	effect	NOUN
cana-5161	153	3	of	of	ADP
cana-5161	153	4	agmatine	agmatine	NOUN
cana-5161	153	5	on	on	ADP
cana-5161	153	6	memory	memory	NOUN
cana-5161	153	7	performance	performance	NOUN
cana-5161	153	8	in	in	ADP
cana-5161	153	9	object	object	NOUN
cana-5161	153	10	recognition	recognition	NOUN
cana-5161	153	11	task	task	NOUN
cana-5161	153	12	in	in	ADP
cana-5161	153	13	alcl3	alcl3	PROPN
cana-5161	153	14	treated	treat	VERB
cana-5161	153	15	rats	rat	NOUN
cana-5161	153	16	.	.	PUNCT
cana-5161	154	1	on	on	ADP
cana-5161	154	2	day	day	NOUN
cana-5161	154	3	20	20	NUM
cana-5161	154	4	following	follow	VERB
cana-5161	154	5	alcl3	alcl3	PROPN
cana-5161	154	6	administration	administration	PROPN
cana-5161	154	7	,	,	PUNCT
cana-5161	154	8	in	in	ADP
cana-5161	154	9	the	the	DET
cana-5161	154	10	sample	sample	NOUN
cana-5161	154	11	phase	phase	NOUN
cana-5161	154	12	(	(	PUNCT
cana-5161	154	13	t1	t1	NOUN
cana-5161	154	14	)	)	PUNCT
cana-5161	154	15	wherein	wherein	SCONJ
cana-5161	154	16	both	both	CCONJ
cana-5161	154	17	the	the	DET
cana-5161	154	18	objects	object	NOUN
cana-5161	154	19	were	be	AUX
cana-5161	154	20	similar	similar	ADJ
cana-5161	154	21	,	,	PUNCT
cana-5161	154	22	all	all	DET
cana-5161	154	23	the	the	DET
cana-5161	154	24	rats	rat	NOUN
cana-5161	154	25	took	take	VERB
cana-5161	154	26	similar	similar	ADJ
cana-5161	154	27	time	time	NOUN
cana-5161	154	28	for	for	ADP
cana-5161	154	29	object	object	NOUN
cana-5161	154	30	exploration	exploration	NOUN
cana-5161	154	31	(	(	PUNCT
cana-5161	154	32	fig	fig	NOUN
cana-5161	154	33	.	.	PUNCT
cana-5161	154	34	12a	12a	NOUN
cana-5161	154	35	)	)	PUNCT
cana-5161	154	36	,	,	PUNCT
cana-5161	154	37	regardless	regardless	ADV
cana-5161	154	38	of	of	ADP
cana-5161	154	39	the	the	DET
cana-5161	154	40	treatment	treatment	NOUN
cana-5161	154	41	.	.	PUNCT
cana-5161	155	1	whereas	whereas	SCONJ
cana-5161	155	2	,	,	PUNCT
cana-5161	155	3	on	on	ADP
cana-5161	155	4	day	day	NOUN
cana-5161	155	5	21	21	NUM
cana-5161	155	6	when	when	SCONJ
cana-5161	155	7	animals	animal	NOUN
cana-5161	155	8	exposed	expose	VERB
cana-5161	155	9	with	with	ADP
cana-5161	155	10	familiar	familiar	ADJ
cana-5161	155	11	and	and	CCONJ
cana-5161	155	12	novel	novel	ADJ
cana-5161	155	13	objects	object	NOUN
cana-5161	155	14	showed	show	VERB
cana-5161	155	15	significant	significant	ADJ
cana-5161	155	16	discrimination	discrimination	NOUN
cana-5161	155	17	.	.	PUNCT
cana-5161	156	1	however	however	ADV
cana-5161	156	2	,	,	PUNCT
cana-5161	156	3	alcl3	alcl3	PROPN
cana-5161	156	4	treated	treat	VERB
cana-5161	156	5	rats	rat	NOUN
cana-5161	156	6	were	be	AUX
cana-5161	156	7	unable	unable	ADJ
cana-5161	156	8	to	to	PART
cana-5161	156	9	discriminate	discriminate	VERB
cana-5161	156	10	between	between	ADP
cana-5161	156	11	familiar	familiar	ADJ
cana-5161	156	12	and	and	CCONJ
cana-5161	156	13	novel	novel	ADJ
cana-5161	156	14	communications	communication	NOUN
cana-5161	156	15	on	on	ADP
cana-5161	156	16	applied	apply	VERB
cana-5161	156	17	nonlinear	nonlinear	ADJ
cana-5161	156	18	analysis	analysis	NOUN
cana-5161	156	19	issn	issn	NOUN
cana-5161	156	20	:	:	PUNCT
cana-5161	156	21	1074	1074	NUM
cana-5161	156	22	-	-	PUNCT
cana-5161	156	23	133x	133x	NUM
cana-5161	156	24	vol	vol	NOUN
cana-5161	156	25	32	32	NUM
cana-5161	156	26	no	no	NOUN
cana-5161	156	27	.	.	PUNCT
cana-5161	157	1	icmasd	icmasd	NOUN
cana-5161	157	2	(	(	PUNCT
cana-5161	157	3	2025	2025	NUM
cana-5161	157	4	)	)	PUNCT
cana-5161	157	5	1361	1361	NUM
cana-5161	158	1	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	158	2	objects	object	VERB
cana-5161	158	3	and	and	CCONJ
cana-5161	158	4	spend	spend	VERB
cana-5161	158	5	almost	almost	ADV
cana-5161	158	6	equal	equal	ADJ
cana-5161	158	7	time	time	NOUN
cana-5161	158	8	to	to	PART
cana-5161	158	9	explore	explore	VERB
cana-5161	158	10	the	the	DET
cana-5161	158	11	familiar	familiar	ADJ
cana-5161	158	12	and	and	CCONJ
cana-5161	158	13	novel	novel	ADJ
cana-5161	158	14	objects	object	NOUN
cana-5161	158	15	.	.	PUNCT
cana-5161	159	1	whereas	whereas	ADV
cana-5161	159	2	,	,	PUNCT
cana-5161	159	3	agmatine	agmatine	NOUN
cana-5161	159	4	treatment	treatment	NOUN
cana-5161	159	5	produced	produce	VERB
cana-5161	159	6	significant	significant	ADJ
cana-5161	159	7	improvement	improvement	NOUN
cana-5161	159	8	in	in	ADP
cana-5161	159	9	discriminating	discriminate	VERB
cana-5161	159	10	ability	ability	NOUN
cana-5161	159	11	between	between	ADP
cana-5161	159	12	familiar	familiar	ADJ
cana-5161	159	13	and	and	CCONJ
cana-5161	159	14	novel	novel	ADJ
cana-5161	159	15	object	object	NOUN
cana-5161	159	16	in	in	ADP
cana-5161	159	17	alcl3	alcl3	PROPN
cana-5161	159	18	treated	treat	VERB
cana-5161	159	19	rats	rat	NOUN
cana-5161	159	20	and	and	CCONJ
cana-5161	159	21	spend	spend	VERB
cana-5161	159	22	more	more	ADJ
cana-5161	159	23	time	time	NOUN
cana-5161	159	24	to	to	PART
cana-5161	159	25	explore	explore	VERB
cana-5161	159	26	novel	novel	ADJ
cana-5161	159	27	object	object	NOUN
cana-5161	159	28	.	.	PUNCT
cana-5161	160	1	unpaired	unpaired	ADJ
cana-5161	160	2	t	t	PROPN
cana-5161	160	3	-	-	PUNCT
cana-5161	160	4	test	test	NOUN
cana-5161	160	5	comparisons	comparison	NOUN
cana-5161	160	6	showed	show	VERB
cana-5161	160	7	significant	significant	ADJ
cana-5161	160	8	difference	difference	NOUN
cana-5161	160	9	in	in	ADP
cana-5161	160	10	exploration	exploration	NOUN
cana-5161	160	11	time	time	NOUN
cana-5161	160	12	(	(	PUNCT
cana-5161	160	13	fig	fig	NOUN
cana-5161	160	14	.	.	PUNCT
cana-5161	160	15	12b	12b	NOUN
cana-5161	160	16	)	)	PUNCT
cana-5161	160	17	and	and	CCONJ
cana-5161	160	18	the	the	DET
cana-5161	160	19	agmatine	agmatine	NOUN
cana-5161	160	20	treated	treat	VERB
cana-5161	160	21	rats	rat	NOUN
cana-5161	160	22	spent	spend	VERB
cana-5161	160	23	more	more	ADJ
cana-5161	160	24	time	time	NOUN
cana-5161	160	25	in	in	ADP
cana-5161	160	26	exploring	explore	VERB
cana-5161	160	27	the	the	DET
cana-5161	160	28	novel	novel	ADJ
cana-5161	160	29	objects	object	NOUN
cana-5161	160	30	(	(	PUNCT
cana-5161	160	31	p<0.05	p<0.05	NOUN
cana-5161	160	32	)	)	PUNCT
cana-5161	160	33	(	(	PUNCT
cana-5161	160	34	fig	fig	NOUN
cana-5161	160	35	.	.	PUNCT
cana-5161	161	1	3a	3a	NUM
cana-5161	161	2	and	and	CCONJ
cana-5161	161	3	3b	3b	NUM
cana-5161	161	4	)	)	PUNCT
cana-5161	161	5	.	.	PUNCT
cana-5161	162	1	figure.3a	figure.3a	PROPN
cana-5161	162	2	effect	effect	NOUN
cana-5161	162	3	of	of	ADP
cana-5161	162	4	agmatine	agmatine	NOUN
cana-5161	162	5	on	on	ADP
cana-5161	162	6	memory	memory	NOUN
cana-5161	162	7	performance	performance	NOUN
cana-5161	162	8	in	in	ADP
cana-5161	162	9	object	object	NOUN
cana-5161	162	10	recognition	recognition	NOUN
cana-5161	162	11	task	task	NOUN
cana-5161	162	12	in	in	ADP
cana-5161	162	13	alcl3	alcl3	PROPN
cana-5161	162	14	treated	treat	VERB
cana-5161	162	15	rats	rat	NOUN
cana-5161	162	16	.	.	PUNCT
cana-5161	163	1	figure.3b	figure.3b	NOUN
cana-5161	163	2	effect	effect	NOUN
cana-5161	163	3	of	of	ADP
cana-5161	163	4	agmatine	agmatine	NOUN
cana-5161	163	5	on	on	ADP
cana-5161	163	6	time	time	NOUN
cana-5161	163	7	spent	spend	VERB
cana-5161	163	8	exploring	explore	VERB
cana-5161	163	9	the	the	DET
cana-5161	163	10	familiar	familiar	ADJ
cana-5161	163	11	and	and	CCONJ
cana-5161	163	12	novel	novel	ADJ
cana-5161	163	13	objects	object	NOUN
cana-5161	163	14	during	during	ADP
cana-5161	163	15	t2	t2	NOUN
cana-5161	163	16	in	in	ADP
cana-5161	163	17	alcl3	alcl3	PROPN
cana-5161	163	18	treated	treat	VERB
cana-5161	163	19	rats	rat	NOUN
cana-5161	163	20	.	.	PUNCT
cana-5161	164	1	*	*	PUNCT
cana-5161	164	2	p<0.05	p<0.05	NOUN
cana-5161	164	3	vs	vs	ADP
cana-5161	164	4	familiar	familiar	ADJ
cana-5161	164	5	object	object	NOUN
cana-5161	164	6	3.2	3.2	NUM
cana-5161	164	7	neurochemical	neurochemical	ADJ
cana-5161	164	8	estimation	estimation	NOUN
cana-5161	164	9	3.2.1	3.2.1	NUM
cana-5161	164	10	effect	effect	NOUN
cana-5161	164	11	of	of	ADP
cana-5161	164	12	agmatine	agmatine	NOUN
cana-5161	164	13	on	on	ADP
cana-5161	164	14	neurotransmitters	neurotransmitter	NOUN
cana-5161	164	15	(	(	PUNCT
cana-5161	164	16	serotonin	serotonin	NOUN
cana-5161	164	17	(	(	PUNCT
cana-5161	164	18	5	5	NUM
cana-5161	164	19	-	-	SYM
cana-5161	164	20	ht	ht	NOUN
cana-5161	164	21	)	)	PUNCT
cana-5161	164	22	,	,	PUNCT
cana-5161	164	23	dopamine	dopamine	NOUN
cana-5161	164	24	(	(	PUNCT
cana-5161	164	25	da	da	NOUN
cana-5161	164	26	)	)	PUNCT
cana-5161	164	27	and	and	CCONJ
cana-5161	164	28	norepinephrine	norepinephrine	NOUN
cana-5161	164	29	(	(	PUNCT
cana-5161	164	30	ne	ne	NOUN
cana-5161	164	31	)	)	PUNCT
cana-5161	164	32	levels	level	NOUN
cana-5161	164	33	in	in	ADP
cana-5161	164	34	alcl3	alcl3	PROPN
cana-5161	164	35	treated	treat	VERB
cana-5161	164	36	rats	rat	NOUN
cana-5161	164	37	.	.	PUNCT
cana-5161	165	1	alcl3	alcl3	PROPN
cana-5161	165	2	treated	treat	VERB
cana-5161	165	3	rats	rat	NOUN
cana-5161	165	4	showed	show	VERB
cana-5161	165	5	significant	significant	ADJ
cana-5161	165	6	decrease	decrease	NOUN
cana-5161	165	7	in	in	ADP
cana-5161	165	8	the	the	DET
cana-5161	165	9	level	level	NOUN
cana-5161	165	10	of	of	ADP
cana-5161	165	11	neurotransmitter	neurotransmitter	NOUN
cana-5161	165	12	serotonin	serotonin	NOUN
cana-5161	165	13	(	(	PUNCT
cana-5161	165	14	p<0.05	p<0.05	NOUN
cana-5161	165	15	)	)	PUNCT
cana-5161	165	16	,	,	PUNCT
cana-5161	165	17	dopamine	dopamine	NOUN
cana-5161	165	18	(	(	PUNCT
cana-5161	165	19	p<0.05	p<0.05	NOUN
cana-5161	165	20	)	)	PUNCT
cana-5161	165	21	and	and	CCONJ
cana-5161	165	22	norepinephrine	norepinephrine	NOUN
cana-5161	165	23	(	(	PUNCT
cana-5161	165	24	p<0.05	p<0.05	NOUN
cana-5161	165	25	)	)	PUNCT
cana-5161	165	26	as	as	SCONJ
cana-5161	165	27	compared	compare	VERB
cana-5161	165	28	with	with	ADP
cana-5161	165	29	vehicle	vehicle	NOUN
cana-5161	165	30	control	control	NOUN
cana-5161	165	31	.	.	PUNCT
cana-5161	166	1	however	however	ADV
cana-5161	166	2	,	,	PUNCT
cana-5161	166	3	treatment	treatment	NOUN
cana-5161	166	4	with	with	ADP
cana-5161	166	5	agmatine	agmatine	NOUN
cana-5161	166	6	(	(	PUNCT
cana-5161	166	7	3	3	NUM
cana-5161	166	8	,	,	PUNCT
cana-5161	166	9	10	10	NUM
cana-5161	166	10	and	and	CCONJ
cana-5161	166	11	30	30	NUM
cana-5161	166	12	mg	mg	NUM
cana-5161	166	13	/	/	SYM
cana-5161	166	14	kg	kg	PROPN
cana-5161	166	15	)	)	PUNCT
cana-5161	166	16	dose	dose	NOUN
cana-5161	166	17	dependently	dependently	ADV
cana-5161	166	18	significantly	significantly	ADV
cana-5161	166	19	attenuated	attenuate	VERB
cana-5161	166	20	the	the	DET
cana-5161	166	21	reduction	reduction	NOUN
cana-5161	166	22	in	in	ADP
cana-5161	166	23	serotonin	serotonin	NOUN
cana-5161	166	24	(	(	PUNCT
cana-5161	166	25	p<0.05	p<0.05	NOUN
cana-5161	166	26	)	)	PUNCT
cana-5161	166	27	,	,	PUNCT
cana-5161	166	28	dopamine	dopamine	NOUN
cana-5161	166	29	(	(	PUNCT
cana-5161	166	30	p<0.05	p<0.05	NOUN
cana-5161	166	31	)	)	PUNCT
cana-5161	166	32	and	and	CCONJ
cana-5161	166	33	norepinephrine	norepinephrine	NOUN
cana-5161	166	34	(	(	PUNCT
cana-5161	166	35	p<0.05	p<0.05	NOUN
cana-5161	166	36	)	)	PUNCT
cana-5161	166	37	levels	level	NOUN
cana-5161	166	38	as	as	SCONJ
cana-5161	166	39	compare	compare	VERB
cana-5161	166	40	communications	communication	NOUN
cana-5161	166	41	on	on	ADP
cana-5161	166	42	applied	apply	VERB
cana-5161	166	43	nonlinear	nonlinear	ADJ
cana-5161	166	44	analysis	analysis	NOUN
cana-5161	166	45	issn	issn	NOUN
cana-5161	166	46	:	:	PUNCT
cana-5161	166	47	1074	1074	NUM
cana-5161	166	48	-	-	PUNCT
cana-5161	166	49	133x	133x	NUM
cana-5161	166	50	vol	vol	NOUN
cana-5161	166	51	32	32	NUM
cana-5161	166	52	no	no	NOUN
cana-5161	166	53	.	.	PUNCT
cana-5161	167	1	icmasd	icmasd	NOUN
cana-5161	167	2	(	(	PUNCT
cana-5161	167	3	2025	2025	NUM
cana-5161	167	4	)	)	PUNCT
cana-5161	167	5	1362	1362	NUM
cana-5161	167	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	167	7	with	with	ADP
cana-5161	167	8	alcl3	alcl3	PROPN
cana-5161	167	9	treated	treat	VERB
cana-5161	167	10	rats	rat	NOUN
cana-5161	167	11	.	.	PUNCT
cana-5161	168	1	among	among	ADP
cana-5161	168	2	selected	select	VERB
cana-5161	168	3	doses	dose	NOUN
cana-5161	168	4	,	,	PUNCT
cana-5161	168	5	agmatine	agmatine	NOUN
cana-5161	168	6	(	(	PUNCT
cana-5161	168	7	10	10	NUM
cana-5161	168	8	&	&	CCONJ
cana-5161	168	9	30	30	NUM
cana-5161	168	10	mg	mg	PROPN
cana-5161	168	11	/	/	SYM
cana-5161	168	12	kg	kg	PROPN
cana-5161	168	13	)	)	PUNCT
cana-5161	168	14	was	be	AUX
cana-5161	168	15	found	find	VERB
cana-5161	168	16	to	to	ADP
cana-5161	168	17	more	more	ADV
cana-5161	168	18	effective	effective	ADJ
cana-5161	168	19	in	in	ADP
cana-5161	168	20	restoring	restore	VERB
cana-5161	168	21	the	the	DET
cana-5161	168	22	level	level	NOUN
cana-5161	168	23	of	of	ADP
cana-5161	168	24	catecholamines	catecholamine	NOUN
cana-5161	168	25	(	(	PUNCT
cana-5161	168	26	5	5	NUM
cana-5161	168	27	-	-	SYM
cana-5161	168	28	ht	ht	PROPN
cana-5161	168	29	,	,	PUNCT
cana-5161	168	30	da	da	PROPN
cana-5161	168	31	and	and	CCONJ
cana-5161	168	32	ne	ne	NOUN
cana-5161	168	33	)	)	PUNCT
cana-5161	168	34	(	(	PUNCT
cana-5161	168	35	fig.4	fig.4	PROPN
cana-5161	168	36	)	)	PUNCT
cana-5161	168	37	.	.	PUNCT
cana-5161	169	1	figure.4	figure.4	ADJ
cana-5161	169	2	effect	effect	NOUN
cana-5161	169	3	of	of	ADP
cana-5161	169	4	agmatine	agmatine	NOUN
cana-5161	169	5	on	on	ADP
cana-5161	169	6	catecholamine	catecholamine	NOUN
cana-5161	169	7	level	level	NOUN
cana-5161	169	8	in	in	ADP
cana-5161	169	9	alcl3	alcl3	PROPN
cana-5161	169	10	treated	treat	VERB
cana-5161	169	11	rats	rat	NOUN
cana-5161	169	12	.	.	PUNCT
cana-5161	170	1	values	value	NOUN
cana-5161	170	2	are	be	AUX
cana-5161	170	3	expressed	express	VERB
cana-5161	170	4	as	as	ADP
cana-5161	170	5	mean	mean	NOUN
cana-5161	170	6	±	±	NUM
cana-5161	170	7	sd	sd	NOUN
cana-5161	170	8	.	.	PUNCT
cana-5161	171	1	data	datum	NOUN
cana-5161	171	2	analyzed	analyze	VERB
cana-5161	171	3	by	by	ADP
cana-5161	171	4	one	one	NUM
cana-5161	171	5	way	way	NOUN
cana-5161	171	6	anova	anova	PROPN
cana-5161	171	7	followed	follow	VERB
cana-5161	171	8	by	by	ADP
cana-5161	171	9	tukey	tukey	PROPN
cana-5161	171	10	’s	’s	PART
cana-5161	171	11	post	post	X
cana-5161	171	12	hoc	hoc	X
cana-5161	171	13	test	test	NOUN
cana-5161	171	14	.	.	PUNCT
cana-5161	172	1	*	*	PUNCT
cana-5161	172	2	p<0.05	p<0.05	PROPN
cana-5161	172	3	vs	vs	ADP
cana-5161	172	4	vehicle	vehicle	NOUN
cana-5161	172	5	control	control	NOUN
cana-5161	172	6	,	,	PUNCT
cana-5161	172	7	#	#	NOUN
cana-5161	172	8	p<0.05	p<0.05	NOUN
cana-5161	172	9	vs	vs	ADP
cana-5161	172	10	alcl3	alcl3	PROPN
cana-5161	172	11	,	,	PUNCT
cana-5161	172	12	$	$	SYM
cana-5161	172	13	p<0.05	p<0.05	NOUN
cana-5161	172	14	vs	vs	ADP
cana-5161	172	15	alcl3	alcl3	PROPN
cana-5161	172	16	+	+	NOUN
cana-5161	172	17	agmatine	agmatine	NOUN
cana-5161	172	18	(	(	PUNCT
cana-5161	172	19	3	3	NUM
cana-5161	172	20	mg	mg	PROPN
cana-5161	172	21	/	/	SYM
cana-5161	172	22	kg	kg	PROPN
cana-5161	172	23	)	)	PUNCT
cana-5161	172	24	,	,	PUNCT
cana-5161	172	25	@	@	ADP
cana-5161	172	26	p<0.05	p<0.05	NOUN
cana-5161	172	27	vs	vs	ADP
cana-5161	172	28	alcl3	alcl3	PROPN
cana-5161	172	29	+	+	NOUN
cana-5161	172	30	agmatine	agmatine	NOUN
cana-5161	172	31	(	(	PUNCT
cana-5161	172	32	10	10	NUM
cana-5161	172	33	mg	mg	NUM
cana-5161	172	34	/	/	SYM
cana-5161	172	35	kg	kg	NOUN
cana-5161	172	36	)	)	PUNCT
cana-5161	172	37	3.2.2	3.2.2	NUM
cana-5161	172	38	effect	effect	NOUN
cana-5161	172	39	of	of	ADP
cana-5161	172	40	agmatine	agmatine	NOUN
cana-5161	172	41	on	on	ADP
cana-5161	172	42	glutamate	glutamate	ADJ
cana-5161	172	43	level	level	NOUN
cana-5161	172	44	in	in	ADP
cana-5161	172	45	alcl3	alcl3	PROPN
cana-5161	172	46	treated	treat	VERB
cana-5161	172	47	rats	rat	NOUN
cana-5161	172	48	.	.	PUNCT
cana-5161	173	1	alcl3	alcl3	PROPN
cana-5161	173	2	treated	treat	VERB
cana-5161	173	3	rats	rat	NOUN
cana-5161	173	4	showed	show	VERB
cana-5161	173	5	significant	significant	ADJ
cana-5161	173	6	increase	increase	NOUN
cana-5161	173	7	in	in	ADP
cana-5161	173	8	the	the	DET
cana-5161	173	9	level	level	NOUN
cana-5161	173	10	of	of	ADP
cana-5161	173	11	glutamate	glutamate	NOUN
cana-5161	173	12	(	(	PUNCT
cana-5161	173	13	p<0.05	p<0.05	NOUN
cana-5161	173	14	)	)	PUNCT
cana-5161	173	15	as	as	SCONJ
cana-5161	173	16	compared	compare	VERB
cana-5161	173	17	to	to	ADP
cana-5161	173	18	vehicle	vehicle	NOUN
cana-5161	173	19	control	control	NOUN
cana-5161	173	20	.	.	PUNCT
cana-5161	174	1	however	however	ADV
cana-5161	174	2	,	,	PUNCT
cana-5161	174	3	chronic	chronic	ADJ
cana-5161	174	4	treatment	treatment	NOUN
cana-5161	174	5	with	with	ADP
cana-5161	174	6	agmatine	agmatine	NOUN
cana-5161	174	7	(	(	PUNCT
cana-5161	174	8	3	3	NUM
cana-5161	174	9	,	,	PUNCT
cana-5161	174	10	10	10	NUM
cana-5161	174	11	and	and	CCONJ
cana-5161	174	12	30	30	NUM
cana-5161	174	13	mg	mg	NUM
cana-5161	174	14	/	/	SYM
cana-5161	174	15	kg	kg	PROPN
cana-5161	174	16	)	)	PUNCT
cana-5161	174	17	dose	dose	NOUN
cana-5161	174	18	dependently	dependently	ADV
cana-5161	174	19	showed	show	VERB
cana-5161	174	20	significant	significant	ADJ
cana-5161	174	21	decrease	decrease	NOUN
cana-5161	174	22	in	in	ADP
cana-5161	174	23	glutamate	glutamate	NOUN
cana-5161	174	24	(	(	PUNCT
cana-5161	174	25	p<0.05	p<0.05	NOUN
cana-5161	174	26	)	)	PUNCT
cana-5161	174	27	level	level	NOUN
cana-5161	174	28	as	as	SCONJ
cana-5161	174	29	compared	compare	VERB
cana-5161	174	30	with	with	ADP
cana-5161	174	31	alcl3	alcl3	PROPN
cana-5161	174	32	treated	treat	VERB
cana-5161	174	33	rats	rat	NOUN
cana-5161	174	34	.	.	PUNCT
cana-5161	175	1	among	among	ADP
cana-5161	175	2	selected	select	VERB
cana-5161	175	3	doses	dose	NOUN
cana-5161	175	4	,	,	PUNCT
cana-5161	175	5	agmatine	agmatine	NOUN
cana-5161	175	6	(	(	PUNCT
cana-5161	175	7	10	10	NUM
cana-5161	175	8	&	&	CCONJ
cana-5161	175	9	30mg	30mg	NUM
cana-5161	175	10	/	/	SYM
cana-5161	175	11	kg	kg	PROPN
cana-5161	175	12	)	)	PUNCT
cana-5161	175	13	showed	show	VERB
cana-5161	175	14	more	more	ADV
cana-5161	175	15	effective	effective	ADJ
cana-5161	175	16	in	in	ADP
cana-5161	175	17	prevention	prevention	NOUN
cana-5161	175	18	of	of	ADP
cana-5161	175	19	alteration	alteration	NOUN
cana-5161	175	20	of	of	ADP
cana-5161	175	21	glutamate	glutamate	ADJ
cana-5161	175	22	levels	level	NOUN
cana-5161	175	23	(	(	PUNCT
cana-5161	175	24	fig.5	fig.5	PROPN
cana-5161	175	25	)	)	PUNCT
cana-5161	175	26	.	.	PUNCT
cana-5161	176	1	figure.5	figure.5	PRON
cana-5161	176	2	effect	effect	NOUN
cana-5161	176	3	of	of	ADP
cana-5161	176	4	agmatine	agmatine	NOUN
cana-5161	176	5	on	on	ADP
cana-5161	176	6	glutamate	glutamate	ADJ
cana-5161	176	7	level	level	NOUN
cana-5161	176	8	in	in	ADP
cana-5161	176	9	alcl3	alcl3	PROPN
cana-5161	176	10	treated	treat	VERB
cana-5161	176	11	rats	rat	NOUN
cana-5161	176	12	.	.	PUNCT
cana-5161	177	1	communications	communication	NOUN
cana-5161	177	2	on	on	ADP
cana-5161	177	3	applied	apply	VERB
cana-5161	177	4	nonlinear	nonlinear	ADJ
cana-5161	177	5	analysis	analysis	NOUN
cana-5161	177	6	issn	issn	NOUN
cana-5161	177	7	:	:	PUNCT
cana-5161	177	8	1074	1074	NUM
cana-5161	177	9	-	-	PUNCT
cana-5161	177	10	133x	133x	NUM
cana-5161	177	11	vol	vol	NOUN
cana-5161	177	12	32	32	NUM
cana-5161	177	13	no	no	NOUN
cana-5161	177	14	.	.	PUNCT
cana-5161	178	1	icmasd	icmasd	NOUN
cana-5161	178	2	(	(	PUNCT
cana-5161	178	3	2025	2025	NUM
cana-5161	178	4	)	)	PUNCT
cana-5161	178	5	1363	1363	NUM
cana-5161	179	1	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	179	2	values	value	NOUN
cana-5161	179	3	are	be	AUX
cana-5161	179	4	expressed	express	VERB
cana-5161	179	5	as	as	ADP
cana-5161	179	6	mean	mean	NOUN
cana-5161	179	7	±	±	NUM
cana-5161	179	8	sd	sd	NOUN
cana-5161	179	9	.	.	PUNCT
cana-5161	180	1	data	datum	NOUN
cana-5161	180	2	analyzed	analyze	VERB
cana-5161	180	3	by	by	ADP
cana-5161	180	4	one	one	NUM
cana-5161	180	5	way	way	NOUN
cana-5161	180	6	anova	anova	PROPN
cana-5161	180	7	followed	follow	VERB
cana-5161	180	8	by	by	ADP
cana-5161	180	9	tukey	tukey	PROPN
cana-5161	180	10	’s	’s	PART
cana-5161	180	11	post	post	X
cana-5161	180	12	hoc	hoc	X
cana-5161	180	13	test	test	NOUN
cana-5161	180	14	.	.	PUNCT
cana-5161	181	1	*	*	PUNCT
cana-5161	181	2	p<0.05	p<0.05	PROPN
cana-5161	181	3	vs	vs	ADP
cana-5161	181	4	vehicle	vehicle	NOUN
cana-5161	181	5	control	control	NOUN
cana-5161	181	6	,	,	PUNCT
cana-5161	181	7	#	#	NOUN
cana-5161	181	8	p<0.05	p<0.05	NOUN
cana-5161	181	9	vs	vs	ADP
cana-5161	181	10	alcl3	alcl3	PROPN
cana-5161	181	11	,	,	PUNCT
cana-5161	181	12	$	$	SYM
cana-5161	181	13	p<0.05	p<0.05	NOUN
cana-5161	181	14	vs	vs	ADP
cana-5161	181	15	alcl3	alcl3	PROPN
cana-5161	181	16	+	+	NOUN
cana-5161	181	17	agmatine	agmatine	NOUN
cana-5161	181	18	(	(	PUNCT
cana-5161	181	19	3	3	NUM
cana-5161	181	20	mg	mg	PROPN
cana-5161	181	21	/	/	SYM
cana-5161	181	22	kg	kg	PROPN
cana-5161	181	23	)	)	PUNCT
cana-5161	181	24	,	,	PUNCT
cana-5161	181	25	@	@	ADP
cana-5161	181	26	p<0.05	p<0.05	NOUN
cana-5161	181	27	vs	vs	ADP
cana-5161	181	28	alcl3	alcl3	PROPN
cana-5161	181	29	+	+	NOUN
cana-5161	181	30	agmatine	agmatine	NOUN
cana-5161	181	31	(	(	PUNCT
cana-5161	181	32	10	10	NUM
cana-5161	181	33	mg	mg	NUM
cana-5161	181	34	/	/	SYM
cana-5161	181	35	kg	kg	NOUN
cana-5161	181	36	)	)	PUNCT
cana-5161	181	37	3.2.3	3.2.3	NUM
cana-5161	181	38	effect	effect	NOUN
cana-5161	181	39	of	of	ADP
cana-5161	181	40	agmatine	agmatine	NOUN
cana-5161	181	41	on	on	ADP
cana-5161	181	42	gaba	gaba	NOUN
cana-5161	181	43	level	level	NOUN
cana-5161	181	44	in	in	ADP
cana-5161	181	45	alcl3	alcl3	PROPN
cana-5161	181	46	treated	treat	VERB
cana-5161	181	47	rats	rat	NOUN
cana-5161	181	48	.	.	PUNCT
cana-5161	182	1	alcl3	alcl3	PROPN
cana-5161	182	2	treated	treat	VERB
cana-5161	182	3	rats	rat	NOUN
cana-5161	182	4	showed	show	VERB
cana-5161	182	5	significant	significant	ADJ
cana-5161	182	6	decrease	decrease	NOUN
cana-5161	182	7	in	in	ADP
cana-5161	182	8	the	the	DET
cana-5161	182	9	level	level	NOUN
cana-5161	182	10	of	of	ADP
cana-5161	182	11	gaba	gaba	NOUN
cana-5161	182	12	(	(	PUNCT
cana-5161	182	13	p<0.05	p<0.05	NOUN
cana-5161	182	14	)	)	PUNCT
cana-5161	182	15	as	as	SCONJ
cana-5161	182	16	compared	compare	VERB
cana-5161	182	17	to	to	ADP
cana-5161	182	18	vehicle	vehicle	NOUN
cana-5161	182	19	control	control	NOUN
cana-5161	182	20	.	.	PUNCT
cana-5161	183	1	however	however	ADV
cana-5161	183	2	,	,	PUNCT
cana-5161	183	3	chronic	chronic	ADJ
cana-5161	183	4	treatment	treatment	NOUN
cana-5161	183	5	with	with	ADP
cana-5161	183	6	agmatine	agmatine	NOUN
cana-5161	183	7	(	(	PUNCT
cana-5161	183	8	3	3	NUM
cana-5161	183	9	,	,	PUNCT
cana-5161	183	10	10	10	NUM
cana-5161	183	11	and	and	CCONJ
cana-5161	183	12	30	30	NUM
cana-5161	183	13	mg	mg	NUM
cana-5161	183	14	/	/	SYM
cana-5161	183	15	kg	kg	PROPN
cana-5161	183	16	)	)	PUNCT
cana-5161	183	17	dose	dose	NOUN
cana-5161	183	18	dependently	dependently	ADV
cana-5161	183	19	showed	show	VERB
cana-5161	183	20	significant	significant	ADJ
cana-5161	183	21	increase	increase	NOUN
cana-5161	183	22	in	in	ADP
cana-5161	183	23	gaba	gaba	NOUN
cana-5161	183	24	(	(	PUNCT
cana-5161	183	25	p<0.05	p<0.05	NOUN
cana-5161	183	26	)	)	PUNCT
cana-5161	183	27	level	level	NOUN
cana-5161	183	28	as	as	SCONJ
cana-5161	183	29	compared	compare	VERB
cana-5161	183	30	with	with	ADP
cana-5161	183	31	alcl3	alcl3	PROPN
cana-5161	183	32	treated	treat	VERB
cana-5161	183	33	rats	rat	NOUN
cana-5161	183	34	.	.	PUNCT
cana-5161	184	1	among	among	ADP
cana-5161	184	2	selected	select	VERB
cana-5161	184	3	doses	dose	NOUN
cana-5161	184	4	,	,	PUNCT
cana-5161	184	5	agmatine	agmatine	NOUN
cana-5161	184	6	(	(	PUNCT
cana-5161	184	7	10	10	NUM
cana-5161	184	8	&	&	CCONJ
cana-5161	184	9	30mg	30mg	NUM
cana-5161	184	10	/	/	SYM
cana-5161	184	11	kg	kg	PROPN
cana-5161	184	12	)	)	PUNCT
cana-5161	184	13	showed	show	VERB
cana-5161	184	14	more	more	ADV
cana-5161	184	15	effective	effective	ADJ
cana-5161	184	16	in	in	ADP
cana-5161	184	17	prevention	prevention	NOUN
cana-5161	184	18	of	of	ADP
cana-5161	184	19	alteration	alteration	NOUN
cana-5161	184	20	of	of	ADP
cana-5161	184	21	gaba	gaba	NOUN
cana-5161	184	22	levels	level	NOUN
cana-5161	184	23	(	(	PUNCT
cana-5161	184	24	fig	fig	NOUN
cana-5161	184	25	.	.	PUNCT
cana-5161	185	1	6	6	NUM
cana-5161	185	2	)	)	PUNCT
cana-5161	185	3	.	.	PUNCT
cana-5161	186	1	figure.6	figure.6	NOUN
cana-5161	186	2	effect	effect	NOUN
cana-5161	186	3	of	of	ADP
cana-5161	186	4	agmatine	agmatine	NOUN
cana-5161	186	5	on	on	ADP
cana-5161	186	6	gaba	gaba	NOUN
cana-5161	186	7	level	level	NOUN
cana-5161	186	8	in	in	ADP
cana-5161	186	9	alcl3	alcl3	PROPN
cana-5161	186	10	treated	treat	VERB
cana-5161	186	11	rats	rat	NOUN
cana-5161	186	12	.	.	PUNCT
cana-5161	187	1	values	value	NOUN
cana-5161	187	2	are	be	AUX
cana-5161	187	3	expressed	express	VERB
cana-5161	187	4	as	as	ADP
cana-5161	187	5	mean	mean	NOUN
cana-5161	187	6	±	±	NUM
cana-5161	187	7	sd	sd	NOUN
cana-5161	187	8	.	.	PUNCT
cana-5161	188	1	data	datum	NOUN
cana-5161	188	2	analyzed	analyze	VERB
cana-5161	188	3	by	by	ADP
cana-5161	188	4	one	one	NUM
cana-5161	188	5	way	way	NOUN
cana-5161	188	6	anova	anova	PROPN
cana-5161	188	7	followed	follow	VERB
cana-5161	188	8	by	by	ADP
cana-5161	188	9	tukey	tukey	PROPN
cana-5161	188	10	’s	’s	PART
cana-5161	188	11	post	post	X
cana-5161	188	12	hoc	hoc	X
cana-5161	188	13	test	test	NOUN
cana-5161	188	14	.	.	PUNCT
cana-5161	189	1	*	*	PUNCT
cana-5161	189	2	p<0.05	p<0.05	PROPN
cana-5161	189	3	vs	vs	ADP
cana-5161	189	4	vehicle	vehicle	NOUN
cana-5161	189	5	control	control	NOUN
cana-5161	189	6	,	,	PUNCT
cana-5161	189	7	#	#	NOUN
cana-5161	189	8	p<0.05	p<0.05	NOUN
cana-5161	189	9	vs	vs	ADP
cana-5161	189	10	alcl3	alcl3	PROPN
cana-5161	189	11	,	,	PUNCT
cana-5161	189	12	$	$	SYM
cana-5161	189	13	p<0.05	p<0.05	NOUN
cana-5161	189	14	vs	vs	ADP
cana-5161	189	15	alcl3	alcl3	PROPN
cana-5161	189	16	+	+	NOUN
cana-5161	189	17	agmatine	agmatine	NOUN
cana-5161	189	18	(	(	PUNCT
cana-5161	189	19	3	3	NUM
cana-5161	189	20	mg	mg	PROPN
cana-5161	189	21	/	/	SYM
cana-5161	189	22	kg	kg	PROPN
cana-5161	189	23	)	)	PUNCT
cana-5161	189	24	,	,	PUNCT
cana-5161	189	25	@	@	ADP
cana-5161	189	26	p<0.05	p<0.05	NOUN
cana-5161	189	27	vs	vs	ADP
cana-5161	189	28	alcl3	alcl3	PROPN
cana-5161	189	29	+	+	NOUN
cana-5161	189	30	agmatine	agmatine	NOUN
cana-5161	189	31	(	(	PUNCT
cana-5161	189	32	10	10	NUM
cana-5161	189	33	mg	mg	NUM
cana-5161	189	34	/	/	SYM
cana-5161	189	35	kg	kg	NOUN
cana-5161	189	36	)	)	PUNCT
cana-5161	189	37	3.3	3.3	NUM
cana-5161	189	38	biochemical	biochemical	ADJ
cana-5161	189	39	parameters	parameter	NOUN
cana-5161	189	40	3.3.1	3.3.1	NUM
cana-5161	189	41	effect	effect	NOUN
cana-5161	189	42	of	of	ADP
cana-5161	189	43	agmatine	agmatine	ADJ
cana-5161	189	44	treatment	treatment	NOUN
cana-5161	189	45	on	on	ADP
cana-5161	189	46	oxidative	oxidative	ADJ
cana-5161	189	47	stress	stress	NOUN
cana-5161	189	48	parameters	parameter	NOUN
cana-5161	189	49	(	(	PUNCT
cana-5161	189	50	mda	mda	PROPN
cana-5161	189	51	,	,	PUNCT
cana-5161	189	52	gsh	gsh	PROPN
cana-5161	189	53	,	,	PUNCT
cana-5161	189	54	nitrite	nitrite	NOUN
cana-5161	189	55	and	and	CCONJ
cana-5161	189	56	ache	ache	NOUN
cana-5161	189	57	levels	level	NOUN
cana-5161	189	58	)	)	PUNCT
cana-5161	189	59	in	in	ADP
cana-5161	189	60	alcl3	alcl3	PROPN
cana-5161	189	61	treated	treat	VERB
cana-5161	189	62	rats	rat	NOUN
cana-5161	189	63	.	.	PUNCT
cana-5161	190	1	alcl3	alcl3	PROPN
cana-5161	190	2	administration	administration	NOUN
cana-5161	190	3	in	in	ADP
cana-5161	190	4	rats	rat	NOUN
cana-5161	190	5	caused	cause	VERB
cana-5161	190	6	elevation	elevation	NOUN
cana-5161	190	7	in	in	ADP
cana-5161	190	8	malondialdehyde	malondialdehyde	PROPN
cana-5161	190	9	,	,	PUNCT
cana-5161	190	10	nitrite	nitrite	NOUN
cana-5161	190	11	,	,	PUNCT
cana-5161	190	12	ache	ache	ADV
cana-5161	190	13	level	level	NOUN
cana-5161	190	14	and	and	CCONJ
cana-5161	190	15	depletion	depletion	NOUN
cana-5161	190	16	of	of	ADP
cana-5161	190	17	glutathione	glutathione	NOUN
cana-5161	190	18	levels	level	NOUN
cana-5161	190	19	(	(	PUNCT
cana-5161	190	20	p<0.05	p<0.05	NOUN
cana-5161	190	21	)	)	PUNCT
cana-5161	190	22	in	in	ADP
cana-5161	190	23	the	the	DET
cana-5161	190	24	hippocampal	hippocampal	ADJ
cana-5161	190	25	regions	region	NOUN
cana-5161	190	26	of	of	ADP
cana-5161	190	27	rat	rat	NOUN
cana-5161	190	28	brain	brain	NOUN
cana-5161	190	29	,	,	PUNCT
cana-5161	190	30	indicating	indicate	VERB
cana-5161	190	31	elevated	elevated	ADJ
cana-5161	190	32	oxidative	oxidative	ADJ
cana-5161	190	33	stress	stress	NOUN
cana-5161	190	34	.	.	PUNCT
cana-5161	191	1	however	however	ADV
cana-5161	191	2	,	,	PUNCT
cana-5161	191	3	administration	administration	NOUN
cana-5161	191	4	of	of	ADP
cana-5161	191	5	agmatine	agmatine	PROPN
cana-5161	191	6	dose	dose	NOUN
cana-5161	191	7	dependently	dependently	ADV
cana-5161	191	8	attenuated	attenuate	VERB
cana-5161	191	9	alcl3	alcl3	PUNCT
cana-5161	192	1	induced	induce	VERB
cana-5161	192	2	elevation	elevation	NOUN
cana-5161	192	3	in	in	ADP
cana-5161	192	4	oxidative	oxidative	ADJ
cana-5161	192	5	stress	stress	NOUN
cana-5161	192	6	(	(	PUNCT
cana-5161	192	7	p<0.05	p<0.05	NOUN
cana-5161	192	8	)	)	PUNCT
cana-5161	192	9	,	,	PUNCT
cana-5161	192	10	ache	ache	ADV
cana-5161	192	11	level	level	NOUN
cana-5161	192	12	and	and	CCONJ
cana-5161	192	13	restored	restore	VERB
cana-5161	192	14	depleted	depleted	ADJ
cana-5161	192	15	glutathione	glutathione	NOUN
cana-5161	192	16	levels	level	NOUN
cana-5161	192	17	,	,	PUNCT
cana-5161	192	18	suggesting	suggest	VERB
cana-5161	192	19	its	its	PRON
cana-5161	192	20	antioxidant	antioxidant	ADJ
cana-5161	192	21	potential	potential	NOUN
cana-5161	192	22	(	(	PUNCT
cana-5161	192	23	table	table	NOUN
cana-5161	192	24	1	1	NUM
cana-5161	192	25	)	)	PUNCT
cana-5161	192	26	.	.	PUNCT
cana-5161	193	1	communications	communication	NOUN
cana-5161	193	2	on	on	ADP
cana-5161	193	3	applied	apply	VERB
cana-5161	193	4	nonlinear	nonlinear	ADJ
cana-5161	193	5	analysis	analysis	NOUN
cana-5161	193	6	issn	issn	NOUN
cana-5161	193	7	:	:	PUNCT
cana-5161	193	8	1074	1074	NUM
cana-5161	193	9	-	-	PUNCT
cana-5161	193	10	133x	133x	NUM
cana-5161	193	11	vol	vol	NOUN
cana-5161	193	12	32	32	NUM
cana-5161	193	13	no	no	NOUN
cana-5161	193	14	.	.	PUNCT
cana-5161	194	1	icmasd	icmasd	NOUN
cana-5161	194	2	(	(	PUNCT
cana-5161	194	3	2025	2025	NUM
cana-5161	194	4	)	)	PUNCT
cana-5161	194	5	1364	1364	NUM
cana-5161	194	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	195	1	table.1	table.1	NOUN
cana-5161	195	2	effect	effect	NOUN
cana-5161	195	3	of	of	ADP
cana-5161	195	4	agmatine	agmatine	NOUN
cana-5161	195	5	on	on	ADP
cana-5161	195	6	brain	brain	NOUN
cana-5161	195	7	oxidative	oxidative	ADJ
cana-5161	195	8	stress	stress	NOUN
cana-5161	195	9	parameters	parameter	NOUN
cana-5161	195	10	and	and	CCONJ
cana-5161	195	11	acetylcholinesterase	acetylcholinesterase	NOUN
cana-5161	195	12	activity	activity	NOUN
cana-5161	195	13	in	in	ADP
cana-5161	195	14	alcl3	alcl3	PROPN
cana-5161	195	15	treated	treat	VERB
cana-5161	195	16	rats	rat	NOUN
cana-5161	195	17	.	.	PUNCT
cana-5161	196	1	treatment	treatment	NOUN
cana-5161	196	2	mda	mda	PROPN
cana-5161	196	3	gsh	gsh	PROPN
cana-5161	196	4	nitrite	nitrite	PROPN
cana-5161	196	5	ache	ache	PROPN
cana-5161	196	6	(	(	PUNCT
cana-5161	196	7	nmol	nmol	NOUN
cana-5161	196	8	/	/	SYM
cana-5161	196	9	mg	mg	PROPN
cana-5161	196	10	protein	protein	NOUN
cana-5161	196	11	)	)	PUNCT
cana-5161	196	12	(	(	PUNCT
cana-5161	196	13	µ	µ	PROPN
cana-5161	196	14	mol	mol	NOUN
cana-5161	196	15	/	/	SYM
cana-5161	196	16	mg	mg	PROPN
cana-5161	196	17	protein	protein	NOUN
cana-5161	196	18	)	)	PUNCT
cana-5161	196	19	(	(	PUNCT
cana-5161	196	20	nmol	nmol	NOUN
cana-5161	196	21	/	/	SYM
cana-5161	196	22	mg	mg	PROPN
cana-5161	196	23	protein	protein	NOUN
cana-5161	196	24	)	)	PUNCT
cana-5161	196	25	(	(	PUNCT
cana-5161	196	26	µ	µ	PROPN
cana-5161	196	27	mol	mol	NOUN
cana-5161	196	28	/	/	SYM
cana-5161	196	29	min	min	NOUN
cana-5161	196	30	/	/	SYM
cana-5161	196	31	mg	mg	PROPN
cana-5161	196	32	protein	protein	NOUN
cana-5161	196	33	)	)	PUNCT
cana-5161	196	34	(	(	PUNCT
cana-5161	196	35	lowry	lowry	PROPN
cana-5161	196	36	et	et	PROPN
cana-5161	196	37	al	al	PROPN
cana-5161	196	38	.	.	PROPN
cana-5161	196	39	,	,	PUNCT
cana-5161	196	40	1951	1951	NUM
cana-5161	196	41	)	)	PUNCT
cana-5161	196	42	vehicle	vehicle	NOUN
cana-5161	196	43	control	control	NOUN
cana-5161	196	44	0.092±	0.092±	NUM
cana-5161	197	1	0.0072	0.0072	NUM
cana-5161	197	2	0.098±	0.098±	NOUN
cana-5161	197	3	0.0035	0.0035	NUM
cana-5161	197	4	1.88±	1.88±	NUM
cana-5161	197	5	0.374	0.374	NUM
cana-5161	197	6	145.4±	145.4±	NUM
cana-5161	197	7	21.79	21.79	NUM
cana-5161	197	8	alcl3	alcl3	NOUN
cana-5161	197	9	0.206±	0.206±	NUM
cana-5161	198	1	0.0106	0.0106	NUM
cana-5161	198	2	*	*	SYM
cana-5161	198	3	0.054±	0.054±	NUM
cana-5161	199	1	0.0011	0.0011	NUM
cana-5161	199	2	*	*	X
cana-5161	199	3	3.87±	3.87±	NUM
cana-5161	199	4	0.137	0.137	NUM
cana-5161	199	5	*	*	NUM
cana-5161	199	6	371.2±	371.2±	NUM
cana-5161	199	7	53.41	53.41	NUM
cana-5161	199	8	*	*	PUNCT
cana-5161	199	9	agmatine	agmatine	VERB
cana-5161	199	10	0.192±	0.192±	NUM
cana-5161	199	11	0.0108	0.0108	NUM
cana-5161	199	12	#	#	NOUN
cana-5161	199	13	0.062±0.0039	0.062±0.0039	NOUN
cana-5161	199	14	#	#	NOUN
cana-5161	199	15	2.78±0.189	2.78±0.189	NOUN
cana-5161	199	16	#	#	NOUN
cana-5161	199	17	355.0±	355.0±	NUM
cana-5161	199	18	63.91	63.91	NUM
cana-5161	199	19	#	#	NOUN
cana-5161	199	20	(	(	PUNCT
cana-5161	199	21	3	3	NUM
cana-5161	199	22	mg	mg	PROPN
cana-5161	199	23	/	/	SYM
cana-5161	199	24	kg	kg	NOUN
cana-5161	199	25	)	)	PUNCT
cana-5161	199	26	agmatine	agmatine	NOUN
cana-5161	199	27	0.183±	0.183±	X
cana-5161	200	1	0.0115	0.0115	NUM
cana-5161	200	2	#	#	NOUN
cana-5161	200	3	$	$	SYM
cana-5161	200	4	0.085±	0.085±	NUM
cana-5161	200	5	0.0044	0.0044	NUM
cana-5161	200	6	#	#	NOUN
cana-5161	200	7	$	$	SYM
cana-5161	200	8	1.97±	1.97±	NUM
cana-5161	200	9	0.435	0.435	NUM
cana-5161	200	10	#	#	NOUN
cana-5161	200	11	$	$	SYM
cana-5161	200	12	321.6±62.91	321.6±62.91	NUM
cana-5161	200	13	#	#	NOUN
cana-5161	200	14	$	$	NOUN
cana-5161	200	15	(	(	PUNCT
cana-5161	200	16	10	10	NUM
cana-5161	200	17	mg	mg	PROPN
cana-5161	200	18	/	/	SYM
cana-5161	200	19	kg	kg	NOUN
cana-5161	200	20	)	)	PUNCT
cana-5161	200	21	agmatine	agmatine	NOUN
cana-5161	200	22	0.144±	0.144±	NOUN
cana-5161	201	1	0.0119	0.0119	NUM
cana-5161	201	2	#	#	NOUN
cana-5161	201	3	$	$	SYM
cana-5161	201	4	@	@	ADP
cana-5161	201	5	0.093±	0.093±	NUM
cana-5161	201	6	0.0045	0.0045	NUM
cana-5161	201	7	#	#	NOUN
cana-5161	201	8	$	$	NOUN
cana-5161	201	9	@	@	ADP
cana-5161	201	10	1.96±	1.96±	NUM
cana-5161	201	11	0.249	0.249	NUM
cana-5161	201	12	#	#	NOUN
cana-5161	201	13	$	$	NOUN
cana-5161	201	14	@	@	ADP
cana-5161	201	15	228.4±	228.4±	NUM
cana-5161	201	16	39.38	39.38	NUM
cana-5161	201	17	#	#	NOUN
cana-5161	201	18	$	$	NOUN
cana-5161	201	19	@	@	ADP
cana-5161	201	20	(	(	PUNCT
cana-5161	201	21	30	30	NUM
cana-5161	201	22	mg	mg	NUM
cana-5161	201	23	/	/	SYM
cana-5161	201	24	kg	kg	NOUN
cana-5161	201	25	)	)	PUNCT
cana-5161	201	26	values	value	NOUN
cana-5161	201	27	are	be	AUX
cana-5161	201	28	expressed	express	VERB
cana-5161	201	29	as	as	ADP
cana-5161	201	30	mean	mean	NOUN
cana-5161	201	31	±	±	NUM
cana-5161	201	32	sd	sd	NOUN
cana-5161	201	33	.	.	PUNCT
cana-5161	202	1	data	datum	NOUN
cana-5161	202	2	analyzed	analyze	VERB
cana-5161	202	3	by	by	ADP
cana-5161	202	4	one	one	NUM
cana-5161	202	5	way	way	NOUN
cana-5161	202	6	anova	anova	PROPN
cana-5161	202	7	followed	follow	VERB
cana-5161	202	8	by	by	ADP
cana-5161	202	9	tukey	tukey	PROPN
cana-5161	202	10	’s	’s	PART
cana-5161	202	11	post	post	X
cana-5161	202	12	hoc	hoc	X
cana-5161	202	13	test	test	NOUN
cana-5161	202	14	.	.	PUNCT
cana-5161	203	1	*	*	PUNCT
cana-5161	203	2	p<0.05	p<0.05	PROPN
cana-5161	203	3	vs	vs	ADP
cana-5161	203	4	vehicle	vehicle	NOUN
cana-5161	203	5	control	control	NOUN
cana-5161	203	6	,	,	PUNCT
cana-5161	203	7	#	#	NOUN
cana-5161	203	8	p<0.05	p<0.05	NOUN
cana-5161	203	9	vs	vs	ADP
cana-5161	203	10	alcl3	alcl3	PROPN
cana-5161	203	11	,	,	PUNCT
cana-5161	203	12	$	$	SYM
cana-5161	203	13	p<0.05	p<0.05	NOUN
cana-5161	203	14	vs	vs	ADP
cana-5161	203	15	alcl3	alcl3	PROPN
cana-5161	203	16	+	+	NOUN
cana-5161	203	17	agmatine	agmatine	NOUN
cana-5161	203	18	(	(	PUNCT
cana-5161	203	19	3	3	NUM
cana-5161	203	20	mg	mg	PROPN
cana-5161	203	21	/	/	SYM
cana-5161	203	22	kg	kg	PROPN
cana-5161	203	23	)	)	PUNCT
cana-5161	203	24	,	,	PUNCT
cana-5161	203	25	@	@	ADP
cana-5161	203	26	p<0.05	p<0.05	NOUN
cana-5161	203	27	vs	vs	ADP
cana-5161	203	28	alcl3	alcl3	PROPN
cana-5161	203	29	+	+	NOUN
cana-5161	203	30	agmatine	agmatine	NOUN
cana-5161	203	31	(	(	PUNCT
cana-5161	203	32	10	10	NUM
cana-5161	203	33	mg	mg	NUM
cana-5161	203	34	/	/	SYM
cana-5161	203	35	kg	kg	NOUN
cana-5161	203	36	)	)	PUNCT
cana-5161	203	37	.	.	PUNCT
cana-5161	204	1	mda	mda	PROPN
cana-5161	204	2	-	-	PUNCT
cana-5161	204	3	malondialdehyde	malondialdehyde	PROPN
cana-5161	204	4	,	,	PUNCT
cana-5161	204	5	gshreduced	gshreduce	VERB
cana-5161	204	6	glutathione	glutathione	NOUN
cana-5161	204	7	,	,	PUNCT
cana-5161	204	8	acheacetylcholinesterase	acheacetylcholinesterase	NOUN
cana-5161	204	9	.	.	PUNCT
cana-5161	205	1	4	4	X
cana-5161	205	2	.	.	X
cana-5161	205	3	discussion	discussion	NOUN
cana-5161	205	4	:	:	PUNCT
cana-5161	205	5	the	the	DET
cana-5161	205	6	present	present	ADJ
cana-5161	205	7	study	study	NOUN
cana-5161	205	8	demonstrates	demonstrate	VERB
cana-5161	205	9	the	the	DET
cana-5161	205	10	neuroprotective	neuroprotective	ADJ
cana-5161	205	11	potential	potential	NOUN
cana-5161	205	12	of	of	ADP
cana-5161	205	13	agmatine	agmatine	NOUN
cana-5161	205	14	against	against	ADP
cana-5161	205	15	aluminium	aluminium	NOUN
cana-5161	205	16	chloride	chloride	NOUN
cana-5161	205	17	(	(	PUNCT
cana-5161	205	18	alcl₃)-induced	alcl₃)-induce	VERB
cana-5161	205	19	cognitive	cognitive	ADJ
cana-5161	205	20	decline	decline	NOUN
cana-5161	205	21	in	in	ADP
cana-5161	205	22	rats	rat	NOUN
cana-5161	205	23	.	.	PUNCT
cana-5161	206	1	oral	oral	ADJ
cana-5161	206	2	administration	administration	NOUN
cana-5161	206	3	of	of	ADP
cana-5161	206	4	alcl₃	alcl₃	NOUN
cana-5161	206	5	in	in	ADP
cana-5161	206	6	rats	rat	NOUN
cana-5161	206	7	resulted	result	VERB
cana-5161	206	8	in	in	ADP
cana-5161	206	9	cognitive	cognitive	ADJ
cana-5161	206	10	impairment	impairment	NOUN
cana-5161	206	11	,	,	PUNCT
cana-5161	206	12	increased	increase	VERB
cana-5161	206	13	oxidative	oxidative	ADJ
cana-5161	206	14	stress	stress	NOUN
cana-5161	206	15	,	,	PUNCT
cana-5161	206	16	neuroinflammation	neuroinflammation	NOUN
cana-5161	206	17	,	,	PUNCT
cana-5161	206	18	and	and	CCONJ
cana-5161	206	19	disruption	disruption	NOUN
cana-5161	206	20	of	of	ADP
cana-5161	206	21	hippocampal	hippocampal	ADJ
cana-5161	206	22	neurotransmitter	neurotransmitter	NOUN
cana-5161	206	23	levels	level	NOUN
cana-5161	206	24	.	.	PUNCT
cana-5161	207	1	aggregates	aggregate	NOUN
cana-5161	207	2	of	of	ADP
cana-5161	207	3	amyloid	amyloid	NOUN
cana-5161	207	4	beta	beta	NOUN
cana-5161	207	5	(	(	PUNCT
cana-5161	207	6	aβ	aβ	NOUN
cana-5161	207	7	)	)	PUNCT
cana-5161	207	8	are	be	AUX
cana-5161	207	9	well	well	ADV
cana-5161	207	10	-	-	PUNCT
cana-5161	207	11	established	establish	VERB
cana-5161	207	12	in	in	ADP
cana-5161	207	13	their	their	PRON
cana-5161	207	14	ability	ability	NOUN
cana-5161	207	15	to	to	PART
cana-5161	207	16	activate	activate	VERB
cana-5161	207	17	multiple	multiple	ADJ
cana-5161	207	18	neurotoxic	neurotoxic	ADJ
cana-5161	207	19	pathways	pathway	NOUN
cana-5161	207	20	,	,	PUNCT
cana-5161	207	21	thereby	thereby	ADV
cana-5161	207	22	promoting	promote	VERB
cana-5161	207	23	neuronal	neuronal	ADJ
cana-5161	207	24	cell	cell	NOUN
cana-5161	207	25	death	death	NOUN
cana-5161	207	26	in	in	ADP
cana-5161	207	27	various	various	ADJ
cana-5161	207	28	brain	brain	NOUN
cana-5161	207	29	regions	region	NOUN
cana-5161	207	30	(	(	PUNCT
cana-5161	207	31	albrekkan	albrekkan	PROPN
cana-5161	207	32	and	and	CCONJ
cana-5161	207	33	kelly	kelly	PROPN
cana-5161	207	34	-	-	PUNCT
cana-5161	207	35	worden	worden	NOUN
cana-5161	207	36	,	,	PUNCT
cana-5161	207	37	2013	2013	NUM
cana-5161	207	38	)	)	PUNCT
cana-5161	207	39	.	.	PUNCT
cana-5161	208	1	the	the	DET
cana-5161	208	2	results	result	NOUN
cana-5161	208	3	of	of	ADP
cana-5161	208	4	the	the	DET
cana-5161	208	5	present	present	ADJ
cana-5161	208	6	study	study	NOUN
cana-5161	208	7	are	be	AUX
cana-5161	208	8	consistent	consistent	ADJ
cana-5161	208	9	with	with	ADP
cana-5161	208	10	previous	previous	ADJ
cana-5161	208	11	findings	finding	NOUN
cana-5161	208	12	that	that	PRON
cana-5161	208	13	report	report	VERB
cana-5161	208	14	similar	similar	ADJ
cana-5161	208	15	neurotoxic	neurotoxic	ADJ
cana-5161	208	16	alterations	alteration	NOUN
cana-5161	208	17	following	follow	VERB
cana-5161	208	18	aluminium	aluminium	NOUN
cana-5161	208	19	chloride	chloride	NOUN
cana-5161	208	20	(	(	PUNCT
cana-5161	208	21	alcl₃	alcl₃	NOUN
cana-5161	208	22	)	)	PUNCT
cana-5161	208	23	administration	administration	NOUN
cana-5161	208	24	in	in	ADP
cana-5161	208	25	rats	rat	NOUN
cana-5161	208	26	(	(	PUNCT
cana-5161	208	27	lakshmi	lakshmi	NOUN
cana-5161	208	28	et	et	NOUN
cana-5161	208	29	al	al	PROPN
cana-5161	208	30	.	.	PROPN
cana-5161	208	31	,	,	PUNCT
cana-5161	208	32	2015	2015	NUM
cana-5161	208	33	)	)	PUNCT
cana-5161	208	34	.	.	PUNCT
cana-5161	209	1	n	n	CCONJ
cana-5161	209	2	the	the	DET
cana-5161	209	3	present	present	ADJ
cana-5161	209	4	study	study	NOUN
cana-5161	209	5	,	,	PUNCT
cana-5161	209	6	aluminium	aluminium	NOUN
cana-5161	209	7	chloride	chloride	NOUN
cana-5161	209	8	(	(	PUNCT
cana-5161	209	9	alcl₃	alcl₃	NOUN
cana-5161	209	10	)	)	PUNCT
cana-5161	209	11	administration	administration	NOUN
cana-5161	209	12	induced	induce	VERB
cana-5161	209	13	both	both	CCONJ
cana-5161	209	14	spatial	spatial	ADJ
cana-5161	209	15	and	and	CCONJ
cana-5161	209	16	non	non	ADJ
cana-5161	209	17	-	-	ADJ
cana-5161	209	18	spatial	spatial	ADJ
cana-5161	209	19	memory	memory	NOUN
cana-5161	209	20	deficits	deficit	NOUN
cana-5161	209	21	in	in	ADP
cana-5161	209	22	rats	rat	NOUN
cana-5161	209	23	.	.	PUNCT
cana-5161	210	1	the	the	DET
cana-5161	210	2	rats	rat	NOUN
cana-5161	210	3	exhibited	exhibit	VERB
cana-5161	210	4	impaired	impaired	ADJ
cana-5161	210	5	learning	learning	NOUN
cana-5161	210	6	and	and	CCONJ
cana-5161	210	7	memory	memory	NOUN
cana-5161	210	8	in	in	ADP
cana-5161	210	9	the	the	DET
cana-5161	210	10	morris	morris	PROPN
cana-5161	210	11	water	water	NOUN
cana-5161	210	12	maze	maze	NOUN
cana-5161	210	13	,	,	PUNCT
cana-5161	210	14	demonstrated	demonstrate	VERB
cana-5161	210	15	an	an	DET
cana-5161	210	16	inability	inability	NOUN
cana-5161	210	17	to	to	PART
cana-5161	210	18	distinguish	distinguish	VERB
cana-5161	210	19	between	between	ADP
cana-5161	210	20	familiar	familiar	ADJ
cana-5161	210	21	and	and	CCONJ
cana-5161	210	22	novel	novel	ADJ
cana-5161	210	23	objects	object	NOUN
cana-5161	210	24	in	in	ADP
cana-5161	210	25	the	the	DET
cana-5161	210	26	object	object	NOUN
cana-5161	210	27	recognition	recognition	NOUN
cana-5161	210	28	task	task	NOUN
cana-5161	210	29	,	,	PUNCT
cana-5161	210	30	and	and	CCONJ
cana-5161	210	31	showed	show	VERB
cana-5161	210	32	altered	alter	VERB
cana-5161	210	33	locomotor	locomotor	NOUN
cana-5161	210	34	activity	activity	NOUN
cana-5161	210	35	in	in	ADP
cana-5161	210	36	the	the	DET
cana-5161	210	37	open	open	ADJ
cana-5161	210	38	field	field	NOUN
cana-5161	210	39	test	test	NOUN
cana-5161	210	40	.	.	PUNCT
cana-5161	211	1	these	these	DET
cana-5161	211	2	findings	finding	NOUN
cana-5161	211	3	are	be	AUX
cana-5161	211	4	in	in	ADP
cana-5161	211	5	line	line	NOUN
cana-5161	211	6	with	with	ADP
cana-5161	211	7	prior	prior	ADJ
cana-5161	211	8	research	research	NOUN
cana-5161	211	9	that	that	PRON
cana-5161	211	10	has	have	AUX
cana-5161	211	11	also	also	ADV
cana-5161	211	12	reported	report	VERB
cana-5161	211	13	spatial	spatial	ADJ
cana-5161	211	14	and	and	CCONJ
cana-5161	211	15	non	non	ADJ
cana-5161	211	16	-	-	ADJ
cana-5161	211	17	spatial	spatial	ADJ
cana-5161	211	18	learning	learning	NOUN
cana-5161	211	19	impairments	impairment	NOUN
cana-5161	211	20	following	follow	VERB
cana-5161	211	21	alcl₃	alcl₃	PROPN
cana-5161	211	22	administration	administration	PROPN
cana-5161	211	23	(	(	PUNCT
cana-5161	211	24	nampoothiri	nampoothiri	NOUN
cana-5161	211	25	et	et	PROPN
cana-5161	211	26	al	al	PROPN
cana-5161	211	27	.	.	PROPN
cana-5161	211	28	,	,	PUNCT
cana-5161	211	29	2015	2015	NUM
cana-5161	211	30	)	)	PUNCT
cana-5161	211	31	.	.	PUNCT
cana-5161	212	1	the	the	DET
cana-5161	212	2	morris	morris	PROPN
cana-5161	212	3	water	water	PROPN
cana-5161	212	4	maze	maze	NOUN
cana-5161	212	5	(	(	PUNCT
cana-5161	212	6	mwm	mwm	NOUN
cana-5161	212	7	)	)	PUNCT
cana-5161	212	8	test	test	NOUN
cana-5161	212	9	was	be	AUX
cana-5161	212	10	originally	originally	ADV
cana-5161	212	11	developed	develop	VERB
cana-5161	212	12	to	to	PART
cana-5161	212	13	assess	assess	VERB
cana-5161	212	14	hippocampus	hippocampus	NOUN
cana-5161	212	15	-	-	PUNCT
cana-5161	212	16	dependent	dependent	ADJ
cana-5161	212	17	cognitive	cognitive	ADJ
cana-5161	212	18	functions	function	NOUN
cana-5161	212	19	(	(	PUNCT
cana-5161	212	20	morris	morris	PROPN
cana-5161	212	21	,	,	PUNCT
cana-5161	212	22	1984	1984	NUM
cana-5161	212	23	)	)	PUNCT
cana-5161	212	24	,	,	PUNCT
cana-5161	212	25	however	however	ADV
cana-5161	212	26	,	,	PUNCT
cana-5161	212	27	it	it	PRON
cana-5161	212	28	also	also	ADV
cana-5161	212	29	involves	involve	VERB
cana-5161	212	30	the	the	DET
cana-5161	212	31	coordinated	coordinate	VERB
cana-5161	212	32	activity	activity	NOUN
cana-5161	212	33	of	of	ADP
cana-5161	212	34	various	various	ADJ
cana-5161	212	35	brain	brain	NOUN
cana-5161	212	36	regions	region	NOUN
cana-5161	212	37	,	,	PUNCT
cana-5161	212	38	including	include	VERB
cana-5161	212	39	the	the	DET
cana-5161	212	40	hippocampus	hippocampus	NOUN
cana-5161	212	41	.	.	PUNCT
cana-5161	213	1	whereas	whereas	SCONJ
cana-5161	213	2	recognition	recognition	NOUN
cana-5161	213	3	memory	memory	NOUN
cana-5161	213	4	refers	refer	VERB
cana-5161	213	5	to	to	ADP
cana-5161	213	6	the	the	DET
cana-5161	213	7	ability	ability	NOUN
cana-5161	213	8	to	to	PART
cana-5161	213	9	distinguish	distinguish	VERB
cana-5161	213	10	between	between	ADP
cana-5161	213	11	novel	novel	NOUN
cana-5161	213	12	and	and	CCONJ
cana-5161	213	13	familiar	familiar	ADJ
cana-5161	213	14	stimuli	stimulus	NOUN
cana-5161	213	15	,	,	PUNCT
cana-5161	213	16	and	and	CCONJ
cana-5161	213	17	the	the	DET
cana-5161	213	18	functional	functional	ADJ
cana-5161	213	19	integrity	integrity	NOUN
cana-5161	213	20	of	of	ADP
cana-5161	213	21	the	the	DET
cana-5161	213	22	temporal	temporal	ADJ
cana-5161	213	23	lobe	lobe	NOUN
cana-5161	213	24	,	,	PUNCT
cana-5161	213	25	particularly	particularly	ADV
cana-5161	213	26	the	the	DET
cana-5161	213	27	hippocampus	hippocampus	NOUN
cana-5161	213	28	,	,	PUNCT
cana-5161	213	29	is	be	AUX
cana-5161	213	30	critical	critical	ADJ
cana-5161	213	31	for	for	ADP
cana-5161	213	32	the	the	DET
cana-5161	213	33	encoding	encoding	NOUN
cana-5161	213	34	,	,	PUNCT
cana-5161	213	35	communications	communication	NOUN
cana-5161	213	36	on	on	ADP
cana-5161	213	37	applied	apply	VERB
cana-5161	213	38	nonlinear	nonlinear	ADJ
cana-5161	213	39	analysis	analysis	NOUN
cana-5161	213	40	issn	issn	NOUN
cana-5161	213	41	:	:	PUNCT
cana-5161	213	42	1074	1074	NUM
cana-5161	213	43	-	-	PUNCT
cana-5161	213	44	133x	133x	NUM
cana-5161	213	45	vol	vol	NOUN
cana-5161	213	46	32	32	NUM
cana-5161	213	47	no	no	NOUN
cana-5161	213	48	.	.	PUNCT
cana-5161	214	1	icmasd	icmasd	NOUN
cana-5161	214	2	(	(	PUNCT
cana-5161	214	3	2025	2025	NUM
cana-5161	214	4	)	)	PUNCT
cana-5161	214	5	1365	1365	NUM
cana-5161	214	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	214	7	storage	storage	NOUN
cana-5161	214	8	,	,	PUNCT
cana-5161	214	9	and	and	CCONJ
cana-5161	214	10	retrieval	retrieval	NOUN
cana-5161	214	11	of	of	ADP
cana-5161	214	12	this	this	DET
cana-5161	214	13	form	form	NOUN
cana-5161	214	14	of	of	ADP
cana-5161	214	15	memory	memory	NOUN
cana-5161	214	16	(	(	PUNCT
cana-5161	214	17	pitsikas	pitsikas	PROPN
cana-5161	214	18	et	et	PROPN
cana-5161	214	19	al	al	PROPN
cana-5161	214	20	.	.	PROPN
cana-5161	214	21	,	,	PUNCT
cana-5161	214	22	2001	2001	NUM
cana-5161	214	23	)	)	PUNCT
cana-5161	214	24	.	.	PUNCT
cana-5161	215	1	thus	thus	ADV
cana-5161	215	2	,	,	PUNCT
cana-5161	215	3	in	in	ADP
cana-5161	215	4	the	the	DET
cana-5161	215	5	present	present	ADJ
cana-5161	215	6	study	study	NOUN
cana-5161	215	7	,	,	PUNCT
cana-5161	215	8	aluminium	aluminium	NOUN
cana-5161	215	9	chloride	chloride	NOUN
cana-5161	215	10	(	(	PUNCT
cana-5161	215	11	alcl₃	alcl₃	NOUN
cana-5161	215	12	)	)	PUNCT
cana-5161	215	13	administration	administration	NOUN
cana-5161	215	14	appears	appear	VERB
cana-5161	215	15	to	to	PART
cana-5161	215	16	induce	induce	VERB
cana-5161	215	17	functional	functional	ADJ
cana-5161	215	18	damage	damage	NOUN
cana-5161	215	19	to	to	ADP
cana-5161	215	20	hippocampal	hippocampal	ADJ
cana-5161	215	21	neurons	neuron	NOUN
cana-5161	215	22	,	,	PUNCT
cana-5161	215	23	leading	lead	VERB
cana-5161	215	24	to	to	ADP
cana-5161	215	25	impairments	impairment	NOUN
cana-5161	215	26	in	in	ADP
cana-5161	215	27	learning	learning	NOUN
cana-5161	215	28	and	and	CCONJ
cana-5161	215	29	memory	memory	NOUN
cana-5161	215	30	.	.	PUNCT
cana-5161	216	1	it	it	PRON
cana-5161	216	2	has	have	AUX
cana-5161	216	3	been	be	AUX
cana-5161	216	4	proposed	propose	VERB
cana-5161	216	5	that	that	SCONJ
cana-5161	216	6	the	the	DET
cana-5161	216	7	cognitive	cognitive	ADJ
cana-5161	216	8	deficits	deficit	NOUN
cana-5161	216	9	observed	observe	VERB
cana-5161	216	10	following	follow	VERB
cana-5161	216	11	alcl₃	alcl₃	NOUN
cana-5161	216	12	exposure	exposure	NOUN
cana-5161	216	13	are	be	AUX
cana-5161	216	14	linked	link	VERB
cana-5161	216	15	to	to	ADP
cana-5161	216	16	disruptions	disruption	NOUN
cana-5161	216	17	in	in	ADP
cana-5161	216	18	synaptic	synaptic	ADJ
cana-5161	216	19	transmission	transmission	NOUN
cana-5161	216	20	and	and	CCONJ
cana-5161	216	21	neurodegeneration	neurodegeneration	NOUN
cana-5161	216	22	within	within	ADP
cana-5161	216	23	the	the	DET
cana-5161	216	24	hippocampal	hippocampal	ADJ
cana-5161	216	25	region	region	NOUN
cana-5161	216	26	(	(	PUNCT
cana-5161	216	27	abdel	abdel	PROPN
cana-5161	216	28	-	-	PUNCT
cana-5161	216	29	zaher	zaher	PROPN
cana-5161	216	30	et	et	PROPN
cana-5161	216	31	al	al	PROPN
cana-5161	216	32	.	.	PROPN
cana-5161	216	33	,	,	PUNCT
cana-5161	216	34	2017	2017	NUM
cana-5161	216	35	)	)	PUNCT
cana-5161	216	36	.	.	PUNCT
cana-5161	217	1	in	in	ADP
cana-5161	217	2	this	this	DET
cana-5161	217	3	study	study	NOUN
cana-5161	217	4	,	,	PUNCT
cana-5161	217	5	treatment	treatment	NOUN
cana-5161	217	6	with	with	ADP
cana-5161	217	7	agmatine	agmatine	NOUN
cana-5161	217	8	resulted	result	VERB
cana-5161	217	9	in	in	ADP
cana-5161	217	10	a	a	DET
cana-5161	217	11	significant	significant	ADJ
cana-5161	217	12	,	,	PUNCT
cana-5161	217	13	dose	dose	NOUN
cana-5161	217	14	-	-	PUNCT
cana-5161	217	15	dependent	dependent	ADJ
cana-5161	217	16	attenuation	attenuation	NOUN
cana-5161	217	17	of	of	ADP
cana-5161	217	18	aluminium	aluminium	NOUN
cana-5161	217	19	chloride	chloride	NOUN
cana-5161	217	20	(	(	PUNCT
cana-5161	217	21	alcl₃)induced	alcl₃)induce	VERB
cana-5161	217	22	impairments	impairment	NOUN
cana-5161	217	23	in	in	ADP
cana-5161	217	24	both	both	CCONJ
cana-5161	217	25	spatial	spatial	ADJ
cana-5161	217	26	and	and	CCONJ
cana-5161	217	27	non	non	ADJ
cana-5161	217	28	-	-	ADJ
cana-5161	217	29	spatial	spatial	ADJ
cana-5161	217	30	learning	learning	NOUN
cana-5161	217	31	and	and	CCONJ
cana-5161	217	32	memory	memory	NOUN
cana-5161	217	33	in	in	ADP
cana-5161	217	34	rats	rat	NOUN
cana-5161	217	35	,	,	PUNCT
cana-5161	217	36	suggesting	suggest	VERB
cana-5161	217	37	a	a	DET
cana-5161	217	38	protective	protective	ADJ
cana-5161	217	39	effect	effect	NOUN
cana-5161	217	40	on	on	ADP
cana-5161	217	41	hippocampal	hippocampal	ADJ
cana-5161	217	42	neurons	neuron	NOUN
cana-5161	217	43	.	.	PUNCT
cana-5161	218	1	it	it	PRON
cana-5161	218	2	is	be	AUX
cana-5161	218	3	well	well	ADV
cana-5161	218	4	-	-	PUNCT
cana-5161	218	5	established	establish	VERB
cana-5161	218	6	that	that	SCONJ
cana-5161	218	7	hippocampal	hippocampal	ADJ
cana-5161	218	8	activity	activity	NOUN
cana-5161	218	9	is	be	AUX
cana-5161	218	10	modulated	modulate	VERB
cana-5161	218	11	by	by	ADP
cana-5161	218	12	a	a	DET
cana-5161	218	13	variety	variety	NOUN
cana-5161	218	14	of	of	ADP
cana-5161	218	15	neurotransmitters	neurotransmitter	NOUN
cana-5161	218	16	and	and	CCONJ
cana-5161	218	17	neuromodulators	neuromodulator	NOUN
cana-5161	218	18	(	(	PUNCT
cana-5161	218	19	khakpai	khakpai	NOUN
cana-5161	218	20	et	et	PROPN
cana-5161	218	21	al	al	PROPN
cana-5161	218	22	.	.	PROPN
cana-5161	218	23	,	,	PUNCT
cana-5161	218	24	2013	2013	NUM
cana-5161	218	25	)	)	PUNCT
cana-5161	218	26	.	.	PUNCT
cana-5161	219	1	it	it	PRON
cana-5161	219	2	has	have	AUX
cana-5161	219	3	been	be	AUX
cana-5161	219	4	demonstrated	demonstrate	VERB
cana-5161	219	5	that	that	SCONJ
cana-5161	219	6	the	the	DET
cana-5161	219	7	hippocampus	hippocampus	NOUN
cana-5161	219	8	is	be	AUX
cana-5161	219	9	densely	densely	ADV
cana-5161	219	10	populated	populate	VERB
cana-5161	219	11	with	with	ADP
cana-5161	219	12	cholinergic	cholinergic	ADJ
cana-5161	219	13	,	,	PUNCT
cana-5161	219	14	glutamatergic	glutamatergic	ADJ
cana-5161	219	15	,	,	PUNCT
cana-5161	219	16	gabaergic	gabaergic	ADJ
cana-5161	219	17	,	,	PUNCT
cana-5161	219	18	and	and	CCONJ
cana-5161	219	19	monoaminergic	monoaminergic	ADJ
cana-5161	219	20	axon	axon	NOUN
cana-5161	219	21	terminals	terminal	NOUN
cana-5161	219	22	.	.	PUNCT
cana-5161	220	1	these	these	DET
cana-5161	220	2	neurotransmitter	neurotransmitter	NOUN
cana-5161	220	3	systems	system	NOUN
cana-5161	220	4	are	be	AUX
cana-5161	220	5	known	know	VERB
cana-5161	220	6	to	to	PART
cana-5161	220	7	play	play	VERB
cana-5161	220	8	critical	critical	ADJ
cana-5161	220	9	roles	role	NOUN
cana-5161	220	10	in	in	ADP
cana-5161	220	11	the	the	DET
cana-5161	220	12	encoding	encoding	NOUN
cana-5161	220	13	,	,	PUNCT
cana-5161	220	14	storage	storage	NOUN
cana-5161	220	15	,	,	PUNCT
cana-5161	220	16	and	and	CCONJ
cana-5161	220	17	expression	expression	NOUN
cana-5161	220	18	of	of	ADP
cana-5161	220	19	memory	memory	NOUN
cana-5161	220	20	(	(	PUNCT
cana-5161	220	21	dani	dani	PROPN
cana-5161	220	22	and	and	CCONJ
cana-5161	220	23	bertrand	bertrand	PROPN
cana-5161	220	24	,	,	PUNCT
cana-5161	220	25	2007	2007	NUM
cana-5161	220	26	,	,	PUNCT
cana-5161	220	27	gulpinar	gulpinar	NOUN
cana-5161	220	28	and	and	CCONJ
cana-5161	220	29	yegen	yegen	NOUN
cana-5161	220	30	,	,	PUNCT
cana-5161	220	31	2004	2004	NUM
cana-5161	220	32	)	)	PUNCT
cana-5161	220	33	.	.	PUNCT
cana-5161	221	1	administration	administration	NOUN
cana-5161	221	2	of	of	ADP
cana-5161	221	3	aluminium	aluminium	NOUN
cana-5161	221	4	chloride	chloride	NOUN
cana-5161	221	5	(	(	PUNCT
cana-5161	221	6	alcl₃	alcl₃	NOUN
cana-5161	221	7	)	)	PUNCT
cana-5161	221	8	in	in	ADP
cana-5161	221	9	rats	rat	NOUN
cana-5161	221	10	resulted	result	VERB
cana-5161	221	11	in	in	ADP
cana-5161	221	12	a	a	DET
cana-5161	221	13	significant	significant	ADJ
cana-5161	221	14	reduction	reduction	NOUN
cana-5161	221	15	in	in	ADP
cana-5161	221	16	the	the	DET
cana-5161	221	17	levels	level	NOUN
cana-5161	221	18	of	of	ADP
cana-5161	221	19	monoamines	monoamine	NOUN
cana-5161	221	20	,	,	PUNCT
cana-5161	221	21	including	include	VERB
cana-5161	221	22	norepinephrine	norepinephrine	NOUN
cana-5161	221	23	(	(	PUNCT
cana-5161	221	24	ne	ne	NOUN
cana-5161	221	25	)	)	PUNCT
cana-5161	221	26	,	,	PUNCT
cana-5161	221	27	dopamine	dopamine	NOUN
cana-5161	221	28	(	(	PUNCT
cana-5161	221	29	da	da	NOUN
cana-5161	221	30	)	)	PUNCT
cana-5161	221	31	,	,	PUNCT
cana-5161	221	32	and	and	CCONJ
cana-5161	221	33	serotonin	serotonin	VERB
cana-5161	221	34	(	(	PUNCT
cana-5161	221	35	5	5	NUM
cana-5161	221	36	-	-	SYM
cana-5161	221	37	ht	ht	NOUN
cana-5161	221	38	)	)	PUNCT
cana-5161	221	39	.	.	PUNCT
cana-5161	222	1	additionally	additionally	ADV
cana-5161	222	2	,	,	PUNCT
cana-5161	222	3	a	a	DET
cana-5161	222	4	significant	significant	ADJ
cana-5161	222	5	disruption	disruption	NOUN
cana-5161	222	6	in	in	ADP
cana-5161	222	7	the	the	DET
cana-5161	222	8	balance	balance	NOUN
cana-5161	222	9	between	between	ADP
cana-5161	222	10	glutamatergic	glutamatergic	ADJ
cana-5161	222	11	and	and	CCONJ
cana-5161	222	12	gabaergic	gabaergic	ADJ
cana-5161	222	13	signaling	signaling	NOUN
cana-5161	222	14	was	be	AUX
cana-5161	222	15	observed	observe	VERB
cana-5161	222	16	,	,	PUNCT
cana-5161	222	17	with	with	ADP
cana-5161	222	18	alcl₃	alcl₃	NOUN
cana-5161	222	19	treatment	treatment	NOUN
cana-5161	222	20	causing	cause	VERB
cana-5161	222	21	an	an	DET
cana-5161	222	22	increase	increase	NOUN
cana-5161	222	23	in	in	ADP
cana-5161	222	24	hippocampal	hippocampal	ADJ
cana-5161	222	25	glutamate	glutamate	NOUN
cana-5161	222	26	levels	level	NOUN
cana-5161	222	27	and	and	CCONJ
cana-5161	222	28	a	a	DET
cana-5161	222	29	decrease	decrease	NOUN
cana-5161	222	30	in	in	ADP
cana-5161	222	31	gaba	gaba	NOUN
cana-5161	222	32	concentrations	concentration	NOUN
cana-5161	222	33	.	.	PUNCT
cana-5161	223	1	furthermore	furthermore	ADV
cana-5161	223	2	,	,	PUNCT
cana-5161	223	3	a	a	DET
cana-5161	223	4	marked	mark	VERB
cana-5161	223	5	increase	increase	NOUN
cana-5161	223	6	in	in	ADP
cana-5161	223	7	acetylcholinesterase	acetylcholinesterase	NOUN
cana-5161	223	8	(	(	PUNCT
cana-5161	223	9	ache	ache	ADV
cana-5161	223	10	)	)	PUNCT
cana-5161	223	11	activity	activity	NOUN
cana-5161	223	12	was	be	AUX
cana-5161	223	13	detected	detect	VERB
cana-5161	223	14	in	in	ADP
cana-5161	223	15	the	the	DET
cana-5161	223	16	hippocampal	hippocampal	ADJ
cana-5161	223	17	tissue	tissue	NOUN
cana-5161	223	18	of	of	ADP
cana-5161	223	19	alcl₃-treated	alcl₃-treate	VERB
cana-5161	223	20	rats	rat	NOUN
cana-5161	223	21	,	,	PUNCT
cana-5161	223	22	indicating	indicate	VERB
cana-5161	223	23	enhanced	enhanced	ADJ
cana-5161	223	24	acetylcholine	acetylcholine	NOUN
cana-5161	223	25	metabolism	metabolism	NOUN
cana-5161	223	26	.	.	PUNCT
cana-5161	224	1	similar	similar	ADJ
cana-5161	224	2	alterations	alteration	NOUN
cana-5161	224	3	in	in	ADP
cana-5161	224	4	neurotransmitter	neurotransmitter	NOUN
cana-5161	224	5	levels	level	NOUN
cana-5161	224	6	following	follow	VERB
cana-5161	224	7	alcl₃	alcl₃	PROPN
cana-5161	224	8	administration	administration	NOUN
cana-5161	224	9	have	have	AUX
cana-5161	224	10	been	be	AUX
cana-5161	224	11	reported	report	VERB
cana-5161	224	12	in	in	ADP
cana-5161	224	13	previous	previous	ADJ
cana-5161	224	14	studies	study	NOUN
cana-5161	224	15	with	with	ADP
cana-5161	224	16	experimental	experimental	ADJ
cana-5161	224	17	animals	animal	NOUN
cana-5161	224	18	.	.	PUNCT
cana-5161	225	1	notably	notably	ADV
cana-5161	225	2	,	,	PUNCT
cana-5161	225	3	reductions	reduction	NOUN
cana-5161	225	4	in	in	ADP
cana-5161	225	5	monoamine	monoamine	NOUN
cana-5161	225	6	,	,	PUNCT
cana-5161	225	7	acetylcholine	acetylcholine	NOUN
cana-5161	225	8	(	(	PUNCT
cana-5161	225	9	ach	ach	PROPN
cana-5161	225	10	)	)	PUNCT
cana-5161	225	11	,	,	PUNCT
cana-5161	225	12	and	and	CCONJ
cana-5161	225	13	gabaergic	gabaergic	ADJ
cana-5161	225	14	transmission	transmission	NOUN
cana-5161	225	15	,	,	PUNCT
cana-5161	225	16	along	along	ADP
cana-5161	225	17	with	with	ADP
cana-5161	225	18	glutamatergic	glutamatergic	ADJ
cana-5161	225	19	excess	excess	NOUN
cana-5161	225	20	,	,	PUNCT
cana-5161	225	21	have	have	AUX
cana-5161	225	22	also	also	ADV
cana-5161	225	23	been	be	AUX
cana-5161	225	24	observed	observe	VERB
cana-5161	225	25	in	in	ADP
cana-5161	225	26	humans	human	NOUN
cana-5161	225	27	with	with	ADP
cana-5161	225	28	cognitive	cognitive	ADJ
cana-5161	225	29	disorders	disorder	NOUN
cana-5161	225	30	,	,	PUNCT
cana-5161	225	31	including	include	VERB
cana-5161	225	32	ad	ad	NOUN
cana-5161	225	33	(	(	PUNCT
cana-5161	225	34	chen	chen	PROPN
cana-5161	225	35	et	et	PROPN
cana-5161	225	36	al	al	PROPN
cana-5161	225	37	.	.	PROPN
cana-5161	225	38	,	,	PUNCT
cana-5161	225	39	2011	2011	NUM
cana-5161	225	40	)	)	PUNCT
cana-5161	225	41	.	.	PUNCT
cana-5161	226	1	agmatine	agmatine	PROPN
cana-5161	226	2	dose	dose	PROPN
cana-5161	226	3	-	-	PUNCT
cana-5161	226	4	dependently	dependently	ADV
cana-5161	226	5	mitigated	mitigate	VERB
cana-5161	226	6	aluminium	aluminium	NOUN
cana-5161	226	7	chloride	chloride	NOUN
cana-5161	226	8	(	(	PUNCT
cana-5161	226	9	alcl₃)-induced	alcl₃)-induce	VERB
cana-5161	226	10	neurochemical	neurochemical	ADJ
cana-5161	226	11	alterations	alteration	NOUN
cana-5161	226	12	and	and	CCONJ
cana-5161	226	13	facilitated	facilitate	VERB
cana-5161	226	14	recovery	recovery	NOUN
cana-5161	226	15	in	in	ADP
cana-5161	226	16	cholinergic	cholinergic	ADJ
cana-5161	226	17	,	,	PUNCT
cana-5161	226	18	monoaminergic	monoaminergic	ADJ
cana-5161	226	19	,	,	PUNCT
cana-5161	226	20	gabaergic	gabaergic	ADJ
cana-5161	226	21	,	,	PUNCT
cana-5161	226	22	and	and	CCONJ
cana-5161	226	23	glutamatergic	glutamatergic	ADJ
cana-5161	226	24	neurotransmitter	neurotransmitter	NOUN
cana-5161	226	25	systems	system	NOUN
cana-5161	226	26	,	,	PUNCT
cana-5161	226	27	while	while	SCONJ
cana-5161	226	28	reducing	reduce	VERB
cana-5161	226	29	their	their	PRON
cana-5161	226	30	metabolism	metabolism	NOUN
cana-5161	226	31	in	in	ADP
cana-5161	226	32	the	the	DET
cana-5161	226	33	hippocampal	hippocampal	ADJ
cana-5161	226	34	region	region	NOUN
cana-5161	226	35	of	of	ADP
cana-5161	226	36	the	the	DET
cana-5161	226	37	rat	rat	NOUN
cana-5161	226	38	brain	brain	NOUN
cana-5161	226	39	.	.	PUNCT
cana-5161	227	1	therefore	therefore	ADV
cana-5161	227	2	,	,	PUNCT
cana-5161	227	3	the	the	DET
cana-5161	227	4	restoration	restoration	NOUN
cana-5161	227	5	of	of	ADP
cana-5161	227	6	hippocampal	hippocampal	ADJ
cana-5161	227	7	neurotransmission	neurotransmission	NOUN
cana-5161	227	8	may	may	AUX
cana-5161	227	9	be	be	AUX
cana-5161	227	10	a	a	DET
cana-5161	227	11	key	key	ADJ
cana-5161	227	12	factor	factor	NOUN
cana-5161	227	13	contributing	contribute	VERB
cana-5161	227	14	to	to	ADP
cana-5161	227	15	the	the	DET
cana-5161	227	16	observed	observe	VERB
cana-5161	227	17	cognitive	cognitive	ADJ
cana-5161	227	18	improvements	improvement	NOUN
cana-5161	227	19	following	follow	VERB
cana-5161	227	20	agmatine	agmatine	NOUN
cana-5161	227	21	treatment	treatment	NOUN
cana-5161	227	22	in	in	ADP
cana-5161	227	23	alcl₃-treated	alcl₃-treate	VERB
cana-5161	227	24	rats	rat	NOUN
cana-5161	227	25	.	.	PUNCT
cana-5161	228	1	the	the	DET
cana-5161	228	2	hippocampus	hippocampus	NOUN
cana-5161	228	3	is	be	AUX
cana-5161	228	4	known	know	VERB
cana-5161	228	5	to	to	PART
cana-5161	228	6	play	play	VERB
cana-5161	228	7	a	a	DET
cana-5161	228	8	critical	critical	ADJ
cana-5161	228	9	role	role	NOUN
cana-5161	228	10	in	in	ADP
cana-5161	228	11	learning	learning	NOUN
cana-5161	228	12	and	and	CCONJ
cana-5161	228	13	memory	memory	NOUN
cana-5161	228	14	processes	process	NOUN
cana-5161	228	15	.	.	PUNCT
cana-5161	229	1	aluminium	aluminium	NOUN
cana-5161	229	2	chloride	chloride	NOUN
cana-5161	229	3	(	(	PUNCT
cana-5161	229	4	alcl₃	alcl₃	NOUN
cana-5161	229	5	)	)	PUNCT
cana-5161	229	6	has	have	AUX
cana-5161	229	7	been	be	AUX
cana-5161	229	8	shown	show	VERB
cana-5161	229	9	to	to	PART
cana-5161	229	10	induce	induce	VERB
cana-5161	229	11	damage	damage	NOUN
cana-5161	229	12	to	to	ADP
cana-5161	229	13	brain	brain	NOUN
cana-5161	229	14	tissues	tissue	NOUN
cana-5161	229	15	,	,	PUNCT
cana-5161	229	16	which	which	PRON
cana-5161	229	17	are	be	AUX
cana-5161	229	18	particularly	particularly	ADV
cana-5161	229	19	susceptible	susceptible	ADJ
cana-5161	229	20	to	to	ADP
cana-5161	229	21	oxidative	oxidative	ADJ
cana-5161	229	22	stress	stress	NOUN
cana-5161	229	23	,	,	PUNCT
cana-5161	229	24	mitochondrial	mitochondrial	ADJ
cana-5161	229	25	dysfunction	dysfunction	NOUN
cana-5161	229	26	,	,	PUNCT
cana-5161	229	27	and	and	CCONJ
cana-5161	229	28	neuroinflammation	neuroinflammation	NOUN
cana-5161	229	29	(	(	PUNCT
cana-5161	229	30	garcía	garcía	NOUN
cana-5161	229	31	-	-	PUNCT
cana-5161	229	32	escudero	escudero	NOUN
cana-5161	229	33	et	et	PROPN
cana-5161	229	34	al	al	PROPN
cana-5161	229	35	.	.	PROPN
cana-5161	229	36	,	,	PUNCT
cana-5161	229	37	2013	2013	NUM
cana-5161	229	38	)	)	PUNCT
cana-5161	229	39	.	.	PUNCT
cana-5161	230	1	several	several	ADJ
cana-5161	230	2	studies	study	NOUN
cana-5161	230	3	have	have	AUX
cana-5161	230	4	suggested	suggest	VERB
cana-5161	230	5	that	that	SCONJ
cana-5161	230	6	inflammation	inflammation	NOUN
cana-5161	230	7	and	and	CCONJ
cana-5161	230	8	oxidative	oxidative	ADJ
cana-5161	230	9	stress	stress	NOUN
cana-5161	230	10	play	play	VERB
cana-5161	230	11	pivotal	pivotal	ADJ
cana-5161	230	12	roles	role	NOUN
cana-5161	230	13	in	in	ADP
cana-5161	230	14	the	the	DET
cana-5161	230	15	progression	progression	NOUN
cana-5161	230	16	of	of	ADP
cana-5161	230	17	aluminium	aluminium	NOUN
cana-5161	230	18	chloride	chloride	NOUN
cana-5161	230	19	(	(	PUNCT
cana-5161	230	20	alcl₃)-induced	alcl₃)-induce	VERB
cana-5161	230	21	neurotoxicity	neurotoxicity	NOUN
cana-5161	230	22	and	and	CCONJ
cana-5161	230	23	neuronal	neuronal	ADJ
cana-5161	230	24	cell	cell	NOUN
cana-5161	230	25	death	death	NOUN
cana-5161	230	26	.	.	PUNCT
cana-5161	231	1	in	in	ADP
cana-5161	231	2	the	the	DET
cana-5161	231	3	present	present	ADJ
cana-5161	231	4	study	study	NOUN
cana-5161	231	5	,	,	PUNCT
cana-5161	231	6	alcl₃	alcl₃	PROPN
cana-5161	231	7	administration	administration	NOUN
cana-5161	231	8	resulted	result	VERB
cana-5161	231	9	in	in	ADP
cana-5161	231	10	a	a	DET
cana-5161	231	11	significant	significant	ADJ
cana-5161	231	12	increase	increase	NOUN
cana-5161	231	13	in	in	ADP
cana-5161	231	14	oxidative	oxidative	ADJ
cana-5161	231	15	stress	stress	NOUN
cana-5161	231	16	markers	marker	NOUN
cana-5161	231	17	,	,	PUNCT
cana-5161	231	18	including	include	VERB
cana-5161	231	19	malondialdehyde	malondialdehyde	NOUN
cana-5161	231	20	(	(	PUNCT
cana-5161	231	21	mda	mda	PROPN
cana-5161	231	22	)	)	PUNCT
cana-5161	231	23	and	and	CCONJ
cana-5161	231	24	nitrite	nitrite	NOUN
cana-5161	231	25	levels	level	NOUN
cana-5161	231	26	,	,	PUNCT
cana-5161	231	27	while	while	SCONJ
cana-5161	231	28	concurrently	concurrently	ADV
cana-5161	231	29	decreasing	decrease	VERB
cana-5161	231	30	glutathione	glutathione	NOUN
cana-5161	231	31	levels	level	NOUN
cana-5161	231	32	.	.	PUNCT
cana-5161	232	1	previous	previous	ADJ
cana-5161	232	2	research	research	NOUN
cana-5161	232	3	has	have	AUX
cana-5161	232	4	indicated	indicate	VERB
cana-5161	232	5	that	that	SCONJ
cana-5161	232	6	free	free	ADJ
cana-5161	232	7	radicals	radical	NOUN
cana-5161	232	8	are	be	AUX
cana-5161	232	9	highly	highly	ADV
cana-5161	232	10	effective	effective	ADJ
cana-5161	232	11	at	at	ADP
cana-5161	232	12	inducing	induce	VERB
cana-5161	232	13	neuronal	neuronal	ADJ
cana-5161	232	14	cell	cell	NOUN
cana-5161	232	15	death	death	NOUN
cana-5161	232	16	and	and	CCONJ
cana-5161	232	17	may	may	AUX
cana-5161	232	18	be	be	AUX
cana-5161	232	19	involved	involve	VERB
cana-5161	232	20	in	in	ADP
cana-5161	232	21	the	the	DET
cana-5161	232	22	pathogenesis	pathogenesis	NOUN
cana-5161	232	23	of	of	ADP
cana-5161	232	24	neurodegenerative	neurodegenerative	ADJ
cana-5161	232	25	diseases	disease	NOUN
cana-5161	232	26	(	(	PUNCT
cana-5161	232	27	perry	perry	PROPN
cana-5161	232	28	et	et	PROPN
cana-5161	232	29	al	al	PROPN
cana-5161	232	30	.	.	PROPN
cana-5161	232	31	,	,	PUNCT
cana-5161	232	32	2002	2002	NUM
cana-5161	232	33	,	,	PUNCT
cana-5161	232	34	ischiropoulos	ischiropoulos	NOUN
cana-5161	232	35	and	and	CCONJ
cana-5161	232	36	beckman	beckman	NOUN
cana-5161	232	37	,	,	PUNCT
cana-5161	232	38	2003	2003	NUM
cana-5161	232	39	)	)	PUNCT
cana-5161	232	40	.	.	PUNCT
cana-5161	233	1	numerous	numerous	ADJ
cana-5161	233	2	studies	study	NOUN
cana-5161	233	3	have	have	AUX
cana-5161	233	4	documented	document	VERB
cana-5161	233	5	that	that	SCONJ
cana-5161	233	6	aluminium	aluminium	NOUN
cana-5161	233	7	chloride	chloride	NOUN
cana-5161	233	8	(	(	PUNCT
cana-5161	233	9	alcl₃	alcl₃	NOUN
cana-5161	233	10	)	)	PUNCT
cana-5161	233	11	induces	induce	VERB
cana-5161	233	12	mitochondrial	mitochondrial	ADJ
cana-5161	233	13	dysfunction	dysfunction	NOUN
cana-5161	233	14	,	,	PUNCT
cana-5161	233	15	which	which	PRON
cana-5161	233	16	subsequently	subsequently	ADV
cana-5161	233	17	leads	lead	VERB
cana-5161	233	18	to	to	ADP
cana-5161	233	19	the	the	DET
cana-5161	233	20	generation	generation	NOUN
cana-5161	233	21	of	of	ADP
cana-5161	233	22	free	free	ADJ
cana-5161	233	23	radicals	radical	NOUN
cana-5161	233	24	and	and	CCONJ
cana-5161	233	25	oxidative	oxidative	ADJ
cana-5161	233	26	damage	damage	NOUN
cana-5161	233	27	(	(	PUNCT
cana-5161	233	28	kawahara	kawahara	NOUN
cana-5161	233	29	and	and	CCONJ
cana-5161	233	30	kato	kato	PROPN
cana-5161	233	31	-	-	PUNCT
cana-5161	233	32	negishi	negishi	PROPN
cana-5161	233	33	,	,	PUNCT
cana-5161	233	34	2011	2011	NUM
cana-5161	233	35	)	)	PUNCT
cana-5161	233	36	.	.	PUNCT
cana-5161	234	1	the	the	DET
cana-5161	234	2	results	result	NOUN
cana-5161	234	3	suggest	suggest	VERB
cana-5161	234	4	that	that	SCONJ
cana-5161	234	5	aluminium	aluminium	NOUN
cana-5161	234	6	chloride	chloride	NOUN
cana-5161	234	7	(	(	PUNCT
cana-5161	234	8	alcl₃	alcl₃	NOUN
cana-5161	234	9	)	)	PUNCT
cana-5161	234	10	induces	induce	VERB
cana-5161	234	11	mitochondrial	mitochondrial	ADJ
cana-5161	234	12	oxidative	oxidative	ADJ
cana-5161	234	13	damage	damage	NOUN
cana-5161	234	14	through	through	ADP
cana-5161	234	15	increased	increase	VERB
cana-5161	234	16	oxidative	oxidative	ADJ
cana-5161	234	17	communications	communication	NOUN
cana-5161	234	18	on	on	ADP
cana-5161	234	19	applied	apply	VERB
cana-5161	234	20	nonlinear	nonlinear	ADJ
cana-5161	234	21	analysis	analysis	NOUN
cana-5161	234	22	issn	issn	NOUN
cana-5161	234	23	:	:	PUNCT
cana-5161	234	24	1074	1074	NUM
cana-5161	234	25	-	-	PUNCT
cana-5161	234	26	133x	133x	NUM
cana-5161	234	27	vol	vol	NOUN
cana-5161	234	28	32	32	NUM
cana-5161	234	29	no	no	NOUN
cana-5161	234	30	.	.	PUNCT
cana-5161	235	1	icmasd	icmasd	NOUN
cana-5161	235	2	(	(	PUNCT
cana-5161	235	3	2025	2025	NUM
cana-5161	235	4	)	)	PUNCT
cana-5161	235	5	1366	1366	NUM
cana-5161	235	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	235	7	stress	stress	NOUN
cana-5161	235	8	and	and	CCONJ
cana-5161	235	9	decreased	decrease	VERB
cana-5161	235	10	antioxidant	antioxidant	ADJ
cana-5161	235	11	levels	level	NOUN
cana-5161	235	12	.	.	PUNCT
cana-5161	236	1	treatment	treatment	NOUN
cana-5161	236	2	with	with	ADP
cana-5161	236	3	agmatine	agmatine	NOUN
cana-5161	236	4	significantly	significantly	ADV
cana-5161	236	5	and	and	CCONJ
cana-5161	236	6	dose	dose	NOUN
cana-5161	236	7	-	-	PUNCT
cana-5161	236	8	dependently	dependently	ADV
cana-5161	236	9	mitigated	mitigate	VERB
cana-5161	236	10	alcl₃-induced	alcl₃-induce	VERB
cana-5161	236	11	oxidative	oxidative	ADJ
cana-5161	236	12	stress	stress	NOUN
cana-5161	236	13	and	and	CCONJ
cana-5161	236	14	restored	restore	VERB
cana-5161	236	15	the	the	DET
cana-5161	236	16	levels	level	NOUN
cana-5161	236	17	of	of	ADP
cana-5161	236	18	antioxidant	antioxidant	ADJ
cana-5161	236	19	enzymes	enzyme	NOUN
cana-5161	236	20	,	,	PUNCT
cana-5161	236	21	such	such	ADJ
cana-5161	236	22	as	as	ADP
cana-5161	236	23	glutathione	glutathione	NOUN
cana-5161	236	24	(	(	PUNCT
cana-5161	236	25	gsh	gsh	PROPN
cana-5161	236	26	)	)	PUNCT
cana-5161	236	27	,	,	PUNCT
cana-5161	236	28	indicating	indicate	VERB
cana-5161	236	29	its	its	PRON
cana-5161	236	30	antioxidant	antioxidant	ADJ
cana-5161	236	31	properties	property	NOUN
cana-5161	236	32	.	.	PUNCT
cana-5161	237	1	several	several	ADJ
cana-5161	237	2	studies	study	NOUN
cana-5161	237	3	have	have	AUX
cana-5161	237	4	demonstrated	demonstrate	VERB
cana-5161	237	5	that	that	SCONJ
cana-5161	237	6	agmatine	agmatine	NOUN
cana-5161	237	7	possesses	possess	VERB
cana-5161	237	8	both	both	CCONJ
cana-5161	237	9	antioxidant	antioxidant	ADJ
cana-5161	237	10	and	and	CCONJ
cana-5161	237	11	anti	anti	ADJ
cana-5161	237	12	-	-	ADJ
cana-5161	237	13	inflammatory	inflammatory	ADJ
cana-5161	237	14	effects	effect	NOUN
cana-5161	237	15	in	in	ADP
cana-5161	237	16	various	various	ADJ
cana-5161	237	17	experimental	experimental	ADJ
cana-5161	237	18	models	model	NOUN
cana-5161	237	19	.	.	PUNCT
cana-5161	238	1	the	the	DET
cana-5161	238	2	findings	finding	NOUN
cana-5161	238	3	of	of	ADP
cana-5161	238	4	the	the	DET
cana-5161	238	5	present	present	ADJ
cana-5161	238	6	study	study	NOUN
cana-5161	238	7	imply	imply	VERB
cana-5161	238	8	that	that	SCONJ
cana-5161	238	9	the	the	DET
cana-5161	238	10	improvement	improvement	NOUN
cana-5161	238	11	in	in	ADP
cana-5161	238	12	cognitive	cognitive	ADJ
cana-5161	238	13	function	function	NOUN
cana-5161	238	14	observed	observe	VERB
cana-5161	238	15	in	in	ADP
cana-5161	238	16	alcl₃-treated	alcl₃-treate	VERB
cana-5161	238	17	rats	rat	NOUN
cana-5161	238	18	following	follow	VERB
cana-5161	238	19	agmatine	agmatine	PROPN
cana-5161	238	20	administration	administration	NOUN
cana-5161	238	21	may	may	AUX
cana-5161	238	22	be	be	AUX
cana-5161	238	23	attributed	attribute	VERB
cana-5161	238	24	to	to	ADP
cana-5161	238	25	its	its	PRON
cana-5161	238	26	antioxidant	antioxidant	ADJ
cana-5161	238	27	and	and	CCONJ
cana-5161	238	28	neuromodulatory	neuromodulatory	ADJ
cana-5161	238	29	activities	activity	NOUN
cana-5161	238	30	.	.	PUNCT
cana-5161	239	1	5	5	X
cana-5161	239	2	.	.	X
cana-5161	239	3	conclusions	conclusion	NOUN
cana-5161	239	4	:	:	PUNCT
cana-5161	239	5	in	in	ADP
cana-5161	239	6	conclusion	conclusion	NOUN
cana-5161	239	7	,	,	PUNCT
cana-5161	239	8	administration	administration	NOUN
cana-5161	239	9	of	of	ADP
cana-5161	239	10	aluminium	aluminium	NOUN
cana-5161	239	11	chloride	chloride	NOUN
cana-5161	239	12	(	(	PUNCT
cana-5161	239	13	alcl₃	alcl₃	NOUN
cana-5161	239	14	)	)	PUNCT
cana-5161	239	15	via	via	ADP
cana-5161	239	16	oral	oral	ADJ
cana-5161	239	17	gavage	gavage	NOUN
cana-5161	239	18	(	(	PUNCT
cana-5161	239	19	p.o	p.o	PROPN
cana-5161	239	20	.	.	PROPN
cana-5161	239	21	)	)	PUNCT
cana-5161	239	22	resulted	result	VERB
cana-5161	239	23	in	in	ADP
cana-5161	239	24	significant	significant	ADJ
cana-5161	239	25	impairments	impairment	NOUN
cana-5161	239	26	in	in	ADP
cana-5161	239	27	learning	learning	NOUN
cana-5161	239	28	and	and	CCONJ
cana-5161	239	29	memory	memory	NOUN
cana-5161	239	30	,	,	PUNCT
cana-5161	239	31	which	which	PRON
cana-5161	239	32	were	be	AUX
cana-5161	239	33	associated	associate	VERB
cana-5161	239	34	with	with	ADP
cana-5161	239	35	altered	altered	ADJ
cana-5161	239	36	brain	brain	NOUN
cana-5161	239	37	neurochemistry	neurochemistry	NOUN
cana-5161	239	38	,	,	PUNCT
cana-5161	239	39	increased	increase	VERB
cana-5161	239	40	oxidative	oxidative	ADJ
cana-5161	239	41	stress	stress	NOUN
cana-5161	239	42	,	,	PUNCT
cana-5161	239	43	and	and	CCONJ
cana-5161	239	44	neuroinflammation	neuroinflammation	NOUN
cana-5161	239	45	.	.	PUNCT
cana-5161	240	1	agmatine	agmatine	PROPN
cana-5161	240	2	treatment	treatment	NOUN
cana-5161	240	3	,	,	PUNCT
cana-5161	240	4	in	in	ADP
cana-5161	240	5	a	a	DET
cana-5161	240	6	dosedependent	dosedependent	NOUN
cana-5161	240	7	manner	manner	NOUN
cana-5161	240	8	,	,	PUNCT
cana-5161	240	9	attenuated	attenuate	VERB
cana-5161	240	10	alcl₃-induced	alcl₃-induced	ADJ
cana-5161	240	11	cognitive	cognitive	ADJ
cana-5161	240	12	deficits	deficit	NOUN
cana-5161	240	13	,	,	PUNCT
cana-5161	240	14	oxidative	oxidative	ADJ
cana-5161	240	15	stress	stress	NOUN
cana-5161	240	16	,	,	PUNCT
cana-5161	240	17	neuroinflammation	neuroinflammation	NOUN
cana-5161	240	18	,	,	PUNCT
cana-5161	240	19	and	and	CCONJ
cana-5161	240	20	restored	restore	VERB
cana-5161	240	21	brain	brain	NOUN
cana-5161	240	22	neurochemical	neurochemical	ADJ
cana-5161	240	23	balance	balance	NOUN
cana-5161	240	24	.	.	PUNCT
cana-5161	241	1	the	the	DET
cana-5161	241	2	observed	observe	VERB
cana-5161	241	3	cognitive	cognitive	ADJ
cana-5161	241	4	improvement	improvement	NOUN
cana-5161	241	5	in	in	ADP
cana-5161	241	6	alcl₃-treated	alcl₃-treate	VERB
cana-5161	241	7	rats	rat	NOUN
cana-5161	241	8	following	follow	VERB
cana-5161	241	9	agmatine	agmatine	PROPN
cana-5161	241	10	administration	administration	NOUN
cana-5161	241	11	may	may	AUX
cana-5161	241	12	be	be	AUX
cana-5161	241	13	attributed	attribute	VERB
cana-5161	241	14	to	to	ADP
cana-5161	241	15	its	its	PRON
cana-5161	241	16	antioxidant	antioxidant	ADJ
cana-5161	241	17	and	and	CCONJ
cana-5161	241	18	anti	anti	ADJ
cana-5161	241	19	-	-	ADJ
cana-5161	241	20	inflammatory	inflammatory	ADJ
cana-5161	241	21	properties	property	NOUN
cana-5161	241	22	,	,	PUNCT
cana-5161	241	23	as	as	ADV
cana-5161	241	24	well	well	ADV
cana-5161	241	25	as	as	ADP
cana-5161	241	26	its	its	PRON
cana-5161	241	27	ability	ability	NOUN
cana-5161	241	28	to	to	PART
cana-5161	241	29	modulate	modulate	VERB
cana-5161	241	30	hippocampal	hippocampal	ADJ
cana-5161	241	31	neurochemistry	neurochemistry	NOUN
cana-5161	241	32	.	.	PUNCT
cana-5161	242	1	these	these	DET
cana-5161	242	2	findings	finding	NOUN
cana-5161	242	3	suggest	suggest	VERB
cana-5161	242	4	that	that	SCONJ
cana-5161	242	5	agmatine	agmatine	NOUN
cana-5161	242	6	could	could	AUX
cana-5161	242	7	serve	serve	VERB
cana-5161	242	8	as	as	ADP
cana-5161	242	9	a	a	DET
cana-5161	242	10	potential	potential	ADJ
cana-5161	242	11	therapeutic	therapeutic	ADJ
cana-5161	242	12	candidate	candidate	NOUN
cana-5161	242	13	for	for	ADP
cana-5161	242	14	the	the	DET
cana-5161	242	15	management	management	NOUN
cana-5161	242	16	of	of	ADP
cana-5161	242	17	cognitive	cognitive	ADJ
cana-5161	242	18	disorders	disorder	NOUN
cana-5161	242	19	,	,	PUNCT
cana-5161	242	20	including	include	VERB
cana-5161	242	21	alzheimer	alzheimer	PROPN
cana-5161	242	22	's	's	PART
cana-5161	242	23	disease	disease	NOUN
cana-5161	242	24	.	.	PUNCT
cana-5161	243	1	acknowledgements	acknowledgement	NOUN
cana-5161	243	2	we	we	PRON
cana-5161	243	3	would	would	AUX
cana-5161	243	4	like	like	VERB
cana-5161	243	5	to	to	PART
cana-5161	243	6	express	express	VERB
cana-5161	243	7	our	our	PRON
cana-5161	243	8	gratitude	gratitude	NOUN
cana-5161	243	9	to	to	ADP
cana-5161	243	10	vandana	vandana	PROPN
cana-5161	243	11	bhatia	bhatia	PROPN
cana-5161	243	12	,	,	PUNCT
cana-5161	243	13	dr	dr	PROPN
cana-5161	243	14	.	.	PROPN
cana-5161	243	15	vir	vir	PROPN
cana-5161	243	16	vikram	vikram	PROPN
cana-5161	243	17	sharma	sharma	PROPN
cana-5161	243	18	,	,	PUNCT
cana-5161	243	19	priyanka	priyanka	PROPN
cana-5161	243	20	kashyap	kashyap	PROPN
cana-5161	243	21	,	,	PUNCT
cana-5161	243	22	anjali	anjali	PROPN
cana-5161	243	23	chandel	chandel	PROPN
cana-5161	243	24	,	,	PUNCT
cana-5161	243	25	dr	dr	PROPN
cana-5161	243	26	.	.	PROPN
cana-5161	243	27	swati	swati	PROPN
cana-5161	243	28	rana	rana	PROPN
cana-5161	243	29	,	,	PUNCT
cana-5161	243	30	dheeraj	dheeraj	PROPN
cana-5161	243	31	for	for	ADP
cana-5161	243	32	their	their	PRON
cana-5161	243	33	invaluable	invaluable	ADJ
cana-5161	243	34	contributions	contribution	NOUN
cana-5161	243	35	to	to	ADP
cana-5161	243	36	this	this	DET
cana-5161	243	37	research	research	NOUN
cana-5161	243	38	paper	paper	NOUN
cana-5161	243	39	.	.	PUNCT
cana-5161	244	1	author	author	NOUN
cana-5161	244	2	contributions	contributions	PROPN
cana-5161	244	3	vandana	vandana	PROPN
cana-5161	244	4	bhatia	bhatia	PROPN
cana-5161	244	5	,	,	PUNCT
cana-5161	244	6	anjali	anjali	PROPN
cana-5161	244	7	chandel	chandel	PROPN
cana-5161	244	8	conceptualized	conceptualize	VERB
cana-5161	244	9	the	the	DET
cana-5161	244	10	research	research	NOUN
cana-5161	244	11	paper	paper	NOUN
cana-5161	244	12	,	,	PUNCT
cana-5161	244	13	designed	design	VERB
cana-5161	244	14	the	the	DET
cana-5161	244	15	structure	structure	NOUN
cana-5161	244	16	of	of	ADP
cana-5161	244	17	the	the	DET
cana-5161	244	18	manuscript	manuscript	NOUN
cana-5161	244	19	,	,	PUNCT
cana-5161	244	20	and	and	CCONJ
cana-5161	244	21	led	lead	VERB
cana-5161	244	22	the	the	DET
cana-5161	244	23	writing	writing	NOUN
cana-5161	244	24	process	process	NOUN
cana-5161	244	25	.	.	PUNCT
cana-5161	245	1	priyanka	priyanka	PROPN
cana-5161	245	2	kashyap	kashyap	PROPN
cana-5161	245	3	,	,	PUNCT
cana-5161	245	4	dr	dr	PROPN
cana-5161	245	5	.	.	PROPN
cana-5161	245	6	swati	swati	PROPN
cana-5161	245	7	rana	rana	PROPN
cana-5161	245	8	,	,	PUNCT
cana-5161	245	9	&	&	CCONJ
cana-5161	245	10	dheeraj	dheeraj	PROPN
cana-5161	245	11	conducted	conduct	VERB
cana-5161	245	12	an	an	DET
cana-5161	245	13	extensive	extensive	ADJ
cana-5161	245	14	literature	literature	NOUN
cana-5161	245	15	review	review	NOUN
cana-5161	245	16	,	,	PUNCT
cana-5161	245	17	contributed	contribute	VERB
cana-5161	245	18	to	to	ADP
cana-5161	245	19	the	the	DET
cana-5161	245	20	writing	writing	NOUN
cana-5161	245	21	of	of	ADP
cana-5161	245	22	the	the	DET
cana-5161	245	23	various	various	ADJ
cana-5161	245	24	section	section	NOUN
cana-5161	245	25	in	in	ADP
cana-5161	245	26	manuscript	manuscript	NOUN
cana-5161	245	27	,	,	PUNCT
cana-5161	245	28	and	and	CCONJ
cana-5161	245	29	assisted	assist	VERB
cana-5161	245	30	in	in	ADP
cana-5161	245	31	refining	refine	VERB
cana-5161	245	32	the	the	DET
cana-5161	245	33	manuscripts	manuscript	NOUN
cana-5161	245	34	framework	framework	NOUN
cana-5161	245	35	.	.	PUNCT
cana-5161	246	1	dr	dr	PROPN
cana-5161	246	2	.	.	PROPN
cana-5161	246	3	vir	vir	PROPN
cana-5161	246	4	vikram	vikram	PROPN
cana-5161	246	5	provided	provide	VERB
cana-5161	246	6	critical	critical	ADJ
cana-5161	246	7	revisions	revision	NOUN
cana-5161	246	8	and	and	CCONJ
cana-5161	246	9	feedback	feedback	NOUN
cana-5161	246	10	,	,	PUNCT
cana-5161	246	11	ensuring	ensure	VERB
cana-5161	246	12	the	the	DET
cana-5161	246	13	accuracy	accuracy	NOUN
cana-5161	246	14	and	and	CCONJ
cana-5161	246	15	scientific	scientific	ADJ
cana-5161	246	16	integrity	integrity	NOUN
cana-5161	246	17	of	of	ADP
cana-5161	246	18	the	the	DET
cana-5161	246	19	content	content	NOUN
cana-5161	246	20	.	.	PUNCT
cana-5161	247	1	all	all	DET
cana-5161	247	2	authors	author	NOUN
cana-5161	247	3	participated	participate	VERB
cana-5161	247	4	in	in	ADP
cana-5161	247	5	reviewing	review	VERB
cana-5161	247	6	and	and	CCONJ
cana-5161	247	7	editing	edit	VERB
cana-5161	247	8	the	the	DET
cana-5161	247	9	manuscript	manuscript	NOUN
cana-5161	247	10	,	,	PUNCT
cana-5161	247	11	approved	approve	VERB
cana-5161	247	12	the	the	DET
cana-5161	247	13	final	final	ADJ
cana-5161	247	14	version	version	NOUN
cana-5161	247	15	,	,	PUNCT
cana-5161	247	16	and	and	CCONJ
cana-5161	247	17	agreed	agree	VERB
cana-5161	247	18	to	to	PART
cana-5161	247	19	be	be	AUX
cana-5161	247	20	accountable	accountable	ADJ
cana-5161	247	21	for	for	ADP
cana-5161	247	22	all	all	DET
cana-5161	247	23	aspects	aspect	NOUN
cana-5161	247	24	of	of	ADP
cana-5161	247	25	the	the	DET
cana-5161	247	26	work	work	NOUN
cana-5161	247	27	.	.	PUNCT
cana-5161	248	1	conflicts	conflict	NOUN
cana-5161	248	2	of	of	ADP
cana-5161	248	3	interest	interest	NOUN
cana-5161	248	4	“	"	PUNCT
cana-5161	248	5	the	the	DET
cana-5161	248	6	authors	author	NOUN
cana-5161	248	7	declare	declare	VERB
cana-5161	248	8	that	that	SCONJ
cana-5161	248	9	they	they	PRON
cana-5161	248	10	have	have	VERB
cana-5161	248	11	no	no	DET
cana-5161	248	12	conflicts	conflict	NOUN
cana-5161	248	13	of	of	ADP
cana-5161	248	14	interest	interest	NOUN
cana-5161	248	15	.	.	PUNCT
cana-5161	248	16	”	"	PUNCT
cana-5161	249	1	reference	reference	NOUN
cana-5161	249	2	:	:	PUNCT
cana-5161	250	1	[	[	X
cana-5161	250	2	1	1	X
cana-5161	250	3	]	]	X
cana-5161	250	4	abdel	abdel	PROPN
cana-5161	250	5	-	-	PUNCT
cana-5161	250	6	zaher	zaher	PROPN
cana-5161	250	7	,	,	PUNCT
cana-5161	250	8	a.	a.	PROPN
cana-5161	250	9	o.	o.	PROPN
cana-5161	250	10	,	,	PUNCT
cana-5161	250	11	hamdy	hamdy	PROPN
cana-5161	250	12	,	,	PUNCT
cana-5161	250	13	m.	m.	NOUN
cana-5161	250	14	m.	m.	NOUN
cana-5161	250	15	,	,	PUNCT
cana-5161	250	16	abdel	abdel	PROPN
cana-5161	250	17	-	-	PUNCT
cana-5161	250	18	rahman	rahman	PROPN
cana-5161	250	19	,	,	PUNCT
cana-5161	250	20	m.	m.	PROPN
cana-5161	250	21	s.	s.	PROPN
cana-5161	250	22	&	&	CCONJ
cana-5161	250	23	abd	abd	PROPN
cana-5161	250	24	el	el	PROPN
cana-5161	250	25	-	-	PROPN
cana-5161	250	26	hamid	hamid	PROPN
cana-5161	250	27	,	,	PUNCT
cana-5161	250	28	d.	d.	PROPN
cana-5161	250	29	h.	h.	PROPN
cana-5161	250	30	2017	2017	NUM
cana-5161	250	31	.	.	PUNCT
cana-5161	251	1	protective	protective	ADJ
cana-5161	251	2	effect	effect	NOUN
cana-5161	251	3	of	of	ADP
cana-5161	251	4	citicoline	citicoline	NOUN
cana-5161	251	5	against	against	ADP
cana-5161	251	6	aluminum	aluminum	NOUN
cana-5161	251	7	-	-	PUNCT
cana-5161	251	8	induced	induce	VERB
cana-5161	251	9	cognitive	cognitive	ADJ
cana-5161	251	10	impairments	impairment	NOUN
cana-5161	251	11	in	in	ADP
cana-5161	251	12	rats	rat	NOUN
cana-5161	251	13	.	.	PUNCT
cana-5161	252	1	toxicology	toxicology	NOUN
cana-5161	252	2	and	and	CCONJ
cana-5161	252	3	industrial	industrial	ADJ
cana-5161	252	4	health	health	NOUN
cana-5161	252	5	,	,	PUNCT
cana-5161	252	6	33	33	NUM
cana-5161	252	7	,	,	PUNCT
cana-5161	252	8	308	308	NUM
cana-5161	252	9	-	-	SYM
cana-5161	252	10	317	317	NUM
cana-5161	252	11	.	.	PUNCT
cana-5161	253	1	[	[	X
cana-5161	253	2	2	2	NUM
cana-5161	253	3	]	]	PUNCT
cana-5161	253	4	albrekkan	albrekkan	PROPN
cana-5161	253	5	,	,	PUNCT
cana-5161	253	6	f.	f.	PROPN
cana-5161	253	7	m.	m.	PROPN
cana-5161	253	8	&	&	CCONJ
cana-5161	253	9	kelly	kelly	PROPN
cana-5161	253	10	-	-	PUNCT
cana-5161	253	11	worden	worden	NOUN
cana-5161	253	12	,	,	PUNCT
cana-5161	253	13	m.	m.	NOUN
cana-5161	253	14	2013	2013	NUM
cana-5161	253	15	.	.	PUNCT
cana-5161	254	1	mitochondrial	mitochondrial	ADJ
cana-5161	254	2	dysfunction	dysfunction	NOUN
cana-5161	254	3	and	and	CCONJ
cana-5161	254	4	alzheimer	alzheimer	PROPN
cana-5161	254	5	’s	’s	PART
cana-5161	254	6	disease	disease	NOUN
cana-5161	254	7	.	.	PUNCT
cana-5161	255	1	communications	communication	NOUN
cana-5161	255	2	on	on	ADP
cana-5161	255	3	applied	apply	VERB
cana-5161	255	4	nonlinear	nonlinear	ADJ
cana-5161	255	5	analysis	analysis	NOUN
cana-5161	255	6	issn	issn	NOUN
cana-5161	255	7	:	:	PUNCT
cana-5161	255	8	1074	1074	NUM
cana-5161	255	9	-	-	PUNCT
cana-5161	255	10	133x	133x	NUM
cana-5161	255	11	vol	vol	NOUN
cana-5161	255	12	32	32	NUM
cana-5161	255	13	no	no	NOUN
cana-5161	255	14	.	.	PUNCT
cana-5161	256	1	icmasd	icmasd	NOUN
cana-5161	256	2	(	(	PUNCT
cana-5161	256	3	2025	2025	NUM
cana-5161	256	4	)	)	PUNCT
cana-5161	256	5	1367	1367	NUM
cana-5161	256	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	257	1	[	[	X
cana-5161	257	2	3	3	NUM
cana-5161	257	3	]	]	X
cana-5161	257	4	arteni	arteni	NOUN
cana-5161	257	5	,	,	PUNCT
cana-5161	257	6	n.	n.	PROPN
cana-5161	257	7	s.	s.	PROPN
cana-5161	257	8	,	,	PUNCT
cana-5161	257	9	lavinsky	lavinsky	PROPN
cana-5161	257	10	,	,	PUNCT
cana-5161	257	11	d.	d.	PROPN
cana-5161	257	12	,	,	PUNCT
cana-5161	257	13	rodrigues	rodrigues	PROPN
cana-5161	257	14	,	,	PUNCT
cana-5161	257	15	a.	a.	PROPN
cana-5161	257	16	l.	l.	PROPN
cana-5161	257	17	,	,	PUNCT
cana-5161	257	18	frison	frison	PROPN
cana-5161	257	19	,	,	PUNCT
cana-5161	257	20	v.	v.	PROPN
cana-5161	257	21	b.	b.	PROPN
cana-5161	257	22	&	&	CCONJ
cana-5161	257	23	netto	netto	PROPN
cana-5161	257	24	,	,	PUNCT
cana-5161	257	25	c.	c.	PROPN
cana-5161	257	26	a.	a.	PROPN
cana-5161	257	27	2002	2002	NUM
cana-5161	257	28	.	.	PUNCT
cana-5161	258	1	agmatine	agmatine	PROPN
cana-5161	258	2	facilitates	facilitate	VERB
cana-5161	258	3	memory	memory	NOUN
cana-5161	258	4	of	of	ADP
cana-5161	258	5	an	an	DET
cana-5161	258	6	inhibitory	inhibitory	ADJ
cana-5161	258	7	avoidance	avoidance	NOUN
cana-5161	258	8	task	task	NOUN
cana-5161	258	9	in	in	ADP
cana-5161	258	10	adult	adult	NOUN
cana-5161	258	11	rats	rat	NOUN
cana-5161	258	12	.	.	PUNCT
cana-5161	259	1	neurobiology	neurobiology	NOUN
cana-5161	259	2	of	of	ADP
cana-5161	259	3	learning	learning	NOUN
cana-5161	259	4	and	and	CCONJ
cana-5161	259	5	memory	memory	NOUN
cana-5161	259	6	,	,	PUNCT
cana-5161	259	7	78	78	NUM
cana-5161	259	8	,	,	PUNCT
cana-5161	259	9	465	465	NUM
cana-5161	259	10	-	-	SYM
cana-5161	259	11	469	469	NUM
cana-5161	259	12	.	.	PUNCT
cana-5161	260	1	[	[	X
cana-5161	260	2	4	4	NUM
cana-5161	260	3	]	]	X
cana-5161	260	4	barone	barone	PROPN
cana-5161	260	5	,	,	PUNCT
cana-5161	260	6	e.	e.	PROPN
cana-5161	260	7	,	,	PUNCT
cana-5161	260	8	di	di	PROPN
cana-5161	260	9	domenico	domenico	PROPN
cana-5161	260	10	,	,	PUNCT
cana-5161	260	11	f.	f.	PROPN
cana-5161	260	12	,	,	PUNCT
cana-5161	260	13	mancuso	mancuso	PROPN
cana-5161	260	14	,	,	PUNCT
cana-5161	260	15	c.	c.	PROPN
cana-5161	260	16	&	&	CCONJ
cana-5161	260	17	butterfield	butterfield	PROPN
cana-5161	260	18	,	,	PUNCT
cana-5161	260	19	d.	d.	PROPN
cana-5161	260	20	a.	a.	PROPN
cana-5161	260	21	2014	2014	NUM
cana-5161	260	22	.	.	PUNCT
cana-5161	261	1	the	the	DET
cana-5161	261	2	janus	janus	PROPN
cana-5161	261	3	face	face	NOUN
cana-5161	261	4	of	of	ADP
cana-5161	261	5	the	the	DET
cana-5161	261	6	heme	heme	NOUN
cana-5161	261	7	oxygenase	oxygenase	NOUN
cana-5161	261	8	/	/	SYM
cana-5161	261	9	biliverdin	biliverdin	NOUN
cana-5161	261	10	reductase	reductase	NOUN
cana-5161	261	11	system	system	NOUN
cana-5161	261	12	in	in	ADP
cana-5161	261	13	alzheimer	alzheimer	PROPN
cana-5161	261	14	disease	disease	PROPN
cana-5161	261	15	:	:	PUNCT
cana-5161	261	16	it	it	PRON
cana-5161	261	17	's	be	AUX
cana-5161	261	18	time	time	NOUN
cana-5161	261	19	for	for	ADP
cana-5161	261	20	reconciliation	reconciliation	NOUN
cana-5161	261	21	.	.	PUNCT
cana-5161	262	1	neurobiology	neurobiology	NOUN
cana-5161	262	2	of	of	ADP
cana-5161	262	3	disease	disease	NOUN
cana-5161	262	4	,	,	PUNCT
cana-5161	262	5	62	62	NUM
cana-5161	262	6	,	,	PUNCT
cana-5161	262	7	144	144	NUM
cana-5161	262	8	-	-	SYM
cana-5161	262	9	159	159	NUM
cana-5161	262	10	.	.	PUNCT
cana-5161	263	1	[	[	X
cana-5161	263	2	5	5	NUM
cana-5161	263	3	]	]	PUNCT
cana-5161	263	4	bence	bence	NOUN
cana-5161	263	5	,	,	PUNCT
cana-5161	263	6	a.	a.	PROPN
cana-5161	263	7	k.	k.	PROPN
cana-5161	263	8	,	,	PUNCT
cana-5161	263	9	worthen	worthen	PROPN
cana-5161	263	10	,	,	PUNCT
cana-5161	263	11	d.	d.	PROPN
cana-5161	263	12	r.	r.	PROPN
cana-5161	263	13	,	,	PUNCT
cana-5161	263	14	stables	stable	NOUN
cana-5161	263	15	,	,	PUNCT
cana-5161	263	16	j.	j.	PROPN
cana-5161	263	17	p.	p.	PROPN
cana-5161	263	18	&	&	CCONJ
cana-5161	263	19	crooks	crooks	PROPN
cana-5161	263	20	,	,	PUNCT
cana-5161	263	21	p.	p.	NOUN
cana-5161	263	22	a.	a.	NOUN
cana-5161	263	23	2003	2003	NUM
cana-5161	263	24	.	.	PUNCT
cana-5161	264	1	an	an	DET
cana-5161	264	2	in	in	ADP
cana-5161	264	3	vivo	vivo	ADJ
cana-5161	264	4	evaluation	evaluation	NOUN
cana-5161	264	5	of	of	ADP
cana-5161	264	6	the	the	DET
cana-5161	264	7	antiseizure	antiseizure	NOUN
cana-5161	264	8	activity	activity	NOUN
cana-5161	264	9	and	and	CCONJ
cana-5161	264	10	acute	acute	ADJ
cana-5161	264	11	neurotoxicity	neurotoxicity	NOUN
cana-5161	264	12	of	of	ADP
cana-5161	264	13	agmatine	agmatine	NOUN
cana-5161	264	14	.	.	PUNCT
cana-5161	265	1	pharmacology	pharmacology	NOUN
cana-5161	265	2	biochemistry	biochemistry	NOUN
cana-5161	265	3	and	and	CCONJ
cana-5161	265	4	behavior	behavior	NOUN
cana-5161	265	5	,	,	PUNCT
cana-5161	265	6	74	74	NUM
cana-5161	265	7	,	,	PUNCT
cana-5161	265	8	771	771	NUM
cana-5161	265	9	-	-	SYM
cana-5161	265	10	775	775	NUM
cana-5161	265	11	.	.	PUNCT
cana-5161	266	1	[	[	X
cana-5161	266	2	6	6	NUM
cana-5161	266	3	]	]	PUNCT
cana-5161	266	4	bonda	bonda	PROPN
cana-5161	266	5	,	,	PUNCT
cana-5161	266	6	d.	d.	PROPN
cana-5161	266	7	j.	j.	PROPN
cana-5161	266	8	,	,	PUNCT
cana-5161	266	9	wang	wang	PROPN
cana-5161	266	10	,	,	PUNCT
cana-5161	266	11	x.	x.	PROPN
cana-5161	266	12	,	,	PUNCT
cana-5161	266	13	perry	perry	PROPN
cana-5161	266	14	,	,	PUNCT
cana-5161	266	15	g.	g.	PROPN
cana-5161	266	16	,	,	PUNCT
cana-5161	266	17	nunomura	nunomura	NOUN
cana-5161	266	18	,	,	PUNCT
cana-5161	266	19	a.	a.	NOUN
cana-5161	266	20	,	,	PUNCT
cana-5161	266	21	tabaton	tabaton	PROPN
cana-5161	266	22	,	,	PUNCT
cana-5161	266	23	m.	m.	NOUN
cana-5161	266	24	,	,	PUNCT
cana-5161	266	25	zhu	zhu	PROPN
cana-5161	266	26	,	,	PUNCT
cana-5161	266	27	x.	x.	PROPN
cana-5161	266	28	&	&	CCONJ
cana-5161	266	29	smith	smith	PROPN
cana-5161	266	30	,	,	PUNCT
cana-5161	266	31	m.	m.	NOUN
cana-5161	266	32	a.	a.	PROPN
cana-5161	266	33	2010	2010	NUM
cana-5161	266	34	.	.	PUNCT
cana-5161	267	1	oxidative	oxidative	ADJ
cana-5161	267	2	stress	stress	NOUN
cana-5161	267	3	in	in	ADP
cana-5161	267	4	alzheimer	alzheimer	PROPN
cana-5161	267	5	disease	disease	PROPN
cana-5161	267	6	:	:	PUNCT
cana-5161	267	7	a	a	DET
cana-5161	267	8	possibility	possibility	NOUN
cana-5161	267	9	for	for	ADP
cana-5161	267	10	prevention	prevention	NOUN
cana-5161	267	11	.	.	PUNCT
cana-5161	268	1	neuropharmacology	neuropharmacology	NOUN
cana-5161	268	2	,	,	PUNCT
cana-5161	268	3	59	59	NUM
cana-5161	268	4	,	,	PUNCT
cana-5161	268	5	290	290	NUM
cana-5161	268	6	-	-	SYM
cana-5161	268	7	294	294	NUM
cana-5161	268	8	.	.	PUNCT
cana-5161	269	1	[	[	X
cana-5161	269	2	7	7	NUM
cana-5161	269	3	]	]	X
cana-5161	269	4	butterfield	butterfield	PROPN
cana-5161	269	5	,	,	PUNCT
cana-5161	269	6	d.	d.	PROPN
cana-5161	269	7	a.	a.	PROPN
cana-5161	269	8	,	,	PUNCT
cana-5161	269	9	swomley	swomley	NOUN
cana-5161	269	10	,	,	PUNCT
cana-5161	269	11	a.	a.	NOUN
cana-5161	269	12	m.	m.	PROPN
cana-5161	269	13	&	&	CCONJ
cana-5161	269	14	sultana	sultana	PROPN
cana-5161	269	15	,	,	PUNCT
cana-5161	269	16	r.	r.	PROPN
cana-5161	269	17	2013	2013	NUM
cana-5161	269	18	.	.	PUNCT
cana-5161	270	1	amyloid	amyloid	NOUN
cana-5161	270	2	β	β	X
cana-5161	270	3	-	-	NOUN
cana-5161	270	4	peptide	peptide	ADJ
cana-5161	270	5	(	(	PUNCT
cana-5161	270	6	1	1	NUM
cana-5161	270	7	–	–	PUNCT
cana-5161	270	8	42)-induced	42)-induced	ADJ
cana-5161	270	9	oxidative	oxidative	ADJ
cana-5161	270	10	stress	stress	NOUN
cana-5161	270	11	in	in	ADP
cana-5161	270	12	alzheimer	alzheimer	PROPN
cana-5161	270	13	disease	disease	NOUN
cana-5161	270	14	:	:	PUNCT
cana-5161	270	15	importance	importance	NOUN
cana-5161	270	16	in	in	ADP
cana-5161	270	17	disease	disease	NOUN
cana-5161	270	18	pathogenesis	pathogenesis	NOUN
cana-5161	270	19	and	and	CCONJ
cana-5161	270	20	progression	progression	NOUN
cana-5161	270	21	.	.	PUNCT
cana-5161	271	1	antioxidants	antioxidant	NOUN
cana-5161	271	2	&	&	CCONJ
cana-5161	271	3	redox	redox	PROPN
cana-5161	271	4	signaling	signal	VERB
cana-5161	271	5	,	,	PUNCT
cana-5161	271	6	19	19	NUM
cana-5161	271	7	,	,	PUNCT
cana-5161	271	8	823	823	NUM
cana-5161	271	9	-	-	SYM
cana-5161	271	10	835	835	NUM
cana-5161	271	11	.	.	PUNCT
cana-5161	272	1	[	[	X
cana-5161	272	2	8	8	NUM
cana-5161	272	3	]	]	X
cana-5161	272	4	chen	chen	PROPN
cana-5161	272	5	,	,	PUNCT
cana-5161	272	6	k.	k.	PROPN
cana-5161	272	7	h.	h.	PROPN
cana-5161	272	8	,	,	PUNCT
cana-5161	272	9	reese	reese	PROPN
cana-5161	272	10	,	,	PUNCT
cana-5161	272	11	e.	e.	PROPN
cana-5161	272	12	a.	a.	PROPN
cana-5161	272	13	,	,	PUNCT
cana-5161	272	14	kim	kim	PROPN
cana-5161	272	15	,	,	PUNCT
cana-5161	272	16	h.-w	h.-w	PROPN
cana-5161	272	17	.	.	PUNCT
cana-5161	272	18	,	,	PUNCT
cana-5161	272	19	rapoport	rapoport	NOUN
cana-5161	272	20	,	,	PUNCT
cana-5161	272	21	s.	s.	PROPN
cana-5161	272	22	i.	i.	PROPN
cana-5161	272	23	&	&	CCONJ
cana-5161	272	24	rao	rao	PROPN
cana-5161	272	25	,	,	PUNCT
cana-5161	272	26	j.	j.	PROPN
cana-5161	272	27	s.	s.	PROPN
cana-5161	272	28	2011	2011	NUM
cana-5161	272	29	.	.	PUNCT
cana-5161	273	1	disturbed	disturb	VERB
cana-5161	273	2	neurotransmitter	neurotransmitter	NOUN
cana-5161	273	3	transporter	transporter	NOUN
cana-5161	273	4	expression	expression	NOUN
cana-5161	273	5	in	in	ADP
cana-5161	273	6	alzheimer	alzheimer	PROPN
cana-5161	273	7	disease	disease	PROPN
cana-5161	273	8	brain	brain	PROPN
cana-5161	273	9	.	.	PUNCT
cana-5161	274	1	journal	journal	PROPN
cana-5161	274	2	of	of	ADP
cana-5161	274	3	alzheimer	alzheimer	PROPN
cana-5161	274	4	's	's	PART
cana-5161	274	5	disease	disease	NOUN
cana-5161	274	6	:	:	PUNCT
cana-5161	274	7	jad	jad	PROPN
cana-5161	274	8	,	,	PUNCT
cana-5161	274	9	26	26	NUM
cana-5161	274	10	,	,	PUNCT
cana-5161	274	11	755	755	NUM
cana-5161	274	12	.	.	PUNCT
cana-5161	275	1	[	[	X
cana-5161	275	2	9	9	NUM
cana-5161	275	3	]	]	X
cana-5161	275	4	dani	dani	PROPN
cana-5161	275	5	,	,	PUNCT
cana-5161	275	6	j.	j.	PROPN
cana-5161	275	7	a.	a.	PROPN
cana-5161	275	8	&	&	CCONJ
cana-5161	275	9	bertrand	bertrand	PROPN
cana-5161	275	10	,	,	PUNCT
cana-5161	275	11	d.	d.	PROPN
cana-5161	275	12	2007	2007	NUM
cana-5161	275	13	.	.	PUNCT
cana-5161	276	1	nicotinic	nicotinic	ADJ
cana-5161	276	2	acetylcholine	acetylcholine	NOUN
cana-5161	276	3	receptors	receptor	NOUN
cana-5161	276	4	and	and	CCONJ
cana-5161	276	5	nicotinic	nicotinic	ADJ
cana-5161	276	6	cholinergic	cholinergic	ADJ
cana-5161	276	7	mechanisms	mechanism	NOUN
cana-5161	276	8	of	of	ADP
cana-5161	276	9	the	the	DET
cana-5161	276	10	central	central	ADJ
cana-5161	276	11	nervous	nervous	ADJ
cana-5161	276	12	system	system	NOUN
cana-5161	276	13	.	.	PUNCT
cana-5161	277	1	annu	annu	NOUN
cana-5161	277	2	.	.	PUNCT
cana-5161	278	1	rev	rev	PROPN
cana-5161	278	2	.	.	PROPN
cana-5161	278	3	pharmacol	pharmacol	PROPN
cana-5161	278	4	.	.	PUNCT
cana-5161	279	1	toxicol	toxicol	PROPN
cana-5161	279	2	.	.	PUNCT
cana-5161	279	3	,	,	PUNCT
cana-5161	279	4	47	47	NUM
cana-5161	279	5	,	,	PUNCT
cana-5161	279	6	699	699	NUM
cana-5161	279	7	-	-	SYM
cana-5161	279	8	729	729	NUM
cana-5161	279	9	.	.	PUNCT
cana-5161	280	1	[	[	X
cana-5161	280	2	10	10	NUM
cana-5161	280	3	]	]	X
cana-5161	280	4	dua	dua	PROPN
cana-5161	280	5	,	,	PUNCT
cana-5161	280	6	r.	r.	PROPN
cana-5161	280	7	,	,	PUNCT
cana-5161	280	8	sunkaria	sunkaria	PROPN
cana-5161	280	9	,	,	PUNCT
cana-5161	280	10	a.	a.	PROPN
cana-5161	280	11	,	,	PUNCT
cana-5161	280	12	kumar	kumar	PROPN
cana-5161	280	13	,	,	PUNCT
cana-5161	280	14	v.	v.	PROPN
cana-5161	280	15	&	&	CCONJ
cana-5161	280	16	gill	gill	PROPN
cana-5161	280	17	,	,	PUNCT
cana-5161	280	18	k.	k.	PROPN
cana-5161	280	19	d.	d.	PROPN
cana-5161	280	20	2010	2010	NUM
cana-5161	280	21	.	.	PUNCT
cana-5161	280	22	impaired	impair	VERB
cana-5161	280	23	mitochondrial	mitochondrial	ADJ
cana-5161	280	24	energy	energy	NOUN
cana-5161	280	25	metabolism	metabolism	NOUN
cana-5161	280	26	and	and	CCONJ
cana-5161	280	27	kinetic	kinetic	ADJ
cana-5161	280	28	properties	property	NOUN
cana-5161	280	29	of	of	ADP
cana-5161	280	30	cytochrome	cytochrome	ADJ
cana-5161	280	31	oxidase	oxidase	NOUN
cana-5161	280	32	following	follow	VERB
cana-5161	280	33	acute	acute	ADJ
cana-5161	280	34	aluminium	aluminium	NOUN
cana-5161	280	35	phosphide	phosphide	ADJ
cana-5161	280	36	exposure	exposure	NOUN
cana-5161	280	37	in	in	ADP
cana-5161	280	38	rat	rat	NOUN
cana-5161	280	39	liver	liver	NOUN
cana-5161	280	40	.	.	PUNCT
cana-5161	281	1	food	food	NOUN
cana-5161	281	2	and	and	CCONJ
cana-5161	281	3	chemical	chemical	NOUN
cana-5161	281	4	toxicology	toxicology	NOUN
cana-5161	281	5	,	,	PUNCT
cana-5161	281	6	48	48	NUM
cana-5161	281	7	,	,	PUNCT
cana-5161	281	8	53	53	NUM
cana-5161	281	9	-	-	SYM
cana-5161	281	10	60	60	NUM
cana-5161	281	11	.	.	PUNCT
cana-5161	282	1	[	[	X
cana-5161	282	2	11	11	NUM
cana-5161	282	3	]	]	PUNCT
cana-5161	282	4	fairbanks	fairbank	NOUN
cana-5161	282	5	,	,	PUNCT
cana-5161	282	6	c.	c.	PROPN
cana-5161	282	7	a.	a.	PROPN
cana-5161	282	8	,	,	PUNCT
cana-5161	282	9	schreiber	schreiber	PROPN
cana-5161	282	10	,	,	PUNCT
cana-5161	282	11	k.	k.	PROPN
cana-5161	282	12	l.	l.	PROPN
cana-5161	282	13	,	,	PUNCT
cana-5161	282	14	brewer	brewer	PROPN
cana-5161	282	15	,	,	PUNCT
cana-5161	282	16	k.	k.	PROPN
cana-5161	282	17	l.	l.	PROPN
cana-5161	282	18	,	,	PUNCT
cana-5161	282	19	yu	yu	PROPN
cana-5161	282	20	,	,	PUNCT
cana-5161	282	21	c.-g	c.-g	PROPN
cana-5161	282	22	.	.	PUNCT
cana-5161	282	23	,	,	PUNCT
cana-5161	282	24	stone	stone	NOUN
cana-5161	282	25	,	,	PUNCT
cana-5161	282	26	l.	l.	PROPN
cana-5161	282	27	s.	s.	PROPN
cana-5161	282	28	,	,	PUNCT
cana-5161	282	29	kitto	kitto	PROPN
cana-5161	282	30	,	,	PUNCT
cana-5161	282	31	k.	k.	PROPN
cana-5161	282	32	f.	f.	PROPN
cana-5161	282	33	,	,	PUNCT
cana-5161	282	34	nguyen	nguyen	PROPN
cana-5161	282	35	,	,	PUNCT
cana-5161	282	36	h.	h.	PROPN
cana-5161	282	37	o.	o.	PROPN
cana-5161	282	38	,	,	PUNCT
cana-5161	282	39	grocholski	grocholski	NOUN
cana-5161	282	40	,	,	PUNCT
cana-5161	282	41	b.	b.	PROPN
cana-5161	282	42	m.	m.	PROPN
cana-5161	282	43	,	,	PUNCT
cana-5161	282	44	shoeman	shoeman	PROPN
cana-5161	282	45	,	,	PUNCT
cana-5161	282	46	d.	d.	PROPN
cana-5161	282	47	w.	w.	PROPN
cana-5161	282	48	&	&	CCONJ
cana-5161	282	49	kehl	kehl	PROPN
cana-5161	282	50	,	,	PUNCT
cana-5161	282	51	l.	l.	PROPN
cana-5161	282	52	j.	j.	PROPN
cana-5161	282	53	2000	2000	PROPN
cana-5161	282	54	.	.	PUNCT
cana-5161	282	55	agmatine	agmatine	NOUN
cana-5161	282	56	reverses	reverse	VERB
cana-5161	282	57	pain	pain	NOUN
cana-5161	282	58	induced	induce	VERB
cana-5161	282	59	by	by	ADP
cana-5161	282	60	inflammation	inflammation	NOUN
cana-5161	282	61	,	,	PUNCT
cana-5161	282	62	neuropathy	neuropathy	ADJ
cana-5161	282	63	,	,	PUNCT
cana-5161	282	64	and	and	CCONJ
cana-5161	282	65	spinal	spinal	ADJ
cana-5161	282	66	cord	cord	NOUN
cana-5161	282	67	injury	injury	NOUN
cana-5161	282	68	.	.	PUNCT
cana-5161	283	1	proceedings	proceeding	NOUN
cana-5161	283	2	of	of	ADP
cana-5161	283	3	the	the	DET
cana-5161	283	4	national	national	PROPN
cana-5161	283	5	academy	academy	PROPN
cana-5161	283	6	of	of	ADP
cana-5161	283	7	sciences	sciences	PROPN
cana-5161	283	8	,	,	PUNCT
cana-5161	283	9	97	97	NUM
cana-5161	283	10	,	,	PUNCT
cana-5161	283	11	10584	10584	NUM
cana-5161	283	12	-	-	SYM
cana-5161	283	13	10589	10589	NUM
cana-5161	283	14	.	.	PUNCT
cana-5161	284	1	[	[	X
cana-5161	284	2	12	12	NUM
cana-5161	284	3	]	]	PUNCT
cana-5161	284	4	garcía	garcía	NOUN
cana-5161	284	5	-	-	PUNCT
cana-5161	284	6	escudero	escudero	NOUN
cana-5161	284	7	,	,	PUNCT
cana-5161	284	8	v.	v.	NOUN
cana-5161	284	9	,	,	PUNCT
cana-5161	284	10	martín	martín	NOUN
cana-5161	284	11	-	-	PUNCT
cana-5161	284	12	maestro	maestro	NOUN
cana-5161	284	13	,	,	PUNCT
cana-5161	284	14	p.	p.	PROPN
cana-5161	284	15	,	,	PUNCT
cana-5161	284	16	perry	perry	PROPN
cana-5161	284	17	,	,	PUNCT
cana-5161	284	18	g.	g.	PROPN
cana-5161	284	19	&	&	CCONJ
cana-5161	284	20	avila	avila	PROPN
cana-5161	284	21	,	,	PUNCT
cana-5161	284	22	j.	j.	PROPN
cana-5161	284	23	2013	2013	NUM
cana-5161	284	24	.	.	PUNCT
cana-5161	285	1	deconstructing	deconstruct	VERB
cana-5161	285	2	mitochondrial	mitochondrial	ADJ
cana-5161	285	3	dysfunction	dysfunction	NOUN
cana-5161	285	4	in	in	ADP
cana-5161	285	5	alzheimer	alzheimer	PROPN
cana-5161	285	6	disease	disease	PROPN
cana-5161	285	7	.	.	PUNCT
cana-5161	286	1	oxidative	oxidative	ADJ
cana-5161	286	2	medicine	medicine	NOUN
cana-5161	286	3	and	and	CCONJ
cana-5161	286	4	cellular	cellular	ADJ
cana-5161	286	5	longevity	longevity	NOUN
cana-5161	286	6	,	,	PUNCT
cana-5161	286	7	2013	2013	NUM
cana-5161	286	8	.	.	PUNCT
cana-5161	287	1	[	[	X
cana-5161	287	2	13	13	NUM
cana-5161	287	3	]	]	X
cana-5161	287	4	gilad	gilad	NOUN
cana-5161	287	5	,	,	PUNCT
cana-5161	287	6	g.	g.	PROPN
cana-5161	287	7	m.	m.	PROPN
cana-5161	287	8	,	,	PUNCT
cana-5161	287	9	gilad	gilad	NOUN
cana-5161	287	10	,	,	PUNCT
cana-5161	287	11	v.	v.	PROPN
cana-5161	287	12	h.	h.	PROPN
cana-5161	287	13	,	,	PUNCT
cana-5161	287	14	finberg	finberg	PROPN
cana-5161	287	15	,	,	PUNCT
cana-5161	287	16	j.	j.	PROPN
cana-5161	287	17	p.	p.	PROPN
cana-5161	287	18	&	&	CCONJ
cana-5161	287	19	rabey	rabey	PROPN
cana-5161	287	20	,	,	PUNCT
cana-5161	287	21	j.	j.	PROPN
cana-5161	287	22	m.	m.	PROPN
cana-5161	287	23	2005	2005	NUM
cana-5161	287	24	.	.	PUNCT
cana-5161	288	1	neurochemical	neurochemical	ADJ
cana-5161	288	2	evidence	evidence	NOUN
cana-5161	288	3	for	for	ADP
cana-5161	288	4	agmatine	agmatine	ADJ
cana-5161	288	5	modulation	modulation	NOUN
cana-5161	288	6	of	of	ADP
cana-5161	288	7	1	1	NUM
cana-5161	288	8	-	-	PUNCT
cana-5161	288	9	methyl-4	methyl-4	NUM
cana-5161	288	10	-	-	PUNCT
cana-5161	288	11	phenyl-1	phenyl-1	NOUN
cana-5161	288	12	,	,	PUNCT
cana-5161	288	13	2	2	NUM
cana-5161	288	14	,	,	PUNCT
cana-5161	288	15	3	3	NUM
cana-5161	288	16	,	,	PUNCT
cana-5161	288	17	6	6	NUM
cana-5161	288	18	-	-	PUNCT
cana-5161	288	19	tetrahydropyridine	tetrahydropyridine	ADJ
cana-5161	288	20	(	(	PUNCT
cana-5161	288	21	mptp	mptp	ADJ
cana-5161	288	22	)	)	PUNCT
cana-5161	288	23	neurotoxicity	neurotoxicity	NOUN
cana-5161	288	24	.	.	PUNCT
cana-5161	289	1	neurochemical	neurochemical	ADJ
cana-5161	289	2	research	research	NOUN
cana-5161	289	3	,	,	PUNCT
cana-5161	289	4	30	30	NUM
cana-5161	289	5	,	,	PUNCT
cana-5161	289	6	713	713	NUM
cana-5161	289	7	-	-	SYM
cana-5161	289	8	719	719	NUM
cana-5161	289	9	.	.	PUNCT
cana-5161	290	1	[	[	X
cana-5161	290	2	14	14	NUM
cana-5161	290	3	]	]	X
cana-5161	290	4	giorgetti	giorgetti	PROPN
cana-5161	290	5	,	,	PUNCT
cana-5161	290	6	m.	m.	NOUN
cana-5161	290	7	,	,	PUNCT
cana-5161	290	8	gibbons	gibbon	NOUN
cana-5161	290	9	,	,	PUNCT
cana-5161	290	10	j.	j.	PROPN
cana-5161	290	11	,	,	PUNCT
cana-5161	290	12	bernales	bernale	NOUN
cana-5161	290	13	,	,	PUNCT
cana-5161	290	14	s.	s.	PROPN
cana-5161	290	15	&	&	CCONJ
cana-5161	290	16	alfaro	alfaro	PROPN
cana-5161	290	17	,	,	PUNCT
cana-5161	290	18	i.	i.	PROPN
cana-5161	290	19	2010	2010	NUM
cana-5161	290	20	.	.	PUNCT
cana-5161	291	1	drieu	drieu	PROPN
cana-5161	291	2	la	la	PROPN
cana-5161	291	3	rc	rc	PROPN
cana-5161	291	4	,	,	PUNCT
cana-5161	291	5	cremers	cremers	PROPN
cana-5161	291	6	t	t	PROPN
cana-5161	291	7	,	,	PUNCT
cana-5161	291	8	altar	altar	NOUN
cana-5161	291	9	ca	ca	NOUN
cana-5161	291	10	,	,	PUNCT
cana-5161	291	11	wronski	wronski	ADJ
cana-5161	291	12	r	r	NOUN
cana-5161	291	13	,	,	PUNCT
cana-5161	291	14	hutter	hutter	NOUN
cana-5161	291	15	-	-	PUNCT
cana-5161	291	16	paier	paier	NOUN
cana-5161	291	17	b	b	NOUN
cana-5161	291	18	,	,	PUNCT
cana-5161	291	19	protter	protter	VERB
cana-5161	291	20	a	a	DET
cana-5161	291	21	a	a	DET
cana-5161	291	22	:	:	PUNCT
cana-5161	291	23	cognition	cognition	NOUN
cana-5161	291	24	-	-	PUNCT
cana-5161	291	25	enhancing	enhance	VERB
cana-5161	291	26	properties	property	NOUN
cana-5161	291	27	of	of	ADP
cana-5161	291	28	dimebon	dimebon	NOUN
cana-5161	291	29	in	in	ADP
cana-5161	291	30	a	a	DET
cana-5161	291	31	rat	rat	NOUN
cana-5161	291	32	novel	novel	ADJ
cana-5161	291	33	object	object	NOUN
cana-5161	291	34	recognition	recognition	NOUN
cana-5161	291	35	task	task	NOUN
cana-5161	291	36	are	be	AUX
cana-5161	291	37	unlikely	unlikely	ADJ
cana-5161	291	38	to	to	PART
cana-5161	291	39	be	be	AUX
cana-5161	291	40	associated	associate	VERB
cana-5161	291	41	with	with	ADP
cana-5161	291	42	acetylcholinesterase	acetylcholinesterase	NOUN
cana-5161	291	43	inhibition	inhibition	NOUN
cana-5161	291	44	or	or	CCONJ
cana-5161	291	45	n	n	CCONJ
cana-5161	291	46	-	-	PUNCT
cana-5161	291	47	methyl	methyl	NOUN
cana-5161	291	48	-	-	PUNCT
cana-5161	291	49	d	d	NOUN
cana-5161	291	50	-	-	PUNCT
cana-5161	291	51	aspartate	aspartate	ADJ
cana-5161	291	52	receptor	receptor	NOUN
cana-5161	291	53	antagonism	antagonism	NOUN
cana-5161	291	54	.	.	PUNCT
cana-5161	292	1	j	j	PROPN
cana-5161	292	2	pharmacol	pharmacol	PROPN
cana-5161	292	3	exp	exp	NOUN
cana-5161	292	4	ther	ther	ADV
cana-5161	292	5	,	,	PUNCT
cana-5161	292	6	333	333	NUM
cana-5161	292	7	,	,	PUNCT
cana-5161	292	8	748	748	NUM
cana-5161	292	9	-	-	SYM
cana-5161	292	10	757	757	NOUN
cana-5161	292	11	.	.	PUNCT
cana-5161	293	1	[	[	X
cana-5161	293	2	15	15	NUM
cana-5161	293	3	]	]	X
cana-5161	293	4	gulpinar	gulpinar	NOUN
cana-5161	293	5	,	,	PUNCT
cana-5161	293	6	m.	m.	NOUN
cana-5161	293	7	&	&	CCONJ
cana-5161	293	8	yegen	yegen	PROPN
cana-5161	293	9	,	,	PUNCT
cana-5161	293	10	b.	b.	PROPN
cana-5161	293	11	2004	2004	NUM
cana-5161	293	12	.	.	PUNCT
cana-5161	294	1	the	the	DET
cana-5161	294	2	physiology	physiology	NOUN
cana-5161	294	3	of	of	ADP
cana-5161	294	4	learning	learning	NOUN
cana-5161	294	5	and	and	CCONJ
cana-5161	294	6	memory	memory	NOUN
cana-5161	294	7	:	:	PUNCT
cana-5161	294	8	role	role	NOUN
cana-5161	294	9	of	of	ADP
cana-5161	294	10	peptides	peptide	NOUN
cana-5161	294	11	and	and	CCONJ
cana-5161	294	12	stress	stress	NOUN
cana-5161	294	13	.	.	PUNCT
cana-5161	295	1	current	current	ADJ
cana-5161	295	2	protein	protein	NOUN
cana-5161	295	3	and	and	CCONJ
cana-5161	295	4	peptide	peptide	NOUN
cana-5161	295	5	science	science	NOUN
cana-5161	295	6	,	,	PUNCT
cana-5161	295	7	5	5	NUM
cana-5161	295	8	,	,	PUNCT
cana-5161	295	9	457	457	NUM
cana-5161	295	10	-	-	SYM
cana-5161	295	11	473	473	NUM
cana-5161	295	12	.	.	PUNCT
cana-5161	296	1	communications	communication	NOUN
cana-5161	296	2	on	on	ADP
cana-5161	296	3	applied	apply	VERB
cana-5161	296	4	nonlinear	nonlinear	ADJ
cana-5161	296	5	analysis	analysis	NOUN
cana-5161	296	6	issn	issn	NOUN
cana-5161	296	7	:	:	PUNCT
cana-5161	296	8	1074	1074	NUM
cana-5161	296	9	-	-	PUNCT
cana-5161	296	10	133x	133x	NUM
cana-5161	296	11	vol	vol	NOUN
cana-5161	296	12	32	32	NUM
cana-5161	296	13	no	no	NOUN
cana-5161	296	14	.	.	PUNCT
cana-5161	297	1	icmasd	icmasd	NOUN
cana-5161	297	2	(	(	PUNCT
cana-5161	297	3	2025	2025	NUM
cana-5161	297	4	)	)	PUNCT
cana-5161	297	5	1368	1368	NUM
cana-5161	297	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	298	1	[	[	X
cana-5161	298	2	16	16	NUM
cana-5161	298	3	]	]	X
cana-5161	298	4	ischiropoulos	ischiropoulo	NOUN
cana-5161	298	5	,	,	PUNCT
cana-5161	298	6	h.	h.	PROPN
cana-5161	298	7	&	&	CCONJ
cana-5161	298	8	beckman	beckman	PROPN
cana-5161	298	9	,	,	PUNCT
cana-5161	298	10	j.	j.	PROPN
cana-5161	298	11	s.	s.	PROPN
cana-5161	298	12	2003	2003	NUM
cana-5161	298	13	.	.	PUNCT
cana-5161	298	14	oxidative	oxidative	ADJ
cana-5161	298	15	stress	stress	NOUN
cana-5161	298	16	and	and	CCONJ
cana-5161	298	17	nitration	nitration	NOUN
cana-5161	298	18	in	in	ADP
cana-5161	298	19	neurodegeneration	neurodegeneration	NOUN
cana-5161	298	20	:	:	PUNCT
cana-5161	298	21	cause	cause	NOUN
cana-5161	298	22	,	,	PUNCT
cana-5161	298	23	effect	effect	NOUN
cana-5161	298	24	,	,	PUNCT
cana-5161	298	25	or	or	CCONJ
cana-5161	298	26	association	association	NOUN
cana-5161	298	27	?	?	PUNCT
cana-5161	299	1	the	the	DET
cana-5161	299	2	journal	journal	NOUN
cana-5161	299	3	of	of	ADP
cana-5161	299	4	clinical	clinical	ADJ
cana-5161	299	5	investigation	investigation	NOUN
cana-5161	299	6	,	,	PUNCT
cana-5161	299	7	111	111	NUM
cana-5161	299	8	,	,	PUNCT
cana-5161	299	9	163	163	NUM
cana-5161	299	10	-	-	SYM
cana-5161	299	11	169	169	NUM
cana-5161	299	12	.	.	PUNCT
cana-5161	300	1	[	[	X
cana-5161	300	2	17	17	NUM
cana-5161	300	3	]	]	X
cana-5161	300	4	kawahara	kawahara	NOUN
cana-5161	300	5	,	,	PUNCT
cana-5161	300	6	m.	m.	PROPN
cana-5161	300	7	&	&	CCONJ
cana-5161	300	8	kato	kato	PROPN
cana-5161	300	9	-	-	PUNCT
cana-5161	300	10	negishi	negishi	PROPN
cana-5161	300	11	,	,	PUNCT
cana-5161	300	12	m.	m.	NOUN
cana-5161	300	13	2011	2011	NUM
cana-5161	300	14	.	.	PUNCT
cana-5161	301	1	link	link	NOUN
cana-5161	301	2	between	between	ADP
cana-5161	301	3	aluminum	aluminum	NOUN
cana-5161	301	4	and	and	CCONJ
cana-5161	301	5	the	the	DET
cana-5161	301	6	pathogenesis	pathogenesis	NOUN
cana-5161	301	7	of	of	ADP
cana-5161	301	8	alzheimer	alzheimer	PROPN
cana-5161	301	9	's	's	PART
cana-5161	301	10	disease	disease	NOUN
cana-5161	301	11	:	:	PUNCT
cana-5161	301	12	the	the	DET
cana-5161	301	13	integration	integration	NOUN
cana-5161	301	14	of	of	ADP
cana-5161	301	15	the	the	DET
cana-5161	301	16	aluminum	aluminum	NOUN
cana-5161	301	17	and	and	CCONJ
cana-5161	301	18	amyloid	amyloid	NOUN
cana-5161	301	19	cascade	cascade	NOUN
cana-5161	301	20	hypotheses	hypothesis	NOUN
cana-5161	301	21	.	.	PUNCT
cana-5161	302	1	international	international	ADJ
cana-5161	302	2	journal	journal	PROPN
cana-5161	302	3	of	of	ADP
cana-5161	302	4	alzheimer	alzheimer	PROPN
cana-5161	302	5	’s	’s	PART
cana-5161	302	6	disease	disease	NOUN
cana-5161	302	7	,	,	PUNCT
cana-5161	302	8	2011	2011	NUM
cana-5161	302	9	.	.	PUNCT
cana-5161	303	1	[	[	X
cana-5161	303	2	18	18	NUM
cana-5161	303	3	]	]	PUNCT
cana-5161	303	4	khakpai	khakpai	PROPN
cana-5161	303	5	,	,	PUNCT
cana-5161	303	6	f.	f.	PROPN
cana-5161	303	7	,	,	PUNCT
cana-5161	303	8	nasehi	nasehi	PROPN
cana-5161	303	9	,	,	PUNCT
cana-5161	303	10	m.	m.	NOUN
cana-5161	303	11	,	,	PUNCT
cana-5161	303	12	haeri	haeri	ADJ
cana-5161	303	13	-	-	PUNCT
cana-5161	303	14	rohani	rohani	ADJ
cana-5161	303	15	,	,	PUNCT
cana-5161	303	16	a.	a.	NOUN
cana-5161	303	17	,	,	PUNCT
cana-5161	303	18	eidi	eidi	PROPN
cana-5161	303	19	,	,	PUNCT
cana-5161	303	20	a.	a.	PROPN
cana-5161	303	21	&	&	CCONJ
cana-5161	303	22	zarrindast	zarrindast	PROPN
cana-5161	303	23	,	,	PUNCT
cana-5161	303	24	m.	m.	PROPN
cana-5161	303	25	r.	r.	PROPN
cana-5161	303	26	2013	2013	NUM
cana-5161	303	27	.	.	PUNCT
cana-5161	304	1	septo	septo	NOUN
cana-5161	304	2	-	-	PUNCT
cana-5161	304	3	hippocampo	hippocampo	NOUN
cana-5161	304	4	-	-	PUNCT
cana-5161	304	5	septal	septal	NOUN
cana-5161	304	6	loop	loop	NOUN
cana-5161	304	7	and	and	CCONJ
cana-5161	304	8	memory	memory	NOUN
cana-5161	304	9	formation	formation	NOUN
cana-5161	304	10	.	.	PUNCT
cana-5161	305	1	basic	basic	ADJ
cana-5161	305	2	and	and	CCONJ
cana-5161	305	3	clinical	clinical	ADJ
cana-5161	305	4	neuroscience	neuroscience	NOUN
cana-5161	305	5	,	,	PUNCT
cana-5161	305	6	4	4	NUM
cana-5161	305	7	,	,	PUNCT
cana-5161	305	8	5	5	NUM
cana-5161	305	9	.	.	PUNCT
cana-5161	306	1	[	[	X
cana-5161	306	2	19	19	NUM
cana-5161	306	3	]	]	X
cana-5161	306	4	kolesnikov	kolesnikov	NOUN
cana-5161	306	5	,	,	PUNCT
cana-5161	306	6	y.	y.	PROPN
cana-5161	306	7	,	,	PUNCT
cana-5161	306	8	jain	jain	PROPN
cana-5161	306	9	,	,	PUNCT
cana-5161	306	10	s.	s.	PROPN
cana-5161	306	11	&	&	CCONJ
cana-5161	306	12	pasternak	pasternak	PROPN
cana-5161	306	13	,	,	PUNCT
cana-5161	306	14	g.	g.	PROPN
cana-5161	306	15	w.	w.	PROPN
cana-5161	306	16	1996	1996	NUM
cana-5161	306	17	.	.	PUNCT
cana-5161	307	1	modulation	modulation	NOUN
cana-5161	307	2	of	of	ADP
cana-5161	307	3	opioid	opioid	ADJ
cana-5161	307	4	analgesia	analgesia	NOUN
cana-5161	307	5	by	by	ADP
cana-5161	307	6	agmatine	agmatine	NOUN
cana-5161	307	7	.	.	PUNCT
cana-5161	308	1	european	european	PROPN
cana-5161	308	2	journal	journal	PROPN
cana-5161	308	3	of	of	ADP
cana-5161	308	4	pharmacology	pharmacology	NOUN
cana-5161	308	5	,	,	PUNCT
cana-5161	308	6	296	296	NUM
cana-5161	308	7	,	,	PUNCT
cana-5161	308	8	17	17	NUM
cana-5161	308	9	-	-	SYM
cana-5161	308	10	22	22	NUM
cana-5161	308	11	.	.	PUNCT
cana-5161	309	1	[	[	X
cana-5161	309	2	20	20	NUM
cana-5161	309	3	]	]	SYM
cana-5161	309	4	kumar	kumar	PROPN
cana-5161	309	5	,	,	PUNCT
cana-5161	309	6	p.	p.	PROPN
cana-5161	309	7	,	,	PUNCT
cana-5161	309	8	kalonia	kalonia	PROPN
cana-5161	309	9	,	,	PUNCT
cana-5161	309	10	h.	h.	PROPN
cana-5161	309	11	&	&	CCONJ
cana-5161	309	12	kumar	kumar	PROPN
cana-5161	309	13	,	,	PUNCT
cana-5161	309	14	a.	a.	NOUN
cana-5161	309	15	2011	2011	NUM
cana-5161	309	16	.	.	PUNCT
cana-5161	310	1	role	role	NOUN
cana-5161	310	2	of	of	ADP
cana-5161	310	3	lox	lox	PROPN
cana-5161	310	4	/	/	SYM
cana-5161	310	5	cox	cox	PROPN
cana-5161	310	6	pathways	pathway	NOUN
cana-5161	310	7	in	in	ADP
cana-5161	310	8	3‐	3‐	NUM
cana-5161	310	9	nitropropionic	nitropropionic	ADJ
cana-5161	310	10	acid‐induced	acid‐induce	VERB
cana-5161	310	11	huntington	huntington	PROPN
cana-5161	310	12	's	's	PART
cana-5161	310	13	disease‐like	disease‐like	ADJ
cana-5161	310	14	symptoms	symptom	NOUN
cana-5161	310	15	in	in	ADP
cana-5161	310	16	rats	rat	NOUN
cana-5161	310	17	:	:	PUNCT
cana-5161	310	18	protective	protective	ADJ
cana-5161	310	19	effect	effect	NOUN
cana-5161	310	20	of	of	ADP
cana-5161	310	21	licofelone	licofelone	NOUN
cana-5161	310	22	.	.	PUNCT
cana-5161	311	1	british	british	PROPN
cana-5161	311	2	journal	journal	PROPN
cana-5161	311	3	of	of	ADP
cana-5161	311	4	pharmacology	pharmacology	NOUN
cana-5161	311	5	,	,	PUNCT
cana-5161	311	6	164	164	NUM
cana-5161	311	7	,	,	PUNCT
cana-5161	311	8	644	644	NUM
cana-5161	311	9	-	-	SYM
cana-5161	311	10	654	654	NUM
cana-5161	311	11	.	.	PUNCT
cana-5161	312	1	[	[	X
cana-5161	312	2	21	21	NUM
cana-5161	312	3	]	]	X
cana-5161	312	4	kumar	kumar	PROPN
cana-5161	312	5	,	,	PUNCT
cana-5161	312	6	v.	v.	PROPN
cana-5161	312	7	,	,	PUNCT
cana-5161	312	8	bal	bal	PROPN
cana-5161	312	9	,	,	PUNCT
cana-5161	312	10	a.	a.	PROPN
cana-5161	312	11	&	&	CCONJ
cana-5161	312	12	gill	gill	PROPN
cana-5161	312	13	,	,	PUNCT
cana-5161	312	14	k.	k.	PROPN
cana-5161	312	15	d.	d.	PROPN
cana-5161	312	16	2009	2009	NUM
cana-5161	312	17	.	.	PUNCT
cana-5161	312	18	susceptibility	susceptibility	NOUN
cana-5161	312	19	of	of	ADP
cana-5161	312	20	mitochondrial	mitochondrial	ADJ
cana-5161	312	21	superoxide	superoxide	NOUN
cana-5161	312	22	dismutase	dismutase	NOUN
cana-5161	312	23	to	to	ADP
cana-5161	312	24	aluminium	aluminium	NOUN
cana-5161	312	25	induced	induce	VERB
cana-5161	312	26	oxidative	oxidative	ADJ
cana-5161	312	27	damage	damage	NOUN
cana-5161	312	28	.	.	PUNCT
cana-5161	313	1	toxicology	toxicology	NOUN
cana-5161	313	2	,	,	PUNCT
cana-5161	313	3	255	255	NUM
cana-5161	313	4	,	,	PUNCT
cana-5161	313	5	117	117	NUM
cana-5161	313	6	-	-	SYM
cana-5161	313	7	123	123	NUM
cana-5161	313	8	.	.	PUNCT
cana-5161	314	1	[	[	X
cana-5161	314	2	22	22	NUM
cana-5161	314	3	]	]	PUNCT
cana-5161	314	4	lakshmi	lakshmi	NOUN
cana-5161	314	5	,	,	PUNCT
cana-5161	314	6	b.	b.	PROPN
cana-5161	314	7	,	,	PUNCT
cana-5161	314	8	sudhakar	sudhakar	PROPN
cana-5161	314	9	,	,	PUNCT
cana-5161	314	10	m.	m.	NOUN
cana-5161	314	11	&	&	CCONJ
cana-5161	314	12	prakash	prakash	PROPN
cana-5161	314	13	,	,	PUNCT
cana-5161	314	14	k.	k.	PROPN
cana-5161	314	15	s.	s.	PROPN
cana-5161	314	16	2015	2015	NUM
cana-5161	314	17	.	.	PUNCT
cana-5161	315	1	protective	protective	ADJ
cana-5161	315	2	effect	effect	NOUN
cana-5161	315	3	of	of	ADP
cana-5161	315	4	selenium	selenium	NOUN
cana-5161	315	5	against	against	ADP
cana-5161	315	6	aluminum	aluminum	NOUN
cana-5161	315	7	chloride	chloride	NOUN
cana-5161	315	8	-	-	PUNCT
cana-5161	315	9	induced	induce	VERB
cana-5161	315	10	alzheimer	alzheimer	NOUN
cana-5161	315	11	’s	’s	PART
cana-5161	315	12	disease	disease	NOUN
cana-5161	315	13	:	:	PUNCT
cana-5161	315	14	behavioral	behavioral	ADJ
cana-5161	315	15	and	and	CCONJ
cana-5161	315	16	biochemical	biochemical	ADJ
cana-5161	315	17	alterations	alteration	NOUN
cana-5161	315	18	in	in	ADP
cana-5161	315	19	rats	rat	NOUN
cana-5161	315	20	.	.	PUNCT
cana-5161	316	1	biological	biological	ADJ
cana-5161	316	2	trace	trace	NOUN
cana-5161	316	3	element	element	NOUN
cana-5161	316	4	research	research	NOUN
cana-5161	316	5	,	,	PUNCT
cana-5161	316	6	165	165	NUM
cana-5161	316	7	,	,	PUNCT
cana-5161	316	8	67	67	NUM
cana-5161	316	9	-	-	SYM
cana-5161	316	10	74	74	NUM
cana-5161	316	11	.	.	PUNCT
cana-5161	317	1	[	[	X
cana-5161	317	2	23	23	NUM
cana-5161	317	3	]	]	SYM
cana-5161	317	4	li	li	PROPN
cana-5161	317	5	,	,	PUNCT
cana-5161	317	6	y.	y.	PROPN
cana-5161	317	7	f.	f.	PROPN
cana-5161	317	8	,	,	PUNCT
cana-5161	317	9	gong	gong	PROPN
cana-5161	317	10	,	,	PUNCT
cana-5161	317	11	z.	z.	PROPN
cana-5161	317	12	h.	h.	PROPN
cana-5161	317	13	,	,	PUNCT
cana-5161	317	14	cao	cao	PROPN
cana-5161	317	15	,	,	PUNCT
cana-5161	317	16	j.	j.	PROPN
cana-5161	317	17	b.	b.	PROPN
cana-5161	317	18	,	,	PUNCT
cana-5161	317	19	wang	wang	PROPN
cana-5161	317	20	,	,	PUNCT
cana-5161	317	21	h.	h.	PROPN
cana-5161	317	22	l.	l.	PROPN
cana-5161	317	23	,	,	PUNCT
cana-5161	317	24	luo	luo	PROPN
cana-5161	317	25	,	,	PUNCT
cana-5161	317	26	z.	z.	PROPN
cana-5161	317	27	p.	p.	PROPN
cana-5161	317	28	&	&	CCONJ
cana-5161	317	29	li	li	PROPN
cana-5161	317	30	,	,	PUNCT
cana-5161	317	31	j.	j.	PROPN
cana-5161	317	32	2003	2003	NUM
cana-5161	317	33	.	.	PUNCT
cana-5161	318	1	antidepressantlike	antidepressantlike	INTJ
cana-5161	318	2	effect	effect	NOUN
cana-5161	318	3	of	of	ADP
cana-5161	318	4	agmatine	agmatine	NOUN
cana-5161	318	5	and	and	CCONJ
cana-5161	318	6	its	its	PRON
cana-5161	318	7	possible	possible	ADJ
cana-5161	318	8	mechanism	mechanism	NOUN
cana-5161	318	9	.	.	PUNCT
cana-5161	319	1	european	european	PROPN
cana-5161	319	2	journal	journal	PROPN
cana-5161	319	3	of	of	ADP
cana-5161	319	4	pharmacology	pharmacology	NOUN
cana-5161	319	5	,	,	PUNCT
cana-5161	319	6	469	469	NUM
cana-5161	319	7	,	,	PUNCT
cana-5161	319	8	81	81	NUM
cana-5161	319	9	-	-	SYM
cana-5161	319	10	88	88	NUM
cana-5161	319	11	.	.	PUNCT
cana-5161	320	1	[	[	X
cana-5161	320	2	24	24	NUM
cana-5161	320	3	]	]	PUNCT
cana-5161	320	4	lowry	lowry	NOUN
cana-5161	320	5	,	,	PUNCT
cana-5161	320	6	o.	o.	NOUN
cana-5161	320	7	,	,	PUNCT
cana-5161	320	8	rosebrough	rosebrough	NOUN
cana-5161	320	9	,	,	PUNCT
cana-5161	320	10	n.	n.	NOUN
cana-5161	320	11	,	,	PUNCT
cana-5161	320	12	farr	farr	PROPN
cana-5161	320	13	,	,	PUNCT
cana-5161	320	14	a.	a.	PROPN
cana-5161	320	15	&	&	CCONJ
cana-5161	320	16	randall	randall	PROPN
cana-5161	320	17	,	,	PUNCT
cana-5161	320	18	r.	r.	PROPN
cana-5161	320	19	1951	1951	NUM
cana-5161	320	20	.	.	PUNCT
cana-5161	321	1	protein	protein	NOUN
cana-5161	321	2	measurement	measurement	NOUN
cana-5161	321	3	with	with	ADP
cana-5161	321	4	the	the	DET
cana-5161	321	5	folin	folin	PROPN
cana-5161	321	6	phenol	phenol	NOUN
cana-5161	321	7	reagent	reagent	ADJ
cana-5161	321	8	j	j	PROPN
cana-5161	321	9	biol	biol	PROPN
cana-5161	321	10	chem	chem	NOUN
cana-5161	321	11	193	193	NUM
cana-5161	321	12	:	:	PUNCT
cana-5161	321	13	265–275	265–275	NUM
cana-5161	321	14	.	.	PUNCT
cana-5161	322	1	find	find	VERB
cana-5161	322	2	this	this	DET
cana-5161	322	3	article	article	NOUN
cana-5161	322	4	online	online	ADV
cana-5161	322	5	.	.	PUNCT
cana-5161	323	1	[	[	X
cana-5161	323	2	25	25	NUM
cana-5161	323	3	]	]	PUNCT
cana-5161	323	4	moretti	moretti	PROPN
cana-5161	323	5	,	,	PUNCT
cana-5161	323	6	m.	m.	NOUN
cana-5161	323	7	,	,	PUNCT
cana-5161	323	8	matheus	matheus	PROPN
cana-5161	323	9	,	,	PUNCT
cana-5161	323	10	f.	f.	PROPN
cana-5161	323	11	c.	c.	PROPN
cana-5161	323	12	,	,	PUNCT
cana-5161	323	13	de	de	PROPN
cana-5161	323	14	oliveira	oliveira	PROPN
cana-5161	323	15	,	,	PUNCT
cana-5161	323	16	p.	p.	NOUN
cana-5161	323	17	a.	a.	NOUN
cana-5161	323	18	,	,	PUNCT
cana-5161	323	19	neis	neis	PROPN
cana-5161	323	20	,	,	PUNCT
cana-5161	323	21	v.	v.	PROPN
cana-5161	323	22	b.	b.	PROPN
cana-5161	323	23	,	,	PUNCT
cana-5161	323	24	ben	ben	PROPN
cana-5161	323	25	,	,	PUNCT
cana-5161	323	26	j.	j.	PROPN
cana-5161	323	27	,	,	PUNCT
cana-5161	323	28	walz	walz	PROPN
cana-5161	323	29	,	,	PUNCT
cana-5161	323	30	r.	r.	PROPN
cana-5161	323	31	,	,	PUNCT
cana-5161	323	32	rodrigues	rodrigues	PROPN
cana-5161	323	33	,	,	PUNCT
cana-5161	323	34	a.	a.	PROPN
cana-5161	323	35	l.	l.	PROPN
cana-5161	323	36	s.	s.	PROPN
cana-5161	323	37	&	&	CCONJ
cana-5161	323	38	prediger	prediger	PROPN
cana-5161	323	39	,	,	PUNCT
cana-5161	323	40	r.	r.	PROPN
cana-5161	323	41	d.	d.	PROPN
cana-5161	323	42	2014	2014	NUM
cana-5161	323	43	.	.	PUNCT
cana-5161	323	44	1	1	NUM
cana-5161	323	45	departamento	departamento	NOUN
cana-5161	323	46	de	de	PROPN
cana-5161	323	47	farmacologia	farmacologia	NOUN
cana-5161	323	48	,	,	PUNCT
cana-5161	323	49	centro	centro	PROPN
cana-5161	323	50	de	de	PROPN
cana-5161	323	51	ciencias	ciencias	PROPN
cana-5161	323	52	biologicas	biologicas	PROPN
cana-5161	323	53	,	,	PUNCT
cana-5161	323	54	universidade	universidade	PROPN
cana-5161	323	55	federal	federal	PROPN
cana-5161	323	56	de	de	PROPN
cana-5161	323	57	santa	santa	PROPN
cana-5161	323	58	catarina	catarina	PROPN
cana-5161	323	59	,	,	PUNCT
cana-5161	323	60	ufsc	ufsc	PROPN
cana-5161	323	61	,	,	PUNCT
cana-5161	323	62	florianopolis	florianopolis	PROPN
cana-5161	323	63	,	,	PUNCT
cana-5161	323	64	sc	sc	PROPN
cana-5161	323	65	,	,	PUNCT
cana-5161	323	66	brazil	brazil	PROPN
cana-5161	323	67	,	,	PUNCT
cana-5161	323	68	2	2	NUM
cana-5161	323	69	departamento	departamento	PROPN
cana-5161	323	70	de	de	PROPN
cana-5161	323	71	clinica	clinica	PROPN
cana-5161	323	72	medica	medica	PROPN
cana-5161	323	73	,	,	PUNCT
cana-5161	323	74	hospital	hospital	NOUN
cana-5161	323	75	universitario	universitario	NOUN
cana-5161	323	76	,	,	PUNCT
cana-5161	323	77	universidade	universidade	PROPN
cana-5161	323	78	federal	federal	PROPN
cana-5161	323	79	de	de	PROPN
cana-5161	323	80	santa	santa	PROPN
cana-5161	323	81	catarina	catarina	PROPN
cana-5161	323	82	,	,	PUNCT
cana-5161	323	83	ufsc	ufsc	PROPN
cana-5161	323	84	,	,	PUNCT
cana-5161	323	85	florianopolis	florianopolis	PROPN
cana-5161	323	86	,	,	PUNCT
cana-5161	323	87	sc	sc	PROPN
cana-5161	323	88	,	,	PUNCT
cana-5161	323	89	brazil	brazil	PROPN
cana-5161	323	90	,	,	PUNCT
cana-5161	323	91	3	3	NUM
cana-5161	323	92	departamento	departamento	PROPN
cana-5161	323	93	de	de	PROPN
cana-5161	323	94	bioquimica	bioquimica	PROPN
cana-5161	323	95	,	,	PUNCT
cana-5161	323	96	centro	centro	PROPN
cana-5161	323	97	de	de	PROPN
cana-5161	323	98	ciencias	ciencias	PROPN
cana-5161	323	99	biologicas	biologicas	PROPN
cana-5161	323	100	,	,	PUNCT
cana-5161	323	101	universidade	universidade	PROPN
cana-5161	323	102	federal	federal	PROPN
cana-5161	323	103	de	de	PROPN
cana-5161	323	104	santa	santa	PROPN
cana-5161	323	105	catarina	catarina	PROPN
cana-5161	323	106	,	,	PUNCT
cana-5161	323	107	ufsc	ufsc	PROPN
cana-5161	323	108	,	,	PUNCT
cana-5161	323	109	florianopolis	florianopolis	PROPN
cana-5161	323	110	,	,	PUNCT
cana-5161	323	111	sc	sc	PROPN
cana-5161	323	112	,	,	PUNCT
cana-5161	323	113	brazil	brazil	PROPN
cana-5161	323	114	.	.	PUNCT
cana-5161	324	1	frontiers	frontier	NOUN
cana-5161	324	2	in	in	ADP
cana-5161	324	3	bioscience	bioscience	NOUN
cana-5161	324	4	,	,	PUNCT
cana-5161	324	5	6	6	NUM
cana-5161	324	6	,	,	PUNCT
cana-5161	324	7	341	341	NUM
cana-5161	324	8	-	-	SYM
cana-5161	324	9	359	359	NUM
cana-5161	324	10	.	.	PUNCT
cana-5161	325	1	[	[	X
cana-5161	325	2	26	26	NUM
cana-5161	325	3	]	]	X
cana-5161	325	4	morris	morris	PROPN
cana-5161	325	5	,	,	PUNCT
cana-5161	325	6	r.	r.	PROPN
cana-5161	325	7	1984	1984	NUM
cana-5161	325	8	.	.	PUNCT
cana-5161	326	1	developments	development	NOUN
cana-5161	326	2	of	of	ADP
cana-5161	326	3	a	a	DET
cana-5161	326	4	water	water	NOUN
cana-5161	326	5	-	-	PUNCT
cana-5161	326	6	maze	maze	NOUN
cana-5161	326	7	procedure	procedure	NOUN
cana-5161	326	8	for	for	ADP
cana-5161	326	9	studying	study	VERB
cana-5161	326	10	spatial	spatial	ADJ
cana-5161	326	11	learning	learning	NOUN
cana-5161	326	12	in	in	ADP
cana-5161	326	13	the	the	DET
cana-5161	326	14	rat	rat	PROPN
cana-5161	326	15	.	.	PROPN
cana-5161	326	16	journal	journal	PROPN
cana-5161	326	17	of	of	ADP
cana-5161	326	18	neuroscience	neuroscience	NOUN
cana-5161	326	19	methods	method	NOUN
cana-5161	326	20	,	,	PUNCT
cana-5161	326	21	11	11	NUM
cana-5161	326	22	,	,	PUNCT
cana-5161	326	23	47	47	NUM
cana-5161	326	24	-	-	SYM
cana-5161	326	25	60	60	NUM
cana-5161	326	26	.	.	PUNCT
cana-5161	327	1	[	[	X
cana-5161	327	2	27	27	NUM
cana-5161	327	3	]	]	X
cana-5161	327	4	nampoothiri	nampoothiri	NOUN
cana-5161	327	5	,	,	PUNCT
cana-5161	327	6	m.	m.	NOUN
cana-5161	327	7	,	,	PUNCT
cana-5161	327	8	john	john	PROPN
cana-5161	327	9	,	,	PUNCT
cana-5161	327	10	j.	j.	PROPN
cana-5161	327	11	,	,	PUNCT
cana-5161	327	12	kumar	kumar	PROPN
cana-5161	327	13	,	,	PUNCT
cana-5161	327	14	n.	n.	PROPN
cana-5161	327	15	,	,	PUNCT
cana-5161	327	16	mudgal	mudgal	PROPN
cana-5161	327	17	,	,	PUNCT
cana-5161	327	18	j.	j.	PROPN
cana-5161	327	19	,	,	PUNCT
cana-5161	327	20	nampurath	nampurath	PROPN
cana-5161	327	21	,	,	PUNCT
cana-5161	327	22	g.	g.	PROPN
cana-5161	327	23	k.	k.	PROPN
cana-5161	327	24	&	&	CCONJ
cana-5161	327	25	chamallamudi	chamallamudi	PROPN
cana-5161	327	26	,	,	PUNCT
cana-5161	327	27	m.	m.	PROPN
cana-5161	327	28	r.	r.	PROPN
cana-5161	327	29	2015	2015	NUM
cana-5161	327	30	.	.	PUNCT
cana-5161	328	1	modulatory	modulatory	ADJ
cana-5161	328	2	role	role	NOUN
cana-5161	328	3	of	of	ADP
cana-5161	328	4	simvastatin	simvastatin	NOUN
cana-5161	328	5	against	against	ADP
cana-5161	328	6	aluminium	aluminium	NOUN
cana-5161	328	7	chlorideinduced	chlorideinduce	VERB
cana-5161	328	8	behavioural	behavioural	ADJ
cana-5161	328	9	and	and	CCONJ
cana-5161	328	10	biochemical	biochemical	ADJ
cana-5161	328	11	changes	change	NOUN
cana-5161	328	12	in	in	ADP
cana-5161	328	13	rats	rat	NOUN
cana-5161	328	14	.	.	PUNCT
cana-5161	329	1	behavioural	behavioural	ADJ
cana-5161	329	2	neurology	neurology	NOUN
cana-5161	329	3	,	,	PUNCT
cana-5161	329	4	2015	2015	NUM
cana-5161	329	5	.	.	PUNCT
cana-5161	330	1	[	[	X
cana-5161	330	2	28	28	NUM
cana-5161	330	3	]	]	X
cana-5161	330	4	newairy	newairy	NOUN
cana-5161	330	5	,	,	PUNCT
cana-5161	330	6	a.-s	a.-	NOUN
cana-5161	330	7	.	.	PUNCT
cana-5161	331	1	a.	a.	NOUN
cana-5161	331	2	,	,	PUNCT
cana-5161	331	3	salama	salama	PROPN
cana-5161	331	4	,	,	PUNCT
cana-5161	331	5	a.	a.	PROPN
cana-5161	331	6	f.	f.	PROPN
cana-5161	331	7	,	,	PUNCT
cana-5161	331	8	hussien	hussien	PROPN
cana-5161	331	9	,	,	PUNCT
cana-5161	331	10	h.	h.	PROPN
cana-5161	331	11	m.	m.	PROPN
cana-5161	331	12	&	&	CCONJ
cana-5161	331	13	yousef	yousef	PROPN
cana-5161	331	14	,	,	PUNCT
cana-5161	331	15	m.	m.	NOUN
cana-5161	331	16	i.	i.	PROPN
cana-5161	331	17	2009	2009	NUM
cana-5161	331	18	.	.	PUNCT
cana-5161	332	1	propolis	propoli	NOUN
cana-5161	332	2	alleviates	alleviate	VERB
cana-5161	332	3	aluminium	aluminium	NOUN
cana-5161	332	4	-	-	PUNCT
cana-5161	332	5	induced	induce	VERB
cana-5161	332	6	lipid	lipid	NOUN
cana-5161	332	7	peroxidation	peroxidation	NOUN
cana-5161	332	8	and	and	CCONJ
cana-5161	332	9	biochemical	biochemical	ADJ
cana-5161	332	10	parameters	parameter	NOUN
cana-5161	332	11	in	in	ADP
cana-5161	332	12	male	male	ADJ
cana-5161	332	13	rats	rat	NOUN
cana-5161	332	14	.	.	PUNCT
cana-5161	333	1	food	food	NOUN
cana-5161	333	2	and	and	CCONJ
cana-5161	333	3	chemical	chemical	NOUN
cana-5161	333	4	toxicology	toxicology	NOUN
cana-5161	333	5	,	,	PUNCT
cana-5161	333	6	47	47	NUM
cana-5161	333	7	,	,	PUNCT
cana-5161	333	8	1093	1093	NUM
cana-5161	333	9	-	-	SYM
cana-5161	333	10	1098	1098	NUM
cana-5161	333	11	.	.	PUNCT
cana-5161	334	1	[	[	X
cana-5161	334	2	29	29	NUM
cana-5161	334	3	]	]	X
cana-5161	334	4	perry	perry	PROPN
cana-5161	334	5	,	,	PUNCT
cana-5161	334	6	g.	g.	PROPN
cana-5161	334	7	,	,	PUNCT
cana-5161	334	8	cash	cash	NOUN
cana-5161	334	9	,	,	PUNCT
cana-5161	334	10	a.	a.	PROPN
cana-5161	334	11	d.	d.	PROPN
cana-5161	334	12	&	&	CCONJ
cana-5161	334	13	smith	smith	PROPN
cana-5161	334	14	,	,	PUNCT
cana-5161	334	15	m.	m.	NOUN
cana-5161	334	16	a.	a.	PROPN
cana-5161	334	17	2002	2002	NUM
cana-5161	334	18	.	.	PUNCT
cana-5161	334	19	alzheimer	alzheimer	PROPN
cana-5161	334	20	disease	disease	NOUN
cana-5161	334	21	and	and	CCONJ
cana-5161	334	22	oxidative	oxidative	ADJ
cana-5161	334	23	stress	stress	NOUN
cana-5161	334	24	.	.	PUNCT
cana-5161	334	25	biomed	biome	VERB
cana-5161	334	26	research	research	NOUN
cana-5161	334	27	international	international	PROPN
cana-5161	334	28	,	,	PUNCT
cana-5161	334	29	2	2	NUM
cana-5161	334	30	,	,	PUNCT
cana-5161	334	31	120	120	NUM
cana-5161	334	32	-	-	SYM
cana-5161	334	33	123	123	NUM
cana-5161	334	34	.	.	PUNCT
cana-5161	335	1	communications	communication	NOUN
cana-5161	335	2	on	on	ADP
cana-5161	335	3	applied	apply	VERB
cana-5161	335	4	nonlinear	nonlinear	ADJ
cana-5161	335	5	analysis	analysis	NOUN
cana-5161	335	6	issn	issn	NOUN
cana-5161	335	7	:	:	PUNCT
cana-5161	335	8	1074	1074	NUM
cana-5161	335	9	-	-	PUNCT
cana-5161	335	10	133x	133x	NUM
cana-5161	335	11	vol	vol	NOUN
cana-5161	335	12	32	32	NUM
cana-5161	335	13	no	no	NOUN
cana-5161	335	14	.	.	PUNCT
cana-5161	336	1	icmasd	icmasd	NOUN
cana-5161	336	2	(	(	PUNCT
cana-5161	336	3	2025	2025	NUM
cana-5161	336	4	)	)	PUNCT
cana-5161	336	5	1369	1369	NUM
cana-5161	336	6	https://internationalpubls.com	https://internationalpubls.com	X
cana-5161	337	1	[	[	X
cana-5161	337	2	30	30	NUM
cana-5161	337	3	]	]	X
cana-5161	337	4	pitsikas	pitsikas	NOUN
cana-5161	337	5	,	,	PUNCT
cana-5161	337	6	n.	n.	NOUN
cana-5161	337	7	,	,	PUNCT
cana-5161	337	8	rigamonti	rigamonti	PROPN
cana-5161	337	9	,	,	PUNCT
cana-5161	337	10	a.	a.	PROPN
cana-5161	337	11	e.	e.	PROPN
cana-5161	337	12	,	,	PUNCT
cana-5161	337	13	cella	cella	PROPN
cana-5161	337	14	,	,	PUNCT
cana-5161	337	15	s.	s.	PROPN
cana-5161	337	16	g.	g.	PROPN
cana-5161	337	17	,	,	PUNCT
cana-5161	337	18	locatelli	locatelli	NOUN
cana-5161	337	19	,	,	PUNCT
cana-5161	337	20	v.	v.	ADV
cana-5161	337	21	,	,	PUNCT
cana-5161	337	22	sala	sala	PROPN
cana-5161	337	23	,	,	PUNCT
cana-5161	337	24	m.	m.	NOUN
cana-5161	337	25	&	&	CCONJ
cana-5161	337	26	muller	muller	PROPN
cana-5161	337	27	,	,	PUNCT
cana-5161	337	28	e.	e.	PROPN
cana-5161	337	29	e.	e.	PROPN
cana-5161	337	30	2001	2001	PROPN
cana-5161	337	31	.	.	PUNCT
cana-5161	338	1	effects	effect	NOUN
cana-5161	338	2	of	of	ADP
cana-5161	338	3	molsidomine	molsidomine	NOUN
cana-5161	338	4	on	on	ADP
cana-5161	338	5	scopolamine	scopolamine	NOUN
cana-5161	338	6	-	-	PUNCT
cana-5161	338	7	induced	induce	VERB
cana-5161	338	8	amnesia	amnesia	NOUN
cana-5161	338	9	and	and	CCONJ
cana-5161	338	10	hypermotility	hypermotility	NOUN
cana-5161	338	11	in	in	ADP
cana-5161	338	12	the	the	DET
cana-5161	338	13	rat	rat	NOUN
cana-5161	338	14	.	.	PROPN
cana-5161	338	15	european	european	PROPN
cana-5161	338	16	journal	journal	PROPN
cana-5161	338	17	of	of	ADP
cana-5161	338	18	pharmacology	pharmacology	NOUN
cana-5161	338	19	,	,	PUNCT
cana-5161	338	20	426	426	NUM
cana-5161	338	21	,	,	PUNCT
cana-5161	338	22	193	193	NUM
cana-5161	338	23	-	-	SYM
cana-5161	338	24	200	200	NUM
cana-5161	338	25	.	.	PUNCT
cana-5161	339	1	[	[	X
cana-5161	339	2	31	31	NUM
cana-5161	339	3	]	]	SYM
cana-5161	339	4	santos	santo	NOUN
cana-5161	339	5	,	,	PUNCT
cana-5161	339	6	a.	a.	PROPN
cana-5161	339	7	r.	r.	PROPN
cana-5161	339	8	,	,	PUNCT
cana-5161	339	9	gadotti	gadotti	NOUN
cana-5161	339	10	,	,	PUNCT
cana-5161	339	11	v.	v.	ADP
cana-5161	339	12	m.	m.	NOUN
cana-5161	339	13	,	,	PUNCT
cana-5161	339	14	oliveira	oliveira	PROPN
cana-5161	339	15	,	,	PUNCT
cana-5161	339	16	g.	g.	PROPN
cana-5161	339	17	l.	l.	PROPN
cana-5161	339	18	,	,	PUNCT
cana-5161	339	19	tibola	tibola	PROPN
cana-5161	339	20	,	,	PUNCT
cana-5161	339	21	d.	d.	PROPN
cana-5161	339	22	,	,	PUNCT
cana-5161	339	23	paszcuk	paszcuk	NOUN
cana-5161	339	24	,	,	PUNCT
cana-5161	339	25	a.	a.	PROPN
cana-5161	339	26	f.	f.	PROPN
cana-5161	339	27	,	,	PUNCT
cana-5161	339	28	neto	neto	PROPN
cana-5161	339	29	,	,	PUNCT
cana-5161	339	30	a.	a.	NOUN
cana-5161	339	31	,	,	PUNCT
cana-5161	339	32	spindola	spindola	PROPN
cana-5161	339	33	,	,	PUNCT
cana-5161	339	34	h.	h.	PROPN
cana-5161	339	35	m.	m.	PROPN
cana-5161	339	36	,	,	PUNCT
cana-5161	339	37	souza	souza	PROPN
cana-5161	339	38	,	,	PUNCT
cana-5161	339	39	m.	m.	NOUN
cana-5161	339	40	m.	m.	NOUN
cana-5161	339	41	,	,	PUNCT
cana-5161	339	42	rodrigues	rodrigues	PROPN
cana-5161	339	43	,	,	PUNCT
cana-5161	339	44	a.	a.	PROPN
cana-5161	339	45	l.	l.	PROPN
cana-5161	339	46	s.	s.	PROPN
cana-5161	339	47	&	&	CCONJ
cana-5161	339	48	calixto	calixto	PROPN
cana-5161	339	49	,	,	PUNCT
cana-5161	339	50	j.	j.	PROPN
cana-5161	339	51	b.	b.	PROPN
cana-5161	339	52	2005	2005	NUM
cana-5161	339	53	.	.	PUNCT
cana-5161	340	1	mechanisms	mechanism	NOUN
cana-5161	340	2	involved	involve	VERB
cana-5161	340	3	in	in	ADP
cana-5161	340	4	the	the	DET
cana-5161	340	5	antinociception	antinociception	NOUN
cana-5161	340	6	caused	cause	VERB
cana-5161	340	7	by	by	ADP
cana-5161	340	8	agmatine	agmatine	NOUN
cana-5161	340	9	in	in	ADP
cana-5161	340	10	mice	mouse	NOUN
cana-5161	340	11	.	.	PUNCT
cana-5161	341	1	neuropharmacology	neuropharmacology	NOUN
cana-5161	341	2	,	,	PUNCT
cana-5161	341	3	48	48	NUM
cana-5161	341	4	,	,	PUNCT
cana-5161	341	5	1021	1021	NUM
cana-5161	341	6	-	-	SYM
cana-5161	341	7	1034	1034	NUM
cana-5161	341	8	.	.	PUNCT
cana-5161	342	1	[	[	X
cana-5161	342	2	32	32	NUM
cana-5161	342	3	]	]	PUNCT
cana-5161	342	4	schafer	schafer	NOUN
cana-5161	342	5	,	,	PUNCT
cana-5161	342	6	u.	u.	PROPN
cana-5161	342	7	&	&	CCONJ
cana-5161	342	8	seifert	seifert	PROPN
cana-5161	342	9	,	,	PUNCT
cana-5161	342	10	m.	m.	NOUN
cana-5161	342	11	2006	2006	NUM
cana-5161	342	12	.	.	PUNCT
cana-5161	343	1	oral	oral	ADJ
cana-5161	343	2	intake	intake	NOUN
cana-5161	343	3	of	of	ADP
cana-5161	343	4	aluminum	aluminum	NOUN
cana-5161	343	5	from	from	ADP
cana-5161	343	6	foodstuffs	foodstuff	NOUN
cana-5161	343	7	,	,	PUNCT
cana-5161	343	8	food	food	NOUN
cana-5161	343	9	additives	additive	NOUN
cana-5161	343	10	,	,	PUNCT
cana-5161	343	11	food	food	NOUN
cana-5161	343	12	packaging	packaging	NOUN
cana-5161	343	13	,	,	PUNCT
cana-5161	343	14	cookware	cookware	NOUN
cana-5161	343	15	and	and	CCONJ
cana-5161	343	16	pharmaceutical	pharmaceutical	ADJ
cana-5161	343	17	preparations	preparation	NOUN
cana-5161	343	18	with	with	ADP
cana-5161	343	19	respect	respect	NOUN
cana-5161	343	20	to	to	ADP
cana-5161	343	21	dietary	dietary	ADJ
cana-5161	343	22	regulations	regulation	NOUN
cana-5161	343	23	.	.	PUNCT
cana-5161	344	1	trace	trace	NOUN
cana-5161	344	2	elements	element	NOUN
cana-5161	344	3	and	and	CCONJ
cana-5161	344	4	electrolytes	electrolyte	NOUN
cana-5161	344	5	,	,	PUNCT
cana-5161	344	6	23	23	NUM
cana-5161	344	7	,	,	PUNCT
cana-5161	344	8	150	150	NUM
cana-5161	344	9	.	.	PUNCT
cana-5161	345	1	[	[	X
cana-5161	345	2	33	33	NUM
cana-5161	345	3	]	]	X
cana-5161	345	4	sethi	sethi	PROPN
cana-5161	345	5	,	,	PUNCT
cana-5161	345	6	p.	p.	PROPN
cana-5161	345	7	,	,	PUNCT
cana-5161	345	8	jyoti	jyoti	PROPN
cana-5161	345	9	,	,	PUNCT
cana-5161	345	10	a.	a.	PROPN
cana-5161	345	11	,	,	PUNCT
cana-5161	345	12	singh	singh	PROPN
cana-5161	345	13	,	,	PUNCT
cana-5161	345	14	r.	r.	PROPN
cana-5161	345	15	,	,	PUNCT
cana-5161	345	16	hussain	hussain	PROPN
cana-5161	345	17	,	,	PUNCT
cana-5161	345	18	e.	e.	PROPN
cana-5161	345	19	&	&	CCONJ
cana-5161	345	20	sharma	sharma	PROPN
cana-5161	345	21	,	,	PUNCT
cana-5161	345	22	d.	d.	PROPN
cana-5161	345	23	2008	2008	NUM
cana-5161	345	24	.	.	PUNCT
cana-5161	346	1	aluminium	aluminium	NOUN
cana-5161	346	2	-	-	PUNCT
cana-5161	346	3	induced	induce	VERB
cana-5161	346	4	electrophysiological	electrophysiological	ADJ
cana-5161	346	5	,	,	PUNCT
cana-5161	346	6	biochemical	biochemical	ADJ
cana-5161	346	7	and	and	CCONJ
cana-5161	346	8	cognitive	cognitive	ADJ
cana-5161	346	9	modifications	modification	NOUN
cana-5161	346	10	in	in	ADP
cana-5161	346	11	the	the	DET
cana-5161	346	12	hippocampus	hippocampus	NOUN
cana-5161	346	13	of	of	ADP
cana-5161	346	14	aging	age	VERB
cana-5161	346	15	rats	rat	NOUN
cana-5161	346	16	.	.	PUNCT
cana-5161	347	1	neurotoxicology	neurotoxicology	NOUN
cana-5161	347	2	,	,	PUNCT
cana-5161	347	3	29	29	NUM
cana-5161	347	4	,	,	PUNCT
cana-5161	347	5	1069	1069	NUM
cana-5161	347	6	-	-	SYM
cana-5161	347	7	1079	1079	NUM
cana-5161	347	8	.	.	PUNCT
cana-5161	348	1	[	[	X
cana-5161	348	2	34	34	NUM
cana-5161	348	3	]	]	X
cana-5161	348	4	shuchang	shuchang	PROPN
cana-5161	348	5	,	,	PUNCT
cana-5161	348	6	h.	h.	PROPN
cana-5161	348	7	,	,	PUNCT
cana-5161	348	8	qiao	qiao	PROPN
cana-5161	348	9	,	,	PUNCT
cana-5161	348	10	n.	n.	PROPN
cana-5161	348	11	,	,	PUNCT
cana-5161	348	12	piye	piye	PROPN
cana-5161	348	13	,	,	PUNCT
cana-5161	348	14	n.	n.	PROPN
cana-5161	348	15	,	,	PUNCT
cana-5161	348	16	mingwei	mingwei	PROPN
cana-5161	348	17	,	,	PUNCT
cana-5161	348	18	h.	h.	PROPN
cana-5161	348	19	,	,	PUNCT
cana-5161	348	20	xiaoshu	xiaoshu	PROPN
cana-5161	348	21	,	,	PUNCT
cana-5161	348	22	s.	s.	PROPN
cana-5161	348	23	,	,	PUNCT
cana-5161	348	24	feng	feng	PROPN
cana-5161	348	25	,	,	PUNCT
cana-5161	348	26	s.	s.	PROPN
cana-5161	348	27	,	,	PUNCT
cana-5161	348	28	sheng	sheng	PROPN
cana-5161	348	29	,	,	PUNCT
cana-5161	348	30	w.	w.	PROPN
cana-5161	348	31	&	&	CCONJ
cana-5161	348	32	opler	opler	PROPN
cana-5161	348	33	,	,	PUNCT
cana-5161	348	34	m.	m.	NOUN
cana-5161	348	35	2008	2008	NUM
cana-5161	348	36	.	.	PUNCT
cana-5161	349	1	protective	protective	ADJ
cana-5161	349	2	effects	effect	NOUN
cana-5161	349	3	of	of	ADP
cana-5161	349	4	gastrodia	gastrodia	NOUN
cana-5161	349	5	elata	elata	NOUN
cana-5161	349	6	on	on	ADP
cana-5161	349	7	aluminium	aluminium	NOUN
cana-5161	349	8	-	-	PUNCT
cana-5161	349	9	chloride	chloride	NOUN
cana-5161	349	10	-	-	PUNCT
cana-5161	349	11	induced	induced	ADJ
cana-5161	349	12	learning	learning	NOUN
cana-5161	349	13	impairments	impairment	NOUN
cana-5161	349	14	and	and	CCONJ
cana-5161	349	15	alterations	alteration	NOUN
cana-5161	349	16	of	of	ADP
cana-5161	349	17	amino	amino	NOUN
cana-5161	349	18	acid	acid	NOUN
cana-5161	349	19	neurotransmitter	neurotransmitter	NOUN
cana-5161	349	20	release	release	NOUN
cana-5161	349	21	in	in	ADP
cana-5161	349	22	adult	adult	NOUN
cana-5161	349	23	rats	rat	NOUN
cana-5161	349	24	.	.	PUNCT
cana-5161	350	1	restorative	restorative	ADJ
cana-5161	350	2	neurology	neurology	NOUN
cana-5161	350	3	and	and	CCONJ
cana-5161	350	4	neuroscience	neuroscience	NOUN
cana-5161	350	5	,	,	PUNCT
cana-5161	350	6	26	26	NUM
cana-5161	350	7	,	,	PUNCT
cana-5161	350	8	467	467	NUM
cana-5161	350	9	-	-	SYM
cana-5161	350	10	473	473	NUM
cana-5161	350	11	.	.	PUNCT
cana-5161	351	1	[	[	X
cana-5161	351	2	35	35	NUM
cana-5161	351	3	]	]	SYM
cana-5161	351	4	song	song	NOUN
cana-5161	351	5	,	,	PUNCT
cana-5161	351	6	j.	j.	PROPN
cana-5161	351	7	,	,	PUNCT
cana-5161	351	8	hur	hur	PROPN
cana-5161	351	9	,	,	PUNCT
cana-5161	351	10	b.	b.	PROPN
cana-5161	351	11	e.	e.	PROPN
cana-5161	351	12	,	,	PUNCT
cana-5161	351	13	bokara	bokara	PROPN
cana-5161	351	14	,	,	PUNCT
cana-5161	351	15	k.	k.	PROPN
cana-5161	351	16	k.	k.	PROPN
cana-5161	351	17	,	,	PUNCT
cana-5161	351	18	yang	yang	PROPN
cana-5161	351	19	,	,	PUNCT
cana-5161	351	20	w.	w.	PROPN
cana-5161	351	21	,	,	PUNCT
cana-5161	351	22	cho	cho	PROPN
cana-5161	351	23	,	,	PUNCT
cana-5161	351	24	h.	h.	PROPN
cana-5161	351	25	j.	j.	PROPN
cana-5161	351	26	,	,	PUNCT
cana-5161	351	27	park	park	PROPN
cana-5161	351	28	,	,	PUNCT
cana-5161	351	29	k.	k.	PROPN
cana-5161	351	30	a.	a.	PROPN
cana-5161	351	31	,	,	PUNCT
cana-5161	351	32	lee	lee	PROPN
cana-5161	351	33	,	,	PUNCT
cana-5161	351	34	w.	w.	PROPN
cana-5161	351	35	t.	t.	PROPN
cana-5161	351	36	,	,	PUNCT
cana-5161	351	37	lee	lee	PROPN
cana-5161	351	38	,	,	PUNCT
cana-5161	351	39	k.	k.	PROPN
cana-5161	351	40	m.	m.	PROPN
cana-5161	351	41	&	&	CCONJ
cana-5161	351	42	lee	lee	PROPN
cana-5161	351	43	,	,	PUNCT
cana-5161	351	44	j.	j.	PROPN
cana-5161	351	45	e.	e.	PROPN
cana-5161	351	46	2014	2014	NUM
cana-5161	351	47	.	.	PUNCT
cana-5161	352	1	agmatine	agmatine	NOUN
cana-5161	352	2	improves	improve	VERB
cana-5161	352	3	cognitive	cognitive	ADJ
cana-5161	352	4	dysfunction	dysfunction	NOUN
cana-5161	352	5	and	and	CCONJ
cana-5161	352	6	prevents	prevent	VERB
cana-5161	352	7	cell	cell	NOUN
cana-5161	352	8	death	death	NOUN
cana-5161	352	9	in	in	ADP
cana-5161	352	10	a	a	DET
cana-5161	352	11	streptozotocin	streptozotocin	NOUN
cana-5161	352	12	-	-	PUNCT
cana-5161	352	13	induced	induce	VERB
cana-5161	352	14	alzheimer	alzheimer	NOUN
cana-5161	352	15	rat	rat	NOUN
cana-5161	352	16	model	model	NOUN
cana-5161	352	17	.	.	PUNCT
cana-5161	353	1	yonsei	yonsei	PROPN
cana-5161	353	2	medical	medical	PROPN
cana-5161	353	3	journal	journal	PROPN
cana-5161	353	4	,	,	PUNCT
cana-5161	353	5	55	55	NUM
cana-5161	353	6	,	,	PUNCT
cana-5161	353	7	689	689	NUM
cana-5161	353	8	-	-	SYM
cana-5161	353	9	699	699	NUM
cana-5161	353	10	.	.	PUNCT
cana-5161	354	1	[	[	X
cana-5161	354	2	36	36	NUM
cana-5161	354	3	]	]	X
cana-5161	354	4	sreekumaran	sreekumaran	ADJ
cana-5161	354	5	,	,	PUNCT
cana-5161	354	6	e.	e.	PROPN
cana-5161	354	7	&	&	CCONJ
cana-5161	354	8	ramakrishna	ramakrishna	PROPN
cana-5161	354	9	,	,	PUNCT
cana-5161	354	10	t.	t.	PROPN
cana-5161	354	11	2002	2002	NUM
cana-5161	354	12	.	.	PUNCT
cana-5161	355	1	spatial	spatial	ADJ
cana-5161	355	2	memory	memory	NOUN
cana-5161	355	3	loss	loss	NOUN
cana-5161	355	4	in	in	ADP
cana-5161	355	5	rat	rat	NOUN
cana-5161	355	6	due	due	ADP
cana-5161	355	7	to	to	ADP
cana-5161	355	8	aluminium	aluminium	NOUN
cana-5161	355	9	toxicity	toxicity	NOUN
cana-5161	355	10	is	be	AUX
cana-5161	355	11	reversed	reverse	VERB
cana-5161	355	12	by	by	ADP
cana-5161	355	13	desferrioxamine	desferrioxamine	NOUN
cana-5161	355	14	/	/	SYM
cana-5161	355	15	pyridoxine	pyridoxine	NOUN
cana-5161	355	16	.	.	PUNCT
cana-5161	356	1	alzheimer	alzheimer	PROPN
cana-5161	356	2	’s	’s	PART
cana-5161	356	3	reports	report	NOUN
cana-5161	356	4	,	,	PUNCT
cana-5161	356	5	5	5	NUM
cana-5161	356	6	,	,	PUNCT
cana-5161	356	7	25	25	NUM
cana-5161	356	8	-	-	SYM
cana-5161	356	9	28	28	NUM
cana-5161	356	10	.	.	PUNCT
cana-5161	357	1	[	[	X
cana-5161	357	2	37	37	NUM
cana-5161	357	3	]	]	SYM
cana-5161	357	4	su	su	PROPN
cana-5161	357	5	,	,	PUNCT
cana-5161	357	6	r.-b	r.-b	PROPN
cana-5161	357	7	.	.	PROPN
cana-5161	357	8	,	,	PUNCT
cana-5161	357	9	wei	wei	PROPN
cana-5161	357	10	,	,	PUNCT
cana-5161	357	11	x.-l	x.-l	PROPN
cana-5161	357	12	.	.	PUNCT
cana-5161	357	13	,	,	PUNCT
cana-5161	357	14	zheng	zheng	PROPN
cana-5161	357	15	,	,	PUNCT
cana-5161	357	16	j.-q	j.-q	PROPN
cana-5161	357	17	.	.	PROPN
cana-5161	357	18	,	,	PUNCT
cana-5161	357	19	liu	liu	PROPN
cana-5161	357	20	,	,	PUNCT
cana-5161	357	21	y.	y.	PROPN
cana-5161	357	22	,	,	PUNCT
cana-5161	357	23	lu	lu	PROPN
cana-5161	357	24	,	,	PUNCT
cana-5161	357	25	x.-q	x.-q	PROPN
cana-5161	357	26	.	.	PROPN
cana-5161	357	27	&	&	CCONJ
cana-5161	357	28	li	li	PROPN
cana-5161	357	29	,	,	PUNCT
cana-5161	357	30	j.	j.	PROPN
cana-5161	357	31	2004	2004	NUM
cana-5161	357	32	.	.	PUNCT
cana-5161	358	1	anticonvulsive	anticonvulsive	ADJ
cana-5161	358	2	effect	effect	NOUN
cana-5161	358	3	of	of	ADP
cana-5161	358	4	agmatine	agmatine	NOUN
cana-5161	358	5	in	in	ADP
cana-5161	358	6	mice	mouse	NOUN
cana-5161	358	7	.	.	PUNCT
cana-5161	359	1	pharmacology	pharmacology	NOUN
cana-5161	359	2	biochemistry	biochemistry	NOUN
cana-5161	359	3	and	and	CCONJ
cana-5161	359	4	behavior	behavior	NOUN
cana-5161	359	5	,	,	PUNCT
cana-5161	359	6	77	77	NUM
cana-5161	359	7	,	,	PUNCT
cana-5161	359	8	345	345	NUM
cana-5161	359	9	-	-	SYM
cana-5161	359	10	349	349	NUM
cana-5161	359	11	.	.	PUNCT
cana-5161	360	1	[	[	X
cana-5161	360	2	38	38	NUM
cana-5161	360	3	]	]	PUNCT
cana-5161	360	4	sun	sun	NOUN
cana-5161	360	5	,	,	PUNCT
cana-5161	360	6	z.-z	z.-z	PROPN
cana-5161	360	7	.	.	PROPN
cana-5161	360	8	,	,	PUNCT
cana-5161	360	9	chen	chen	PROPN
cana-5161	360	10	,	,	PUNCT
cana-5161	360	11	z.-b	z.-b	PROPN
cana-5161	360	12	.	.	PROPN
cana-5161	360	13	,	,	PUNCT
cana-5161	360	14	jiang	jiang	PROPN
cana-5161	360	15	,	,	PUNCT
cana-5161	360	16	h.	h.	PROPN
cana-5161	360	17	,	,	PUNCT
cana-5161	360	18	li	li	PROPN
cana-5161	360	19	,	,	PUNCT
cana-5161	360	20	l.-l	l.-l	PROPN
cana-5161	360	21	.	.	PUNCT
cana-5161	360	22	,	,	PUNCT
cana-5161	360	23	li	li	PROPN
cana-5161	360	24	,	,	PUNCT
cana-5161	360	25	e.-g	e.-g	PROPN
cana-5161	360	26	.	.	PROPN
cana-5161	360	27	&	&	CCONJ
cana-5161	360	28	xu	xu	PROPN
cana-5161	360	29	,	,	PUNCT
cana-5161	360	30	y.	y.	PROPN
cana-5161	360	31	2009	2009	NUM
cana-5161	360	32	.	.	PUNCT
cana-5161	361	1	alteration	alteration	NOUN
cana-5161	361	2	of	of	ADP
cana-5161	361	3	aβ	aβ	DET
cana-5161	361	4	metabolism	metabolism	NOUN
cana-5161	361	5	-	-	PUNCT
cana-5161	361	6	related	relate	VERB
cana-5161	361	7	molecules	molecule	NOUN
cana-5161	361	8	in	in	ADP
cana-5161	361	9	predementia	predementia	NOUN
cana-5161	361	10	induced	induce	VERB
cana-5161	361	11	by	by	ADP
cana-5161	361	12	alcl3	alcl3	PROPN
cana-5161	361	13	and	and	CCONJ
cana-5161	361	14	d	d	NOUN
cana-5161	361	15	-	-	PUNCT
cana-5161	361	16	galactose	galactose	ADJ
cana-5161	361	17	.	.	PUNCT
cana-5161	362	1	age	age	NOUN
cana-5161	362	2	,	,	PUNCT
cana-5161	362	3	31	31	NUM
cana-5161	362	4	,	,	PUNCT
cana-5161	362	5	277284	277284	NUM
cana-5161	362	6	.	.	PUNCT
cana-5161	363	1	[	[	X
cana-5161	363	2	39	39	NUM
cana-5161	363	3	]	]	X
cana-5161	363	4	tabor	tabor	NOUN
cana-5161	363	5	,	,	PUNCT
cana-5161	363	6	c.	c.	PROPN
cana-5161	363	7	w.	w.	PROPN
cana-5161	363	8	&	&	CCONJ
cana-5161	363	9	tabor	tabor	PROPN
cana-5161	363	10	,	,	PUNCT
cana-5161	363	11	h.	h.	PROPN
cana-5161	363	12	1984	1984	NUM
cana-5161	363	13	.	.	PUNCT
cana-5161	364	1	polyamines	polyamine	NOUN
cana-5161	364	2	.	.	PUNCT
cana-5161	365	1	annual	annual	ADJ
cana-5161	365	2	review	review	NOUN
cana-5161	365	3	of	of	ADP
cana-5161	365	4	biochemistry	biochemistry	NOUN
cana-5161	365	5	,	,	PUNCT
cana-5161	365	6	53	53	NUM
cana-5161	365	7	,	,	PUNCT
cana-5161	365	8	749	749	NUM
cana-5161	365	9	-	-	PUNCT
cana-5161	365	10	790	790	NUM
cana-5161	365	11	.	.	PUNCT
cana-5161	366	1	[	[	X
cana-5161	366	2	40	40	NUM
cana-5161	366	3	]	]	SYM
cana-5161	366	4	thangarajan	thangarajan	NOUN
cana-5161	366	5	,	,	PUNCT
cana-5161	366	6	s.	s.	PROPN
cana-5161	366	7	,	,	PUNCT
cana-5161	366	8	deivasigamani	deivasigamani	PROPN
cana-5161	366	9	,	,	PUNCT
cana-5161	366	10	a.	a.	PROPN
cana-5161	366	11	,	,	PUNCT
cana-5161	366	12	natarajan	natarajan	PROPN
cana-5161	366	13	,	,	PUNCT
cana-5161	366	14	s.	s.	PROPN
cana-5161	366	15	s.	s.	PROPN
cana-5161	366	16	,	,	PUNCT
cana-5161	366	17	krishnan	krishnan	PROPN
cana-5161	366	18	,	,	PUNCT
cana-5161	366	19	p.	p.	PROPN
cana-5161	366	20	&	&	CCONJ
cana-5161	366	21	mohanan	mohanan	PROPN
cana-5161	366	22	,	,	PUNCT
cana-5161	366	23	s.	s.	PROPN
cana-5161	366	24	k.	k.	PROPN
cana-5161	366	25	2014	2014	NUM
cana-5161	366	26	.	.	PUNCT
cana-5161	367	1	neuroprotective	neuroprotective	ADJ
cana-5161	367	2	activity	activity	NOUN
cana-5161	367	3	of	of	ADP
cana-5161	367	4	l	l	NOUN
cana-5161	367	5	-	-	NOUN
cana-5161	367	6	theanine	theanine	NOUN
cana-5161	367	7	on	on	ADP
cana-5161	367	8	3	3	NUM
cana-5161	367	9	-	-	ADJ
cana-5161	367	10	nitropropionic	nitropropionic	ADJ
cana-5161	367	11	acidinduced	acidinduced	ADJ
cana-5161	367	12	neurotoxicity	neurotoxicity	NOUN
cana-5161	367	13	in	in	ADP
cana-5161	367	14	rat	rat	NOUN
cana-5161	367	15	striatum	striatum	NOUN
cana-5161	367	16	.	.	PUNCT
cana-5161	368	1	international	international	ADJ
cana-5161	368	2	journal	journal	PROPN
cana-5161	368	3	of	of	ADP
cana-5161	368	4	neuroscience	neuroscience	NOUN
cana-5161	368	5	,	,	PUNCT
cana-5161	368	6	124	124	NUM
cana-5161	368	7	,	,	PUNCT
cana-5161	368	8	673	673	NUM
cana-5161	368	9	-	-	SYM
cana-5161	368	10	684	684	NUM
cana-5161	368	11	.	.	PUNCT
cana-5161	369	1	[	[	X
cana-5161	369	2	41	41	NUM
cana-5161	369	3	]	]	PUNCT
cana-5161	369	4	thirunavukkarasu	thirunavukkarasu	PROPN
cana-5161	369	5	,	,	PUNCT
cana-5161	369	6	s.	s.	PROPN
cana-5161	369	7	v.	v.	PROPN
cana-5161	369	8	,	,	PUNCT
cana-5161	369	9	venkataraman	venkataraman	PROPN
cana-5161	369	10	,	,	PUNCT
cana-5161	369	11	s.	s.	PROPN
cana-5161	369	12	,	,	PUNCT
cana-5161	369	13	raja	raja	PROPN
cana-5161	369	14	,	,	PUNCT
cana-5161	369	15	s.	s.	PROPN
cana-5161	369	16	&	&	CCONJ
cana-5161	369	17	upadhyay	upadhyay	PROPN
cana-5161	369	18	,	,	PUNCT
cana-5161	369	19	l.	l.	PROPN
cana-5161	369	20	2012	2012	NUM
cana-5161	369	21	.	.	PUNCT
cana-5161	370	1	neuroprotective	neuroprotective	ADJ
cana-5161	370	2	effect	effect	NOUN
cana-5161	370	3	of	of	ADP
cana-5161	370	4	manasamitra	manasamitra	ADJ
cana-5161	370	5	vatakam	vatakam	NOUN
cana-5161	370	6	against	against	ADP
cana-5161	370	7	aluminium	aluminium	NOUN
cana-5161	370	8	induced	induce	VERB
cana-5161	370	9	cognitive	cognitive	ADJ
cana-5161	370	10	impairment	impairment	NOUN
cana-5161	370	11	and	and	CCONJ
cana-5161	370	12	oxidative	oxidative	ADJ
cana-5161	370	13	damage	damage	NOUN
cana-5161	370	14	in	in	ADP
cana-5161	370	15	the	the	DET
cana-5161	370	16	cortex	cortex	NOUN
cana-5161	370	17	and	and	CCONJ
cana-5161	370	18	hippocampus	hippocampus	NOUN
cana-5161	370	19	of	of	ADP
cana-5161	370	20	rat	rat	NOUN
cana-5161	370	21	brain	brain	NOUN
cana-5161	370	22	.	.	PUNCT
cana-5161	371	1	drug	drug	NOUN
cana-5161	371	2	and	and	CCONJ
cana-5161	371	3	chemical	chemical	NOUN
cana-5161	371	4	toxicology	toxicology	NOUN
cana-5161	371	5	,	,	PUNCT
cana-5161	371	6	35	35	NUM
cana-5161	371	7	,	,	PUNCT
cana-5161	371	8	104	104	NUM
cana-5161	371	9	-	-	SYM
cana-5161	371	10	115	115	NUM
cana-5161	371	11	.	.	PUNCT
cana-5161	372	1	[	[	X
cana-5161	372	2	42	42	NUM
cana-5161	372	3	]	]	PUNCT
cana-5161	372	4	uzbay	uzbay	PROPN
cana-5161	372	5	,	,	PUNCT
cana-5161	372	6	i.	i.	PROPN
cana-5161	372	7	t.	t.	PROPN
cana-5161	372	8	,	,	PUNCT
cana-5161	372	9	yeşilyurt	yeşilyurt	PROPN
cana-5161	372	10	,	,	PUNCT
cana-5161	372	11	ö.	ö.	PROPN
cana-5161	372	12	,	,	PUNCT
cana-5161	372	13	çelik	çelik	NOUN
cana-5161	372	14	,	,	PUNCT
cana-5161	372	15	t.	t.	PROPN
cana-5161	372	16	,	,	PUNCT
cana-5161	372	17	ergün	ergün	PROPN
cana-5161	372	18	,	,	PUNCT
cana-5161	372	19	h.	h.	PROPN
cana-5161	372	20	&	&	CCONJ
cana-5161	372	21	işımer	işımer	PROPN
cana-5161	372	22	,	,	PUNCT
cana-5161	372	23	a.	a.	NOUN
cana-5161	372	24	2000	2000	NUM
cana-5161	372	25	.	.	PUNCT
cana-5161	373	1	effects	effect	NOUN
cana-5161	373	2	of	of	ADP
cana-5161	373	3	agmatine	agmatine	NOUN
cana-5161	373	4	on	on	ADP
cana-5161	373	5	ethanol	ethanol	NOUN
cana-5161	373	6	withdrawal	withdrawal	NOUN
cana-5161	373	7	syndrome	syndrome	NOUN
cana-5161	373	8	in	in	ADP
cana-5161	373	9	rats	rat	NOUN
cana-5161	373	10	.	.	PUNCT
cana-5161	374	1	behavioural	behavioural	ADJ
cana-5161	374	2	brain	brain	NOUN
cana-5161	374	3	research	research	NOUN
cana-5161	374	4	,	,	PUNCT
cana-5161	374	5	107	107	NUM
cana-5161	374	6	,	,	PUNCT
cana-5161	374	7	153	153	NUM
cana-5161	374	8	-	-	SYM
cana-5161	374	9	159	159	NUM
cana-5161	374	10	.	.	PUNCT
cana-5161	375	1	[	[	X
cana-5161	375	2	43	43	NUM
cana-5161	375	3	]	]	X
cana-5161	375	4	yankner	yankner	NOUN
cana-5161	375	5	,	,	PUNCT
cana-5161	375	6	b.	b.	PROPN
cana-5161	375	7	a.	a.	PROPN
cana-5161	375	8	1996	1996	NUM
cana-5161	375	9	.	.	PUNCT
cana-5161	376	1	mechanisms	mechanism	NOUN
cana-5161	376	2	of	of	ADP
cana-5161	376	3	neuronal	neuronal	ADJ
cana-5161	376	4	degeneration	degeneration	NOUN
cana-5161	376	5	in	in	ADP
cana-5161	376	6	alzheimer	alzheimer	PROPN
cana-5161	376	7	's	's	PART
cana-5161	376	8	disease	disease	NOUN
cana-5161	376	9	.	.	PUNCT
cana-5161	377	1	neuron	neuron	PROPN
cana-5161	377	2	,	,	PUNCT
cana-5161	377	3	16	16	NUM
cana-5161	377	4	,	,	PUNCT
cana-5161	377	5	921	921	NUM
cana-5161	377	6	-	-	SYM
cana-5161	377	7	932	932	NUM
cana-5161	377	8	.	.	PUNCT